{"initialLink":"https://en.wikipedia.org/wiki/Pfizer","sanitizedLink":"https://en.wikipedia.org/wiki/Pfizer","finalLink":"https://en.wikipedia.org/wiki/Pfizer","htmlEmbed":"<script>window.contexterSetup=window.contexterSetup||function(){window.contexterSetupComplete=!0;class ContexterLink extends HTMLAnchorElement{constructor(){super()}connectedCallback(){this.setAttribute(\"target\",\"_blank\")}}customElements.define(\"contexter-link\",ContexterLink,{extends:\"a\"}),customElements.define(\"contexter-inner\",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className=\"contexter-box__inner\"}}),customElements.define(\"contexter-thumbnail\",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className=\"contexter-box__thumbnail\"}}),customElements.define(\"contexter-byline\",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className=\"contexter-box__byline\"}}),customElements.define(\"contexter-keywordset\",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className=\"contexter-box__keywordset\"}}),customElements.define(\"contexter-linkset\",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className=\"contexter-box__linkset\"}}),customElements.define(\"contexter-meta\",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className=\"contexter-box__meta\"}}),customElements.define(\"contexter-summary\",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className=\"p-summary entry-summary\"}}),customElements.define(\"contexter-box-head\",class extends HTMLElement{constructor(){super()}connectedCallback(){this.className=\"contexter-box__head\"}}),customElements.define(\"contexter-box-inner\",class extends HTMLElement{constructor(){super()}connectedCallback(){}});class ContexterBox extends HTMLElement{constructor(){super(),this.first=!0,this.shadow=this.attachShadow({mode:\"open\"})}connectedCallback(){if(this.first){this.first=!1;var style=document.createElement(\"style\"),lightDomStyle=(style.innerHTML=`:host {--background: #f5f6f7;--border: darkblue;--blue: #0000ee;--font-color: black;--inner-border: black;font-family: Franklin,Arial,Helvetica,sans-serif;font-size: 14px;background: var(--background);width: 600px;color: var(--font-color);min-height: 90px;display: block;padding: 8px;border: 1px solid var(--border);cursor: pointer;box-sizing: border-box;margin: 6px;contain: content;margin: 6px auto;}// can only select top-level nodes with slotted::slotted(*) {max-width: 100%;display:block;}::slotted([slot=thumbnail]) {max-width: 100%;display:block;}::slotted([slot=header]) {width: 100%;font-size: 1.25rem;font-weight: bold;display:block;margin-bottom: 6px;}::slotted([slot=author]) {max-width: 50%;font-size: 12px;display:inline-block;float: left;}::slotted([slot=time]) {max-width: 50%;font-size: 12px;display:inline-block;float: right;}::slotted([slot=summary]) {width: 100%;margin-top: 6px;padding: 10px 2px;border-top: 1px solid var(--inner-border);font-size: 15px;display:inline-block;margin-bottom: 6px;}contexter-meta {height: auto;margin-bottom: 4px;width: 100%;display: grid;position: relative;min-height: 16px;grid-template-columns: repeat(2, 1fr);}::slotted([slot=keywords]) {width: 80%;padding: 2px 4px;border-top: 1px solid var(--inner-border);font-size: 11px;display: block;float: right;font-style: italic;text-align: right;grid-column: 2/2;grid-row: 1;align-self: end;justify-self: end;}::slotted([slot=keywords]):empty {border-top: 0px solid var(--inner-border);}::slotted([slot=archive-link]) {font-size: 1em;display: inline;}::slotted([slot=archive-link])::after {content: \"|\";display: inline;color: var(--font-color);text-decoration: none;margin: 0 .5em;}::slotted([slot=read-link]) {font-size: 1em;display: inline;}contexter-linkset {width: 80%;padding: 2px 4px;font-size: 13px;float: left;font-weight: bold;grid-row: 1;grid-column: 1/2;align-self: end;justify-self: start;}/* Extra small devices (phones, 600px and down) */@media only screen and (max-width: 600px) {:host {width: 310px;}}/* Small devices (portrait tablets and large phones, 600px and up) */@media only screen and (min-width: 600px) {...}/* Medium devices (landscape tablets, 768px and up) */@media only screen and (min-width: 768px) {...}/* Large devices (laptops/desktops, 992px and up) */@media only screen and (min-width: 992px) {...}/* Extra large devices (large laptops and desktops, 1200px and up) */@media only screen and (min-width: 1200px) {...}@media (prefers-color-scheme: dark){:host {--background: #354150;--border: #1f2b37;--blue: #55b0ff;--font-color: #ffffff;--inner-border: #787a7c;background: var(--background);border: 1px solid var(--border)}}`,document.createElement(\"style\"));lightDomStyle.innerHTML=`contexter-box {contain: content;}contexter-box .read-link {font-weight: bold;}contexter-box a {color: #0000ee;}contexter-box img {width: 100%;border: 0;padding: 0;margin: 0;}/* Extra small devices (phones, 600px and down) */@media only screen and (max-width: 600px) {...}/* Small devices (portrait tablets and large phones, 600px and up) */@media only screen and (min-width: 600px) {...}/* Medium devices (landscape tablets, 768px and up) */@media only screen and (min-width: 768px) {...}/* Large devices (laptops/desktops, 992px and up) */@media only screen and (min-width: 992px) {...}/* Extra large devices (large laptops and desktops, 1200px and up) */@media only screen and (min-width: 1200px) {...}@media (prefers-color-scheme: dark){contexter-box a {color: #55b0ff;}}`,this.appendChild(lightDomStyle),this.shadow.appendChild(style);const innerContainer=document.createElement(\"contexter-box-inner\"),innerSlotThumbnail=(this.shadow.appendChild(innerContainer),document.createElement(\"slot\")),innerSlotHeader=(innerSlotThumbnail.name=\"thumbnail\",innerContainer.appendChild(innerSlotThumbnail),document.createElement(\"slot\")),innerSlotAuthor=(innerSlotHeader.name=\"header\",innerContainer.appendChild(innerSlotHeader),document.createElement(\"slot\")),innerSlotTime=(innerSlotAuthor.name=\"author\",innerContainer.appendChild(innerSlotAuthor),document.createElement(\"slot\")),innerSlotSummary=(innerSlotTime.name=\"time\",innerContainer.appendChild(innerSlotTime),document.createElement(\"slot\")),metaContainer=(innerSlotSummary.name=\"summary\",innerContainer.appendChild(innerSlotSummary),document.createElement(\"contexter-meta\")),innerSlotInfo=(innerContainer.appendChild(metaContainer),document.createElement(\"slot\")),linkContainer=(innerSlotInfo.name=\"keywords\",metaContainer.appendChild(innerSlotInfo),document.createElement(\"contexter-linkset\")),innerSlotArchiveLink=(metaContainer.appendChild(linkContainer),document.createElement(\"slot\")),innerSlotReadLink=(innerSlotArchiveLink.name=\"archive-link\",linkContainer.appendChild(innerSlotArchiveLink),document.createElement(\"slot\"));innerSlotReadLink.name=\"read-link\",linkContainer.appendChild(innerSlotReadLink),this.className=\"contexter-box\",this.onclick=e=>{if(!e.target.className.includes(\"read-link\")&&!e.target.className.includes(\"title-link\")){const mainLinks=this.querySelectorAll(\"a.main-link\");mainLinks[0].click()}}}}}customElements.define(\"contexter-box\",ContexterBox)},window.contexterSetupComplete||window.contexterSetup();</script><contexter-box class=\"link-card h-entry hentry\" itemscope=\"\" itemtype=\"https://schema.org/CreativeWork\"><contexter-thumbnail class=\"thumbnail\" slot=\"thumbnail\"><img src=\"https://upload.wikimedia.org/wikipedia/commons/9/94/Pfizer_World_Headquarters_Entrance.jpg\" alt=\"\" itemprop=\"image\" /></contexter-thumbnail><contexter-box-head slot=\"header\" class=\"p-name entry-title\" itemprop=\"headline\"><contexter-box-head slot=\"header\" class=\"p-name entry-title\" itemprop=\"headline\"><a is=\"contexter-link\" href=\"https://en.wikipedia.org/wiki/Pfizer\" itemprop=\"url\">American multinational pharmaceutical corporation</a></contexter-box-head></contexter-box-head><contexter-byline class=\"p-author author\" slot=\"author\"><span class=\"p-name byline\" rel=\"author\" itemprop=\"author\">Contributors to Wikimedia projects</span></contexter-byline><time class=\"dt-published published\" slot=\"time\" itemprop=\"datePublished\" datetime=\"2002-07-15T03:25:40.000Z\">6/14/2002</time><contexter-summary class=\"p-summary entry-summary\" itemprop=\"abstract\" slot=\"summary\"><p>Coordinates: 40°45′01″N 73°58′21″W﻿ / ﻿40.75028°N 73.97250°W</p></contexter-summary><contexter-keywordset itemprop=\"keywords\" slot=\"keywords\"></contexter-keywordset><a is=\"contexter-link\" href=\"https://en.wikipedia.org/wiki/Pfizer\" class=\"read-link main-link\" itemprop=\"sameAs\" slot=\"read-link\">Read</a></contexter-box>","linkId":"d8bc90005c518867a7ca0a1144086799ffccf91b","data":{"originalLink":"https://en.wikipedia.org/wiki/Pfizer","sanitizedLink":"https://en.wikipedia.org/wiki/Pfizer","canonical":"https://en.wikipedia.org/wiki/Pfizer","htmlText":"<!DOCTYPE html>\n<html class=\"client-nojs\" lang=\"en\" dir=\"ltr\">\n<head>\n<meta charset=\"UTF-8\"/>\n<title>Pfizer - Wikipedia</title>\n<script>document.documentElement.className=\"client-js\";RLCONF={\"wgBreakFrames\":false,\"wgSeparatorTransformTable\":[\"\",\"\"],\"wgDigitTransformTable\":[\"\",\"\"],\"wgDefaultDateFormat\":\"dmy\",\"wgMonthNames\":[\"\",\"January\",\"February\",\"March\",\"April\",\"May\",\"June\",\"July\",\"August\",\"September\",\"October\",\"November\",\"December\"],\"wgRequestId\":\"6434551b-b941-4f79-9ee4-fb28883d1eb5\",\"wgCSPNonce\":false,\"wgCanonicalNamespace\":\"\",\"wgCanonicalSpecialPageName\":false,\"wgNamespaceNumber\":0,\"wgPageName\":\"Pfizer\",\"wgTitle\":\"Pfizer\",\"wgCurRevisionId\":1081304371,\"wgRevisionId\":1081304371,\"wgArticleId\":62304,\"wgIsArticle\":true,\"wgIsRedirect\":false,\"wgAction\":\"view\",\"wgUserName\":null,\"wgUserGroups\":[\"*\"],\"wgCategories\":[\"CS1 maint: url-status\",\"CS1: long volume value\",\"CS1 maint: unfit URL\",\"Articles with short description\",\"Short description matches Wikidata\",\"Use American English from November 2015\",\"All Wikipedia articles written in American English\",\"Use mdy dates from November 2015\",\"Coordinates not on Wikidata\",\n\"Commons category link from Wikidata\",\"Articles with ISNI identifiers\",\"Articles with WORLDCATID identifiers\",\"Articles with GND identifiers\",\"Articles with J9U identifiers\",\"Articles with LCCN identifiers\",\"Articles with NKC identifiers\",\"Articles with NLA identifiers\",\"Pfizer\",\"Companies listed on the New York Stock Exchange\",\"1849 establishments in New York (state)\",\"Clinical trial organizations\",\"Companies based in Manhattan\",\"American brands\",\"American companies established in 1849\",\"Former components of the Dow Jones Industrial Average\",\"Multinational companies based in New York City\",\"Pharmaceutical companies of the United States\",\"Publicly traded companies based in New York City\",\"Research and development in the United States\",\"Companies listed on the Bombay Stock Exchange\",\"Orphan drug companies\",\"Life sciences industry\",\"Pharmaceutical companies established in 1849\",\"Vaccine producers\",\"COVID-19 vaccine producers\"],\"wgPageContentLanguage\":\"en\",\"wgPageContentModel\":\"wikitext\",\n\"wgRelevantPageName\":\"Pfizer\",\"wgRelevantArticleId\":62304,\"wgIsProbablyEditable\":true,\"wgRelevantPageIsProbablyEditable\":true,\"wgRestrictionEdit\":[],\"wgRestrictionMove\":[],\"wgFlaggedRevsParams\":{\"tags\":{\"status\":{\"levels\":-1}}},\"wgVisualEditor\":{\"pageLanguageCode\":\"en\",\"pageLanguageDir\":\"ltr\",\"pageVariantFallbacks\":\"en\"},\"wgMFDisplayWikibaseDescriptions\":{\"search\":true,\"nearby\":true,\"watchlist\":true,\"tagline\":false},\"wgWMESchemaEditAttemptStepOversample\":false,\"wgWMEPageLength\":100000,\"wgNoticeProject\":\"wikipedia\",\"wgMediaViewerOnClick\":true,\"wgMediaViewerEnabledByDefault\":true,\"wgPopupsFlags\":10,\"wgULSCurrentAutonym\":\"English\",\"wgCoordinates\":{\"lat\":40.750277777777775,\"lon\":-73.9725},\"wgEditSubmitButtonLabelPublish\":true,\"wgCentralAuthMobileDomain\":false,\"wgULSPosition\":\"interlanguage\",\"wgULSisCompactLinksEnabled\":true,\"wgWikibaseItemId\":\"Q206921\",\"wgGENewcomerTasksGuidanceEnabled\":true,\"wgGEAskQuestionEnabled\":false,\"wgGELinkRecommendationsFrontendEnabled\":false};RLSTATE={\n\"ext.globalCssJs.user.styles\":\"ready\",\"site.styles\":\"ready\",\"user.styles\":\"ready\",\"ext.globalCssJs.user\":\"ready\",\"user\":\"ready\",\"user.options\":\"loading\",\"ext.cite.styles\":\"ready\",\"skins.vector.styles.legacy\":\"ready\",\"jquery.makeCollapsible.styles\":\"ready\",\"ext.visualEditor.desktopArticleTarget.noscript\":\"ready\",\"ext.wikimediaBadges\":\"ready\",\"ext.uls.interlanguage\":\"ready\",\"wikibase.client.init\":\"ready\"};RLPAGEMODULES=[\"ext.cite.ux-enhancements\",\"site\",\"mediawiki.page.ready\",\"jquery.makeCollapsible\",\"mediawiki.toc\",\"skins.vector.legacy.js\",\"ext.gadget.ReferenceTooltips\",\"ext.gadget.charinsert\",\"ext.gadget.extra-toolbar-buttons\",\"ext.gadget.refToolbar\",\"ext.gadget.switcher\",\"mmv.head\",\"mmv.bootstrap.autostart\",\"ext.visualEditor.desktopArticleTarget.init\",\"ext.visualEditor.targetLoader\",\"ext.eventLogging\",\"ext.wikimediaEvents\",\"ext.navigationTiming\",\"ext.cx.eventlogging.campaigns\",\"ext.centralNotice.geoIP\",\"ext.centralNotice.startUp\",\"ext.centralauth.centralautologin\",\"ext.popups\",\n\"ext.uls.compactlinks\",\"ext.uls.interface\",\"ext.growthExperiments.SuggestedEditSession\"];</script>\n<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement(\"user.options@1i9g4\",function($,jQuery,require,module){mw.user.tokens.set({\"patrolToken\":\"+\\\\\",\"watchToken\":\"+\\\\\",\"csrfToken\":\"+\\\\\"});});});</script>\n<link rel=\"stylesheet\" href=\"/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cjquery.makeCollapsible.styles%7Cskins.vector.styles.legacy%7Cwikibase.client.init&amp;only=styles&amp;skin=vector\"/>\n<script async=\"\" src=\"/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=vector\"></script>\n<meta name=\"ResourceLoaderDynamicStyles\" content=\"\"/>\n<link rel=\"stylesheet\" href=\"/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector\"/>\n<meta name=\"generator\" content=\"MediaWiki 1.39.0-wmf.5\"/>\n<meta name=\"referrer\" content=\"origin\"/>\n<meta name=\"referrer\" content=\"origin-when-crossorigin\"/>\n<meta name=\"referrer\" content=\"origin-when-cross-origin\"/>\n<meta name=\"format-detection\" content=\"telephone=no\"/>\n<meta property=\"og:image\" content=\"https://upload.wikimedia.org/wikipedia/commons/thumb/9/94/Pfizer_World_Headquarters_Entrance.jpg/1200px-Pfizer_World_Headquarters_Entrance.jpg\"/>\n<meta property=\"og:image:width\" content=\"1200\"/>\n<meta property=\"og:image:height\" content=\"814\"/>\n<meta property=\"og:image\" content=\"https://upload.wikimedia.org/wikipedia/commons/thumb/9/94/Pfizer_World_Headquarters_Entrance.jpg/800px-Pfizer_World_Headquarters_Entrance.jpg\"/>\n<meta property=\"og:image:width\" content=\"800\"/>\n<meta property=\"og:image:height\" content=\"543\"/>\n<meta property=\"og:image\" content=\"https://upload.wikimedia.org/wikipedia/commons/thumb/9/94/Pfizer_World_Headquarters_Entrance.jpg/640px-Pfizer_World_Headquarters_Entrance.jpg\"/>\n<meta property=\"og:image:width\" content=\"640\"/>\n<meta property=\"og:image:height\" content=\"434\"/>\n<meta property=\"og:title\" content=\"Pfizer - Wikipedia\"/>\n<meta property=\"og:type\" content=\"website\"/>\n<link rel=\"preconnect\" href=\"//upload.wikimedia.org\"/>\n<link rel=\"alternate\" media=\"only screen and (max-width: 720px)\" href=\"//en.m.wikipedia.org/wiki/Pfizer\"/>\n<link rel=\"alternate\" type=\"application/x-wiki\" title=\"Edit this page\" href=\"/w/index.php?title=Pfizer&amp;action=edit\"/>\n<link rel=\"apple-touch-icon\" href=\"/static/apple-touch/wikipedia.png\"/>\n<link rel=\"shortcut icon\" href=\"/static/favicon/wikipedia.ico\"/>\n<link rel=\"search\" type=\"application/opensearchdescription+xml\" href=\"/w/opensearch_desc.php\" title=\"Wikipedia (en)\"/>\n<link rel=\"EditURI\" type=\"application/rsd+xml\" href=\"//en.wikipedia.org/w/api.php?action=rsd\"/>\n<link rel=\"license\" href=\"https://creativecommons.org/licenses/by-sa/3.0/\"/>\n<link rel=\"canonical\" href=\"https://en.wikipedia.org/wiki/Pfizer\"/>\n<link rel=\"dns-prefetch\" href=\"//meta.wikimedia.org\" />\n<link rel=\"dns-prefetch\" href=\"//login.wikimedia.org\"/>\n</head>\n<body class=\"mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Pfizer rootpage-Pfizer skin-vector action-view skin-vector-legacy\"><div id=\"mw-page-base\" class=\"noprint\"></div>\n<div id=\"mw-head-base\" class=\"noprint\"></div>\n<div id=\"content\" class=\"mw-body\" role=\"main\">\n\t<a id=\"top\"></a>\n\t<div id=\"siteNotice\"><!-- CentralNotice --></div>\n\t<div class=\"mw-indicators\">\n\t</div>\n\t<h1 id=\"firstHeading\" class=\"firstHeading mw-first-heading\">Pfizer</h1>\n\t<div id=\"bodyContent\" class=\"vector-body\">\n\t\t<div id=\"siteSub\" class=\"noprint\">From Wikipedia, the free encyclopedia</div>\n\t\t<div id=\"contentSub\"></div>\n\t\t<div id=\"contentSub2\"></div>\n\t\t\n\t\t<div id=\"jump-to-nav\"></div>\n\t\t<a class=\"mw-jump-link\" href=\"#mw-head\">Jump to navigation</a>\n\t\t<a class=\"mw-jump-link\" href=\"#searchInput\">Jump to search</a>\n\t\t<div id=\"mw-content-text\" class=\"mw-body-content mw-content-ltr\" lang=\"en\" dir=\"ltr\"><div class=\"mw-parser-output\"><div class=\"shortdescription nomobile noexcerpt noprint searchaux\" style=\"display:none\">American multinational pharmaceutical corporation</div>\n<style data-mw-deduplicate=\"TemplateStyles:r1033289096\">.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}</style><div role=\"note\" class=\"hatnote navigation-not-searchable\">For the COVID-19 vaccine, see <a href=\"/wiki/Pfizer%E2%80%93BioNTech_COVID-19_vaccine\" title=\"Pfizer–BioNTech COVID-19 vaccine\">Pfizer–BioNTech COVID-19 vaccine</a>. For other uses, see <a href=\"/wiki/Pfizer_(disambiguation)\" class=\"mw-disambig\" title=\"Pfizer (disambiguation)\">Pfizer (disambiguation)</a>.</div>\n<p>\n\n<span style=\"font-size: small;\"><span id=\"coordinates\"><a href=\"/wiki/Geographic_coordinate_system\" title=\"Geographic coordinate system\">Coordinates</a>: <style data-mw-deduplicate=\"TemplateStyles:r1073938472\">.mw-parser-output .geo-default,.mw-parser-output .geo-dms,.mw-parser-output .geo-dec{display:inline}.mw-parser-output .geo-nondefault,.mw-parser-output .geo-multi-punct{display:none}.mw-parser-output .longitude,.mw-parser-output .latitude{white-space:nowrap}</style><span class=\"plainlinks nourlexpansion\"><a class=\"external text\" href=\"//geohack.toolforge.org/geohack.php?pagename=Pfizer&amp;params=40_45_01_N_73_58_21_W_\"><span class=\"geo-default\"><span class=\"geo-dms\" title=\"Maps, aerial photos, and other data for this location\"><span class=\"latitude\">40°45′01″N</span> <span class=\"longitude\">73°58′21″W</span></span></span><span class=\"geo-multi-punct\">&#xfeff; / &#xfeff;</span><span class=\"geo-nondefault\"><span class=\"geo-dec\" title=\"Maps, aerial photos, and other data for this location\">40.75028°N 73.97250°W</span><span style=\"display:none\">&#xfeff; / <span class=\"geo\">40.75028; -73.97250</span></span></span></a></span></span></span>\n</p>\n<style data-mw-deduplicate=\"TemplateStyles:r1066479718\">.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}body.skin-minerva .mw-parser-output .infobox-header,body.skin-minerva .mw-parser-output .infobox-subheader,body.skin-minerva .mw-parser-output .infobox-above,body.skin-minerva .mw-parser-output .infobox-title,body.skin-minerva .mw-parser-output .infobox-image,body.skin-minerva .mw-parser-output .infobox-full-data,body.skin-minerva .mw-parser-output .infobox-below{text-align:center}</style><table class=\"infobox vcard\"><caption class=\"infobox-title fn org\" style=\"font-size: 125%;\">Pfizer Inc.</caption><tbody><tr><td colspan=\"2\" class=\"infobox-image logo\"><a href=\"/wiki/File:Pfizer_(2021).svg\" class=\"image\"><img alt=\"Pfizer (2021).svg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/57/Pfizer_%282021%29.svg/220px-Pfizer_%282021%29.svg.png\" decoding=\"async\" width=\"220\" height=\"90\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/57/Pfizer_%282021%29.svg/330px-Pfizer_%282021%29.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/57/Pfizer_%282021%29.svg/440px-Pfizer_%282021%29.svg.png 2x\" data-file-width=\"1000\" data-file-height=\"409\" /></a></td></tr><tr><td colspan=\"2\" class=\"infobox-image logo\"><a href=\"/wiki/File:Pfizer_World_Headquarters_Entrance.jpg\" class=\"image\"><img alt=\"Pfizer World Headquarters Entrance.jpg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/94/Pfizer_World_Headquarters_Entrance.jpg/250px-Pfizer_World_Headquarters_Entrance.jpg\" decoding=\"async\" width=\"250\" height=\"170\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/94/Pfizer_World_Headquarters_Entrance.jpg/375px-Pfizer_World_Headquarters_Entrance.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/94/Pfizer_World_Headquarters_Entrance.jpg/500px-Pfizer_World_Headquarters_Entrance.jpg 2x\" data-file-width=\"4908\" data-file-height=\"3330\" /></a><div class=\"infobox-caption\">Pfizer <a href=\"/wiki/Headquarters\" title=\"Headquarters\">headquarters</a> on <a href=\"/wiki/42nd_Street_(Manhattan)\" title=\"42nd Street (Manhattan)\">42nd Street</a> in Midtown Manhattan</div></td></tr><tr><th scope=\"row\" class=\"infobox-label\" style=\"padding-right: 0.5em;\">Type</th><td class=\"infobox-data category\" style=\"line-height: 1.35em;\"><a href=\"/wiki/Public_company\" title=\"Public company\">Public</a></td></tr><tr><th scope=\"row\" class=\"infobox-label\" style=\"padding-right: 0.5em;\"><div style=\"display:inline-block; line-height:1.2em; padding:0.1em 0;\"><a href=\"/wiki/Ticker_symbol\" title=\"Ticker symbol\">Traded as</a></div></th><td class=\"infobox-data\" style=\"line-height: 1.35em;\"><div class=\"plainlist\"><ul><li><a href=\"/wiki/New_York_Stock_Exchange\" title=\"New York Stock Exchange\">NYSE</a>:&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://www.nyse.com/quote/XNYS:PFE\">PFE</a></li><li><a href=\"/wiki/S%26P_100\" title=\"S&amp;P 100\">S&amp;P 100</a> component</li><li><a href=\"/wiki/S%26P_500\" title=\"S&amp;P 500\">S&amp;P 500</a> component</li><li><a href=\"/wiki/Russell_1000_Index\" title=\"Russell 1000 Index\">Russell 1000 Index</a> component</li></ul></div></td></tr><tr><th scope=\"row\" class=\"infobox-label\" style=\"padding-right: 0.5em;\">Industry</th><td class=\"infobox-data category\" style=\"line-height: 1.35em;\"><div class=\"plainlist\"><ul><li><a href=\"/wiki/Pharmaceutical_industry\" title=\"Pharmaceutical industry\">Pharmaceutical</a></li><li><a href=\"/wiki/Biotechnology\" title=\"Biotechnology\">Biotechnology</a></li></ul></div></td></tr><tr><th scope=\"row\" class=\"infobox-label\" style=\"padding-right: 0.5em;\">Founded</th><td class=\"infobox-data\" style=\"line-height: 1.35em;\">1849<span class=\"noprint\">&#59;&#32;173&#160;years ago</span><span style=\"display:none\">&#160;(<span class=\"bday dtstart published updated\">1849</span>)</span> in New York City</td></tr><tr><th scope=\"row\" class=\"infobox-label\" style=\"padding-right: 0.5em;\">Founders</th><td class=\"infobox-data agent\" style=\"line-height: 1.35em;\"><div class=\"plainlist\"><ul><li><a href=\"/wiki/Charles_Pfizer\" title=\"Charles Pfizer\">Charles Pfizer</a></li><li><a href=\"/wiki/Charles_F._Erhart\" title=\"Charles F. Erhart\">Charles F. Erhart</a></li></ul></div></td></tr><tr><th scope=\"row\" class=\"infobox-label\" style=\"padding-right: 0.5em;\">Headquarters</th><td class=\"infobox-data label\" style=\"line-height: 1.35em;\">235 East 42nd Street, <div style=\"display: inline;\" class=\"locality\">New York City</div>, <div style=\"display: inline;\" class=\"country-name\">U.S.</div></td></tr><tr><th scope=\"row\" class=\"infobox-label\" style=\"padding-right: 0.5em;\"><div style=\"display:inline-block; line-height:1.2em; padding:0.1em 0;\">Area served</div></th><td class=\"infobox-data\" style=\"line-height: 1.35em;\">Worldwide</td></tr><tr><th scope=\"row\" class=\"infobox-label\" style=\"padding-right: 0.5em;\"><div style=\"display:inline-block; line-height:1.2em; padding:0.1em 0;\">Key people</div></th><td class=\"infobox-data agent\" style=\"line-height: 1.35em;\"><a href=\"/wiki/Albert_Bourla\" title=\"Albert Bourla\">Albert Bourla</a>, <a href=\"/wiki/CEO\" class=\"mw-redirect\" title=\"CEO\">CEO</a><br />Frank A. D’Amelio, <a href=\"/wiki/CFO\" class=\"mw-redirect\" title=\"CFO\">CFO</a><br /><a href=\"/wiki/Scott_Gottlieb\" title=\"Scott Gottlieb\">Scott Gottlieb</a>, Director<br /><a href=\"/wiki/Helen_Hobbs\" title=\"Helen Hobbs\">Helen Hobbs</a>, Director<br /><a href=\"/wiki/Susan_Hockfield\" title=\"Susan Hockfield\">Susan Hockfield</a>, Director<br /><a href=\"/wiki/Dan_Littman\" title=\"Dan Littman\">Dan Littman</a>, Director<br /><a href=\"/wiki/Shantanu_Narayen\" title=\"Shantanu Narayen\">Shantanu Narayen</a>, Director<br /><a href=\"/wiki/Suzanne_Nora_Johnson\" title=\"Suzanne Nora Johnson\">Suzanne Nora Johnson</a>, Director<br /><a href=\"/wiki/James_Quincey\" title=\"James Quincey\">James Quincey</a>, Director<br /><a href=\"/wiki/Jim_Smith_(business_executive)\" title=\"Jim Smith (business executive)\">Jim Smith</a>, Director</td></tr><tr><th scope=\"row\" class=\"infobox-label\" style=\"padding-right: 0.5em;\">Products</th><td class=\"infobox-data\" style=\"line-height: 1.35em;\"><div class=\"hlist hlist-separated\"><ul><li><a href=\"/wiki/Pharmaceutical\" class=\"mw-redirect\" title=\"Pharmaceutical\">Pharmaceuticals</a></li><li><a href=\"/wiki/Vaccine\" title=\"Vaccine\">vaccines</a></li></ul></div></td></tr><tr><th scope=\"row\" class=\"infobox-label\" style=\"padding-right: 0.5em;\">Revenue</th><td class=\"infobox-data\" style=\"line-height: 1.35em;\"><img alt=\"Increase\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png\" decoding=\"async\" title=\"Increase\" width=\"11\" height=\"11\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x\" data-file-width=\"300\" data-file-height=\"300\" /> $41.908 billion&#160;(2020)</td></tr><tr><th scope=\"row\" class=\"infobox-label\" style=\"padding-right: 0.5em;\"><div style=\"display:inline-block; line-height:1.2em; padding:0.1em 0;\"><a href=\"/wiki/Earnings_before_interest_and_taxes\" title=\"Earnings before interest and taxes\">Operating income</a></div></th><td class=\"infobox-data\" style=\"line-height: 1.35em;\"><img alt=\"Decrease\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/11px-Decrease2.svg.png\" decoding=\"async\" title=\"Decrease\" width=\"11\" height=\"11\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/17px-Decrease2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/22px-Decrease2.svg.png 2x\" data-file-width=\"300\" data-file-height=\"300\" /> $7.497 billion&#160;(2020)</td></tr><tr><th scope=\"row\" class=\"infobox-label\" style=\"padding-right: 0.5em;\"><div style=\"display:inline-block; line-height:1.2em; padding:0.1em 0;\"><a href=\"/wiki/Net_income\" title=\"Net income\">Net income</a></div></th><td class=\"infobox-data\" style=\"line-height: 1.35em;\"><img alt=\"Decrease\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/11px-Decrease2.svg.png\" decoding=\"async\" title=\"Decrease\" width=\"11\" height=\"11\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/17px-Decrease2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/22px-Decrease2.svg.png 2x\" data-file-width=\"300\" data-file-height=\"300\" /> $9.616 billion&#160;(2020)</td></tr><tr><th scope=\"row\" class=\"infobox-label\" style=\"padding-right: 0.5em;\"><span class=\"nowrap\"><a href=\"/wiki/Asset\" title=\"Asset\">Total assets</a></span></th><td class=\"infobox-data\" style=\"line-height: 1.35em;\"><img alt=\"Decrease\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/11px-Decrease2.svg.png\" decoding=\"async\" title=\"Decrease\" width=\"11\" height=\"11\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/17px-Decrease2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/22px-Decrease2.svg.png 2x\" data-file-width=\"300\" data-file-height=\"300\" /> $154.229 billion&#160;(2020)</td></tr><tr><th scope=\"row\" class=\"infobox-label\" style=\"padding-right: 0.5em;\"><span class=\"nowrap\"><a href=\"/wiki/Equity_(finance)\" title=\"Equity (finance)\">Total equity</a></span></th><td class=\"infobox-data\" style=\"line-height: 1.35em;\"><img alt=\"Increase\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png\" decoding=\"async\" title=\"Increase\" width=\"11\" height=\"11\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x\" data-file-width=\"300\" data-file-height=\"300\" /> $63.473 billion&#160;(2020)</td></tr><tr><th scope=\"row\" class=\"infobox-label\" style=\"padding-right: 0.5em;\"><div style=\"display:inline-block; line-height:1.2em; padding:0.1em 0;\">Number of employees</div></th><td class=\"infobox-data\" style=\"line-height: 1.35em;\">78,500&#160;(2020)</td></tr><tr><th scope=\"row\" class=\"infobox-label\" style=\"padding-right: 0.5em;\">Website</th><td class=\"infobox-data\" style=\"line-height: 1.35em;\"><span class=\"url\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.pfizer.com/\">www<wbr />.pfizer<wbr />.com</a></span> <a href=\"https://www.wikidata.org/wiki/Q206921#P856\" title=\"Edit this at Wikidata\"><img alt=\"Edit this at Wikidata\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png\" decoding=\"async\" width=\"10\" height=\"10\" style=\"vertical-align: text-top\" class=\"noprint\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x\" data-file-width=\"20\" data-file-height=\"20\" /></a></td></tr><tr><td colspan=\"2\" class=\"infobox-below\" style=\"line-height: 1.35em;\"><b>Footnotes&#160;/&#32;references</b><br /><sup id=\"cite_ref-10K_1-0\" class=\"reference\"><a href=\"#cite_note-10K-1\">&#91;1&#93;</a></sup></td></tr></tbody></table>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:172px;\"><a href=\"/wiki/File:Shinjuku_Bunka_Quint_Building.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/36/Shinjuku_Bunka_Quint_Building.jpg/170px-Shinjuku_Bunka_Quint_Building.jpg\" decoding=\"async\" width=\"170\" height=\"227\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/36/Shinjuku_Bunka_Quint_Building.jpg/255px-Shinjuku_Bunka_Quint_Building.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/36/Shinjuku_Bunka_Quint_Building.jpg/340px-Shinjuku_Bunka_Quint_Building.jpg 2x\" data-file-width=\"600\" data-file-height=\"800\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Shinjuku_Bunka_Quint_Building.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>The headquarters of Pfizer In Tokyo, Japan</div></div></div>\n<p><b>Pfizer Inc.</b> (<span class=\"rt-commentedText nowrap\"><span class=\"IPA nopopups noexcerpt\"><a href=\"/wiki/Help:IPA/English\" title=\"Help:IPA/English\">/<span style=\"border-bottom:1px dotted\"><span title=\"/ˈ/: primary stress follows\">ˈ</span><span title=\"&#39;f&#39; in &#39;find&#39;\">f</span><span title=\"/aɪ/: &#39;i&#39; in &#39;tide&#39;\">aɪ</span><span title=\"&#39;z&#39; in &#39;zoom&#39;\">z</span><span title=\"/ər/: &#39;er&#39; in &#39;letter&#39;\">ər</span></span>/</a></span></span> <a href=\"/wiki/Help:Pronunciation_respelling_key\" title=\"Help:Pronunciation respelling key\"><i title=\"English pronunciation respelling\"><span style=\"font-size:90%\">FY</span>-zər</i></a>)<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup> is an American <a href=\"/wiki/Multinational_corporation\" title=\"Multinational corporation\">multinational</a> <a href=\"/wiki/Pharmaceutical_industry\" title=\"Pharmaceutical industry\">pharmaceutical</a> and <a href=\"/wiki/Biotechnology\" title=\"Biotechnology\">biotechnology</a> corporation headquartered on <a href=\"/wiki/42nd_Street_(Manhattan)\" title=\"42nd Street (Manhattan)\">42nd Street</a> in <a href=\"/wiki/Manhattan\" title=\"Manhattan\">Manhattan, New York City</a>. The company was established in 1849 in New York by two German immigrants, <a href=\"/wiki/Charles_Pfizer\" title=\"Charles Pfizer\">Charles Pfizer</a> (1824–1906) and his cousin <a href=\"/wiki/Charles_F._Erhart\" title=\"Charles F. Erhart\">Charles F. Erhart</a> (1821–1891).\n</p><p>Pfizer develops and produces <a href=\"/wiki/Medicine\" title=\"Medicine\">medicines</a> and <a href=\"/wiki/Vaccine\" title=\"Vaccine\">vaccines</a> for <a href=\"/wiki/Immunology\" title=\"Immunology\">immunology</a>, <a href=\"/wiki/Oncology\" title=\"Oncology\">oncology</a>, <a href=\"/wiki/Cardiology\" title=\"Cardiology\">cardiology</a>, <a href=\"/wiki/Endocrinology\" title=\"Endocrinology\">endocrinology</a>, and <a href=\"/wiki/Neurology\" title=\"Neurology\">neurology</a>. The company has several <a href=\"/wiki/Medication#Blockbuster_drug\" title=\"Medication\">blockbuster drugs</a> or products that each generate more than <span style=\"white-space: nowrap\">US$1</span><span class=\"nowrap\">&#160;</span>billion in annual revenues.<sup id=\"cite_ref-10K_1-1\" class=\"reference\"><a href=\"#cite_note-10K-1\">&#91;1&#93;</a></sup> In 2020, 52% of the company's revenues came from the United States, 6% came from each of China and Japan, and 36% came from other countries.<sup id=\"cite_ref-10K_1-2\" class=\"reference\"><a href=\"#cite_note-10K-1\">&#91;1&#93;</a></sup>\n</p><p>Pfizer was a component of the <a href=\"/wiki/Dow_Jones_Industrial_Average\" title=\"Dow Jones Industrial Average\">Dow Jones Industrial Average</a> <a href=\"/wiki/Stock_market_index\" title=\"Stock market index\">stock market index</a> from 2004 to August 2020.<sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup><sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup><sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup> The company ranks 64th on the <a href=\"/wiki/Fortune_500\" title=\"Fortune 500\">Fortune 500</a><sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup> and 49th on the <a href=\"/wiki/Forbes_Global_2000\" title=\"Forbes Global 2000\">Forbes Global 2000</a>.<sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\" role=\"navigation\" aria-labelledby=\"mw-toc-heading\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2 id=\"mw-toc-heading\">Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#History\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">History</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-2\"><a href=\"#1849–1950:_Early_history\"><span class=\"tocnumber\">1.1</span> <span class=\"toctext\">1849–1950: Early history</span></a></li>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#1950–1980:_Pivot_to_pharmaceutical_research_and_global_expansion\"><span class=\"tocnumber\">1.2</span> <span class=\"toctext\">1950–1980: Pivot to pharmaceutical research and global expansion</span></a></li>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#1980–2000:_Development_of_Viagra,_Zoloft,_and_Lipitor\"><span class=\"tocnumber\">1.3</span> <span class=\"toctext\">1980–2000: Development of Viagra, Zoloft, and Lipitor</span></a></li>\n<li class=\"toclevel-2 tocsection-5\"><a href=\"#2000–2010:_Further_expansion\"><span class=\"tocnumber\">1.4</span> <span class=\"toctext\">2000–2010: Further expansion</span></a>\n<ul>\n<li class=\"toclevel-3 tocsection-6\"><a href=\"#Acquisitions_and_mergers\"><span class=\"tocnumber\">1.4.1</span> <span class=\"toctext\">Acquisitions and mergers</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#2010–2020:_Further_discoveries_and_acquisitions\"><span class=\"tocnumber\">1.5</span> <span class=\"toctext\">2010–2020: Further discoveries and acquisitions</span></a></li>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#2021–onwards:_Corporate_developments_and_acquisitions\"><span class=\"tocnumber\">1.6</span> <span class=\"toctext\">2021–onwards: Corporate developments and acquisitions</span></a></li>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#Acquisition_history\"><span class=\"tocnumber\">1.7</span> <span class=\"toctext\">Acquisition history</span></a></li>\n<li class=\"toclevel-2 tocsection-10\"><a href=\"#COVID-19_vaccine_and_other_initiatives\"><span class=\"tocnumber\">1.8</span> <span class=\"toctext\">COVID-19 vaccine and other initiatives</span></a>\n<ul>\n<li class=\"toclevel-3 tocsection-11\"><a href=\"#COVID-19_pandemic_and_vaccine_development\"><span class=\"tocnumber\">1.8.1</span> <span class=\"toctext\">COVID-19 pandemic and vaccine development</span></a>\n<ul>\n<li class=\"toclevel-4 tocsection-12\"><a href=\"#Initial_development_and_testing\"><span class=\"tocnumber\">1.8.1.1</span> <span class=\"toctext\">Initial development and testing</span></a></li>\n<li class=\"toclevel-4 tocsection-13\"><a href=\"#Efficacy_results_and_authorization\"><span class=\"tocnumber\">1.8.1.2</span> <span class=\"toctext\">Efficacy results and authorization</span></a></li>\n<li class=\"toclevel-4 tocsection-14\"><a href=\"#Manufacturing_and_distribution\"><span class=\"tocnumber\">1.8.1.3</span> <span class=\"toctext\">Manufacturing and distribution</span></a></li>\n<li class=\"toclevel-4 tocsection-15\"><a href=\"#Controversy\"><span class=\"tocnumber\">1.8.1.4</span> <span class=\"toctext\">Controversy</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-3 tocsection-16\"><a href=\"#Other_initiatives\"><span class=\"tocnumber\">1.8.2</span> <span class=\"toctext\">Other initiatives</span></a></li>\n</ul>\n</li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-17\"><a href=\"#Legal_issues\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Legal issues</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-18\"><a href=\"#Aggressive_pharmaceutical_marketing\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">Aggressive pharmaceutical marketing</span></a>\n<ul>\n<li class=\"toclevel-3 tocsection-19\"><a href=\"#Illegal_marketing_of_gabapentin_for_off-label_uses\"><span class=\"tocnumber\">2.1.1</span> <span class=\"toctext\">Illegal marketing of gabapentin for off-label uses</span></a></li>\n<li class=\"toclevel-3 tocsection-20\"><a href=\"#Illegal_marketing_of_Bextra\"><span class=\"tocnumber\">2.1.2</span> <span class=\"toctext\">Illegal marketing of Bextra</span></a></li>\n<li class=\"toclevel-3 tocsection-21\"><a href=\"#Termination_of_Peter_Rost\"><span class=\"tocnumber\">2.1.3</span> <span class=\"toctext\">Termination of Peter Rost</span></a></li>\n<li class=\"toclevel-3 tocsection-22\"><a href=\"#Illegal_marketing_of_Rapamune\"><span class=\"tocnumber\">2.1.4</span> <span class=\"toctext\">Illegal marketing of Rapamune</span></a></li>\n<li class=\"toclevel-3 tocsection-23\"><a href=\"#Illegal_marketing\"><span class=\"tocnumber\">2.1.5</span> <span class=\"toctext\">Illegal marketing</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-2 tocsection-24\"><a href=\"#Removal_of_ads_after_unflattering_article\"><span class=\"tocnumber\">2.2</span> <span class=\"toctext\">Removal of ads after unflattering article</span></a></li>\n<li class=\"toclevel-2 tocsection-25\"><a href=\"#Quigley_Company_asbestos\"><span class=\"tocnumber\">2.3</span> <span class=\"toctext\">Quigley Company asbestos</span></a></li>\n<li class=\"toclevel-2 tocsection-26\"><a href=\"#Shiley_defective_heart_valves\"><span class=\"tocnumber\">2.4</span> <span class=\"toctext\">Shiley defective heart valves</span></a></li>\n<li class=\"toclevel-2 tocsection-27\"><a href=\"#Firing_of_employee_that_filed_suit\"><span class=\"tocnumber\">2.5</span> <span class=\"toctext\">Firing of employee that filed suit</span></a></li>\n<li class=\"toclevel-2 tocsection-28\"><a href=\"#Celebrex_intellectual_property\"><span class=\"tocnumber\">2.6</span> <span class=\"toctext\">Celebrex intellectual property</span></a></li>\n<li class=\"toclevel-2 tocsection-29\"><a href=\"#Nigeria_Trovafloxacin_lawsuit\"><span class=\"tocnumber\">2.7</span> <span class=\"toctext\">Nigeria Trovafloxacin lawsuit</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-30\"><a href=\"#Environmental_record\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Environmental record</span></a></li>\n<li class=\"toclevel-1 tocsection-31\"><a href=\"#Outreach\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Outreach</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-32\"><a href=\"#Political_lobbying\"><span class=\"tocnumber\">4.1</span> <span class=\"toctext\">Political lobbying</span></a></li>\n<li class=\"toclevel-2 tocsection-33\"><a href=\"#Media\"><span class=\"tocnumber\">4.2</span> <span class=\"toctext\">Media</span></a></li>\n<li class=\"toclevel-2 tocsection-34\"><a href=\"#Public_health\"><span class=\"tocnumber\">4.3</span> <span class=\"toctext\">Public health</span></a></li>\n<li class=\"toclevel-2 tocsection-35\"><a href=\"#Medical_research\"><span class=\"tocnumber\">4.4</span> <span class=\"toctext\">Medical research</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-36\"><a href=\"#See_also\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-37\"><a href=\"#References\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-38\"><a href=\"#External_links\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=1\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:172px;\"><a href=\"/wiki/File:Charlespfizer.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/30/Charlespfizer.jpg/170px-Charlespfizer.jpg\" decoding=\"async\" width=\"170\" height=\"220\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/3/30/Charlespfizer.jpg 1.5x\" data-file-width=\"190\" data-file-height=\"246\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Charlespfizer.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>Charles Pfizer (1824–1906)</div></div></div>\n<h3><span id=\"1849.E2.80.931950:_Early_history\"></span><span class=\"mw-headline\" id=\"1849–1950:_Early_history\">1849–1950: Early history</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=2\" title=\"Edit section: 1849–1950: Early history\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Pfizer was founded in 1849 by <a href=\"/wiki/Charles_Pfizer\" title=\"Charles Pfizer\">Charles Pfizer</a> and <a href=\"/wiki/Charles_F._Erhart\" title=\"Charles F. Erhart\">Charles F. Erhart</a>, two cousins who had immigrated to the United States from <a href=\"/wiki/Ludwigsburg\" title=\"Ludwigsburg\">Ludwigsburg, Germany</a>, the year before. The business produced chemical compounds, and was headquartered on Bartlett Street<sup id=\"cite_ref-Citycyclopedia_9-0\" class=\"reference\"><a href=\"#cite_note-Citycyclopedia-9\">&#91;9&#93;</a></sup> in <a href=\"/wiki/Williamsburg,_Brooklyn\" title=\"Williamsburg, Brooklyn\">Williamsburgh, New York</a>, where they produced an <a href=\"/wiki/Antiparasitic\" title=\"Antiparasitic\">antiparasitic</a> called <a href=\"/wiki/Santonin\" title=\"Santonin\">santonin</a>. This was an immediate success, although it was production of <a href=\"/wiki/Citric_acid\" title=\"Citric acid\">citric acid</a> that led to Pfizer's growth in the 1880s. Pfizer continued to buy property in the area (by now the Williamsburg district of the city of <a href=\"/wiki/Brooklyn,_New_York\" class=\"mw-redirect\" title=\"Brooklyn, New York\">Brooklyn, New York</a> and, beginning in 1898, the <a href=\"/wiki/City_of_Greater_New_York\" title=\"City of Greater New York\">City of Greater New York</a>) to expand its lab and factory, retaining offices on Flushing Avenue until the 1960s; the Brooklyn plant ultimately closed in 2009.<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup> Following the success of citric acid, Pfizer (at the now-demolished 295 Washington Avenue) and Erhart (at 280 Washington Avenue) established their main residences in the nearby <a href=\"/wiki/Clinton_Hill,_Brooklyn\" title=\"Clinton Hill, Brooklyn\">Clinton Hill</a> district, known for its concentration of <a href=\"/wiki/Gilded_Age\" title=\"Gilded Age\">Gilded Age</a> wealth. Pfizer spent summers in similarly exclusive <a href=\"/wiki/Newport,_Rhode_Island\" title=\"Newport, Rhode Island\">Newport, Rhode Island</a>, where he died in 1906.\n</p><p>In 1881, Pfizer moved its administrative headquarters to 81 Maiden Lane in <a href=\"/wiki/Manhattan\" title=\"Manhattan\">Manhattan</a>, presaging the company's expansion to <a href=\"/wiki/Chicago,_Illinois\" class=\"mw-redirect\" title=\"Chicago, Illinois\">Chicago, Illinois</a> a year later.<sup id=\"cite_ref-Citycyclopedia_9-1\" class=\"reference\"><a href=\"#cite_note-Citycyclopedia-9\">&#91;9&#93;</a></sup><sup id=\"cite_ref-collection_11-0\" class=\"reference\"><a href=\"#cite_note-collection-11\">&#91;11&#93;</a></sup> By 1906, sales exceeded $3<span class=\"nowrap\">&#160;</span>million.<sup id=\"cite_ref-history_12-0\" class=\"reference\"><a href=\"#cite_note-history-12\">&#91;12&#93;</a></sup>\n</p><p><a href=\"/wiki/World_War_I\" title=\"World War I\">World War I</a> caused a shortage of <a href=\"/wiki/Calcium_citrate\" title=\"Calcium citrate\">calcium citrate</a>, which Pfizer imported from Italy for the manufacture of citric acid, and the company began a search for an alternative supply. Pfizer chemists learned of a fungus that ferments sugar to citric acid, and they were able to commercialize production of citric acid from this source in 1919. The company developed expertise in fermentation technology as a result. These skills were applied to the mass production of <a href=\"/wiki/Penicillin\" title=\"Penicillin\">penicillin</a>, an <a href=\"/wiki/Antibiotic\" title=\"Antibiotic\">antibiotic</a>, during <a href=\"/wiki/World_War_II\" title=\"World War II\">World War II</a> in response to the need to treat injured Allied soldiers.<sup id=\"cite_ref-Fermentation_13-0\" class=\"reference\"><a href=\"#cite_note-Fermentation-13\">&#91;13&#93;</a></sup>\n</p><p>On June 2, 1942, the company incorporated in <a href=\"/wiki/Delaware\" title=\"Delaware\">Delaware</a>.<sup id=\"cite_ref-10K_1-3\" class=\"reference\"><a href=\"#cite_note-10K-1\">&#91;1&#93;</a></sup>\n</p>\n<h3><span id=\"1950.E2.80.931980:_Pivot_to_pharmaceutical_research_and_global_expansion\"></span><span class=\"mw-headline\" id=\"1950–1980:_Pivot_to_pharmaceutical_research_and_global_expansion\">1950–1980: Pivot to pharmaceutical research and global expansion</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=3\" title=\"Edit section: 1950–1980: Pivot to pharmaceutical research and global expansion\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Due to price declines for <a href=\"/wiki/Penicillin\" title=\"Penicillin\">penicillin</a>, Pfizer searched for new antibiotics with greater profit potential. Pfizer discovered <a href=\"/wiki/Oxytetracycline\" title=\"Oxytetracycline\">oxytetracycline</a> in 1950, and this changed the company from a manufacturer of <a href=\"/wiki/Fine_chemical\" title=\"Fine chemical\">fine chemicals</a> to a research-based pharmaceutical company. Pfizer developed a <a href=\"/wiki/Drug_discovery\" title=\"Drug discovery\">drug discovery</a> program focused on in vitro synthesis to augment its research in fermentation technology. In 1959, the company established an <a href=\"/wiki/Animal_health\" class=\"mw-redirect\" title=\"Animal health\">animal health</a> division with a 700-acre (2.8&#160;km<sup>2</sup>) farm and research facility in <a href=\"/wiki/Terre_Haute,_Indiana\" title=\"Terre Haute, Indiana\">Terre Haute, Indiana</a>.<sup id=\"cite_ref-Fermentation_13-1\" class=\"reference\"><a href=\"#cite_note-Fermentation-13\">&#91;13&#93;</a></sup>\n</p><p>By the 1950s, Pfizer had established offices in <a href=\"/wiki/Belgium\" title=\"Belgium\">Belgium</a>, <a href=\"/wiki/Brazil\" title=\"Brazil\">Brazil</a>, <a href=\"/wiki/Canada\" title=\"Canada\">Canada</a>, <a href=\"/wiki/Cuba\" title=\"Cuba\">Cuba</a>, <a href=\"/wiki/Mexico\" title=\"Mexico\">Mexico</a>, <a href=\"/wiki/Panama\" title=\"Panama\">Panama</a>, <a href=\"/wiki/Puerto_Rico\" title=\"Puerto Rico\">Puerto Rico</a>, and the <a href=\"/wiki/United_Kingdom\" title=\"United Kingdom\">United Kingdom</a>. In 1960, the company moved its medical research laboratory operations out of <a href=\"/wiki/New_York_City\" title=\"New York City\">New York City</a> to a new facility in <a href=\"/wiki/Groton,_Connecticut\" title=\"Groton, Connecticut\">Groton, Connecticut</a>. In 1980, Pfizer launched <i>Feldene</i> (<a href=\"/wiki/Piroxicam\" title=\"Piroxicam\">piroxicam</a>), a prescription anti-inflammatory medication that became Pfizer's first product to reach $1<span class=\"nowrap\">&#160;</span>billion in revenue.<sup id=\"cite_ref-history_12-1\" class=\"reference\"><a href=\"#cite_note-history-12\">&#91;12&#93;</a></sup>\n</p><p>In 1965, John Powers, Jr. became <a href=\"/wiki/Chief_executive_officer\" title=\"Chief executive officer\">chief executive officer</a> of the company, succeeding John McKeen.<sup id=\"cite_ref-history_12-2\" class=\"reference\"><a href=\"#cite_note-history-12\">&#91;12&#93;</a></sup>\n</p><p>As the area surrounding its <a href=\"/wiki/Brooklyn\" title=\"Brooklyn\">Brooklyn</a> plant fell into decline in the 1970s and 1980s, the company formed a public-private partnership with New York City that encompassed the construction of low- and middle-income housing, the refurbishment of apartment buildings for the homeless and the establishment of a <a href=\"/wiki/Charter_school\" title=\"Charter school\">charter school</a>.<sup id=\"cite_ref-collection_11-1\" class=\"reference\"><a href=\"#cite_note-collection-11\">&#91;11&#93;</a></sup>\n</p><p>In 1972, <a href=\"/wiki/Edmund_T._Pratt_Jr.\" title=\"Edmund T. Pratt Jr.\">Edmund T. Pratt Jr.</a> became <a href=\"/wiki/Chief_executive_officer\" title=\"Chief executive officer\">chief executive officer</a> of the company, succeeding John Powers, Jr.<sup id=\"cite_ref-history_12-3\" class=\"reference\"><a href=\"#cite_note-history-12\">&#91;12&#93;</a></sup>\n</p>\n<h3><span id=\"1980.E2.80.932000:_Development_of_Viagra.2C_Zoloft.2C_and_Lipitor\"></span><span class=\"mw-headline\" id=\"1980–2000:_Development_of_Viagra,_Zoloft,_and_Lipitor\">1980–2000: Development of Viagra, Zoloft, and Lipitor</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=4\" title=\"Edit section: 1980–2000: Development of Viagra, Zoloft, and Lipitor\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>In 1981, the company received approval for <i>Diflucan</i> (<a href=\"/wiki/Fluconazole\" title=\"Fluconazole\">fluconazole</a>), the first oral treatment for severe <a href=\"/wiki/Fungal_infection\" title=\"Fungal infection\">fungal infections</a> including <a href=\"/wiki/Candidiasis\" title=\"Candidiasis\">candidiasis</a>, <a href=\"/wiki/Blastomycosis\" title=\"Blastomycosis\">blastomycosis</a>, <a href=\"/wiki/Coccidiodomycosis\" class=\"mw-redirect\" title=\"Coccidiodomycosis\">coccidiodomycosis</a>, <a href=\"/wiki/Cryptococcosis\" title=\"Cryptococcosis\">cryptococcosis</a>, <a href=\"/wiki/Histoplasmosis\" title=\"Histoplasmosis\">histoplasmosis</a>, <a href=\"/wiki/Dermatophytosis\" title=\"Dermatophytosis\">dermatophytosis</a>, and <a href=\"/wiki/Pityriasis_versicolor\" class=\"mw-redirect\" title=\"Pityriasis versicolor\">pityriasis versicolor</a>.<sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup>\n</p><p>In 1986, Pfizer acquired the worldwide rights to <i>Zithromax</i> (<a href=\"/wiki/Azithromycin\" title=\"Azithromycin\">azithromycin</a>), a macrolide antibiotic that is recommended by the <a href=\"/wiki/Infectious_Disease_Society_of_America\" class=\"mw-redirect\" title=\"Infectious Disease Society of America\">Infectious Disease Society of America</a> as a first line treatment for certain cases of community-acquired pneumonia, from <a href=\"/wiki/Pliva\" title=\"Pliva\">Pliva</a>.<sup id=\"cite_ref-best_15-0\" class=\"reference\"><a href=\"#cite_note-best-15\">&#91;15&#93;</a></sup><sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup>\n</p><p>In 1989, Pfizer scientists Peter Dunn and Albert Wood created <i>Viagra</i> (<a href=\"/wiki/Sildenafil\" title=\"Sildenafil\">sildenafil</a>) for treating <a href=\"/wiki/High_blood_pressure\" class=\"mw-redirect\" title=\"High blood pressure\">high blood pressure</a> and <a href=\"/wiki/Angina\" title=\"Angina\">angina</a>, a chest pain associated with <a href=\"/wiki/Coronary_artery_disease\" title=\"Coronary artery disease\">coronary artery disease</a>. In 1991, it was patented in the United Kingdom as a heart medication. Early trials for the medication showed that it did not work for the treatment of heart disease, but volunteers in the clinical trials had increased <a href=\"/wiki/Erection\" title=\"Erection\">erections</a> several days after taking the drug. It was patented in the United States in 1996 and received approval by the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> in March 1998. In December 1998, Pfizer hired <a href=\"/wiki/Bob_Dole\" title=\"Bob Dole\">Bob Dole</a> as a spokesperson for the drug.<sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup> The patents for Viagra expired in 2020.<sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup>\n</p><p>In 1991, <a href=\"/wiki/William_C._Steere,_Jr.\" title=\"William C. Steere, Jr.\">William C. Steere, Jr.</a> became <a href=\"/wiki/Chief_executive_officer\" title=\"Chief executive officer\">chief executive officer</a> of the company, succeeding <a href=\"/wiki/Edmund_T._Pratt_Jr.\" title=\"Edmund T. Pratt Jr.\">Edmund T. Pratt Jr.</a><sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup>\n</p><p>In 1991 Pfizer also began marketing <i>Zoloft</i> (<a href=\"/wiki/Sertraline\" title=\"Sertraline\">sertraline</a>), an <a href=\"/wiki/Antidepressant\" title=\"Antidepressant\">antidepressant</a> of the <a href=\"/wiki/Selective_serotonin_reuptake_inhibitor\" title=\"Selective serotonin reuptake inhibitor\">selective serotonin reuptake inhibitor</a> (SSRI) class developed nine years earlier by Pfizer chemists <a href=\"/wiki/Kenneth_Koe\" title=\"Kenneth Koe\">Kenneth Koe</a> and Willard Welch. Sertraline is primarily prescribed for <a href=\"/wiki/Major_depressive_disorder\" title=\"Major depressive disorder\">major depressive disorder</a> in adult <a href=\"/wiki/Outpatients\" class=\"mw-redirect\" title=\"Outpatients\">outpatients</a> as well as <a href=\"/wiki/Obsessive-compulsive_disorder\" class=\"mw-redirect\" title=\"Obsessive-compulsive disorder\">obsessive-compulsive disorder</a>, <a href=\"/wiki/Panic_disorder\" title=\"Panic disorder\">panic disorder</a>, and <a href=\"/wiki/Social_anxiety_disorder\" title=\"Social anxiety disorder\">social anxiety disorder</a> in both adults and children. In 2005, the year before it became a generic drug, sales were over $3<span class=\"nowrap\">&#160;</span>billion and over 100<span class=\"nowrap\">&#160;</span>million people had been treated with the drug.<sup id=\"cite_ref-20\" class=\"reference\"><a href=\"#cite_note-20\">&#91;20&#93;</a></sup> The patent for Zoloft expired in the summer of 2006.<sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup>\n</p><p>In 1996, <a href=\"/wiki/Eisai_(company)\" title=\"Eisai (company)\">Eisai</a>, in partnership with Pfizer, received <a href=\"/wiki/Approved_drug\" title=\"Approved drug\">approval</a> from the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> for <a href=\"/wiki/Donepezil\" title=\"Donepezil\">donepezil</a> under the brand Aricept for treatment of <a href=\"/wiki/Alzheimer%27s_disease\" title=\"Alzheimer&#39;s disease\">Alzheimer's disease</a>;<sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup> Pfizer also received approval for <i>Norvasc</i> (<a href=\"/wiki/Amlodipine\" title=\"Amlodipine\">amlodipine</a>), an <a href=\"/wiki/Antihypertensive\" class=\"mw-redirect\" title=\"Antihypertensive\">antihypertensive</a> drug of the dihydropyridine calcium channel blocker class.<sup id=\"cite_ref-23\" class=\"reference\"><a href=\"#cite_note-23\">&#91;23&#93;</a></sup>\n</p>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Zoloft_bottles.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/48/Zoloft_bottles.jpg/220px-Zoloft_bottles.jpg\" decoding=\"async\" width=\"220\" height=\"196\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/48/Zoloft_bottles.jpg/330px-Zoloft_bottles.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/48/Zoloft_bottles.jpg/440px-Zoloft_bottles.jpg 2x\" data-file-width=\"1223\" data-file-height=\"1088\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Zoloft_bottles.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>Bottles of <i>Zoloft</i> (<a href=\"/wiki/Sertraline\" title=\"Sertraline\">sertraline</a>), an <a href=\"/wiki/Antidepressant\" title=\"Antidepressant\">antidepressant</a></div></div></div>\n<p>In 1997, the company entered into a co-marketing agreement with <a href=\"/wiki/Warner%E2%80%93Lambert\" title=\"Warner–Lambert\">Warner–Lambert</a> for <i>Lipitor</i> (<a href=\"/wiki/Atorvastatin\" title=\"Atorvastatin\">atorvastatin</a>), a <a href=\"/wiki/Statin\" title=\"Statin\">statin</a> for the treatment of <a href=\"/wiki/Hypercholesterolemia\" title=\"Hypercholesterolemia\">hypercholesterolemia</a>. Although atorvastatin was the fifth <a href=\"/wiki/Statin\" title=\"Statin\">statin</a> to be developed, clinical trials showed that atorvastatin caused a more dramatic reduction in <a href=\"/wiki/Low-density_lipoprotein\" title=\"Low-density lipoprotein\">low-density lipoprotein</a> pattern C (LDL-C) than the other statin drugs. Upon its patent expiration in 2011, Lipitor was the best-selling drug ever, with approximately $125<span class=\"nowrap\">&#160;</span>billion in sales over 14.5 years.<sup id=\"cite_ref-24\" class=\"reference\"><a href=\"#cite_note-24\">&#91;24&#93;</a></sup>\n</p>\n<h3><span id=\"2000.E2.80.932010:_Further_expansion\"></span><span class=\"mw-headline\" id=\"2000–2010:_Further_expansion\">2000–2010: Further expansion</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=5\" title=\"Edit section: 2000–2010: Further expansion\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>In 2001, <a href=\"/wiki/Henry_McKinnell\" title=\"Henry McKinnell\">Henry McKinnell</a> became <a href=\"/wiki/Chief_executive_officer\" title=\"Chief executive officer\">chief executive officer</a> of the company, replacing <a href=\"/wiki/William_C._Steere,_Jr.\" title=\"William C. Steere, Jr.\">William C. Steere, Jr.</a><sup id=\"cite_ref-longshot_25-0\" class=\"reference\"><a href=\"#cite_note-longshot-25\">&#91;25&#93;</a></sup>\n</p><p>In 2004, the company received approval for <i>Lyrica</i> (<a href=\"/wiki/Pregabalin\" title=\"Pregabalin\">pregabalin</a>), an <a href=\"/wiki/Anticonvulsant\" title=\"Anticonvulsant\">anticonvulsant</a> and <a href=\"/wiki/Anxiolytic\" title=\"Anxiolytic\">anxiolytic</a> medication used to treat <a href=\"/wiki/Epilepsy\" title=\"Epilepsy\">epilepsy</a>, <a href=\"/wiki/Neuropathic_pain\" title=\"Neuropathic pain\">neuropathic pain</a>, <a href=\"/wiki/Fibromyalgia\" title=\"Fibromyalgia\">fibromyalgia</a>, <a href=\"/wiki/Restless_leg_syndrome\" class=\"mw-redirect\" title=\"Restless leg syndrome\">restless leg syndrome</a>, and <a href=\"/wiki/Generalized_anxiety_disorder\" title=\"Generalized anxiety disorder\">generalized anxiety disorder</a>.<sup id=\"cite_ref-26\" class=\"reference\"><a href=\"#cite_note-26\">&#91;26&#93;</a></sup><sup id=\"cite_ref-27\" class=\"reference\"><a href=\"#cite_note-27\">&#91;27&#93;</a></sup><sup id=\"cite_ref-28\" class=\"reference\"><a href=\"#cite_note-28\">&#91;28&#93;</a></sup> The United States patent on Lyrica was challenged by generic manufacturers and was upheld in 2014, extending the expiration date to 2018.<sup id=\"cite_ref-29\" class=\"reference\"><a href=\"#cite_note-29\">&#91;29&#93;</a></sup> In 2016, the drug had sales of $4.2 billion.<sup id=\"cite_ref-30\" class=\"reference\"><a href=\"#cite_note-30\">&#91;30&#93;</a></sup>\n</p><p>In July 2006, <a href=\"/wiki/Jeff_Kindler\" title=\"Jeff Kindler\">Jeff Kindler</a> was named <a href=\"/wiki/Chief_executive_officer\" title=\"Chief executive officer\">chief executive officer</a> of the company, replacing <a href=\"/wiki/Henry_McKinnell\" title=\"Henry McKinnell\">Henry McKinnell</a>.<sup id=\"cite_ref-longshot_25-1\" class=\"reference\"><a href=\"#cite_note-longshot-25\">&#91;25&#93;</a></sup><sup id=\"cite_ref-31\" class=\"reference\"><a href=\"#cite_note-31\">&#91;31&#93;</a></sup>\n</p><p>On December 3, 2006, Pfizer ceased development of <a href=\"/wiki/Torcetrapib\" title=\"Torcetrapib\">torcetrapib</a>, a drug that increases production of <a href=\"/wiki/High_density_lipoprotein\" class=\"mw-redirect\" title=\"High density lipoprotein\">HDL</a>, or \"good cholesterol\", which reduces <a href=\"/wiki/Low_density_lipoprotein\" class=\"mw-redirect\" title=\"Low density lipoprotein\">LDL</a> thought to be correlated to heart disease. During a <a href=\"/wiki/Phase_III_clinical_trial\" class=\"mw-redirect\" title=\"Phase III clinical trial\">Phase III clinical trial</a> involving 15,000 patients, more deaths than expected occurred in the group that took the medicine, and the <a href=\"/wiki/Mortality_rate\" title=\"Mortality rate\">mortality rate</a> of patients taking the combination of torcetrapib and Lipitor (82 deaths during the study) was 60% higher than those taking Lipitor alone (52 deaths during the study). Lipitor alone was not implicated in the results, but Pfizer lost nearly $1<span class=\"nowrap\">&#160;</span>billion developing the failed drug and its stock price dropped 11% on the day of the announcement.<sup id=\"cite_ref-32\" class=\"reference\"><a href=\"#cite_note-32\">&#91;32&#93;</a></sup><sup id=\"cite_ref-33\" class=\"reference\"><a href=\"#cite_note-33\">&#91;33&#93;</a></sup><sup id=\"cite_ref-34\" class=\"reference\"><a href=\"#cite_note-34\">&#91;34&#93;</a></sup><sup id=\"cite_ref-35\" class=\"reference\"><a href=\"#cite_note-35\">&#91;35&#93;</a></sup>\n</p><p>Between 2007 and 2010, Pfizer spent $3.3<span class=\"nowrap\">&#160;</span>million on investigations and legal fees and recovered about $5.1<span class=\"nowrap\">&#160;</span>million, and had another $5<span class=\"nowrap\">&#160;</span>million of pending recoveries from civil lawsuits against makers of <a href=\"/wiki/Counterfeit\" title=\"Counterfeit\">counterfeit</a> prescription drugs. Pfizer has hired customs and narcotics experts worldwide to track down fakes and assemble evidence that can be used to pursue civil suits for <a href=\"/wiki/Trademark_infringement\" title=\"Trademark infringement\">trademark infringement</a>.<sup id=\"cite_ref-36\" class=\"reference\"><a href=\"#cite_note-36\">&#91;36&#93;</a></sup>\n</p><p>In July 2008, Pfizer announced 275 job cuts at its manufacturing facility in <a href=\"/wiki/Kalamazoo,_Michigan\" title=\"Kalamazoo, Michigan\">Kalamazoo, Michigan</a>. Kalamazoo was previously the world headquarters of <a href=\"/wiki/Upjohn_Company\" class=\"mw-redirect\" title=\"Upjohn Company\">Upjohn Company</a>, which had been acquired as part of Pharmacia.<sup id=\"cite_ref-37\" class=\"reference\"><a href=\"#cite_note-37\">&#91;37&#93;</a></sup><sup id=\"cite_ref-:0_38-0\" class=\"reference\"><a href=\"#cite_note-:0-38\">&#91;38&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Acquisitions_and_mergers\">Acquisitions and mergers</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=6\" title=\"Edit section: Acquisitions and mergers\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>In June 2000, Pfizer acquired Warner-Lambert outright for $116<span class=\"nowrap\">&#160;</span>billion. To satisfy conditions imposed by antitrust regulators at the <a href=\"/wiki/Federal_Trade_Commission\" title=\"Federal Trade Commission\">Federal Trade Commission</a>, Pfizer sold off or transferred stakes in several minor products, including RID (a shampoo for treatment of <a href=\"/wiki/Head_lice_infestation\" title=\"Head lice infestation\">head lice</a>, sold to <a href=\"/wiki/Bayer\" title=\"Bayer\">Bayer</a>) and Warner-Lambert's antidepressant <a href=\"/wiki/Celexa\" class=\"mw-redirect\" title=\"Celexa\">Celexa</a> (which competes with Zoloft).<sup id=\"cite_ref-39\" class=\"reference\"><a href=\"#cite_note-39\">&#91;39&#93;</a></sup> The acquisition created what was, at the time, the second-largest pharmaceutical company worldwide.<sup id=\"cite_ref-40\" class=\"reference\"><a href=\"#cite_note-40\">&#91;40&#93;</a></sup>\n</p><p>In 2003, Pfizer merged with <a href=\"/wiki/Pharmacia\" title=\"Pharmacia\">Pharmacia</a>, and in the process acquired <a href=\"/wiki/G.D._Searle,_LLC\" title=\"G.D. Searle, LLC\">Searle</a> and <a href=\"/wiki/SUGEN\" title=\"SUGEN\">SUGEN</a>. Searle had developed <i>Flagyl</i> (<a href=\"/wiki/Metronidazole\" title=\"Metronidazole\">metronidazole</a>), a <a href=\"/wiki/Nitroimidazole\" title=\"Nitroimidazole\">nitroimidazole</a> antibiotic medication used particularly for <a href=\"/wiki/Anaerobe\" class=\"mw-redirect\" title=\"Anaerobe\">anaerobic</a> <a href=\"/wiki/Bacterium\" class=\"mw-redirect\" title=\"Bacterium\">bacteria</a> and <a href=\"/wiki/Protozoa\" title=\"Protozoa\">protozoa</a>.<sup id=\"cite_ref-:0_38-1\" class=\"reference\"><a href=\"#cite_note-:0-38\">&#91;38&#93;</a></sup><sup id=\"cite_ref-41\" class=\"reference\"><a href=\"#cite_note-41\">&#91;41&#93;</a></sup> Searle also developed <a href=\"/wiki/Celecoxib\" title=\"Celecoxib\">celecoxib</a> (<i>Celebrex</i>) a <a href=\"/wiki/COX-2_inhibitor\" title=\"COX-2 inhibitor\">COX-2 inhibitor</a> and <a href=\"/wiki/Nonsteroidal_anti-inflammatory_drug\" title=\"Nonsteroidal anti-inflammatory drug\">nonsteroidal anti-inflammatory drug</a> (NSAID) used to treat the <a href=\"/wiki/Pain\" title=\"Pain\">pain</a> and <a href=\"/wiki/Inflammation\" title=\"Inflammation\">inflammation</a> in <a href=\"/wiki/Osteoarthritis\" title=\"Osteoarthritis\">osteoarthritis</a>, <a href=\"/wiki/Acute_pain\" class=\"mw-redirect\" title=\"Acute pain\">acute pain</a> in adults, <a href=\"/wiki/Rheumatoid_arthritis\" title=\"Rheumatoid arthritis\">rheumatoid arthritis</a>, <a href=\"/wiki/Ankylosing_spondylitis\" title=\"Ankylosing spondylitis\">ankylosing spondylitis</a>, <a href=\"/wiki/Painful_menstruation\" class=\"mw-redirect\" title=\"Painful menstruation\">painful menstruation</a>, and <a href=\"/wiki/Juvenile_rheumatoid_arthritis\" class=\"mw-redirect\" title=\"Juvenile rheumatoid arthritis\">juvenile rheumatoid arthritis</a>.<sup id=\"cite_ref-42\" class=\"reference\"><a href=\"#cite_note-42\">&#91;42&#93;</a></sup> <a href=\"/wiki/SUGEN\" title=\"SUGEN\">SUGEN</a>, a company focused on <a href=\"/wiki/Protein_kinase\" title=\"Protein kinase\">protein kinase</a> inhibitors, had pioneered the use of ATP-mimetic small molecules to block <a href=\"/wiki/Signal_transduction\" title=\"Signal transduction\">signal transduction</a>. The <a href=\"/wiki/SUGEN\" title=\"SUGEN\">SUGEN</a> facility was shut down in 2003 by Pfizer, with the loss of more than 300 jobs, and several programs were transferred to Pfizer. These included <a href=\"/wiki/Sunitinib\" title=\"Sunitinib\">sunitinib</a> (<i>Sutent</i>), a cancer medication which was approved for human use by the FDA in January 2006.<sup id=\"cite_ref-43\" class=\"reference\"><a href=\"#cite_note-43\">&#91;43&#93;</a></sup><sup id=\"cite_ref-44\" class=\"reference\"><a href=\"#cite_note-44\">&#91;44&#93;</a></sup> A related compound, SU11654 (<a href=\"/wiki/Toceranib\" title=\"Toceranib\">Toceranib</a>), was also approved for <a href=\"/wiki/Cancer_in_dogs\" title=\"Cancer in dogs\">cancer in dogs</a>, and the <a href=\"/wiki/ALK_inhibitor\" title=\"ALK inhibitor\">ALK inhibitor</a> <a href=\"/wiki/Crizotinib\" title=\"Crizotinib\">Crizotinib</a> also grew out of a SUGEN program.<sup id=\"cite_ref-45\" class=\"reference\"><a href=\"#cite_note-45\">&#91;45&#93;</a></sup><sup id=\"cite_ref-46\" class=\"reference\"><a href=\"#cite_note-46\">&#91;46&#93;</a></sup>\n</p><p>In October 2006, the company announced it would acquire PowerMed.<sup id=\"cite_ref-47\" class=\"reference\"><a href=\"#cite_note-47\">&#91;47&#93;</a></sup>\n</p><p>On October 15, 2009, Pfizer acquired <a href=\"/wiki/Wyeth\" title=\"Wyeth\">Wyeth</a> for $68<span class=\"nowrap\">&#160;</span>billion in cash and stock, including the assumption of debt, making Pfizer the largest pharmaceutical company in the world.<sup id=\"cite_ref-48\" class=\"reference\"><a href=\"#cite_note-48\">&#91;48&#93;</a></sup><sup id=\"cite_ref-49\" class=\"reference\"><a href=\"#cite_note-49\">&#91;49&#93;</a></sup><sup id=\"cite_ref-50\" class=\"reference\"><a href=\"#cite_note-50\">&#91;50&#93;</a></sup><sup id=\"cite_ref-worst_51-0\" class=\"reference\"><a href=\"#cite_note-worst-51\">&#91;51&#93;</a></sup><sup id=\"cite_ref-wyethpr_52-0\" class=\"reference\"><a href=\"#cite_note-wyethpr-52\">&#91;52&#93;</a></sup> The acquisition of Wyeth provided Pfizer with a <a href=\"/wiki/Pneumococcal_conjugate_vaccine\" title=\"Pneumococcal conjugate vaccine\">pneumococcal conjugate vaccine</a>, trademarked <a href=\"/wiki/Pneumococcal_conjugate_vaccine#Prevnar\" title=\"Pneumococcal conjugate vaccine\">Prevnar 13</a>; this is used for the prevention of invasive pneumococcal infections. The introduction of the original, 7-valent version of the vaccine, developed by <a href=\"/wiki/Wyeth\" title=\"Wyeth\">Wyeth</a> in February 2000, led to a 75% reduction in the incidence of invasive pneumococcal infections among children under age<span class=\"nowrap\">&#160;</span>5 in the United States. Pfizer introduced an improved version of the vaccine in 2010, for which it was granted a patent in India in 2017. Prevnar 13 provides coverage of 13 bacterial variants, expanding beyond the original 7-valent version.<sup id=\"cite_ref-wyethpr_52-1\" class=\"reference\"><a href=\"#cite_note-wyethpr-52\">&#91;52&#93;</a></sup> By 2012, the rate of invasive infections among children under age<span class=\"nowrap\">&#160;</span>5 had been reduced by an additional 50%.<sup id=\"cite_ref-cdc.gov_53-0\" class=\"reference\"><a href=\"#cite_note-cdc.gov-53\">&#91;53&#93;</a></sup><sup id=\"cite_ref-54\" class=\"reference\"><a href=\"#cite_note-54\">&#91;54&#93;</a></sup>\n</p>\n<h3><span id=\"2010.E2.80.932020:_Further_discoveries_and_acquisitions\"></span><span class=\"mw-headline\" id=\"2010–2020:_Further_discoveries_and_acquisitions\">2010–2020: Further discoveries and acquisitions</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=7\" title=\"Edit section: 2010–2020: Further discoveries and acquisitions\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>In 2010, <a href=\"/wiki/Ian_Read\" title=\"Ian Read\">Ian Read</a> was named <a href=\"/wiki/Chief_executive_officer\" title=\"Chief executive officer\">chief executive officer</a> of the company.<sup id=\"cite_ref-55\" class=\"reference\"><a href=\"#cite_note-55\">&#91;55&#93;</a></sup>\n</p><p>In February 2011, Pfizer announced the closure of its UK research and development facility (formerly also a manufacturing plant) in <a href=\"/wiki/Sandwich,_Kent\" title=\"Sandwich, Kent\">Sandwich, Kent</a>, which at the time employed 2,400 people.<sup id=\"cite_ref-56\" class=\"reference\"><a href=\"#cite_note-56\">&#91;56&#93;</a></sup> In March 2011, Pfizer acquired <a href=\"/wiki/King_Pharmaceuticals\" title=\"King Pharmaceuticals\">King Pharmaceuticals</a> for $3.6<span class=\"nowrap\">&#160;</span>billion in cash. King produced emergency injectables such as the <a href=\"/wiki/EpiPen\" class=\"mw-redirect\" title=\"EpiPen\">EpiPen</a>.<sup id=\"cite_ref-57\" class=\"reference\"><a href=\"#cite_note-57\">&#91;57&#93;</a></sup>\n</p><p>On September 4, 2012, the FDA approved <a href=\"/wiki/Bosutinib\" title=\"Bosutinib\">bosutinib</a> (<i>Bosulif</i>) for <a href=\"/wiki/Chronic_myelogenous_leukemia\" title=\"Chronic myelogenous leukemia\">chronic myelogenous leukemia</a> (CML), a rare type of <a href=\"/wiki/Leukemia\" title=\"Leukemia\">leukemia</a> and a blood and <a href=\"/wiki/Bone_marrow\" title=\"Bone marrow\">bone marrow</a> disease that affects primarily older adults.<sup id=\"cite_ref-58\" class=\"reference\"><a href=\"#cite_note-58\">&#91;58&#93;</a></sup> In November 2012, Pfizer received approval from the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> for Xeljanz, a <a href=\"/wiki/Tofacitinib\" title=\"Tofacitinib\">tofacitinib</a>, for <a href=\"/wiki/Rheumatoid_arthritis\" title=\"Rheumatoid arthritis\">rheumatoid arthritis</a> and <a href=\"/wiki/Ulcerative_colitis\" title=\"Ulcerative colitis\">ulcerative colitis</a>.<sup id=\"cite_ref-59\" class=\"reference\"><a href=\"#cite_note-59\">&#91;59&#93;</a></sup> The drug had sales of $1.77<span class=\"nowrap\">&#160;</span>billion in 2018, and in January 2019, it was the top drug in the United States for <a href=\"/wiki/Direct-to-consumer_advertising\" title=\"Direct-to-consumer advertising\">direct-to-consumer advertising</a>, passing <a href=\"/wiki/Adalimumab\" title=\"Adalimumab\">adalimumab</a> (<i>Humira</i>).<sup id=\"cite_ref-60\" class=\"reference\"><a href=\"#cite_note-60\">&#91;60&#93;</a></sup>\n</p><p>On February 1, 2013, <a href=\"/wiki/Zoetis\" title=\"Zoetis\">Zoetis</a>, the Agriculture Division of Pfizer and later Pfizer Animal Health, became a <a href=\"/wiki/Public_company\" title=\"Public company\">public company</a> via an <a href=\"/wiki/Initial_public_offering\" title=\"Initial public offering\">initial public offering</a>, raising $2.2<span class=\"nowrap\">&#160;</span>billion.<sup id=\"cite_ref-61\" class=\"reference\"><a href=\"#cite_note-61\">&#91;61&#93;</a></sup><sup id=\"cite_ref-62\" class=\"reference\"><a href=\"#cite_note-62\">&#91;62&#93;</a></sup><sup id=\"cite_ref-63\" class=\"reference\"><a href=\"#cite_note-63\">&#91;63&#93;</a></sup><sup id=\"cite_ref-64\" class=\"reference\"><a href=\"#cite_note-64\">&#91;64&#93;</a></sup> Later in 2013, Pfizer completed the <a href=\"/wiki/Corporate_spin-off\" title=\"Corporate spin-off\">corporate spin-off</a> of its remaining stake in <a href=\"/wiki/Zoetis\" title=\"Zoetis\">Zoetis</a>.<sup id=\"cite_ref-65\" class=\"reference\"><a href=\"#cite_note-65\">&#91;65&#93;</a></sup><sup id=\"cite_ref-66\" class=\"reference\"><a href=\"#cite_note-66\">&#91;66&#93;</a></sup>\n</p><p>In September 2014, the company acquired Innopharma for $225<span class=\"nowrap\">&#160;</span>million, plus up to $135<span class=\"nowrap\">&#160;</span>million in milestone payments, in a deal that expanded Pfizer's range of generic and injectable drugs.<sup id=\"cite_ref-67\" class=\"reference\"><a href=\"#cite_note-67\">&#91;67&#93;</a></sup><sup id=\"cite_ref-68\" class=\"reference\"><a href=\"#cite_note-68\">&#91;68&#93;</a></sup>\n</p><p>On January 5, 2015, the company announced it would acquire a controlling interest in Redvax, expanding its vaccine portfolio targeting human <a href=\"/wiki/Cytomegalovirus\" title=\"Cytomegalovirus\">cytomegalovirus</a>.<sup id=\"cite_ref-69\" class=\"reference\"><a href=\"#cite_note-69\">&#91;69&#93;</a></sup> In February 2015, the company received approval from the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> for <a href=\"/wiki/Palbociclib\" title=\"Palbociclib\">palbociclib</a> (<i>Ibrance</i>) for treatment of certain types of <a href=\"/wiki/Breast_cancer\" title=\"Breast cancer\">breast cancer</a>.<sup id=\"cite_ref-70\" class=\"reference\"><a href=\"#cite_note-70\">&#91;70&#93;</a></sup><sup id=\"cite_ref-71\" class=\"reference\"><a href=\"#cite_note-71\">&#91;71&#93;</a></sup> In March 2015, the company announced it would restart its collaboration with <a href=\"/wiki/Eli_Lilly_and_Company\" title=\"Eli Lilly and Company\">Eli Lilly and Company</a> surrounding the <a href=\"/wiki/Phase_III_trial\" class=\"mw-redirect\" title=\"Phase III trial\">Phase III trial</a> of <a href=\"/wiki/Tanezumab\" title=\"Tanezumab\">Tanezumab</a>.<sup id=\"cite_ref-72\" class=\"reference\"><a href=\"#cite_note-72\">&#91;72&#93;</a></sup> In May 2015, Pfizer and a <a href=\"/wiki/Bar-Ilan_University\" title=\"Bar-Ilan University\">Bar-Ilan University</a> laboratory announced a partnership based on the development of medical <a href=\"/wiki/DNA_nanotechnology\" title=\"DNA nanotechnology\">DNA nanotechnology</a>.<sup id=\"cite_ref-73\" class=\"reference\"><a href=\"#cite_note-73\">&#91;73&#93;</a></sup> In June 2015, the company acquired <i>Nimenrix</i> and <i>Mencevax</i>, <a href=\"/wiki/Meningococcal_vaccine\" title=\"Meningococcal vaccine\">meningococcal vaccines</a>, from GlaxoSmithKline for around $130<span class=\"nowrap\">&#160;</span>million.<sup id=\"cite_ref-74\" class=\"reference\"><a href=\"#cite_note-74\">&#91;74&#93;</a></sup> In September 2015, Pfizer acquired <a href=\"/wiki/Hospira\" title=\"Hospira\">Hospira</a> for $17<span class=\"nowrap\">&#160;</span>billion, including the assumption of debt.<sup id=\"cite_ref-75\" class=\"reference\"><a href=\"#cite_note-75\">&#91;75&#93;</a></sup><sup id=\"cite_ref-76\" class=\"reference\"><a href=\"#cite_note-76\">&#91;76&#93;</a></sup><sup id=\"cite_ref-77\" class=\"reference\"><a href=\"#cite_note-77\">&#91;77&#93;</a></sup><sup id=\"cite_ref-78\" class=\"reference\"><a href=\"#cite_note-78\">&#91;78&#93;</a></sup><sup id=\"cite_ref-79\" class=\"reference\"><a href=\"#cite_note-79\">&#91;79&#93;</a></sup><sup id=\"cite_ref-80\" class=\"reference\"><a href=\"#cite_note-80\">&#91;80&#93;</a></sup> <a href=\"/wiki/Hospira\" title=\"Hospira\">Hospira</a> was the largest producer of generic injectable pharmaceuticals in the world.<sup id=\"cite_ref-81\" class=\"reference\"><a href=\"#cite_note-81\">&#91;81&#93;</a></sup> On November 23, 2015, Pfizer and <a href=\"/wiki/Allergan\" title=\"Allergan\">Allergan</a> announced a planned $160<span class=\"nowrap\">&#160;</span>billion merger, in the largest pharmaceutical deal ever and the third largest corporate merger in history. The proposed transaction contemplated that the merged company maintain Allergan's <a href=\"/wiki/Republic_of_Ireland\" title=\"Republic of Ireland\">Republic of Ireland</a> domicile, resulting in the new company being subject to <a href=\"/wiki/Corporation_tax\" class=\"mw-redirect\" title=\"Corporation tax\">corporation tax</a> at the relatively low rate of 12.5%.<sup id=\"cite_ref-82\" class=\"reference\"><a href=\"#cite_note-82\">&#91;82&#93;</a></sup> The deal was to constitute a <a href=\"/wiki/Reverse_merger\" class=\"mw-redirect\" title=\"Reverse merger\">reverse merger</a>, whereby Allergan acquired Pfizer, with the new company then changing its name to \"Pfizer, plc\".<sup id=\"cite_ref-83\" class=\"reference\"><a href=\"#cite_note-83\">&#91;83&#93;</a></sup><sup id=\"cite_ref-84\" class=\"reference\"><a href=\"#cite_note-84\">&#91;84&#93;</a></sup><sup id=\"cite_ref-85\" class=\"reference\"><a href=\"#cite_note-85\">&#91;85&#93;</a></sup> On April 6, 2016, Pfizer and Allergan terminated the merger agreement after the <a href=\"/wiki/Obama_administration\" class=\"mw-redirect\" title=\"Obama administration\">Obama administration</a> and the <a href=\"/wiki/United_States_Department_of_the_Treasury\" title=\"United States Department of the Treasury\">United States Department of the Treasury</a> introduced new laws intended to limit <a href=\"/wiki/Corporate_inversion\" class=\"mw-redirect\" title=\"Corporate inversion\">corporate inversions</a> (the extent to which companies could move their headquarters overseas in order to reduce the amount of taxes they pay).<sup id=\"cite_ref-86\" class=\"reference\"><a href=\"#cite_note-86\">&#91;86&#93;</a></sup><sup id=\"cite_ref-87\" class=\"reference\"><a href=\"#cite_note-87\">&#91;87&#93;</a></sup>\n</p><p>In June 2016, the company acquired <a href=\"/wiki/Anacor_Pharmaceuticals\" class=\"mw-redirect\" title=\"Anacor Pharmaceuticals\">Anacor Pharmaceuticals</a> for $5.2<span class=\"nowrap\">&#160;</span>billion, expanding its portfolio in both inflammation and immunology drugs areas.<sup id=\"cite_ref-88\" class=\"reference\"><a href=\"#cite_note-88\">&#91;88&#93;</a></sup><sup id=\"cite_ref-89\" class=\"reference\"><a href=\"#cite_note-89\">&#91;89&#93;</a></sup> In August 2016, the company made a $40<span class=\"nowrap\">&#160;</span>million bid for the assets of BIND Therapeutics, which was in <a href=\"/wiki/Bankruptcy\" title=\"Bankruptcy\">bankruptcy</a>.<sup id=\"cite_ref-90\" class=\"reference\"><a href=\"#cite_note-90\">&#91;90&#93;</a></sup> The same month, the company acquired Bamboo Therapeutics for $645<span class=\"nowrap\">&#160;</span>million, expanding its gene therapy offerings.<sup id=\"cite_ref-91\" class=\"reference\"><a href=\"#cite_note-91\">&#91;91&#93;</a></sup> In September 2016, the company acquired cancer drug-maker <a href=\"/wiki/Medivation\" title=\"Medivation\">Medivation</a> for $14<span class=\"nowrap\">&#160;</span>billion.<sup id=\"cite_ref-92\" class=\"reference\"><a href=\"#cite_note-92\">&#91;92&#93;</a></sup><sup id=\"cite_ref-93\" class=\"reference\"><a href=\"#cite_note-93\">&#91;93&#93;</a></sup><sup id=\"cite_ref-94\" class=\"reference\"><a href=\"#cite_note-94\">&#91;94&#93;</a></sup> In October 2016, the company licensed the anti-<a href=\"/wiki/CTLA4\" class=\"mw-redirect\" title=\"CTLA4\">CTLA4</a> monoclonal antibody, ONC-392, from OncoImmune.<sup id=\"cite_ref-95\" class=\"reference\"><a href=\"#cite_note-95\">&#91;95&#93;</a></sup><sup id=\"cite_ref-96\" class=\"reference\"><a href=\"#cite_note-96\">&#91;96&#93;</a></sup> In December 2016, Pfizer acquired <a href=\"/wiki/AstraZeneca\" title=\"AstraZeneca\">AstraZeneca</a>'s small-molecule antibiotics business for $1.575 billion.<sup id=\"cite_ref-97\" class=\"reference\"><a href=\"#cite_note-97\">&#91;97&#93;</a></sup><sup id=\"cite_ref-98\" class=\"reference\"><a href=\"#cite_note-98\">&#91;98&#93;</a></sup><sup id=\"cite_ref-99\" class=\"reference\"><a href=\"#cite_note-99\">&#91;99&#93;</a></sup>\n</p><p>In January 2018, Pfizer announced that it would end its work on research into treatments for <a href=\"/wiki/Alzheimer%27s_disease\" title=\"Alzheimer&#39;s disease\">Alzheimer's disease</a> and <a href=\"/wiki/Parkinsonism\" title=\"Parkinsonism\">Parkinsonism</a> (a symptom of <a href=\"/wiki/Parkinson%27s_disease\" title=\"Parkinson&#39;s disease\">Parkinson's disease</a> and other conditions). The company said about 300 researchers would lose their jobs.<sup id=\"cite_ref-100\" class=\"reference\"><a href=\"#cite_note-100\">&#91;100&#93;</a></sup> In July 2018, the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> approved <a href=\"/wiki/Enzalutamide\" title=\"Enzalutamide\">enzalutamide</a>, developed by Pfizer and <a href=\"/wiki/Astellas_Pharma\" title=\"Astellas Pharma\">Astellas Pharma</a> for patients with <a href=\"/wiki/Castration\" title=\"Castration\">castration</a>-resistant <a href=\"/wiki/Prostate_cancer\" title=\"Prostate cancer\">prostate cancer</a>.<sup id=\"cite_ref-101\" class=\"reference\"><a href=\"#cite_note-101\">&#91;101&#93;</a></sup> In August 2018, Pfizer signed an agreement with <a href=\"/wiki/BioNTech\" title=\"BioNTech\">BioNTech</a> to conduct joint research and development activities regarding <a href=\"/wiki/MRNA\" class=\"mw-redirect\" title=\"MRNA\">mRNA</a>-based <a href=\"/wiki/Influenza_vaccine\" title=\"Influenza vaccine\">influenza vaccines</a>.<sup id=\"cite_ref-102\" class=\"reference\"><a href=\"#cite_note-102\">&#91;102&#93;</a></sup> In October 2018, effective January 1, 2019, <a href=\"/wiki/Albert_Bourla\" title=\"Albert Bourla\">Albert Bourla</a> was promoted to <a href=\"/wiki/Chief_executive_officer\" title=\"Chief executive officer\">chief executive officer</a>, succeeding <a href=\"/wiki/Ian_Read\" title=\"Ian Read\">Ian Read</a>, his mentor.<sup id=\"cite_ref-103\" class=\"reference\"><a href=\"#cite_note-103\">&#91;103&#93;</a></sup><sup id=\"cite_ref-104\" class=\"reference\"><a href=\"#cite_note-104\">&#91;104&#93;</a></sup><sup id=\"cite_ref-105\" class=\"reference\"><a href=\"#cite_note-105\">&#91;105&#93;</a></sup><sup id=\"cite_ref-106\" class=\"reference\"><a href=\"#cite_note-106\">&#91;106&#93;</a></sup>\n</p><p>In July 2019, the company acquired Therachon for up to $810<span class=\"nowrap\">&#160;</span>million, expanding its rare disease portfolio through Therachon's recombinant human fibroblast growth factor receptor 3 compound, aimed at treating conditions such as <a href=\"/wiki/Achondroplasia\" title=\"Achondroplasia\">achondroplasia</a>.<sup id=\"cite_ref-107\" class=\"reference\"><a href=\"#cite_note-107\">&#91;107&#93;</a></sup> Also in July, Pfizer acquired <a href=\"/wiki/Array_Biopharma\" class=\"mw-redirect\" title=\"Array Biopharma\">Array Biopharma</a> for $10.6<span class=\"nowrap\">&#160;</span>billion, boosting its oncology pipeline.<sup id=\"cite_ref-108\" class=\"reference\"><a href=\"#cite_note-108\">&#91;108&#93;</a></sup> In August 2019, Pfizer merged its consumer health business with that of GlaxoSmithKline, into a <a href=\"/wiki/Joint_venture\" title=\"Joint venture\">joint venture</a> owned 68% by GlaxoSmithKline and 32% by Pfizer, with plans to make it a <a href=\"/wiki/Public_company\" title=\"Public company\">public company</a>. The transaction built on a 2018 transaction where GlaxoSmithKline acquired <a href=\"/wiki/Novartis\" title=\"Novartis\">Novartis</a>' stake in the GSK-Novartis consumer healthcare joint business.<sup id=\"cite_ref-109\" class=\"reference\"><a href=\"#cite_note-109\">&#91;109&#93;</a></sup><sup id=\"cite_ref-110\" class=\"reference\"><a href=\"#cite_note-110\">&#91;110&#93;</a></sup><sup id=\"cite_ref-111\" class=\"reference\"><a href=\"#cite_note-111\">&#91;111&#93;</a></sup><sup id=\"cite_ref-112\" class=\"reference\"><a href=\"#cite_note-112\">&#91;112&#93;</a></sup> The transaction followed negotiations with other companies including <a href=\"/wiki/Reckitt_Benckiser\" class=\"mw-redirect\" title=\"Reckitt Benckiser\">Reckitt Benckiser</a>,<sup id=\"cite_ref-113\" class=\"reference\"><a href=\"#cite_note-113\">&#91;113&#93;</a></sup> <a href=\"/wiki/Sanofi\" title=\"Sanofi\">Sanofi</a>, <a href=\"/wiki/Johnson_%26_Johnson\" title=\"Johnson &amp; Johnson\">Johnson &amp; Johnson</a>,<sup id=\"cite_ref-114\" class=\"reference\"><a href=\"#cite_note-114\">&#91;114&#93;</a></sup> and <a href=\"/wiki/Procter_%26_Gamble\" title=\"Procter &amp; Gamble\">Procter &amp; Gamble</a>.<sup id=\"cite_ref-115\" class=\"reference\"><a href=\"#cite_note-115\">&#91;115&#93;</a></sup>\n</p><p>In September 2020, the company acquired a 9.9% stake in <a href=\"/w/index.php?title=CStone_Pharmaceuticals&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"CStone Pharmaceuticals (page does not exist)\">CStone Pharmaceuticals</a> for $200<span class=\"nowrap\">&#160;</span>million (HK$1.55<span class=\"nowrap\">&#160;</span>billion), helping to commercialise its anti-<a href=\"/wiki/PD-L1\" title=\"PD-L1\">PD-L1</a> monoclonal antibody, CS1001.<sup id=\"cite_ref-116\" class=\"reference\"><a href=\"#cite_note-116\">&#91;116&#93;</a></sup> In October 2020, the company acquired Arixa Pharmaceuticals.<sup id=\"cite_ref-117\" class=\"reference\"><a href=\"#cite_note-117\">&#91;117&#93;</a></sup> In November 2020, using a <a href=\"/wiki/Reverse_Morris_Trust\" title=\"Reverse Morris Trust\">Reverse Morris Trust</a> structure, Pfizer merged its off-patent branded and <a href=\"/wiki/Generic_drug\" title=\"Generic drug\">generic drug</a> business, known as Upjohn, with <a href=\"/wiki/Mylan\" title=\"Mylan\">Mylan</a> to form <a href=\"/wiki/Viatris\" title=\"Viatris\">Viatris</a>, owned 57% by Pfizer shareholders.<sup id=\"cite_ref-118\" class=\"reference\"><a href=\"#cite_note-118\">&#91;118&#93;</a></sup><sup id=\"cite_ref-119\" class=\"reference\"><a href=\"#cite_note-119\">&#91;119&#93;</a></sup><sup id=\"cite_ref-120\" class=\"reference\"><a href=\"#cite_note-120\">&#91;120&#93;</a></sup>\n</p>\n<h3><span id=\"2021.E2.80.93onwards:_Corporate_developments_and_acquisitions\"></span><span class=\"mw-headline\" id=\"2021–onwards:_Corporate_developments_and_acquisitions\">2021–onwards: Corporate developments and acquisitions</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=8\" title=\"Edit section: 2021–onwards: Corporate developments and acquisitions\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>On January 5, 2021, Pfizer introduced a new <a href=\"/wiki/Logo\" title=\"Logo\">logo</a>.<sup id=\"cite_ref-121\" class=\"reference\"><a href=\"#cite_note-121\">&#91;121&#93;</a></sup> In April 2021, Pfizer acquired Amplyx Pharmaceuticals and its anti-fungal compound Fosmanogepix (APX001).<sup id=\"cite_ref-122\" class=\"reference\"><a href=\"#cite_note-122\">&#91;122&#93;</a></sup><sup id=\"cite_ref-123\" class=\"reference\"><a href=\"#cite_note-123\">&#91;123&#93;</a></sup><sup id=\"cite_ref-124\" class=\"reference\"><a href=\"#cite_note-124\">&#91;124&#93;</a></sup> In August, the company announced it would acquire Trillium Therapeutics Inc and its immuno-oncology portfolio for $2.3 billion ($18.50 per share).<sup id=\"cite_ref-125\" class=\"reference\"><a href=\"#cite_note-125\">&#91;125&#93;</a></sup><sup id=\"cite_ref-126\" class=\"reference\"><a href=\"#cite_note-126\">&#91;126&#93;</a></sup> In December, Pfizer announced that it had agreed to acquire <a href=\"/wiki/Arena_Pharmaceuticals\" title=\"Arena Pharmaceuticals\">Arena Pharmaceuticals</a> for $6.7 billion in cash.<sup id=\"cite_ref-127\" class=\"reference\"><a href=\"#cite_note-127\">&#91;127&#93;</a></sup><sup id=\"cite_ref-128\" class=\"reference\"><a href=\"#cite_note-128\">&#91;128&#93;</a></sup> In March 2022, it was announced the acquisition of Arena Pharmaceuticals had been concluded.<sup id=\"cite_ref-129\" class=\"reference\"><a href=\"#cite_note-129\">&#91;129&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Acquisition_history\">Acquisition history</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=9\" title=\"Edit section: Acquisition history\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<div class=\"mw-collapsible mw-collapsed\" style=\"box-sizing:border-box;width:100%;font-size:95%;padding:4px;border:1px #aaa solid;\"><div style=\"font-size:100%;line-height:1.6;font-weight:bold;background:transparent;text-align:center;;\">Pfizer acquisitions</div><div class=\"mw-collapsible-content\" style=\"background:transparent;text-align:left;;\">\n<style data-mw-deduplicate=\"TemplateStyles:r886050385\">.mw-parser-output .treeview ul{padding:0;margin:0}.mw-parser-output .treeview li{padding:0;margin:0;list-style-type:none;list-style-image:none}.mw-parser-output .treeview li li{background:url(\"//upload.wikimedia.org/wikipedia/commons/f/f2/Treeview-grey-line.png\")no-repeat 0 -2981px;padding-left:21px;text-indent:0.3em}.mw-parser-output .treeview li li:last-child{background-position:0 -5971px}.mw-parser-output .treeview li.emptyline>ul>.mw-empty-elt:first-child+.emptyline,.mw-parser-output .treeview li.emptyline>ul>li:first-child{background-position:0 9px}</style><div class=\"treeview\">\n<ul><li><b>Pfizer</b> <small>(Founded 1849 as Charles Pfizer &amp; Company)</small>\n<ul><li><a href=\"/wiki/Warner%E2%80%93Lambert\" title=\"Warner–Lambert\">Warner–Lambert</a>\n<ul><li>William R. Warner <small>(Founded 1856, merged 1955)</small></li>\n<li>Lambert Pharmacal Company <small>(Merged 1955)</small></li>\n<li>Parke-Davis <small>(Founded 1860, Acq 1976)</small></li>\n<li>Wilkinson Sword <small>(Acq 1993, divested 2003)</small></li>\n<li>Agouron <small>(Acq 1999)</small></li></ul></li>\n<li><a href=\"/wiki/Pharmacia\" title=\"Pharmacia\">Pharmacia</a> <small>(Acq 2002)</small>\n<ul><li><a href=\"/wiki/Pharmacia_%26_Upjohn\" title=\"Pharmacia &amp; Upjohn\">Pharmacia &amp; Upjohn</a> <small>(Merged 2000)</small>\n<ul><li><a href=\"/wiki/Pharmacia\" title=\"Pharmacia\">Pharmacia</a> <small>(Merged 1995)</small>\n<ul><li>Farmitalia Carlo Erba</li>\n<li>Kabi Pharmacia</li>\n<li>Pharmacia Aktiebolaget</li></ul></li>\n<li><a href=\"/wiki/The_Upjohn_Company\" class=\"mw-redirect\" title=\"The Upjohn Company\">The Upjohn Company</a> <small>(Merged 1995)</small></li>\n<li><a href=\"/wiki/Monsanto\" title=\"Monsanto\">Monsanto</a> <small>(Merged 2000, divested 2002)</small></li>\n<li><a href=\"/wiki/G.D._Searle,_LLC\" title=\"G.D. Searle, LLC\">Searle</a> <small>(Merged 2000)</small></li></ul></li></ul></li>\n<li>Esperion Therapeutics <small>(Acq 2003, divested 2008)</small></li>\n<li>Meridica <small>(Acq 2004)</small></li>\n<li>Vicuron Pharmaceuticals <small>(Acq 2005)</small></li>\n<li>Idun <small>(Acq 2005)</small></li>\n<li>Angiosyn <small>(Acq 2005)</small></li>\n<li>Powermed <small>(Acq 2006)</small></li>\n<li>Rinat <small>(Acq 2006)</small></li>\n<li>Coley Pharmaceutical Group <small>(Acq 2007)</small></li>\n<li>CovX <small>(Acq 2007)</small></li>\n<li>Encysive Pharmaceuticals Inc <small>(Acq 2008)</small></li>\n<li><a href=\"/wiki/Wyeth\" title=\"Wyeth\">Wyeth</a> <small>(Acq 2009)</small>\n<ul><li><a href=\"/wiki/Chef_Boyardee\" title=\"Chef Boyardee\">Chef Boyardee</a> <small>(Acq 1946, divested 1996 with food div)</small></li>\n<li>S.M.A. Corporation</li>\n<li>Ayerst Laboratories <small>(Acq 1943)</small></li>\n<li>Fort Dodge Serum Company <small>(Acq 1945)</small></li>\n<li><a href=\"/wiki/Bristol-Myers\" class=\"mw-redirect\" title=\"Bristol-Myers\">Bristol-Myers</a> <small>(Animal Health div)</small></li>\n<li><a href=\"/wiki/Parke-Davis\" title=\"Parke-Davis\">Parke-Davis</a> <small>(Animal Health div)</small></li>\n<li>A.H. Robins</li>\n<li>Sherwood Medical <small>(Acq 1982)</small></li>\n<li><a href=\"/wiki/Genetics_Institute,_Inc.\" class=\"mw-redirect\" title=\"Genetics Institute, Inc.\">Genetics Institute, Inc.</a> <small>(Acq 1992)</small></li>\n<li><a href=\"/wiki/American_Cyanamid\" title=\"American Cyanamid\">American Cyanamid</a> <small>(Acq 1994)</small></li>\n<li>Lederle Laboratories</li>\n<li><a href=\"/wiki/Solvay_S.A.\" title=\"Solvay S.A.\">Solvay</a> <small>(Acq 1995, Animal Health div)</small></li></ul></li>\n<li><a href=\"/wiki/King_Pharmaceuticals\" title=\"King Pharmaceuticals\">King Pharmaceuticals</a> <small>(Acq 2010)</small>\n<ul><li>Monarch Pharmaceuticals, Inc.</li>\n<li>King Pharmaceuticals Research and Development, Inc.</li>\n<li>Meridian Medical Technologies, Inc.</li>\n<li>Parkedale Pharmaceuticals, Inc.</li>\n<li>King Pharmaceuticals Canada Inc.</li>\n<li>Monarch Pharmaceuticals Ireland Limited</li></ul></li>\n<li>Synbiotics Corporation <small>(Acq 2011)</small></li>\n<li>Icagen <small>(Acq 2011)</small></li>\n<li>Ferrosan <small>(Consumer Health div, Acq 2011)</small></li>\n<li>Excaliard Pharmaceuticals <small>(Acq 2011)</small></li>\n<li>Alacer Corp <small>(Acq 2012)</small></li>\n<li>NextWave Pharmaceuticals, Inc <small>(Acq 2012)</small></li>\n<li>Innopharma <small>(Acq 2014)</small></li>\n<li>Redvax GmbH <small>(Acq 2014)</small></li>\n<li>Hospira <small>(Spun off from Abbott Laboratories 2004, Acq 2015)</small> \n<ul><li>Mayne Pharma Ltd <small>(Acq 2007)</small></li>\n<li>Pliva-Croatia</li>\n<li><a href=\"/wiki/Orchid_Chemicals_%26_Pharmaceuticals_Ltd.\" class=\"mw-redirect\" title=\"Orchid Chemicals &amp; Pharmaceuticals Ltd.\">Orchid Chemicals &amp; Pharmaceuticals Ltd.</a> <small>(Generics &amp; Injectables div, Acq 2009)</small> </li>\n<li>Javelin Pharmaceuticals, Inc. <small>(Acq 2010)</small></li>\n<li>TheraDoc <small>(Acq 2010)</small></li>\n<li>Arixa Pharmaceuticals <small>(Acq 2020)</small></li></ul></li>\n<li><a href=\"/wiki/Anacor_Pharmaceuticals\" class=\"mw-redirect\" title=\"Anacor Pharmaceuticals\">Anacor Pharmaceuticals</a> <small>(Acq 2016)</small></li>\n<li>Bamboo Therapeutics <small>(Acq 2016)</small></li>\n<li><a href=\"/wiki/Medivation\" title=\"Medivation\">Medivation</a> <small>(Acq 2016)</small></li>\n<li><a href=\"/wiki/AstraZeneca\" title=\"AstraZeneca\">AstraZeneca</a> <small>(Small molecule antibiotic div, Acq 2016)</small></li>\n<li><a href=\"/wiki/Array_BioPharma\" title=\"Array BioPharma\">Array BioPharma</a> <small>(Acq 2019)</small></li>\n<li>Amplyx Pharmaceuticals <small>(Acq 2021)</small></li>\n<li>Trillium Therapeutics <small>(Acq 2021)</small></li>\n<li><a href=\"/wiki/Arena_Pharmaceuticals\" title=\"Arena Pharmaceuticals\">Arena Pharmaceuticals</a> <small>(Acq TBA)</small></li></ul></li></ul>\n</div>\n</div></div>\n<p><span class=\"anchor\" id=\"Litigation\"></span>\n</p>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Covid19_vaccine_biontech_pfizer_2.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/5b/Covid19_vaccine_biontech_pfizer_2.jpg/220px-Covid19_vaccine_biontech_pfizer_2.jpg\" decoding=\"async\" width=\"220\" height=\"113\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/5b/Covid19_vaccine_biontech_pfizer_2.jpg/330px-Covid19_vaccine_biontech_pfizer_2.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/5b/Covid19_vaccine_biontech_pfizer_2.jpg/440px-Covid19_vaccine_biontech_pfizer_2.jpg 2x\" data-file-width=\"2909\" data-file-height=\"1496\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Covid19_vaccine_biontech_pfizer_2.jpg\" class=\"internal\" title=\"Enlarge\"></a></div><a href=\"/wiki/Pfizer%E2%80%93BioNTech_COVID-19_vaccine\" title=\"Pfizer–BioNTech COVID-19 vaccine\">Pfizer–BioNTech COVID-19 vaccine</a></div></div></div>\n<h3><span class=\"mw-headline\" id=\"COVID-19_vaccine_and_other_initiatives\">COVID-19 vaccine and other initiatives</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=10\" title=\"Edit section: COVID-19 vaccine and other initiatives\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<h4><span class=\"mw-headline\" id=\"COVID-19_pandemic_and_vaccine_development\">COVID-19 pandemic and vaccine development</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=11\" title=\"Edit section: COVID-19 pandemic and vaccine development\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1033289096\"/><div role=\"note\" class=\"hatnote navigation-not-searchable\">See also: <a href=\"/wiki/Pfizer%E2%80%93BioNTech_COVID-19_vaccine\" title=\"Pfizer–BioNTech COVID-19 vaccine\">Pfizer–BioNTech COVID-19 vaccine</a></div>\n<h5><span class=\"mw-headline\" id=\"Initial_development_and_testing\">Initial development and testing</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=12\" title=\"Edit section: Initial development and testing\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h5>\n<p>In March 2020, as the scale of the <a href=\"/wiki/COVID-19_pandemic\" title=\"COVID-19 pandemic\">COVID-19 pandemic</a> became apparent, Pfizer partnered with BioNTech to study and develop <a href=\"/wiki/COVID-19\" title=\"COVID-19\">COVID-19</a> mRNA vaccine candidates. Unlike many of its competitors, Pfizer took no initial research funds from the United States' <a href=\"/wiki/Operation_Warp_Speed\" title=\"Operation Warp Speed\">Operation Warp Speed</a> vaccine development program, instead choosing to invest roughly $2 billion of its own funds. Pfizer CEO Albert Bourla has said that he declined money from Operation Warp Speed to avoid government intervention, stating later that \"when you get money from someone that always comes with strings. They want to see how we are going to progress, what type of moves you are going to do. They want reports. And also, I wanted to keep Pfizer out of politics, by the way.\"<sup id=\"cite_ref-130\" class=\"reference\"><a href=\"#cite_note-130\">&#91;130&#93;</a></sup>\n</p><p>In May 2020, Pfizer began testing four different <a href=\"/wiki/COVID-19_vaccine\" title=\"COVID-19 vaccine\">COVID-19 vaccine</a> variations. Vaccines were injected into the first human participants in the U.S. in early May.<sup id=\"cite_ref-131\" class=\"reference\"><a href=\"#cite_note-131\">&#91;131&#93;</a></sup> In July 2020, Pfizer and BioNTech announced that two of the partners' four <a href=\"/wiki/Messenger_RNA\" title=\"Messenger RNA\">mRNA</a> vaccine candidates had won fast track designation from the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">FDA</a>.<sup id=\"cite_ref-132\" class=\"reference\"><a href=\"#cite_note-132\">&#91;132&#93;</a></sup><sup id=\"cite_ref-133\" class=\"reference\"><a href=\"#cite_note-133\">&#91;133&#93;</a></sup> The company began Phase<span class=\"nowrap\">&#160;</span>II-III testing on 30,000 people in the last week of July 2020 and was slated to be paid $1.95<span class=\"nowrap\">&#160;</span>billion for 100<span class=\"nowrap\">&#160;</span>million doses of the vaccine by the US government.<sup id=\"cite_ref-134\" class=\"reference\"><a href=\"#cite_note-134\">&#91;134&#93;</a></sup> The U.S. deal priced two doses at $39, and the company stated that it would not lower the rates for other countries until the outbreak is no longer a pandemic.<sup id=\"cite_ref-135\" class=\"reference\"><a href=\"#cite_note-135\">&#91;135&#93;</a></sup> Pfizer's CEO stated the companies in the private sector producing a vaccine should make a profit.<sup id=\"cite_ref-136\" class=\"reference\"><a href=\"#cite_note-136\">&#91;136&#93;</a></sup> In September 2020, Pfizer and BioNTech announced that they had completed talks with the European Commission to provide an initial 200<span class=\"nowrap\">&#160;</span>million vaccine doses to the EU, with the option to supply another 100<span class=\"nowrap\">&#160;</span>million doses at a later date.<sup id=\"cite_ref-137\" class=\"reference\"><a href=\"#cite_note-137\">&#91;137&#93;</a></sup><sup id=\"cite_ref-138\" class=\"reference\"><a href=\"#cite_note-138\">&#91;138&#93;</a></sup>\n</p>\n<h5><span class=\"mw-headline\" id=\"Efficacy_results_and_authorization\">Efficacy results and authorization</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=13\" title=\"Edit section: Efficacy results and authorization\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h5>\n<link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1033289096\"/><div role=\"note\" class=\"hatnote navigation-not-searchable\">See also: <a href=\"/wiki/Pfizer%E2%80%93BioNTech_COVID-19_vaccine#Authorizations\" title=\"Pfizer–BioNTech COVID-19 vaccine\">Pfizer–BioNTech COVID-19 vaccine §&#160;Authorizations</a></div>\n<p>On November 9, 2020, Pfizer announced that BioNTech's COVID-19 vaccine, tested on 43,500 people, was found to be 90% effective at preventing symptomatic COVID-19.<sup id=\"cite_ref-139\" class=\"reference\"><a href=\"#cite_note-139\">&#91;139&#93;</a></sup> The efficacy was updated to 95% a week later.<sup id=\"cite_ref-:1_140-0\" class=\"reference\"><a href=\"#cite_note-:1-140\">&#91;140&#93;</a></sup> Akiko Iwasaki, an immunologist interviewed by the <i>New York Times</i>, described the efficacy figure as \"really a spectacular number.\"<sup id=\"cite_ref-141\" class=\"reference\"><a href=\"#cite_note-141\">&#91;141&#93;</a></sup> The announcement made Pfizer and BioNTech the first companies to develop and test a working vaccine for COVID-19.<sup id=\"cite_ref-:1_140-1\" class=\"reference\"><a href=\"#cite_note-:1-140\">&#91;140&#93;</a></sup>\n</p><p>Over the following month and a half, regulators in various countries approved Pfizer's vaccine for emergency use. The United Kingdom approved the vaccine first, on December 2,<sup id=\"cite_ref-142\" class=\"reference\"><a href=\"#cite_note-142\">&#91;142&#93;</a></sup> followed by <a href=\"/wiki/Bahrain\" title=\"Bahrain\">Bahrain</a> on December 4,<sup id=\"cite_ref-Bahrain_Approves_Covid-19_Vaccine_(Al_Jazeera)_143-0\" class=\"reference\"><a href=\"#cite_note-Bahrain_Approves_Covid-19_Vaccine_(Al_Jazeera)-143\">&#91;143&#93;</a></sup> Canada on December 9,<sup id=\"cite_ref-Canada_Approves_Covid-19_Vaccine_(NYT)_144-0\" class=\"reference\"><a href=\"#cite_note-Canada_Approves_Covid-19_Vaccine_(NYT)-144\">&#91;144&#93;</a></sup> and Saudi Arabia on December 10.<sup id=\"cite_ref-Saudi_Arabia_Approves_Covid-19_Vaccine,_Bahrain_To_Distribute_Free_to_Public_(KTLA)_145-0\" class=\"reference\"><a href=\"#cite_note-Saudi_Arabia_Approves_Covid-19_Vaccine,_Bahrain_To_Distribute_Free_to_Public_(KTLA)-145\">&#91;145&#93;</a></sup> On December 10, 2020, the United States FDA held an advisory committee meeting to discuss authorization of the vaccine.<sup id=\"cite_ref-US_FDA_Advisory_Panel_Backs_Covid-19_Vaccine_Approval_(Reuters)_146-0\" class=\"reference\"><a href=\"#cite_note-US_FDA_Advisory_Panel_Backs_Covid-19_Vaccine_Approval_(Reuters)-146\">&#91;146&#93;</a></sup> The next day, the US officially became the 5th country to approve use of Pfizer's vaccine under an Emergency Use Authorization (EUA), with an independent panel voting 17–4 in support of approval.<sup id=\"cite_ref-US_FDA_Advisory_Panel_Backs_Covid-19_Vaccine_Approval_(Reuters)_146-1\" class=\"reference\"><a href=\"#cite_note-US_FDA_Advisory_Panel_Backs_Covid-19_Vaccine_Approval_(Reuters)-146\">&#91;146&#93;</a></sup><sup id=\"cite_ref-147\" class=\"reference\"><a href=\"#cite_note-147\">&#91;147&#93;</a></sup> On December 14, Singapore became one of the first in Asia to approve the vaccine through the <a href=\"/wiki/Health_Sciences_Authority\" title=\"Health Sciences Authority\">Health Sciences Authority</a>.<sup id=\"cite_ref-148\" class=\"reference\"><a href=\"#cite_note-148\">&#91;148&#93;</a></sup> On December 21, the <a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a> (EMA) recommended granting a conditional marketing authorisation for the vaccine in the <a href=\"/wiki/European_Union\" title=\"European Union\">European Union</a>, under the brand name \"Comirnaty.\"<sup id=\"cite_ref-149\" class=\"reference\"><a href=\"#cite_note-149\">&#91;149&#93;</a></sup>\n</p>\n<h5><span class=\"mw-headline\" id=\"Manufacturing_and_distribution\">Manufacturing and distribution</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=14\" title=\"Edit section: Manufacturing and distribution\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h5>\n<link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1033289096\"/><div role=\"note\" class=\"hatnote navigation-not-searchable\">See also: <a href=\"/wiki/Pfizer%E2%80%93BioNTech_COVID-19_vaccine#Manufacturing\" title=\"Pfizer–BioNTech COVID-19 vaccine\">Pfizer–BioNTech COVID-19 vaccine §&#160;Manufacturing</a>, and <a href=\"/wiki/Deployment_of_COVID-19_vaccines\" title=\"Deployment of COVID-19 vaccines\">Deployment of COVID-19 vaccines</a></div>\n<p>As of early May 2021, Pfizer and BioNTech had manufactured at least 430 million vaccine doses, which have been distributed to 91 countries and territories. The companies have said they expect to manufacture nearly 3 billion total vaccine doses in 2021.<sup id=\"cite_ref-150\" class=\"reference\"><a href=\"#cite_note-150\">&#91;150&#93;</a></sup>\n</p>\n<h5><span class=\"mw-headline\" id=\"Controversy\">Controversy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=15\" title=\"Edit section: Controversy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h5>\n<p>In February 2021, after a year long investigation relying on unnamed officials, Pfizer was accused by <a href=\"/wiki/The_Bureau_of_Investigative_Journalism\" class=\"mw-redirect\" title=\"The Bureau of Investigative Journalism\">The Bureau of Investigative Journalism</a> (TBIJ) of employing \"high-level bullying\" against at least two <a href=\"/wiki/Latin_America\" title=\"Latin America\">Latin American</a> countries during negotiations to acquire COVID-19 vaccines, including requesting that the countries put sovereign assets as <a href=\"/wiki/Collateral_(finance)\" title=\"Collateral (finance)\">collateral</a> for payments.<sup id=\"cite_ref-bullied_151-0\" class=\"reference\"><a href=\"#cite_note-bullied-151\">&#91;151&#93;</a></sup> According to TBIJ, these negotiation tactics resulted in a months long delay in Pfizer reaching a vaccine agreement with one country and a complete failure to reach agreements with two other countries, including <a href=\"/wiki/Argentina\" title=\"Argentina\">Argentina</a> and Brazil.<sup id=\"cite_ref-bullied_151-1\" class=\"reference\"><a href=\"#cite_note-bullied-151\">&#91;151&#93;</a></sup>\n</p><p>On 2 November 2021, <a href=\"/wiki/The_BMJ\" title=\"The BMJ\">The BMJ</a> published an article after obtaining information from a <a href=\"/wiki/Whistleblower\" title=\"Whistleblower\">whistleblower</a> from the Ventavia Research Group. Ventavia was hired by Pfizer as a research subcontractor. The company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in <a href=\"/wiki/Pfizer%E2%80%93BioNTech_COVID-19_vaccine#Clinical_trials\" title=\"Pfizer–BioNTech COVID-19 vaccine\">Pfizer’s pivotal phase III trial</a>. The regional director, Brook Jackson, emailed a complaint to the US <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA). Ventavia fired her later the same day.<sup id=\"cite_ref-152\" class=\"reference\"><a href=\"#cite_note-152\">&#91;152&#93;</a></sup> The <a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a> (EMA) stated in a response to the <a href=\"/wiki/European_Parliament\" title=\"European Parliament\">European Parliament</a>, that \"the deficiencies identified do not jeopardize the quality and integrity of the data from the main Comirnaty trial and have no impact on the benefit-risk assessment or on the conclusions on the safety, effectiveness and quality of the vaccine”.<sup id=\"cite_ref-153\" class=\"reference\"><a href=\"#cite_note-153\">&#91;153&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Other_initiatives\">Other initiatives</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=16\" title=\"Edit section: Other initiatives\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>In November 2021 Pfizer started a new COVID-19 oral antivirus treatment, known as <a href=\"/wiki/Nirmatrelvir/ritonavir\" title=\"Nirmatrelvir/ritonavir\">Paxlovid</a>, which according to a recent study reduces the risk of hospitalisation or death by 89%.<sup id=\"cite_ref-154\" class=\"reference\"><a href=\"#cite_note-154\">&#91;154&#93;</a></sup> In January 2022, the Pfizer CEO <a href=\"/wiki/Albert_Bourla\" title=\"Albert Bourla\">Albert Bourla</a> confirmed that the trial results of a fourth dose were pending until March 2022. He also said that the firm was setting up a collaboration to develop an anti-Covid pill treatment along with French company, <a href=\"/wiki/Novasep\" title=\"Novasep\">Novasep</a>. He also said the Covid vaccine was “safe and efficient” for children.<sup id=\"cite_ref-155\" class=\"reference\"><a href=\"#cite_note-155\">&#91;155&#93;</a></sup> <sup id=\"cite_ref-156\" class=\"reference\"><a href=\"#cite_note-156\">&#91;156&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Legal_issues\">Legal issues</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=17\" title=\"Edit section: Legal issues\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Aggressive_pharmaceutical_marketing\">Aggressive pharmaceutical marketing</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=18\" title=\"Edit section: Aggressive pharmaceutical marketing\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1033289096\"/><div role=\"note\" class=\"hatnote navigation-not-searchable\">See also: <a href=\"/wiki/List_of_largest_pharmaceutical_settlements\" title=\"List of largest pharmaceutical settlements\">List of largest pharmaceutical settlements</a> and <a href=\"/wiki/Franklin_v._Parke-Davis\" title=\"Franklin v. Parke-Davis\">Franklin v. Parke-Davis</a></div>\n<p>Pfizer has been accused of aggressive <a href=\"/wiki/Pharmaceutical_marketing\" title=\"Pharmaceutical marketing\">pharmaceutical marketing</a>.<sup id=\"cite_ref-157\" class=\"reference\"><a href=\"#cite_note-157\">&#91;157&#93;</a></sup><sup id=\"cite_ref-158\" class=\"reference\"><a href=\"#cite_note-158\">&#91;158&#93;</a></sup><sup id=\"cite_ref-159\" class=\"reference\"><a href=\"#cite_note-159\">&#91;159&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Illegal_marketing_of_gabapentin_for_off-label_uses\">Illegal marketing of gabapentin for off-label uses</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=19\" title=\"Edit section: Illegal marketing of gabapentin for off-label uses\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>In 1993, the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA) approved <a href=\"/wiki/Gabapentin\" title=\"Gabapentin\">gabapentin</a> only for treatment of <a href=\"/wiki/Seizures\" class=\"mw-redirect\" title=\"Seizures\">seizures</a>. <a href=\"/wiki/Warner%E2%80%93Lambert\" title=\"Warner–Lambert\">Warner–Lambert</a>, which merged with Pfizer in 2000, used <a href=\"/wiki/Continuing_medical_education\" title=\"Continuing medical education\">continuing medical education</a> and <a href=\"/wiki/Medical_research\" title=\"Medical research\">medical research</a>, sponsored articles about the drug for the medical literature, and alleged suppression of unfavorable study results, to promote gabapentin. Within five years, the drug was being widely used for <a href=\"/wiki/Off-label_use\" title=\"Off-label use\">off-label uses</a> such as treatment of pain and psychiatric conditions. Warner–Lambert admitted to violating FDA regulations by promoting the drug for pain, psychiatric conditions, migraine, and other unapproved uses.<sup id=\"cite_ref-160\" class=\"reference\"><a href=\"#cite_note-160\">&#91;160&#93;</a></sup> In 2004, the company paid $430<span class=\"nowrap\">&#160;</span>million in one of the largest settlements to resolve criminal and civil health care liability charges. It was the first off-label promotion case successfully brought under the <a href=\"/wiki/False_Claims_Act\" title=\"False Claims Act\">False Claims Act</a>.<sup id=\"cite_ref-161\" class=\"reference\"><a href=\"#cite_note-161\">&#91;161&#93;</a></sup> A Cochrane review concluded that gabapentin is ineffective in migraine prophylaxis.<sup id=\"cite_ref-162\" class=\"reference\"><a href=\"#cite_note-162\">&#91;162&#93;</a></sup> The <a href=\"/wiki/American_Academy_of_Neurology\" title=\"American Academy of Neurology\">American Academy of Neurology</a> rates it as having unproven efficacy, while the <a href=\"/wiki/Canadian_Headache_Society\" title=\"Canadian Headache Society\">Canadian Headache Society</a> and the <a href=\"/wiki/European_Federation_of_Neurological_Societies\" title=\"European Federation of Neurological Societies\">European Federation of Neurological Societies</a> rate its use as being supported by moderate and low-quality evidence.<sup id=\"cite_ref-163\" class=\"reference\"><a href=\"#cite_note-163\">&#91;163&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Illegal_marketing_of_Bextra\">Illegal marketing of Bextra</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=20\" title=\"Edit section: Illegal marketing of Bextra\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>In September 2009, Pfizer pleaded guilty to the illegal marketing of <a href=\"/wiki/Arthritis\" title=\"Arthritis\">arthritis</a> drug <a href=\"/wiki/Valdecoxib\" title=\"Valdecoxib\">valdecoxib</a> (<i>Bextra</i>) and agreed to a $2.3<span class=\"nowrap\">&#160;</span>billion settlement, the largest <a href=\"/wiki/Health_care_fraud\" title=\"Health care fraud\">health care fraud</a> settlement at that time. Pfizer promoted the sale of the drug for several uses and dosages that the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> specifically declined to approve due to safety concerns. The drug was pulled from the market in 2005.<sup id=\"cite_ref-164\" class=\"reference\"><a href=\"#cite_note-164\">&#91;164&#93;</a></sup><sup id=\"cite_ref-largestdoj_165-0\" class=\"reference\"><a href=\"#cite_note-largestdoj-165\">&#91;165&#93;</a></sup> It was Pfizer's fourth such settlement in a decade.<sup id=\"cite_ref-Settle_166-0\" class=\"reference\"><a href=\"#cite_note-Settle-166\">&#91;166&#93;</a></sup><sup id=\"cite_ref-Improper_167-0\" class=\"reference\"><a href=\"#cite_note-Improper-167\">&#91;167&#93;</a></sup><sup id=\"cite_ref-fine_168-0\" class=\"reference\"><a href=\"#cite_note-fine-168\">&#91;168&#93;</a></sup> The payment included $1.3<span class=\"nowrap\">&#160;</span>billion in criminal penalties for felony violations of the <a href=\"/wiki/Federal_Food,_Drug,_and_Cosmetic_Act\" title=\"Federal Food, Drug, and Cosmetic Act\">Federal Food, Drug, and Cosmetic Act</a>, and $1.0<span class=\"nowrap\">&#160;</span>billion to settle allegations it had illegally promoted the drugs for uses that were not approved by the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA) leading to violations under the <a href=\"/wiki/False_Claims_Act\" title=\"False Claims Act\">False Claims Act</a> as reimbursements were requested from Federal and State programs. The criminal fine was the largest ever assessed in the United States to date.<sup id=\"cite_ref-largestdoj_165-1\" class=\"reference\"><a href=\"#cite_note-largestdoj-165\">&#91;165&#93;</a></sup><sup id=\"cite_ref-Settle_166-1\" class=\"reference\"><a href=\"#cite_note-Settle-166\">&#91;166&#93;</a></sup><sup id=\"cite_ref-Improper_167-1\" class=\"reference\"><a href=\"#cite_note-Improper-167\">&#91;167&#93;</a></sup><sup id=\"cite_ref-fine_168-1\" class=\"reference\"><a href=\"#cite_note-fine-168\">&#91;168&#93;</a></sup> Pfizer entered a <a href=\"/wiki/Corporate_integrity_agreement\" title=\"Corporate integrity agreement\">corporate integrity agreement</a> with the <a href=\"/wiki/Office_of_Inspector_General_(United_States)\" title=\"Office of Inspector General (United States)\">Office of Inspector General</a> that required it to make substantial structural reforms within the company, and publish to its website its post approval commitments and a searchable database of all payments to physicians made by the company.<sup id=\"cite_ref-169\" class=\"reference\"><a href=\"#cite_note-169\">&#91;169&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Termination_of_Peter_Rost\">Termination of Peter Rost</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=21\" title=\"Edit section: Termination of Peter Rost\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p><a href=\"/wiki/Peter_Rost_(doctor)\" title=\"Peter Rost (doctor)\">Peter Rost</a> was vice president in charge of the <a href=\"/wiki/Endocrinology\" title=\"Endocrinology\">endocrinology</a> division at <a href=\"/wiki/Pharmacia\" title=\"Pharmacia\">Pharmacia</a> before its acquisition by Pfizer. During that time he raised concerns internally about <a href=\"/wiki/Kickback_(bribery)\" title=\"Kickback (bribery)\">kickbacks</a> and off-label marketing of Genotropin, Pharmacia's <a href=\"/wiki/Human_growth_hormone\" class=\"mw-redirect\" title=\"Human growth hormone\">human growth hormone</a> drug. Pfizer reported the Pharmacia marketing practices to the FDA and Department of Justice; Rost was unaware of this and filed an FCA lawsuit against Pfizer. Pfizer kept him employed, but isolated him until the FCA suit was unsealed in 2005. The Justice Department declined to intervene, and Pfizer fired him, and he filed a wrongful termination suit against Pfizer. Pfizer won a summary dismissal of the case, with the court ruling that the evidence showed Pfizer had decided to fire Rost prior to learning of his whistleblower activities.<sup id=\"cite_ref-170\" class=\"reference\"><a href=\"#cite_note-170\">&#91;170&#93;</a></sup><sup id=\"cite_ref-171\" class=\"reference\"><a href=\"#cite_note-171\">&#91;171&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Illegal_marketing_of_Rapamune\">Illegal marketing of Rapamune</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=22\" title=\"Edit section: Illegal marketing of Rapamune\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>A \"whistleblower suit\" was filed in 2005 against <a href=\"/wiki/Wyeth\" title=\"Wyeth\">Wyeth</a>, which was acquired by Pfizer in 2009, alleging that the company illegally marketed <a href=\"/wiki/Sirolimus\" title=\"Sirolimus\">sirolimus</a> (<i>Rapamune</i>) for <a href=\"/wiki/Off-label_use\" title=\"Off-label use\">off-label uses</a>, targeted specific doctors and medical facilities to increase sales of Rapamune, tried to get transplant patients to change from their transplant drugs to Rapamune, and specifically targeted <a href=\"/wiki/African-Americans\" class=\"mw-redirect\" title=\"African-Americans\">African-Americans</a>. According to the whistleblowers, Wyeth also provided doctors and hospitals that prescribed the drug with kickbacks such as grants, donations, and other money.<sup id=\"cite_ref-172\" class=\"reference\"><a href=\"#cite_note-172\">&#91;172&#93;</a></sup> In 2013, the company pleaded guilty to criminal mis-branding violations under the <a href=\"/wiki/Federal_Food,_Drug,_and_Cosmetic_Act\" title=\"Federal Food, Drug, and Cosmetic Act\">Federal Food, Drug, and Cosmetic Act</a>. By August 2014, it had paid $491<span class=\"nowrap\">&#160;</span>million in civil and criminal penalties related to Rapamune.<sup id=\"cite_ref-173\" class=\"reference\"><a href=\"#cite_note-173\">&#91;173&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Illegal_marketing\">Illegal marketing</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=23\" title=\"Edit section: Illegal marketing\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>In June 2010, health insurance network <a href=\"/wiki/Blue_Cross_Blue_Shield\" class=\"mw-redirect\" title=\"Blue Cross Blue Shield\">Blue Cross Blue Shield</a> (BCBS) filed a lawsuit against Pfizer for allegedly illegally marketing drugs Bextra, Geodon and Lyrica. BCBS alleged that Pfizer used kickbacks and wrongly persuaded doctors to prescribe the drugs.<sup id=\"cite_ref-174\" class=\"reference\"><a href=\"#cite_note-174\">&#91;174&#93;</a></sup><sup id=\"cite_ref-175\" class=\"reference\"><a href=\"#cite_note-175\">&#91;175&#93;</a></sup> According to the lawsuit, Pfizer handed out 'misleading' materials on <a href=\"/wiki/Off-label_use\" title=\"Off-label use\">off-label uses</a>, sent over 5,000 doctors on trips to the <a href=\"/wiki/Caribbean\" title=\"Caribbean\">Caribbean</a> or around the United States, and paid them $2,000 honoraria in return for listening to lectures about Bextra.<sup id=\"cite_ref-176\" class=\"reference\"><a href=\"#cite_note-176\">&#91;176&#93;</a></sup><sup id=\"cite_ref-177\" class=\"reference\"><a href=\"#cite_note-177\">&#91;177&#93;</a></sup> Despite Pfizer's claims that \"the company's intent was pure\" in fostering a legal exchange of information among doctors, an internal marketing plan revealed that Pfizer intended to train physicians \"to serve as public relations spokespeople.\"<sup id=\"cite_ref-toobig_178-0\" class=\"reference\"><a href=\"#cite_note-toobig-178\">&#91;178&#93;</a></sup> The case was settled in 2014 for $325<span class=\"nowrap\">&#160;</span>million.<sup id=\"cite_ref-179\" class=\"reference\"><a href=\"#cite_note-179\">&#91;179&#93;</a></sup> Fearing that Pfizer is \"<a href=\"/wiki/Too_big_to_fail\" title=\"Too big to fail\">too big to fail</a>\" and that prosecuting the company would result in disruptions to <a href=\"/wiki/Medicare_(United_States)\" title=\"Medicare (United States)\">Medicare</a> and <a href=\"/wiki/Medicaid\" title=\"Medicaid\">Medicaid</a>, federal prosecutors instead charged a subsidiary of a subsidiary of a subsidiary of Pfizer, which is \"nothing more than a shell company whose only function is to plead guilty.\"<sup id=\"cite_ref-toobig_178-1\" class=\"reference\"><a href=\"#cite_note-toobig-178\">&#91;178&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Removal_of_ads_after_unflattering_article\">Removal of ads after unflattering article</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=24\" title=\"Edit section: Removal of ads after unflattering article\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>According to <i><a href=\"/wiki/Harper%27s_Magazine\" title=\"Harper&#39;s Magazine\">Harper's Magazine</a></i> publisher <a href=\"/wiki/John_R._MacArthur\" title=\"John R. MacArthur\">John R. MacArthur</a>, Pfizer withdrew \"between $400,000 and a million dollars\" worth of ads from <i><a href=\"/wiki/Harper%27s_Magazine\" title=\"Harper&#39;s Magazine\">Harper's Magazine</a></i> following an unflattering article on depression medication.<sup id=\"cite_ref-180\" class=\"reference\"><a href=\"#cite_note-180\">&#91;180&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Quigley_Company_asbestos\">Quigley Company asbestos</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=25\" title=\"Edit section: Quigley Company asbestos\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The Quigley Company, which sold <a href=\"/wiki/Asbestos\" title=\"Asbestos\">asbestos</a>-containing insulation products until the early 1970s, was acquired by Pfizer in 1968. In June 2013, asbestos victims and Pfizer negotiated a settlement that required Pfizer to pay a total of $964<span class=\"nowrap\">&#160;</span>million: $430<span class=\"nowrap\">&#160;</span>million to 80% of existing plaintiffs and place an additional $535<span class=\"nowrap\">&#160;</span>million into a settlement trust that will compensate future plaintiffs as well as the remaining 20% of plaintiffs with claims against Pfizer and Quigley. Of that $535<span class=\"nowrap\">&#160;</span>million, $405<span class=\"nowrap\">&#160;</span>million is in a 40-year note from Pfizer, while $100<span class=\"nowrap\">&#160;</span>million is from insurance policies.<sup id=\"cite_ref-181\" class=\"reference\"><a href=\"#cite_note-181\">&#91;181&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Shiley_defective_heart_valves\">Shiley defective heart valves</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=26\" title=\"Edit section: Shiley defective heart valves\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Pfizer purchased Shiley in 1979, at the onset of its Convexo-Concave valve ordeal, involving the <a href=\"/wiki/Bjork%E2%80%93Shiley_valve\" class=\"mw-redirect\" title=\"Bjork–Shiley valve\">Bjork–Shiley valve</a>. Approximately 500 people died when defective <a href=\"/wiki/Heart_valve\" title=\"Heart valve\">heart valves</a> fractured and, in 1994, Pfizer agreed to pay $10.75<span class=\"nowrap\">&#160;</span>million to settle claims by the <a href=\"/wiki/United_States_Department_of_Justice\" title=\"United States Department of Justice\">United States Department of Justice</a> that the company lied to get approval for the valves.<sup id=\"cite_ref-182\" class=\"reference\"><a href=\"#cite_note-182\">&#91;182&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Firing_of_employee_that_filed_suit\">Firing of employee that filed suit</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=27\" title=\"Edit section: Firing of employee that filed suit\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>A federal lawsuit was filed by a scientist claiming she got an infection by a genetically modified <a href=\"/wiki/Lentivirus\" title=\"Lentivirus\">lentivirus</a> while working for Pfizer, resulting in intermittent <a href=\"/wiki/Paralysis\" title=\"Paralysis\">paralysis</a>.<sup id=\"cite_ref-183\" class=\"reference\"><a href=\"#cite_note-183\">&#91;183&#93;</a></sup> A judge dismissed the case citing a lack of evidence that the illness was caused by the virus but the jury ruled that by firing the employee, Pfizer violated laws protecting <a href=\"/wiki/Freedom_of_speech\" title=\"Freedom of speech\">freedom of speech</a> and <a href=\"/wiki/Whistleblower\" title=\"Whistleblower\">whistleblowers</a> and awarded her $1.37<span class=\"nowrap\">&#160;</span>million.<sup id=\"cite_ref-184\" class=\"reference\"><a href=\"#cite_note-184\">&#91;184&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Celebrex_intellectual_property\">Celebrex intellectual property</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=28\" title=\"Edit section: Celebrex intellectual property\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><a href=\"/wiki/Brigham_Young_University\" title=\"Brigham Young University\">Brigham Young University</a> (BYU) said a professor of chemistry, Dr. <a href=\"/wiki/Daniel_L._Simmons\" title=\"Daniel L. Simmons\">Daniel L. Simmons</a>, discovered an enzyme in the 1990s that led towards development of <a href=\"/wiki/Celebrex\" class=\"mw-redirect\" title=\"Celebrex\">Celebrex</a>. BYU was originally seeking a 15% royalty on sales, equating to $9.7<span class=\"nowrap\">&#160;</span>billion. A research agreement had been made between BYU and <a href=\"/wiki/Monsanto\" title=\"Monsanto\">Monsanto</a>, whose pharmaceutical business was later acquired by Pfizer, to develop a better <a href=\"/wiki/Aspirin\" title=\"Aspirin\">aspirin</a>. The enzyme Dr. Simmons claims to have discovered would induce pain and inflammation while causing gastrointestinal problems and Celebrex is used to reduce those issues. A six-year battle ensued because BYU claimed that Pfizer did not give Dr. Simmons credit or compensation, while Pfizer claimed that it had met all obligations regarding the Monsanto agreement. In May 2012, Pfizer settled the allegations, agreeing to pay $450<span class=\"nowrap\">&#160;</span>million.<sup id=\"cite_ref-185\" class=\"reference\"><a href=\"#cite_note-185\">&#91;185&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Nigeria_Trovafloxacin_lawsuit\">Nigeria Trovafloxacin lawsuit</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=29\" title=\"Edit section: Nigeria Trovafloxacin lawsuit\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1033289096\"/><div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Abdullahi_v._Pfizer,_Inc.\" title=\"Abdullahi v. Pfizer, Inc.\">Abdullahi v. Pfizer, Inc.</a></div>\n<p>In 1996, an outbreak of measles, cholera, and bacterial meningitis occurred in Nigeria. Pfizer representatives and personnel from a contract research organization (CRO) traveled to <a href=\"/wiki/Kano_(city)\" title=\"Kano (city)\">Kano</a> to set up a clinical trial and administer an experimental <a href=\"/wiki/Antibiotic\" title=\"Antibiotic\">antibiotic</a>, <a href=\"/wiki/Trovafloxacin\" title=\"Trovafloxacin\">trovafloxacin</a>, to approximately 200 children.<sup id=\"cite_ref-186\" class=\"reference\"><a href=\"#cite_note-186\">&#91;186&#93;</a></sup> Local Kano officials reported that more than fifty children died in the experiment, while many others developed mental and physical deformities.<sup id=\"cite_ref-187\" class=\"reference\"><a href=\"#cite_note-187\">&#91;187&#93;</a></sup> The nature and frequency of both fatalities and other adverse outcomes were similar to those historically found among pediatric patients treated for meningitis in sub-Saharan Africa.<sup id=\"cite_ref-188\" class=\"reference\"><a href=\"#cite_note-188\">&#91;188&#93;</a></sup> In 2001, families of the children, as well as the governments of Kano and Nigeria, filed lawsuits regarding the treatment.<sup id=\"cite_ref-189\" class=\"reference\"><a href=\"#cite_note-189\">&#91;189&#93;</a></sup> According to <i><a href=\"/wiki/Democracy_Now!\" title=\"Democracy Now!\">Democracy Now!</a></i>, \"[r]esearchers did not obtain signed consent forms, and medical personnel said Pfizer did not tell parents their children were getting the experimental drug.\"<sup id=\"cite_ref-DN_190-0\" class=\"reference\"><a href=\"#cite_note-DN-190\">&#91;190&#93;</a></sup> The lawsuits also accused Pfizer of using the outbreak to perform unapproved human testing, as well as allegedly under-dosing a control group being treated with traditional antibiotics in order to skew the results of the trial in favor of Trovan. Nigerian medical personnel as well as at least one Pfizer physician said the trial was conducted without regulatory approval.<sup id=\"cite_ref-191\" class=\"reference\"><a href=\"#cite_note-191\">&#91;191&#93;</a></sup><sup id=\"cite_ref-192\" class=\"reference\"><a href=\"#cite_note-192\">&#91;192&#93;</a></sup>\n</p><p>In 2007, Pfizer published a Statement of Defense letter.<sup id=\"cite_ref-193\" class=\"reference\"><a href=\"#cite_note-193\">&#91;193&#93;</a></sup> The letter stated that the drug's oral form was safer and easier to administer, that Trovan had been used safely in more than five thousand Americans prior to the Nigerian trial, that mortality in the patients treated by Pfizer was lower than that observed historically in African meningitis epidemics, and that no unusual side effects, unrelated to meningitis, were observed after four weeks.\n</p><p>In June 2010, the US Supreme Court rejected Pfizer's appeal against a ruling allowing lawsuits by the Nigerian families to proceed.<sup id=\"cite_ref-194\" class=\"reference\"><a href=\"#cite_note-194\">&#91;194&#93;</a></sup>\n</p><p>In December 2010, a <a href=\"/wiki/United_States_diplomatic_cables_leak\" title=\"United States diplomatic cables leak\">United States diplomatic cables leak</a> was released by <a href=\"/wiki/WikiLeaks\" title=\"WikiLeaks\">WikiLeaks</a> indicating that Pfizer hired investigators to find evidence of corruption against Nigerian attorney general Aondoakaa to persuade him to drop legal action.<sup id=\"cite_ref-195\" class=\"reference\"><a href=\"#cite_note-195\">&#91;195&#93;</a></sup> <i><a href=\"/wiki/The_Washington_Post\" title=\"The Washington Post\">The Washington Post</a></i> reporter Joe Stephens, who helped break the story in 2000, called these actions \"dangerously close to blackmail\".<sup id=\"cite_ref-DN_190-1\" class=\"reference\"><a href=\"#cite_note-DN-190\">&#91;190&#93;</a></sup> In response, the company released a press statement describing the allegations as \"preposterous\" and saying that it acted in good faith.<sup id=\"cite_ref-196\" class=\"reference\"><a href=\"#cite_note-196\">&#91;196&#93;</a></sup> Aondoakka, who had allegedly demanded bribes from Pfizer in return for a settlement of the case,<sup id=\"cite_ref-197\" class=\"reference\"><a href=\"#cite_note-197\">&#91;197&#93;</a></sup> was declared unfit for office and had his U.S. visa revoked in association with corruption charges in 2010.<sup id=\"cite_ref-198\" class=\"reference\"><a href=\"#cite_note-198\">&#91;198&#93;</a></sup><sup id=\"cite_ref-199\" class=\"reference\"><a href=\"#cite_note-199\">&#91;199&#93;</a></sup>\n</p><p>The lawsuits were eventually settled out of court. Pfizer committed to paying US$35 million \"to compensate the families of children in the study\", another US$30 million to \"support healthcare initiatives in Kano\", and 10 million to cover legal costs. Payouts began in 2011.<sup id=\"cite_ref-200\" class=\"reference\"><a href=\"#cite_note-200\">&#91;200&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Environmental_record\">Environmental record</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=30\" title=\"Edit section: Environmental record\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Since 2000, the company has implemented more than 4,000 <a href=\"/wiki/Greenhouse_gas\" title=\"Greenhouse gas\">greenhouse gas</a> reduction projects.<sup id=\"cite_ref-201\" class=\"reference\"><a href=\"#cite_note-201\">&#91;201&#93;</a></sup>\n</p><p>In 2012, the company was named to the <a href=\"/wiki/Carbon_Disclosure_Project\" title=\"Carbon Disclosure Project\">Carbon Disclosure Project</a>'s Carbon Leadership Index in recognition of its efforts to reduce <a href=\"/wiki/Greenhouse_gas_emissions\" title=\"Greenhouse gas emissions\">greenhouse gas emissions</a>.<sup id=\"cite_ref-202\" class=\"reference\"><a href=\"#cite_note-202\">&#91;202&#93;</a></sup>\n</p><p>Pfizer has inherited Wyeth's liabilities in the <a href=\"/wiki/American_Cyanamid\" title=\"American Cyanamid\">American Cyanamid</a> site in <a href=\"/wiki/Bridgewater_Township,_New_Jersey\" title=\"Bridgewater Township, New Jersey\">Bridgewater Township, New Jersey</a>, a highly toxic EPA <a href=\"/wiki/Superfund\" title=\"Superfund\">Superfund</a> site. Pfizer has since attempted to remediate this land in order to clean and develop it for future profits and potential public uses.<sup id=\"cite_ref-203\" class=\"reference\"><a href=\"#cite_note-203\">&#91;203&#93;</a></sup> The <a href=\"/wiki/Sierra_Club\" title=\"Sierra Club\">Sierra Club</a> and the <a href=\"/wiki/Edison_Wetlands_Association\" title=\"Edison Wetlands Association\">Edison Wetlands Association</a> have opposed the cleanup plan, arguing that the area is subject to flooding, which could cause pollutants to leach. The EPA considers the plan the most reasonable from considerations of safety and cost-effectiveness, arguing that an alternative plan involving trucking <a href=\"/wiki/Contaminated_soil\" class=\"mw-redirect\" title=\"Contaminated soil\">contaminated soil</a> off site could expose cleanup workers. The EPA's position is backed by the environmental watchdog group CRISIS.<sup id=\"cite_ref-204\" class=\"reference\"><a href=\"#cite_note-204\">&#91;204&#93;</a></sup>\n</p><p>In June 2002, a chemical explosion at the Groton plant injured 7 people and caused the evacuation of more than 100 homes in the surrounding area.<sup id=\"cite_ref-205\" class=\"reference\"><a href=\"#cite_note-205\">&#91;205&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Outreach\">Outreach</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=31\" title=\"Edit section: Outreach\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Political_lobbying\">Political lobbying</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=32\" title=\"Edit section: Political lobbying\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Pfizer is a member of the <a href=\"/wiki/U.S._Global_Leadership_Coalition\" title=\"U.S. Global Leadership Coalition\">U.S. Global Leadership Coalition</a>, a Washington D.C.-based coalition of more than 400 major companies and NGOs that advocates for a larger International Affairs budget, which funds American diplomatic, humanitarian, and development efforts abroad.<sup id=\"cite_ref-206\" class=\"reference\"><a href=\"#cite_note-206\">&#91;206&#93;</a></sup>\n</p><p>Pfizer is a member company of <a href=\"/wiki/Pharmaceutical_Research_and_Manufacturers_of_America\" title=\"Pharmaceutical Research and Manufacturers of America\">Pharmaceutical Research and Manufacturers of America</a> (PhRMA), a trade association that lobbies the <a href=\"/wiki/U.S._Government\" class=\"mw-redirect\" title=\"U.S. Government\">U.S. Government</a> on behalf of the <a href=\"/wiki/Pharmaceutical_industry\" title=\"Pharmaceutical industry\">pharmaceutical industry</a>.<sup id=\"cite_ref-207\" class=\"reference\"><a href=\"#cite_note-207\">&#91;207&#93;</a></sup> PhRMA has offices in <a href=\"/wiki/Washington,_D.C.\" title=\"Washington, D.C.\">Washington, D.C.</a>, <a href=\"/wiki/Japan\" title=\"Japan\">Japan</a> and the <a href=\"/wiki/United_Arab_Emirates\" title=\"United Arab Emirates\">United Arab Emirates</a>.<sup id=\"cite_ref-208\" class=\"reference\"><a href=\"#cite_note-208\">&#91;208&#93;</a></sup>\n</p><p>Pfizer is a member organization of the <a href=\"/wiki/National_Health_Council\" title=\"National Health Council\">National Health Council</a>, a non-profit organization that lobbies the <a href=\"/wiki/U.S._Government\" class=\"mw-redirect\" title=\"U.S. Government\">U.S. Government</a> on issues related to <a href=\"/wiki/Healthcare_reform_in_the_United_States\" title=\"Healthcare reform in the United States\">healthcare reform</a>.<sup id=\"cite_ref-209\" class=\"reference\"><a href=\"#cite_note-209\">&#91;209&#93;</a></sup>\n</p><p>Pfizer is a member organization of Research!America, a medical research advocacy group.<sup id=\"cite_ref-210\" class=\"reference\"><a href=\"#cite_note-210\">&#91;210&#93;</a></sup>\n</p><p>Pfizer is a partner organization of the <a href=\"/wiki/World_Economic_Forum\" title=\"World Economic Forum\">World Economic Forum</a>,<sup id=\"cite_ref-211\" class=\"reference\"><a href=\"#cite_note-211\">&#91;211&#93;</a></sup> through which CEO <a href=\"/wiki/Albert_Bourla\" title=\"Albert Bourla\">Albert Bourla</a> wrote in 2018 about the need to explore the consequences of tech-based personalized health care through filters of society, economy and politics.<sup id=\"cite_ref-212\" class=\"reference\"><a href=\"#cite_note-212\">&#91;212&#93;</a></sup>\n</p><p><a href=\"/wiki/Scott_Gottlieb\" title=\"Scott Gottlieb\">Scott Gottlieb</a>, who resigned as <a href=\"/wiki/FDA_commissioner\" class=\"mw-redirect\" title=\"FDA commissioner\">FDA commissioner</a> in April 2019, joined the Pfizer <a href=\"/wiki/Board_of_directors\" title=\"Board of directors\">board of directors</a> three months later, in July 2019.<sup id=\"cite_ref-213\" class=\"reference\"><a href=\"#cite_note-213\">&#91;213&#93;</a></sup>\n</p><p>Pfizer is a member of the Personalized Medicine Coalition, a lobbying group with ties to members of the <a href=\"/wiki/United_States_Congress\" title=\"United States Congress\">United States Congress</a>.<sup id=\"cite_ref-214\" class=\"reference\"><a href=\"#cite_note-214\">&#91;214&#93;</a></sup>\n</p><p>Pfizer is a member company of Innovative Medicines Canada, an association of pharmaceutical companies doing business in Canada.<sup id=\"cite_ref-215\" class=\"reference\"><a href=\"#cite_note-215\">&#91;215&#93;</a></sup> The group lobbies the <a href=\"/wiki/Government_of_Ontario\" title=\"Government of Ontario\">Government of Ontario</a> through Rubicon Strategy, a firm owned by <a href=\"/wiki/Progressive_Conservative_Party_of_Ontario\" title=\"Progressive Conservative Party of Ontario\">Progressive Conservative Party of Ontario</a> campaign manager <a href=\"/wiki/Kory_Teneycke\" title=\"Kory Teneycke\">Kory Teneycke</a>.<sup id=\"cite_ref-216\" class=\"reference\"><a href=\"#cite_note-216\">&#91;216&#93;</a></sup><sup id=\"cite_ref-217\" class=\"reference\"><a href=\"#cite_note-217\">&#91;217&#93;</a></sup>\n</p><p>Pfizer has donated between $5,000,000 and $9,999,999 to the <a href=\"/wiki/Foundation_for_the_National_Institutes_of_Health\" title=\"Foundation for the National Institutes of Health\">Foundation for the National Institutes of Health</a> between 1997 and 2020.<sup id=\"cite_ref-218\" class=\"reference\"><a href=\"#cite_note-218\">&#91;218&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Media\">Media</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=33\" title=\"Edit section: Media\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>During the <a href=\"/wiki/COVID-19_pandemic\" title=\"COVID-19 pandemic\">COVID-19 pandemic</a>, Pfizer engaged many forms of media to promote their <a href=\"/wiki/Pfizer_COVID-19_vaccine\" class=\"mw-redirect\" title=\"Pfizer COVID-19 vaccine\">COVID-19 vaccine</a>, including paid editorial content on <a href=\"/wiki/CNBC\" title=\"CNBC\">CNBC</a> and a commissioned <a href=\"/wiki/National_Geographic\" title=\"National Geographic\">National Geographic</a> documentary.<sup id=\"cite_ref-219\" class=\"reference\"><a href=\"#cite_note-219\">&#91;219&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Public_health\">Public health</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=34\" title=\"Edit section: Public health\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Pfizer is one of several pharmaceutical companies disclosed as supporters of the <a href=\"/wiki/Canadian_Public_Health_Association\" title=\"Canadian Public Health Association\">Canadian Public Health Association</a> in their 2018 annual report.<sup id=\"cite_ref-220\" class=\"reference\"><a href=\"#cite_note-220\">&#91;220&#93;</a></sup> \n</p><p>Pfizer has provided funding to the <a href=\"/wiki/Canadian_Paediatric_Society\" title=\"Canadian Paediatric Society\">Canadian Paediatric Society</a>, the organization that administers the Canadian Immunization Monitoring Program, Active (IMPACT) vaccine safety program.<sup id=\"cite_ref-:2_221-0\" class=\"reference\"><a href=\"#cite_note-:2-221\">&#91;221&#93;</a></sup> \n</p><p>Pfizer sponsored a presentation in January 2020 delivered through the <a href=\"/wiki/Provincial_Health_Services_Authority\" title=\"Provincial Health Services Authority\">Provincial Health Services Authority</a> titled \"Vaccine hesitancy: It doesn't matter if the vaccine works if nobody gets it.\"<sup id=\"cite_ref-:2_221-1\" class=\"reference\"><a href=\"#cite_note-:2-221\">&#91;221&#93;</a></sup><sup id=\"cite_ref-222\" class=\"reference\"><a href=\"#cite_note-222\">&#91;222&#93;</a></sup> \n</p>\n<h3><span class=\"mw-headline\" id=\"Medical_research\">Medical research</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=35\" title=\"Edit section: Medical research\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Pfizer is an Industry Partner of the Canadian Frailty Network,<sup id=\"cite_ref-223\" class=\"reference\"><a href=\"#cite_note-223\">&#91;223&#93;</a></sup> which has provided research grants related to <a href=\"/wiki/COVID-19\" title=\"COVID-19\">COVID-19</a>.<sup id=\"cite_ref-224\" class=\"reference\"><a href=\"#cite_note-224\">&#91;224&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=36\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<style data-mw-deduplicate=\"TemplateStyles:r1072126029\">.mw-parser-output .portalbox{float:right;padding:0}.mw-parser-output .portalborder{border:solid #aaa 1px}.mw-parser-output .portalbox.tleft{margin:0.5em 1em 0.5em 0}.mw-parser-output .portalbox.tright{margin:0.5em 0 0.5em 1em}.mw-parser-output .portalbox>ul{display:table;box-sizing:border-box;max-width:175px;font-size:85%;line-height:110%;font-style:italic;font-weight:bold}.mw-parser-output .portalborder>ul{padding:0.1em;background:#f9f9f9}.mw-parser-output .portalbox>ul>li{display:table-row}.mw-parser-output .portalbox>ul>li>span:first-child{display:table-cell;padding:0.2em;vertical-align:middle;text-align:center}.mw-parser-output .portalbox>ul>li>span:last-child{display:table-cell;padding:0.2em 0.2em 0.2em 0.3em;vertical-align:middle}</style><div role=\"navigation\" aria-label=\"Portals\" class=\"noprint plainlist portalbox portalborder tright\">\n<ul>\n<li><span><img alt=\"flag\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/ba/Flag_of_New_York_City.svg/32px-Flag_of_New_York_City.svg.png\" decoding=\"async\" width=\"32\" height=\"19\" class=\"noviewer thumbborder\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/ba/Flag_of_New_York_City.svg/48px-Flag_of_New_York_City.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/ba/Flag_of_New_York_City.svg/64px-Flag_of_New_York_City.svg.png 2x\" data-file-width=\"500\" data-file-height=\"300\" /></span><span><a href=\"/wiki/Portal:New_York_City\" title=\"Portal:New York City\">New York City portal</a></span></li>\n<li><span><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Industry5.svg/28px-Industry5.svg.png\" decoding=\"async\" width=\"28\" height=\"28\" class=\"noviewer\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Industry5.svg/42px-Industry5.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Industry5.svg/56px-Industry5.svg.png 2x\" data-file-width=\"512\" data-file-height=\"512\" /></span><span><a href=\"/wiki/Portal:Companies\" title=\"Portal:Companies\">Companies portal</a></span></li></ul></div>\n<ul><li><a href=\"/wiki/Biotech_and_pharmaceutical_companies_in_the_New_York_metropolitan_area\" class=\"mw-redirect\" title=\"Biotech and pharmaceutical companies in the New York metropolitan area\">Biotech and pharmaceutical companies in the New York metropolitan area</a></li>\n<li><a href=\"/wiki/Companies_of_the_United_States_with_untaxed_profits\" title=\"Companies of the United States with untaxed profits\">Companies of the United States with untaxed profits</a></li>\n<li><a href=\"/wiki/Fire_in_the_Blood_(2013_film)\" title=\"Fire in the Blood (2013 film)\">Fire in the Blood (2013 film)</a></li>\n<li><a href=\"/wiki/List_of_pharmaceutical_companies\" title=\"List of pharmaceutical companies\">List of pharmaceutical companies</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=37\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<style data-mw-deduplicate=\"TemplateStyles:r1011085734\">.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class=\"reflist\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-10K-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-10K_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-10K_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-10K_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-10K_1-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><style data-mw-deduplicate=\"TemplateStyles:r1067248974\">.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:\"\\\"\"\"\\\"\"\"'\"\"'\"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url(\"//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg\")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:linear-gradient(transparent,transparent),url(\"//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg\")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:linear-gradient(transparent,transparent),url(\"//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg\")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:linear-gradient(transparent,transparent),url(\"//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg\")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://s21.q4cdn.com/317678438/files/doc_financials/2020/ar/PFE-2020-Form-10K-FINAL.pdf\">\"Pfizer Inc. 2020 Form 10-K Annual Report\"</a> <span class=\"cs1-format\">(PDF)</span>. Pfizer.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Inc.+2020+Form+10-K+Annual+Report&amp;rft.pub=Pfizer&amp;rft_id=https%3A%2F%2Fs21.q4cdn.com%2F317678438%2Ffiles%2Fdoc_financials%2F2020%2Far%2FPFE-2020-Form-10K-FINAL.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFWells2008\" class=\"citation cs2\">Wells, John C. (2008), <i>Longman Pronunciation Dictionary</i> (3rd&#160;ed.), <a href=\"/wiki/Longman\" title=\"Longman\">Longman</a>, <a href=\"/wiki/ISBN_(identifier)\" class=\"mw-redirect\" title=\"ISBN (identifier)\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/9781405881180\" title=\"Special:BookSources/9781405881180\"><bdi>9781405881180</bdi></a></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Longman+Pronunciation+Dictionary&amp;rft.edition=3rd&amp;rft.pub=Longman&amp;rft.date=2008&amp;rft.isbn=9781405881180&amp;rft.aulast=Wells&amp;rft.aufirst=John+C.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFBomey2020\" class=\"citation news cs1\">Bomey, Nathan (August 25, 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.usatoday.com/story/money/2020/08/25/exxon-pfizer-dow-jones-industrial-average-salesforce-djia/5630916002/\">\"Exxon Mobil, Pfizer removed from Dow Jones Industrial Average; Salesforce, Honeywell added\"</a>. <i><a href=\"/wiki/USA_Today\" title=\"USA Today\">USA Today</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=USA+Today&amp;rft.atitle=Exxon+Mobil%2C+Pfizer+removed+from+Dow+Jones+Industrial+Average%3B+Salesforce%2C+Honeywell+added&amp;rft.date=2020-08-25&amp;rft.aulast=Bomey&amp;rft.aufirst=Nathan&amp;rft_id=https%3A%2F%2Fwww.usatoday.com%2Fstory%2Fmoney%2F2020%2F08%2F25%2Fexxon-pfizer-dow-jones-industrial-average-salesforce-djia%2F5630916002%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFStevens2020\" class=\"citation news cs1\">Stevens, Pippa (August 24, 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.cnbc.com/2020/08/24/salesforce-amgen-and-honeywell-added-to-dow-in-major-shakeup-to-the-average.html\">\"Salesforce, Amgen and Honeywell added to Dow in major shake-up to the average\"</a>. <i><a href=\"/wiki/CNBC\" title=\"CNBC\">CNBC</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNBC&amp;rft.atitle=Salesforce%2C+Amgen+and+Honeywell+added+to+Dow+in+major+shake-up+to+the+average&amp;rft.date=2020-08-24&amp;rft.aulast=Stevens&amp;rft.aufirst=Pippa&amp;rft_id=https%3A%2F%2Fwww.cnbc.com%2F2020%2F08%2F24%2Fsalesforce-amgen-and-honeywell-added-to-dow-in-major-shakeup-to-the-average.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFPonczekGreifeld2020\" class=\"citation news cs1\">Ponczek, Sarah; Greifeld, Katherine (August 24, 2020). <span class=\"cs1-lock-limited\" title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.bloomberg.com/news/articles/2020-08-24/dow-industrials-kicks-out-exxon-in-biggest-shakeup-since-2013\">\"Exxon Booted from Dow Industrials in Major Embrace of Tech\"</a></span>. <i><a href=\"/wiki/Bloomberg_News\" title=\"Bloomberg News\">Bloomberg News</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+News&amp;rft.atitle=Exxon+Booted+from+Dow+Industrials+in+Major+Embrace+of+Tech&amp;rft.date=2020-08-24&amp;rft.aulast=Ponczek&amp;rft.aufirst=Sarah&amp;rft.au=Greifeld%2C+Katherine&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2020-08-24%2Fdow-industrials-kicks-out-exxon-in-biggest-shakeup-since-2013&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\">\n<link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFLevisohn2020\" class=\"citation news cs1\">Levisohn, Ben (August 25, 2020). <span class=\"cs1-lock-limited\" title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.barrons.com/articles/exxon-and-pfizer-just-got-booted-from-the-dow-jones-industrial-average-heres-whats-replacing-them-51598307204\">\"Exxon and Pfizer Just Got Booted From the Dow. Here's What's Replacing Them\"</a></span>. <i><a href=\"/wiki/Barron%27s_(newspaper)\" title=\"Barron&#39;s (newspaper)\">Barron's</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Barron%27s&amp;rft.atitle=Exxon+and+Pfizer+Just+Got+Booted+From+the+Dow.+Here%27s+What%27s+Replacing+Them.&amp;rft.date=2020-08-25&amp;rft.aulast=Levisohn&amp;rft.aufirst=Ben&amp;rft_id=https%3A%2F%2Fwww.barrons.com%2Farticles%2Fexxon-and-pfizer-just-got-booted-from-the-dow-jones-industrial-average-heres-whats-replacing-them-51598307204&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://fortune.com/company/pfizer/fortune500/\">\"Fortune 500: Pfizer\"</a>. <a href=\"/wiki/Fortune_(magazine)\" title=\"Fortune (magazine)\">Fortune</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Fortune+500%3A+Pfizer&amp;rft.pub=Fortune&amp;rft_id=https%3A%2F%2Ffortune.com%2Fcompany%2Fpfizer%2Ffortune500%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.forbes.com/companies/pfizer/?sh=67d299422d6b\">\"Forbes Global 2000: Pfizer\"</a>. <i><a href=\"/wiki/Forbes\" title=\"Forbes\">Forbes</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Forbes&amp;rft.atitle=Forbes+Global+2000%3A+Pfizer&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fcompanies%2Fpfizer%2F%3Fsh%3D67d299422d6b&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-Citycyclopedia-9\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Citycyclopedia_9-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Citycyclopedia_9-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">Kenneth T. Jackson. <i>The Encyclopedia of New York City</i>. The New York Historical Society; Yale University Press; September 1995. P. 895. <link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><a href=\"/wiki/ISBN_(identifier)\" class=\"mw-redirect\" title=\"ISBN (identifier)\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0-300-05536-8\" title=\"Special:BookSources/978-0-300-05536-8\">978-0-300-05536-8</a></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2007/01/28/nyregion/28pfizer.html\">\"Pfizer's Birthplace, Soon Without Pfizer\"</a>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>. January 28, 2007.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer%27s+Birthplace%2C+Soon+Without+Pfizer&amp;rft.date=2007-01-28&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2007%2F01%2F28%2Fnyregion%2F28pfizer.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-collection-11\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-collection_11-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-collection_11-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"http://dlib.nyu.edu/findingaids/html/bhs/arc_084_pfizer/bioghist.html\">\"Guide to the Pfizer Inc. collection ARC.084\"</a>. <a href=\"/wiki/Brooklyn_Public_Library\" title=\"Brooklyn Public Library\">Brooklyn Public Library</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Guide+to+the+Pfizer+Inc.+collection+ARC.084&amp;rft.pub=Brooklyn+Public+Library&amp;rft_id=http%3A%2F%2Fdlib.nyu.edu%2Ffindingaids%2Fhtml%2Fbhs%2Farc_084_pfizer%2Fbioghist.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-history-12\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-history_12-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-history_12-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-history_12-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-history_12-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.pfizer.com/people/history\">\"Our People – The Journey\"</a>. <i>Pfizer</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Pfizer&amp;rft.atitle=Our+People+%E2%80%93+The+Journey&amp;rft_id=https%3A%2F%2Fwww.pfizer.com%2Fpeople%2Fhistory&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span><span class=\"cs1-maint citation-comment\"><code class=\"cs1-code\">{{<a href=\"/wiki/Template:Cite_web\" title=\"Template:Cite web\">cite web</a>}}</code>:  CS1 maint: url-status (<a href=\"/wiki/Category:CS1_maint:_url-status\" title=\"Category:CS1 maint: url-status\">link</a>)</span></span>\n</li>\n<li id=\"cite_note-Fermentation-13\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Fermentation_13-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Fermentation_13-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.acs.org/content/acs/en/education/whatischemistry/landmarks/penicillin.html\">\"Penicillin Production through Deep-tank Fermentation – National Historic Chemical Landmark\"</a>. <a href=\"/wiki/American_Chemical_Society\" title=\"American Chemical Society\">American Chemical Society</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Penicillin+Production+through+Deep-tank+Fermentation+%E2%80%93+National+Historic+Chemical+Landmark&amp;rft.pub=American+Chemical+Society&amp;rft_id=https%3A%2F%2Fwww.acs.org%2Fcontent%2Facs%2Fen%2Feducation%2Fwhatischemistry%2Flandmarks%2Fpenicillin.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.drugs.com/monograph/fluconazole.html\">\"Fluconazole\"</a>. The American Society of Health-System Pharmacists. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20161220231218/https://www.drugs.com/monograph/fluconazole.html\">Archived</a> from the original on December 20, 2016.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Fluconazole&amp;rft.pub=The+American+Society+of+Health-System+Pharmacists&amp;rft_id=https%3A%2F%2Fwww.drugs.com%2Fmonograph%2Ffluconazole.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-best-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-best_15-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.wipo.int/ipadvantage/en/details.jsp?id=906\">\"Azithromycin: A world best-selling Antibiotic\"</a>. <a href=\"/wiki/World_Intellectual_Property_Organization\" title=\"World Intellectual Property Organization\">World Intellectual Property Organization</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Azithromycin%3A+A+world+best-selling+Antibiotic&amp;rft.pub=World+Intellectual+Property+Organization&amp;rft_id=https%3A%2F%2Fwww.wipo.int%2Fipadvantage%2Fen%2Fdetails.jsp%3Fid%3D906&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFMandellWunderinkAnzueto2007\" class=\"citation journal cs1 cs1-prop-long-vol\">Mandell LA, Wunderink RG, Anzueto A,  et&#160;al. (March 2007). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.thoracic.org/statements/resources/mtpi/idsaats-cap.pdf\">\"Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults\"</a> <span class=\"cs1-format\">(PDF)</span>. <i>Clin. Infect. Dis</i>. 44 Suppl 2: S27–72. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1086%2F511159\">10.1086/511159</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7107997\">7107997</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/17278083\">17278083</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin.+Infect.+Dis.&amp;rft.atitle=Infectious+Diseases+Society+of+America%2FAmerican+Thoracic+Society+consensus+guidelines+on+the+management+of+community-acquired+pneumonia+in+adults&amp;rft.volume=44+Suppl+2&amp;rft.pages=S27-72&amp;rft.date=2007-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7107997%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F17278083&amp;rft_id=info%3Adoi%2F10.1086%2F511159&amp;rft.aulast=Mandell&amp;rft.aufirst=LA&amp;rft.au=Wunderink%2C+RG&amp;rft.au=Anzueto%2C+A&amp;rft_id=https%3A%2F%2Fwww.thoracic.org%2Fstatements%2Fresources%2Fmtpi%2Fidsaats-cap.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFWilson2013\" class=\"citation news cs1\">Wilson, Jacque (March 27, 2013). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.cnn.com/2013/03/27/health/viagra-anniversary-timeline/index.html\">\"Viagra: The little blue pill that could\"</a>. <i><a href=\"/wiki/CNN\" title=\"CNN\">CNN</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNN&amp;rft.atitle=Viagra%3A+The+little+blue+pill+that+could&amp;rft.date=2013-03-27&amp;rft.aulast=Wilson&amp;rft.aufirst=Jacque&amp;rft_id=https%3A%2F%2Fwww.cnn.com%2F2013%2F03%2F27%2Fhealth%2Fviagra-anniversary-timeline%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFCox2019\" class=\"citation news cs1\">Cox, David (June 9, 2019). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.theguardian.com/science/2019/jun/09/race-to-replace-viagra-patents-erectile-dysfunction-drug-medical-research-cialis-eroxon\">\"The race to replace Viagra\"</a>. <i><a href=\"/wiki/The_Guardian\" title=\"The Guardian\">The Guardian</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Guardian&amp;rft.atitle=The+race+to+replace+Viagra&amp;rft.date=2019-06-09&amp;rft.aulast=Cox&amp;rft.aufirst=David&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fscience%2F2019%2Fjun%2F09%2Frace-to-replace-viagra-patents-erectile-dysfunction-drug-medical-research-cialis-eroxon&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.latimes.com/archives/la-xpm-1991-03-29-fi-903-story.html\">\"Pfizer Inc., New York, has elected its...\"</a> <i><a href=\"/wiki/Los_Angeles_Times\" title=\"Los Angeles Times\">Los Angeles Times</a></i>. March 29, 1991.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Los+Angeles+Times&amp;rft.atitle=Pfizer+Inc.%2C+New+York%2C+has+elected+its...&amp;rft.date=1991-03-29&amp;rft_id=https%3A%2F%2Fwww.latimes.com%2Farchives%2Fla-xpm-1991-03-29-fi-903-story.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.reed.edu/reed-magazine/in-memoriam/obituaries/_online_only/kenneth-koe-1945.html\">\"Kenneth Koe '45\"</a>. <i>Reed Magazine</i>. <a href=\"/wiki/Reed_College\" title=\"Reed College\">Reed College</a>. December 2015<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">May 18,</span> 2021</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Reed+Magazine&amp;rft.atitle=Kenneth+Koe+%2745&amp;rft.date=2015-12&amp;rft_id=https%3A%2F%2Fwww.reed.edu%2Freed-magazine%2Fin-memoriam%2Fobituaries%2F_online_only%2Fkenneth-koe-1945.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span><span class=\"cs1-maint citation-comment\"><code class=\"cs1-code\">{{<a href=\"/wiki/Template:Cite_web\" title=\"Template:Cite web\">cite web</a>}}</code>:  CS1 maint: url-status (<a href=\"/wiki/Category:CS1_maint:_url-status\" title=\"Category:CS1 maint: url-status\">link</a>)</span></span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFSmith2006\" class=\"citation news cs1\">Smith, Aaron (April 4, 2006). <a rel=\"nofollow\" class=\"external text\" href=\"https://money.cnn.com/2006/04/04/news/companies/antidepressants/\">\"Who stands to gain when Zoloft goes generic?\"</a>. <i><a href=\"/wiki/CNN_Money\" class=\"mw-redirect\" title=\"CNN Money\">CNN Money</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">May 18,</span> 2021</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNN+Money&amp;rft.atitle=Who+stands+to+gain+when+Zoloft+goes+generic%3F&amp;rft.date=2006-04-04&amp;rft.aulast=Smith&amp;rft.aufirst=Aaron&amp;rft_id=https%3A%2F%2Fmoney.cnn.com%2F2006%2F04%2F04%2Fnews%2Fcompanies%2Fantidepressants%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020690s035,021720s008,022568s005lbl.pdf\">\"Highlights of Prescribing Information\"</a> <span class=\"cs1-format\">(PDF)</span>. <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Highlights+of+Prescribing+Information&amp;rft.pub=Food+and+Drug+Administration&amp;rft_id=https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2012%2F020690s035%2C021720s008%2C022568s005lbl.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.accessdata.fda.gov/drugsatfda_docs/nda/96/19-787s007_Amlodipine.cfm\">\"Drug Approval Package\"</a>. <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Drug+Approval+Package&amp;rft.pub=Food+and+Drug+Administration&amp;rft_id=https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Fnda%2F96%2F19-787s007_Amlodipine.cfm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFMehta2011\" class=\"citation news cs1\">Mehta, Praful (November 29, 2011). <a rel=\"nofollow\" class=\"external text\" href=\"https://ihsmarkit.com/research-analysis/lipitor-patent-expiration-atorvastatin-sales.html\">\"Lipitor Patent Expiration - The End of an Era for Atorvastatin Sales\"</a>. <i><a href=\"/wiki/IHS_Markit\" title=\"IHS Markit\">IHS Markit</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">May 18,</span> 2021</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=IHS+Markit&amp;rft.atitle=Lipitor+Patent+Expiration+-+The+End+of+an+Era+for+Atorvastatin+Sales&amp;rft.date=2011-11-29&amp;rft.aulast=Mehta&amp;rft.aufirst=Praful&amp;rft_id=https%3A%2F%2Fihsmarkit.com%2Fresearch-analysis%2Flipitor-patent-expiration-atorvastatin-sales.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-longshot-25\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-longshot_25-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-longshot_25-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFBerenson2006\" class=\"citation news cs1\"><a href=\"/wiki/Alex_Berenson\" title=\"Alex Berenson\">Berenson, Alex</a> (July 29, 2006). <span class=\"cs1-lock-limited\" title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2006/07/29/business/29pfizer.html\">\"A Long Shot Becomes Pfizer's Latest Chief Executive\"</a></span>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=A+Long+Shot+Becomes+Pfizer%27s+Latest+Chief+Executive&amp;rft.date=2006-07-29&amp;rft.aulast=Berenson&amp;rft.aufirst=Alex&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2006%2F07%2F29%2Fbusiness%2F29pfizer.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-26\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.drugs.com/monograph/pregabalin.html\">\"Pregabalin\"</a>. <a href=\"/wiki/American_Society_of_Health-System_Pharmacists\" title=\"American Society of Health-System Pharmacists\">American Society of Health-System Pharmacists</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pregabalin&amp;rft.pub=American+Society+of+Health-System+Pharmacists&amp;rft_id=https%3A%2F%2Fwww.drugs.com%2Fmonograph%2Fpregabalin.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-27\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFFrampton2014\" class=\"citation journal cs1\">Frampton, James E. (September 2014). \"Pregabalin: A Review of its Use in Adults with Generalized Anxiety Disorder\". <i>CNS Drugs</i>. <b>28</b> (9): 835–854. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1007%2Fs40263-014-0192-0\">10.1007/s40263-014-0192-0</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/25149863\">25149863</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:5349255\">5349255</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNS+Drugs&amp;rft.atitle=Pregabalin%3A+A+Review+of+its+Use+in+Adults+with+Generalized+Anxiety+Disorder&amp;rft.volume=28&amp;rft.issue=9&amp;rft.pages=835-854&amp;rft.date=2014-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A5349255%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25149863&amp;rft_id=info%3Adoi%2F10.1007%2Fs40263-014-0192-0&amp;rft.aulast=Frampton&amp;rft.aufirst=James+E.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-28\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFIftikharAlghothaniTrotti2017\" class=\"citation journal cs1\">Iftikhar, I. H.; Alghothani, L.; Trotti, L. M. (December 2017). \"Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis\". <i>European Journal of Neurology</i>. <b>24</b> (12): 1446–1456. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1111%2Fene.13449\">10.1111/ene.13449</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/28888061\">28888061</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:22262972\">22262972</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Neurology&amp;rft.atitle=Gabapentin+enacarbil%2C+pregabalin+and+rotigotine+are+equally+effective+in+restless+legs+syndrome%3A+a+comparative+meta-analysis&amp;rft.volume=24&amp;rft.issue=12&amp;rft.pages=1446-1456&amp;rft.date=2017-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22262972%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28888061&amp;rft_id=info%3Adoi%2F10.1111%2Fene.13449&amp;rft.aulast=Iftikhar&amp;rft.aufirst=I.+H.&amp;rft.au=Alghothani%2C+L.&amp;rft.au=Trotti%2C+L.+M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-29\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFDecker2014\" class=\"citation news cs1\">Decker, Susan (February 6, 2014). <span class=\"cs1-lock-subscription\" title=\"Paid subscription required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.bloomberg.com/news/2014-02-06/pfizer-wins-ruling-to-block-generic-lyrica-until-2018.html\">\"Pfizer Wins Ruling to Block Generic Lyrica Until 2018\"</a></span>. <i><a href=\"/wiki/Bloomberg_News\" title=\"Bloomberg News\">Bloomberg News</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+News&amp;rft.atitle=Pfizer+Wins+Ruling+to+Block+Generic+Lyrica+Until+2018&amp;rft.date=2014-02-06&amp;rft.aulast=Decker&amp;rft.aufirst=Susan&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2F2014-02-06%2Fpfizer-wins-ruling-to-block-generic-lyrica-until-2018.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-30\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFSpeights2017\" class=\"citation news cs1\">Speights, Keith (April 17, 2017). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.fool.com/investing/2017/04/17/how-pfizer-inc-makes-most-of-its-money.aspx\">\"How Pfizer Inc. Makes Most of Its Money\"</a>. <i><a href=\"/wiki/The_Motley_Fool\" title=\"The Motley Fool\">The Motley Fool</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Motley+Fool&amp;rft.atitle=How+Pfizer+Inc.+Makes+Most+of+Its+Money&amp;rft.date=2017-04-17&amp;rft.aulast=Speights&amp;rft.aufirst=Keith&amp;rft_id=https%3A%2F%2Fwww.fool.com%2Finvesting%2F2017%2F04%2F17%2Fhow-pfizer-inc-makes-most-of-its-money.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-31\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://money.cnn.com/2006/07/28/news/companies/pfizer_ceo/index.htm\">\"Pfizer names new CEO\"</a>. <i><a href=\"/wiki/CNN\" title=\"CNN\">CNN</a></i>. July 28, 2006.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNN&amp;rft.atitle=Pfizer+names+new+CEO&amp;rft.date=2006-07-28&amp;rft_id=https%3A%2F%2Fmoney.cnn.com%2F2006%2F07%2F28%2Fnews%2Fcompanies%2Fpfizer_ceo%2Findex.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-32\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-32\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFBerensonPollack2006\" class=\"citation news cs1\">Berenson, Alex; Pollack, Andrew (December 5, 2006). <span class=\"cs1-lock-limited\" title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2006/12/05/health/05pfizer.html\">\"Pfizer Shares Plummet on Loss of a Promising Heart Drug\"</a></span>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+Shares+Plummet+on+Loss+of+a+Promising+Heart+Drug&amp;rft.date=2006-12-05&amp;rft.aulast=Berenson&amp;rft.aufirst=Alex&amp;rft.au=Pollack%2C+Andrew&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2006%2F12%2F05%2Fhealth%2F05pfizer.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-33\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-33\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFBerenson2006\" class=\"citation news cs1\"><a href=\"/wiki/Alex_Berenson\" title=\"Alex Berenson\">Berenson, Alex</a> (December 3, 2006). <span class=\"cs1-lock-limited\" title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2006/12/03/health/03pfizer.html\">\"Pfizer Ends Studies on Drug for Heart Disease\"</a></span>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+Ends+Studies+on+Drug+for+Heart+Disease&amp;rft.date=2006-12-03&amp;rft.aulast=Berenson&amp;rft.aufirst=Alex&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2006%2F12%2F03%2Fhealth%2F03pfizer.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-34\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-34\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFAgovino2006\" class=\"citation news cs1\">Agovino, Theresa (December 3, 2006). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.seattletimes.com/nation-world/cholesterol-drug-trials-are-halted/\">\"Pfizer ends cholesterol drug development\"</a>. <a href=\"/wiki/The_Seattle_Times\" title=\"The Seattle Times\">The Seattle Times</a>. <a href=\"/wiki/Associated_Press\" title=\"Associated Press\">Associated Press</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pfizer+ends+cholesterol+drug+development&amp;rft.date=2006-12-03&amp;rft.aulast=Agovino&amp;rft.aufirst=Theresa&amp;rft_id=https%3A%2F%2Fwww.seattletimes.com%2Fnation-world%2Fcholesterol-drug-trials-are-halted%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-35\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-35\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFTanne2006\" class=\"citation journal cs1\">Tanne, Janice Hopkins (December 16, 2006). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1702474\">\"Pfizer stops clinical trials of heart drug\"</a>. <i>BMJ</i>. <b>333</b> (7581): 1237.2–1237. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1136%2Fbmj.39059.438044.DB\">10.1136/bmj.39059.438044.DB</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1702474\">1702474</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/17170401\">17170401</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMJ&amp;rft.atitle=Pfizer+stops+clinical+trials+of+heart+drug&amp;rft.volume=333&amp;rft.issue=7581&amp;rft.pages=1237.2-1237&amp;rft.date=2006-12-16&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1702474%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F17170401&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.39059.438044.DB&amp;rft.aulast=Tanne&amp;rft.aufirst=Janice+Hopkins&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1702474&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-36\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFBennett2010\" class=\"citation news cs1\">Bennett, Simeon (July 8, 2010). <span class=\"cs1-lock-limited\" title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.bloomberg.com/news/articles/2010-07-08/pfizer-civil-suits-for-drug-counterfeiters\">\"Pfizer: Civil Suits for Drug Counterfeiters\"</a></span>. <i><a href=\"/wiki/Bloomberg_Businessweek\" title=\"Bloomberg Businessweek\">Bloomberg Businessweek</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+Businessweek&amp;rft.atitle=Pfizer%3A+Civil+Suits+for+Drug+Counterfeiters&amp;rft.date=2010-07-08&amp;rft.aulast=Bennett&amp;rft.aufirst=Simeon&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2010-07-08%2Fpfizer-civil-suits-for-drug-counterfeiters&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-37\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-37\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFJones2008\" class=\"citation news cs1\">Jones, Al (July 15, 2008). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.mlive.com/kzgazette/2008/07/pfizer_job_cuts_dont_equal_a_r.html\">\"Pfizer job cuts don't equal a reduction in work load, says company spokesman\"</a>. <i><a href=\"/wiki/Booth_Newspapers\" title=\"Booth Newspapers\">Booth Newspapers</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Booth+Newspapers&amp;rft.atitle=Pfizer+job+cuts+don%27t+equal+a+reduction+in+work+load%2C+says+company+spokesman&amp;rft.date=2008-07-15&amp;rft.aulast=Jones&amp;rft.aufirst=Al&amp;rft_id=https%3A%2F%2Fwww.mlive.com%2Fkzgazette%2F2008%2F07%2Fpfizer_job_cuts_dont_equal_a_r.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-:0-38\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:0_38-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:0_38-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://money.cnn.com/2003/04/16/news/companies/pfizer_pharma/\">\"It's official: Pfizer buys Pharmacia\"</a>. <i><a href=\"/wiki/CNN\" title=\"CNN\">CNN</a></i>. April 16, 2003.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNN&amp;rft.atitle=It%27s+official%3A+Pfizer+buys+Pharmacia&amp;rft.date=2003-04-16&amp;rft_id=https%3A%2F%2Fmoney.cnn.com%2F2003%2F04%2F16%2Fnews%2Fcompanies%2Fpfizer_pharma%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-39\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-39\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFHensley2000\" class=\"citation news cs1\">Hensley, Scott (June 20, 2000). <span class=\"cs1-lock-subscription\" title=\"Paid subscription required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.wsj.com/articles/SB961456765639278103\">\"Pfizer Completes Stormy Takeover Of Warner-Lambert for $116 Billion\"</a></span>. <i><a href=\"/wiki/The_Wall_Street_Journal\" title=\"The Wall Street Journal\">The Wall Street Journal</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=Pfizer+Completes+Stormy+Takeover+Of+Warner-Lambert+for+%24116+Billion&amp;rft.date=2000-06-20&amp;rft.aulast=Hensley&amp;rft.aufirst=Scott&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2FSB961456765639278103&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-40\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-40\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFCampbell2017\" class=\"citation news cs1\">Campbell, Todd (May 15, 2017). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.businessinsider.com/here-are-the-7-biggest-mergers-of-all-time-2017-5#6-warner-lambert-warms-up-to-pfizer-89-billion-2\">\"Here are the 7 biggest mergers of all time\"</a>. <a href=\"/wiki/Business_Insider\" title=\"Business Insider\">Business Insider</a>. <a href=\"/wiki/The_Motley_Fool\" title=\"The Motley Fool\">The Motley Fool</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Here+are+the+7+biggest+mergers+of+all+time&amp;rft.date=2017-05-15&amp;rft.aulast=Campbell&amp;rft.aufirst=Todd&amp;rft_id=https%3A%2F%2Fwww.businessinsider.com%2Fhere-are-the-7-biggest-mergers-of-all-time-2017-5%236-warner-lambert-warms-up-to-pfizer-89-billion-2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-41\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-41\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.drugs.com/monograph/metronidazole.html\">\"Metronidazole Monograph for Professionals\"</a>. <a href=\"/wiki/Drugs.com\" title=\"Drugs.com\">Drugs.com</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Metronidazole+Monograph+for+Professionals&amp;rft.pub=Drugs.com&amp;rft_id=https%3A%2F%2Fwww.drugs.com%2Fmonograph%2Fmetronidazole.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-42\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-42\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.drugs.com/monograph/celecoxib.html\">\"Celecoxib Monograph for Professionals\"</a>. <i>Drugs.com</i>. American Society of Health-System Pharmacists. November 11, 2019.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Drugs.com&amp;rft.atitle=Celecoxib+Monograph+for+Professionals&amp;rft.date=2019-11-11&amp;rft_id=https%3A%2F%2Fwww.drugs.com%2Fmonograph%2Fcelecoxib.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-43\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-43\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.bloomberg.com/news/articles/2005-11-20/the-spirit-of-a-startup-lives-on\">\"The Spirit Of A Startup Lives On\"</a>. <i><a href=\"/wiki/Bloomberg_Businessweek\" title=\"Bloomberg Businessweek\">Bloomberg Businessweek</a></i>. November 21, 2005.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+Businessweek&amp;rft.atitle=The+Spirit+Of+A+Startup+Lives+On&amp;rft.date=2005-11-21&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2005-11-20%2Fthe-spirit-of-a-startup-lives-on&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-44\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-44\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.bizjournals.com/sanfrancisco/stories/2003/04/28/daily24.html\">\"Pfizer expects to shutter South City biotech outpost\"</a>. <i><a href=\"/wiki/American_City_Business_Journals\" title=\"American City Business Journals\">American City Business Journals</a></i>. April 30, 2003.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+City+Business+Journals&amp;rft.atitle=Pfizer+expects+to+shutter+South+City+biotech+outpost&amp;rft.date=2003-04-30&amp;rft_id=https%3A%2F%2Fwww.bizjournals.com%2Fsanfrancisco%2Fstories%2F2003%2F04%2F28%2Fdaily24.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-45\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-45\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFRockoff2011\" class=\"citation news cs1\">Rockoff, Jonathan D. (August 26, 2011). <span class=\"cs1-lock-subscription\" title=\"Paid subscription required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.wsj.com/articles/SB10001424053111904009304576532892704206326\">\"FDA Approves Pfizer Lung-Cancer Drug\"</a></span>. <i><a href=\"/wiki/The_Wall_Street_Journal\" title=\"The Wall Street Journal\">The Wall Street Journal</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=FDA+Approves+Pfizer+Lung-Cancer+Drug&amp;rft.date=2011-08-26&amp;rft.aulast=Rockoff&amp;rft.aufirst=Jonathan+D.&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2FSB10001424053111904009304576532892704206326&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-46\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-46\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFMortlockWilsonKettleGoldberg2017\" class=\"citation book cs1\">Mortlock, A.A.; Wilson, D.M.; Kettle, J.G.; Goldberg, F.W.; Foote, K.M. (2017). \"Selective Kinase Inhibitors in Cancer\". <i>Comprehensive Medicinal Chemistry III</i>. pp.&#160;39–75. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1016%2FB978-0-12-409547-2.12391-1\">10.1016/B978-0-12-409547-2.12391-1</a>. <a href=\"/wiki/ISBN_(identifier)\" class=\"mw-redirect\" title=\"ISBN (identifier)\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0-12-803201-5\" title=\"Special:BookSources/978-0-12-803201-5\"><bdi>978-0-12-803201-5</bdi></a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Selective+Kinase+Inhibitors+in+Cancer&amp;rft.btitle=Comprehensive+Medicinal+Chemistry+III&amp;rft.pages=39-75&amp;rft.date=2017&amp;rft_id=info%3Adoi%2F10.1016%2FB978-0-12-409547-2.12391-1&amp;rft.isbn=978-0-12-803201-5&amp;rft.aulast=Mortlock&amp;rft.aufirst=A.A.&amp;rft.au=Wilson%2C+D.M.&amp;rft.au=Kettle%2C+J.G.&amp;rft.au=Goldberg%2C+F.W.&amp;rft.au=Foote%2C+K.M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-47\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-47\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFBarriaux2006\" class=\"citation news cs1\">Barriaux, Marianne (October 9, 2006). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.theguardian.com/business/2006/oct/09/money5\">\"Pfizer buys vaccine developer PowderMed\"</a>. <i><a href=\"/wiki/The_Guardian\" title=\"The Guardian\">The Guardian</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Guardian&amp;rft.atitle=Pfizer+buys+vaccine+developer+PowderMed&amp;rft.date=2006-10-09&amp;rft.aulast=Barriaux&amp;rft.aufirst=Marianne&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fbusiness%2F2006%2Foct%2F09%2Fmoney5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-48\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-48\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFSorkinWilson2009\" class=\"citation news cs1\"><a href=\"/wiki/Andrew_Ross_Sorkin\" title=\"Andrew Ross Sorkin\">Sorkin, Andrew Ross</a>; <a href=\"/wiki/Duff_Wilson\" title=\"Duff Wilson\">Wilson, Duff</a> (January 25, 2009). <span class=\"cs1-lock-limited\" title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2009/01/26/business/26drug.html\">\"Pfizer Agrees to Pay $68 Billion for Rival Drug Maker Wyeth\"</a></span>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0362-4331\">0362-4331</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+Agrees+to+Pay+%2468+Billion+for+Rival+Drug+Maker+Wyeth&amp;rft.date=2009-01-25&amp;rft.issn=0362-4331&amp;rft.aulast=Sorkin&amp;rft.aufirst=Andrew+Ross&amp;rft.au=Wilson%2C+Duff&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2009%2F01%2F26%2Fbusiness%2F26drug.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-49\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-49\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.reuters.com/article/instant-article/idUSTRE59E4S320091015\">\"Pfizer completes $67 billion deal for rival Wyeth\"</a>. <i><a href=\"/wiki/Reuters\" title=\"Reuters\">Reuters</a></i>. October 15, 2009.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+completes+%2467+billion+deal+for+rival+Wyeth&amp;rft.date=2009-10-15&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Finstant-article%2FidUSTRE59E4S320091015&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-50\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-50\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFKarnitschnigRockoff2009\" class=\"citation news cs1\">Karnitschnig, Matthew; Rockoff, Jonathan D. (January 23, 2009). <span class=\"cs1-lock-subscription\" title=\"Paid subscription required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.wsj.com/articles/SB123268511212809429\">\"Pfizer in Talks to Buy Wyeth\"</a></span>. <i><a href=\"/wiki/The_Wall_Street_Journal\" title=\"The Wall Street Journal\">The Wall Street Journal</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=Pfizer+in+Talks+to+Buy+Wyeth&amp;rft.date=2009-01-23&amp;rft.aulast=Karnitschnig&amp;rft.aufirst=Matthew&amp;rft.au=Rockoff%2C+Jonathan+D.&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2FSB123268511212809429&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-worst-51\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-worst_51-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFEdwards2009\" class=\"citation news cs1\">Edwards, Jim (January 23, 2009). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.cbsnews.com/news/the-pfizer-wyeth-deal-worst-case-scenario/\">\"The Pfizer–Wyeth Deal Worst-Case Scenario\"</a>. <i><a href=\"/wiki/CBS_News\" title=\"CBS News\">CBS News</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CBS+News&amp;rft.atitle=The+Pfizer%E2%80%93Wyeth+Deal+Worst-Case+Scenario&amp;rft.date=2009-01-23&amp;rft.aulast=Edwards&amp;rft.aufirst=Jim&amp;rft_id=https%3A%2F%2Fwww.cbsnews.com%2Fnews%2Fthe-pfizer-wyeth-deal-worst-case-scenario%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-wyethpr-52\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-wyethpr_52-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-wyethpr_52-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.pfizer.com/news/press-release/press-release-detail/pfizer_completes_acquisition_of_wyeth\">\"PFIZER COMPLETES ACQUISITION OF WYETH\"</a> (Press release). Pfizer. October 14, 2009.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=PFIZER+COMPLETES+ACQUISITION+OF+WYETH&amp;rft.pub=Pfizer&amp;rft.date=2009-10-14&amp;rft_id=https%3A%2F%2Fwww.pfizer.com%2Fnews%2Fpress-release%2Fpress-release-detail%2Fpfizer_completes_acquisition_of_wyeth&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-cdc.gov-53\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-cdc.gov_53-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.cdc.gov/abcs/reports-findings/surv-reports.html\">\"CDC – ABCs: Surveillance Reports main page – Active Bacterial Core surveillance\"</a>. April 5, 2019.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=CDC+%E2%80%93+ABCs%3A+Surveillance+Reports+main+page+%E2%80%93+Active+Bacterial+Core+surveillance&amp;rft.date=2019-04-05&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fabcs%2Freports-findings%2Fsurv-reports.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-54\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-54\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFHerper2020\" class=\"citation web cs1\">Herper, Matthew (August 24, 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.statnews.com/2020/08/24/pfizer-edge-in-the-race-for-a-covid-19-vaccine-could-be-a-scientist-with-two-best-sellers-to-her-credit/\">\"In the race for a Covid-19 vaccine, Pfizer turns to a scientist with a history of defying skeptics – and getting results\"</a>. <i><a href=\"/wiki/Stat_(website)\" title=\"Stat (website)\">Stat</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Stat&amp;rft.atitle=In+the+race+for+a+Covid-19+vaccine%2C+Pfizer+turns+to+a+scientist+with+a+history+of+defying+skeptics+%E2%80%93+and+getting+results&amp;rft.date=2020-08-24&amp;rft.aulast=Herper&amp;rft.aufirst=Matthew&amp;rft_id=https%3A%2F%2Fwww.statnews.com%2F2020%2F08%2F24%2Fpfizer-edge-in-the-race-for-a-covid-19-vaccine-could-be-a-scientist-with-two-best-sellers-to-her-credit%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-55\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-55\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.businesswire.com/news/home/20190927005072/en/Ian-Read-to-Retire-as-Executive-Chairman-of-Pfizer%E2%80%99s-Board-of-Directors-Chief-Executive-Officer-Dr.-Albert-Bourla-Named-Chairman\">\"Ian Read to Retire as Executive Chairman of Pfizer's Board of Directors; Chief Executive Officer Dr. Albert Bourla Named Chairman\"</a> (Press release). <a href=\"/wiki/Business_Wire\" title=\"Business Wire\">Business Wire</a>. September 27, 2019.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Ian+Read+to+Retire+as+Executive+Chairman+of+Pfizer%27s+Board+of+Directors%3B+Chief+Executive+Officer+Dr.+Albert+Bourla+Named+Chairman&amp;rft.pub=Business+Wire&amp;rft.date=2019-09-27&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20190927005072%2Fen%2FIan-Read-to-Retire-as-Executive-Chairman-of-Pfizer%25E2%2580%2599s-Board-of-Directors-Chief-Executive-Officer-Dr.-Albert-Bourla-Named-Chairman&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-56\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-56\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.bbc.co.uk/news/business-12335801\">\"Pfizer to close UK research site\"</a>. <i><a href=\"/wiki/BBC_News\" title=\"BBC News\">BBC News</a></i>. February 1, 2011.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Pfizer+to+close+UK+research+site&amp;rft.date=2011-02-01&amp;rft_id=https%3A%2F%2Fwww.bbc.co.uk%2Fnews%2Fbusiness-12335801&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-57\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-57\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFMckinney2011\" class=\"citation news cs1\">Mckinney, Maureen (March 1, 2011). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.modernhealthcare.com/article/20110301/NEWS/303019922/pfizer-closes-king-pharmaceuticals-acquisition\">\"Pfizer closes King Pharmaceuticals acquisition\"</a>. <i><a href=\"/wiki/Modern_Healthcare\" title=\"Modern Healthcare\">Modern Healthcare</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Modern+Healthcare&amp;rft.atitle=Pfizer+closes+King+Pharmaceuticals+acquisition&amp;rft.date=2011-03-01&amp;rft.aulast=Mckinney&amp;rft.aufirst=Maureen&amp;rft_id=https%3A%2F%2Fwww.modernhealthcare.com%2Farticle%2F20110301%2FNEWS%2F303019922%2Fpfizer-closes-king-pharmaceuticals-acquisition&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-58\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-58\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFYukhananov2012\" class=\"citation news cs1\">Yukhananov, Anna (September 4, 2012). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.reuters.com/article/us-pfizer-leukemia/fda-approves-pfizer-leukemia-drug-idUSBRE88314720120904\">\"FDA approves Pfizer leukemia drug\"</a>. <i><a href=\"/wiki/Reuters\" title=\"Reuters\">Reuters</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=FDA+approves+Pfizer+leukemia+drug&amp;rft.date=2012-09-04&amp;rft.aulast=Yukhananov&amp;rft.aufirst=Anna&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-pfizer-leukemia%2Ffda-approves-pfizer-leukemia-drug-idUSBRE88314720120904&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-59\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-59\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/203214orig1s000toc.cfm\">\"Drug Approval Package\"</a>. <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Drug+Approval+Package&amp;rft.pub=Food+and+Drug+Administration&amp;rft_id=https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Fnda%2F2012%2F203214orig1s000toc.cfm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-60\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-60\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFSagonowsky2019\" class=\"citation news cs1\">Sagonowsky, Eric (February 20, 2019). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.fiercepharma.com/pharma/postmarketing-study-pfizer-switches-ra-patients-to-lower-xeljanz-dose-safety-concerns\">\"Pfizer switches RA patients to lower dose of fast-growing Xeljanz as safety issues arise in postmarketing study\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Pfizer+switches+RA+patients+to+lower+dose+of+fast-growing+Xeljanz+as+safety+issues+arise+in+postmarketing+study&amp;rft.date=2019-02-20&amp;rft.aulast=Sagonowsky&amp;rft.aufirst=Eric&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpostmarketing-study-pfizer-switches-ra-patients-to-lower-xeljanz-dose-safety-concerns&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-61\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-61\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.zoetisus.com/news-and-media/zoetis-files-ipo-registration-statement.aspx\">\"Zoetis™ Files IPO Registration Statement\"</a> (Press release). <a href=\"/wiki/Business_Wire\" title=\"Business Wire\">Business Wire</a>. August 13, 2012.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Zoetis%E2%84%A2+Files+IPO+Registration+Statement&amp;rft.pub=Business+Wire&amp;rft.date=2012-08-13&amp;rft_id=https%3A%2F%2Fwww.zoetisus.com%2Fnews-and-media%2Fzoetis-files-ipo-registration-statement.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-62\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-62\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFJ._de_la_Merced2013\" class=\"citation news cs1\">J. de la Merced, Michael (February 1, 2013). <span class=\"cs1-lock-limited\" title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://dealbook.nytimes.com/2013/02/01/shares-of-zoetis-surge-on-debut/\">\"Shares of Zoetis Surge on Debut\"</a></span>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Shares+of+Zoetis+Surge+on+Debut&amp;rft.date=2013-02-01&amp;rft.aulast=J.+de+la+Merced&amp;rft.aufirst=Michael&amp;rft_id=https%3A%2F%2Fdealbook.nytimes.com%2F2013%2F02%2F01%2Fshares-of-zoetis-surge-on-debut%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-63\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-63\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFDieterich2013\" class=\"citation news cs1\">Dieterich, Chris (January 31, 2013). <span class=\"cs1-lock-subscription\" title=\"Paid subscription required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.wsj.com/articles/SB10001424127887323701904578276530830057770\">\"Zoetis Raises $2.2 Billion in IPO\"</a></span>. <i><a href=\"/wiki/The_Wall_Street_Journal\" title=\"The Wall Street Journal\">The Wall Street Journal</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=Zoetis+Raises+%242.2+Billion+in+IPO&amp;rft.date=2013-01-31&amp;rft.aulast=Dieterich&amp;rft.aufirst=Chris&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2FSB10001424127887323701904578276530830057770&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-64\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-64\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.cbsnews.com/news/shares-of-animal-health-company-zoetis-soar-in-ipo/\">\"Shares of animal health company Zoetis soar in IPO\"</a>. <a href=\"/wiki/CBS_News\" title=\"CBS News\">CBS News</a>. <a href=\"/wiki/Associated_Press\" title=\"Associated Press\">Associated Press</a>. February 1, 2013.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Shares+of+animal+health+company+Zoetis+soar+in+IPO&amp;rft.date=2013-02-01&amp;rft_id=https%3A%2F%2Fwww.cbsnews.com%2Fnews%2Fshares-of-animal-health-company-zoetis-soar-in-ipo%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-65\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-65\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFLoftus2013\" class=\"citation news cs1\">Loftus, Peter (May 22, 2013). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.wsj.com/articles/SB10001424127887323975004578498994013821124\">\"Pfizer to Spin Off Remaining Zoetis Stake\"</a>. <i><a href=\"/wiki/The_Wall_Street_Journal\" title=\"The Wall Street Journal\">The Wall Street Journal</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=Pfizer+to+Spin+Off+Remaining+Zoetis+Stake&amp;rft.date=2013-05-22&amp;rft.aulast=Loftus&amp;rft.aufirst=Peter&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2FSB10001424127887323975004578498994013821124&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-66\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-66\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFHumerPierson2013\" class=\"citation news cs1\">Humer, Caroline; Pierson, Ransdell (May 22, 2013). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.reuters.com/article/us-pfizer-zoetis/pfizer-to-spin-off-zoetis-stake-to-shareholders-idUSBRE94L0JB20130522\">\"Pfizer to spin off Zoetis stake to shareholders\"</a>. <i><a href=\"/wiki/Reuters\" title=\"Reuters\">Reuters</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+to+spin+off+Zoetis+stake+to+shareholders&amp;rft.date=2013-05-22&amp;rft.aulast=Humer&amp;rft.aufirst=Caroline&amp;rft.au=Pierson%2C+Ransdell&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-pfizer-zoetis%2Fpfizer-to-spin-off-zoetis-stake-to-shareholders-idUSBRE94L0JB20130522&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-67\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-67\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFWasserman2014\" class=\"citation news cs1\">Wasserman, Emily (September 29, 2014). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.fiercepharma.com/pharma/pfizer-completes-acquisition-of-innopharma\">\"Pfizer Completes Acquisition Of InnoPharma\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Pfizer+Completes+Acquisition+Of+InnoPharma&amp;rft.date=2014-09-29&amp;rft.aulast=Wasserman&amp;rft.aufirst=Emily&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizer-completes-acquisition-of-innopharma&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-68\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-68\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.genengnews.com/news/pfizer-to-acquire-innopharma-for-up-to-360m/\">\"Pfizer to Acquire InnoPharma for Up to $360M\"</a>. <i><a href=\"/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Genengnews.com (page does not exist)\">genengnews.com</a></i>. July 16, 2014.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+to+Acquire+InnoPharma+for+Up+to+%24360M&amp;rft.date=2014-07-16&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fnews%2Fpfizer-to-acquire-innopharma-for-up-to-360m%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-69\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-69\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.genengnews.com/topics/drug-discovery/pfizer-buys-redvax-boosting-vaccine-portfolio/\">\"Pfizer Buys Redvax, Boosting Vaccine Portfolio\"</a>. <i><a href=\"/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Genengnews.com (page does not exist)\">genengnews.com</a></i>. January 5, 2015.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+Buys+Redvax%2C+Boosting+Vaccine+Portfolio&amp;rft.date=2015-01-05&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Ftopics%2Fdrug-discovery%2Fpfizer-buys-redvax-boosting-vaccine-portfolio%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-70\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-70\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFBeaverAmiri-KordestaniCharlabChen2015\" class=\"citation journal cs1\">Beaver, Julia A.; Amiri-Kordestani, Laleh; Charlab, Rosane; Chen, Wei; Palmby, Todd; Tilley, Amy; Zirkelbach, Jeanne Fourie; Yu, Jingyu; Liu, Qi; Zhao, Liang; Crich, Joyce; Chen, Xiao Hong; Hughes, Minerva; Bloomquist, Erik; Tang, Shenghui; Sridhara, Rajeshwari; Kluetz, Paul G.; Kim, Geoffrey; Ibrahim, Amna; Pazdur, Richard; Cortazar, Patricia (November 1, 2015). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1158%2F1078-0432.CCR-15-1185\">\"FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor–Positive, HER2-Negative Metastatic Breast Cancer\"</a>. <i>Clinical Cancer Research</i>. <b>21</b> (21): 4760–4766. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1158%2F1078-0432.CCR-15-1185\">10.1158/1078-0432.CCR-15-1185</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/26324739\">26324739</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:24762535\">24762535</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Cancer+Research&amp;rft.atitle=FDA+Approval%3A+Palbociclib+for+the+Treatment+of+Postmenopausal+Patients+with+Estrogen+Receptor%E2%80%93Positive%2C+HER2-Negative+Metastatic+Breast+Cancer&amp;rft.volume=21&amp;rft.issue=21&amp;rft.pages=4760-4766&amp;rft.date=2015-11-01&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A24762535%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F26324739&amp;rft_id=info%3Adoi%2F10.1158%2F1078-0432.CCR-15-1185&amp;rft.aulast=Beaver&amp;rft.aufirst=Julia+A.&amp;rft.au=Amiri-Kordestani%2C+Laleh&amp;rft.au=Charlab%2C+Rosane&amp;rft.au=Chen%2C+Wei&amp;rft.au=Palmby%2C+Todd&amp;rft.au=Tilley%2C+Amy&amp;rft.au=Zirkelbach%2C+Jeanne+Fourie&amp;rft.au=Yu%2C+Jingyu&amp;rft.au=Liu%2C+Qi&amp;rft.au=Zhao%2C+Liang&amp;rft.au=Crich%2C+Joyce&amp;rft.au=Chen%2C+Xiao+Hong&amp;rft.au=Hughes%2C+Minerva&amp;rft.au=Bloomquist%2C+Erik&amp;rft.au=Tang%2C+Shenghui&amp;rft.au=Sridhara%2C+Rajeshwari&amp;rft.au=Kluetz%2C+Paul+G.&amp;rft.au=Kim%2C+Geoffrey&amp;rft.au=Ibrahim%2C+Amna&amp;rft.au=Pazdur%2C+Richard&amp;rft.au=Cortazar%2C+Patricia&amp;rft_id=%2F%2Fdoi.org%2F10.1158%252F1078-0432.CCR-15-1185&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-71\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-71\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.fda.gov/drugs/resources-information-approved-drugs/palbociclib-ibrance\">\"Palbociclib (IBRANCE)\"</a>. <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a>. February 9, 2019.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Palbociclib+%28IBRANCE%29&amp;rft.pub=Food+and+Drug+Administration&amp;rft.date=2019-02-09&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fdrugs%2Fresources-information-approved-drugs%2Fpalbociclib-ibrance&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-72\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-72\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.genengnews.com/topics/drug-discovery/pfizer-lilly-to-resume-phase-iii-tanezumab-clinical-program/\">\"Pfizer, Lilly to Resume Phase III Tanezumab Clinical Program\"</a>. <i><a href=\"/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Genengnews.com (page does not exist)\">genengnews.com</a></i>. March 23, 2015.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer%2C+Lilly+to+Resume+Phase+III+Tanezumab+Clinical+Program&amp;rft.date=2015-03-23&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Ftopics%2Fdrug-discovery%2Fpfizer-lilly-to-resume-phase-iii-tanezumab-clinical-program%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-73\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-73\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFGali2015\" class=\"citation news cs1\">Gali, Weinreb (May 14, 2015). <a rel=\"nofollow\" class=\"external text\" href=\"https://en.globes.co.il/en/article-pfizer-to-collaborate-on-bar-ilan-dna-robots-1001036703\">\"Pfizer to collaborate on Bar-Ilan DNA robots\"</a>. <i><a href=\"/wiki/Globes_(newspaper)\" title=\"Globes (newspaper)\">Globes</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Globes&amp;rft.atitle=Pfizer+to+collaborate+on+Bar-Ilan+DNA+robots&amp;rft.date=2015-05-14&amp;rft.aulast=Gali&amp;rft.aufirst=Weinreb&amp;rft_id=https%3A%2F%2Fen.globes.co.il%2Fen%2Farticle-pfizer-to-collaborate-on-bar-ilan-dna-robots-1001036703&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-74\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-74\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.genengnews.com/topics/drug-discovery/pfizer-buys-two-gsk-meningitis-vaccines-for-130m/\">\"Pfizer Buys Two GSK Meningitis Vaccines for $130M\"</a>. <i><a href=\"/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Genengnews.com (page does not exist)\">genengnews.com</a></i>. June 22, 2015.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+Buys+Two+GSK+Meningitis+Vaccines+for+%24130M&amp;rft.date=2015-06-22&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Ftopics%2Fdrug-discovery%2Fpfizer-buys-two-gsk-meningitis-vaccines-for-130m%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-75\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-75\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.businesswire.com/news/home/20150903005752/en/Pfizer-Completes-Acquisition-of-Hospira\">\"Pfizer Completes Acquisition of Hospira\"</a> (Press release). Pfizer. September 3, 2015 &#8211; via <a href=\"/wiki/Business_Wire\" title=\"Business Wire\">Business Wire</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Completes+Acquisition+of+Hospira&amp;rft.pub=Pfizer&amp;rft.date=2015-09-03&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20150903005752%2Fen%2FPfizer-Completes-Acquisition-of-Hospira&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-76\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-76\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.thepharmaletter.com/article/pfizer-completes-17-billion-hospira-acquisition\">\"Pfizer completes $17-billion Hospira acquisition\"</a>. <i><a href=\"/wiki/The_Pharma_Letter\" title=\"The Pharma Letter\">The Pharma Letter</a></i>. September 4, 2015.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Pharma+Letter&amp;rft.atitle=Pfizer+completes+%2417-billion+Hospira+acquisition&amp;rft.date=2015-09-04&amp;rft_id=https%3A%2F%2Fwww.thepharmaletter.com%2Farticle%2Fpfizer-completes-17-billion-hospira-acquisition&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-77\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-77\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFGellesThomas2015\" class=\"citation news cs1\">Gelles, David; Thomas, Katie (February 5, 2015). <span class=\"cs1-lock-limited\" title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://dealbook.nytimes.com/2015/02/05/pfizer-to-buy-hospira-a-drug-maker-for-15-2-billion-in-cash\">\"Pfizer Bets $15 Billion on New Class of Generic Drugs\"</a></span>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+Bets+%2415+Billion+on+New+Class+of+Generic+Drugs&amp;rft.date=2015-02-05&amp;rft.aulast=Gelles&amp;rft.aufirst=David&amp;rft.au=Thomas%2C+Katie&amp;rft_id=https%3A%2F%2Fdealbook.nytimes.com%2F2015%2F02%2F05%2Fpfizer-to-buy-hospira-a-drug-maker-for-15-2-billion-in-cash&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-78\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-78\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.sec.gov/Archives/edgar/data/78003/000119312515037588/d866443d8k.htm\">\"8-K\"</a>. <a href=\"/wiki/U.S._Securities_and_Exchange_Commission\" title=\"U.S. Securities and Exchange Commission\">U.S. Securities and Exchange Commission</a>. February 6, 2015.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=8-K&amp;rft.pub=U.S.+Securities+and+Exchange+Commission&amp;rft.date=2015-02-06&amp;rft_id=https%3A%2F%2Fwww.sec.gov%2FArchives%2Fedgar%2Fdata%2F78003%2F000119312515037588%2Fd866443d8k.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-79\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-79\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.pfizer.com/news/press-release/press-release-detail/pfizer_to_acquire_hospira\">\"Pfizer to Acquire Hospira\"</a>. <i>Pfizer</i> (Press release).</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+to+Acquire+Hospira&amp;rft_id=https%3A%2F%2Fwww.pfizer.com%2Fnews%2Fpress-release%2Fpress-release-detail%2Fpfizer_to_acquire_hospira&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-80\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-80\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFNeilan2015\" class=\"citation news cs1\">Neilan, Catherine (February 5, 2015). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.cityam.com/pfizer-hospira-share-prices-soar-after-17bn-deal-announced/\">\"Pfizer, Hospira share prices to soar after $17bn deal announced\"</a>. <i><a href=\"/wiki/City_A.M.\" title=\"City A.M.\">City A.M.</a></i></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=City+A.M.&amp;rft.atitle=Pfizer%2C+Hospira+share+prices+to+soar+after+%2417bn+deal+announced&amp;rft.date=2015-02-05&amp;rft.aulast=Neilan&amp;rft.aufirst=Catherine&amp;rft_id=https%3A%2F%2Fwww.cityam.com%2Fpfizer-hospira-share-prices-soar-after-17bn-deal-announced%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-81\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-81\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFBhallaSingh2009\" class=\"citation news cs1\">Bhalla, Mohit; Singh, Khomba (December 16, 2009). <a rel=\"nofollow\" class=\"external text\" href=\"https://m.economictimes.com/industry/healthcare/biotech/pharmaceuticals/us-based-hospira-to-buy-orchid-chemicals-injectables-biz-for-400-mn/articleshow/5342003.cms\">\"US-based Hospira to buy Orchid Chemicals' injectables biz for $400 mn\"</a>. <i><a href=\"/wiki/The_Economic_Times\" title=\"The Economic Times\">The Economic Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Economic+Times&amp;rft.atitle=US-based+Hospira+to+buy+Orchid+Chemicals%27+injectables+biz+for+%24400+mn&amp;rft.date=2009-12-16&amp;rft.aulast=Bhalla&amp;rft.aufirst=Mohit&amp;rft.au=Singh%2C+Khomba&amp;rft_id=https%3A%2F%2Fm.economictimes.com%2Findustry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fus-based-hospira-to-buy-orchid-chemicals-injectables-biz-for-400-mn%2Farticleshow%2F5342003.cms&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-82\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-82\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.bbc.co.uk/news/business-34900344\">\"Pfizer seals $160bn Allergan deal to create drugs giant\"</a>. <i><a href=\"/wiki/BBC_News\" title=\"BBC News\">BBC News</a></i>. November 23, 2015.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Pfizer+seals+%24160bn+Allergan+deal+to+create+drugs+giant&amp;rft.date=2015-11-23&amp;rft_id=https%3A%2F%2Fwww.bbc.co.uk%2Fnews%2Fbusiness-34900344&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-83\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-83\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFPiersonBerkrot2015\" class=\"citation news cs1\">Pierson, Ransdell; Berkrot, Bill (November 24, 2015). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.reuters.com/article/us-allergan-m-a-pfizer/pfizer-to-buy-allergan-in-160-billion-deal-idUSKBN0TB0UT20151124\">\"Pfizer to buy Allergan in $160 billion deal\"</a>. <i><a href=\"/wiki/Reuters\" title=\"Reuters\">Reuters</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+to+buy+Allergan+in+%24160+billion+deal&amp;rft.date=2015-11-24&amp;rft.aulast=Pierson&amp;rft.aufirst=Ransdell&amp;rft.au=Berkrot%2C+Bill&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-allergan-m-a-pfizer%2Fpfizer-to-buy-allergan-in-160-billion-deal-idUSKBN0TB0UT20151124&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-84\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-84\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.genengnews.com/news/pfizer-to-acquire-allergan-for-160b/\">\"Pfizer to Acquire Allergan for $160B\"</a>. <i><a href=\"/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Genengnews.com (page does not exist)\">genengnews.com</a></i>. November 23, 2015.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+to+Acquire+Allergan+for+%24160B&amp;rft.date=2015-11-23&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fnews%2Fpfizer-to-acquire-allergan-for-160b%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-85\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-85\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFKoons2015\" class=\"citation news cs1\">Koons, Cynthia (November 22, 2015). <span class=\"cs1-lock-limited\" title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.bloomberg.com/news/articles/2015-11-22/pfizer-allergan-said-to-be-close-to-150-billion-merger\">\"Pfizer and Allergan to Combine With Joint Value of $160 Billion\"</a></span>. <i><a href=\"/wiki/Bloomberg_News\" title=\"Bloomberg News\">Bloomberg News</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+News&amp;rft.atitle=Pfizer+and+Allergan+to+Combine+With+Joint+Value+of+%24160+Billion&amp;rft.date=2015-11-22&amp;rft.aulast=Koons&amp;rft.aufirst=Cynthia&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2015-11-22%2Fpfizer-allergan-said-to-be-close-to-150-billion-merger&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-86\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-86\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFBray2016\" class=\"citation news cs1\">Bray, Chad (April 6, 2016). <span class=\"cs1-lock-limited\" title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2016/04/07/business/dealbook/pfizer-allergan-merger.html\">\"Pfizer and Allergan Call Off Merger After Tax-Rule Changes\"</a></span>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+and+Allergan+Call+Off+Merger+After+Tax-Rule+Changes&amp;rft.date=2016-04-06&amp;rft.aulast=Bray&amp;rft.aufirst=Chad&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2016%2F04%2F07%2Fbusiness%2Fdealbook%2Fpfizer-allergan-merger.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-87\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-87\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFHumerBanerjee2016\" class=\"citation news cs1\">Humer, Caroline; Banerjee, Ankur (April 6, 2016). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.reuters.com/article/us-allergan-m-a-pfizer-idUSKCN0X3188\">\"Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change\"</a>. <i><a href=\"/wiki/Reuters\" title=\"Reuters\">Reuters</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer%2C+Allergan+scrap+%24160+billion+deal+after+U.S.+tax+rule+change&amp;rft.date=2016-04-06&amp;rft.aulast=Humer&amp;rft.aufirst=Caroline&amp;rft.au=Banerjee%2C+Ankur&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-allergan-m-a-pfizer-idUSKCN0X3188&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-88\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-88\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.businesswire.com/news/home/20160624005299/en/Pfizer-Completes-Acquisition-of-Anacor\">\"Pfizer Completes Acquisition of Anacor\"</a> (Press release). Pfizer. June 24, 2016 &#8211; via <a href=\"/wiki/Business_Wire\" title=\"Business Wire\">Business Wire</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Completes+Acquisition+of+Anacor&amp;rft.pub=Pfizer&amp;rft.date=2016-06-24&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20160624005299%2Fen%2FPfizer-Completes-Acquisition-of-Anacor&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-89\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-89\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.genengnews.com/news/pfizer-to-acquire-anacor-pharmaceuticals-for-5-2b/\">\"Pfizer to Acquire Anacor Pharmaceuticals for $5.2B\"</a>. <i><a href=\"/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Genengnews.com (page does not exist)\">genengnews.com</a></i>. May 16, 2016.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+to+Acquire+Anacor+Pharmaceuticals+for+%245.2B&amp;rft.date=2016-05-16&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fnews%2Fpfizer-to-acquire-anacor-pharmaceuticals-for-5-2b%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-90\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-90\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.genengnews.com/news/pfizer-places-high-bid-of-40m-for-bind-therapeutics/\">\"Pfizer Places High Bid of $40M for BIND Therapeutics\"</a>. <i><a href=\"/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Genengnews.com (page does not exist)\">genengnews.com</a></i>. July 27, 2016.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+Places+High+Bid+of+%2440M+for+BIND+Therapeutics&amp;rft.date=2016-07-27&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fnews%2Fpfizer-places-high-bid-of-40m-for-bind-therapeutics%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-91\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-91\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.genengnews.com/news/pfizer-acquires-bamboo-therapeutics-in-a-645m-deal/\">\"Pfizer Acquires Bamboo Therapeutics in a $645M Deal\"</a>. <i><a href=\"/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Genengnews.com (page does not exist)\">genengnews.com</a></i>. August 1, 2016.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+Acquires+Bamboo+Therapeutics+in+a+%24645M+Deal&amp;rft.date=2016-08-01&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fnews%2Fpfizer-acquires-bamboo-therapeutics-in-a-645m-deal%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-92\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-92\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.genengnews.com/news/pfizer-to-acquire-medivation-for-14b/\">\"Pfizer to Acquire Medivation for $14B\"</a>. <i><a href=\"/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Genengnews.com (page does not exist)\">genengnews.com</a></i>. August 22, 2016.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+to+Acquire+Medivation+for+%2414B&amp;rft.date=2016-08-22&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fnews%2Fpfizer-to-acquire-medivation-for-14b%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-93\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-93\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.bbc.co.uk/news/business-37150531\">\"Pfizer to buy cancer drug firm Medivation for $14bn\"</a>. <i><a href=\"/wiki/BBC_News\" title=\"BBC News\">BBC News</a></i>. August 22, 2016.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Pfizer+to+buy+cancer+drug+firm+Medivation+for+%2414bn&amp;rft.date=2016-08-22&amp;rft_id=https%3A%2F%2Fwww.bbc.co.uk%2Fnews%2Fbusiness-37150531&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-94\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-94\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.businesswire.com/news/home/20160928005824/en/\">\"Pfizer Completes Acquisition of Medivation\"</a> (Press release). OncoImmune. September 28, 2016 &#8211; via <a href=\"/wiki/Business_Wire\" title=\"Business Wire\">Business Wire</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Completes+Acquisition+of+Medivation&amp;rft.pub=OncoImmune&amp;rft.date=2016-09-28&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20160928005824%2Fen%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-95\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-95\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.genengnews.com/topics/drug-discovery/oncoimmune-licenses-onc-392-to-pfizer-for-up-to-250m/\">\"OncoImmune Licenses ONC-392 to Pfizer for Up to $250M\"</a>. <i><a href=\"/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Genengnews.com (page does not exist)\">genengnews.com</a></i>. October 15, 2016.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=OncoImmune+Licenses+ONC-392+to+Pfizer+for+Up+to+%24250M&amp;rft.date=2016-10-15&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Ftopics%2Fdrug-discovery%2Foncoimmune-licenses-onc-392-to-pfizer-for-up-to-250m%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-96\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-96\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.businesswire.com/news/home/20160915005151/en/OncoImmune-Announces-Option-and-License-Agreement-with-Pfizer-Inc.\">\"OncoImmune Announces Option and License Agreement with Pfizer Inc\"</a> (Press release). Pfizer. September 15, 2016 &#8211; via <a href=\"/wiki/Business_Wire\" title=\"Business Wire\">Business Wire</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=OncoImmune+Announces+Option+and+License+Agreement+with+Pfizer+Inc.&amp;rft.pub=Pfizer&amp;rft.date=2016-09-15&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20160915005151%2Fen%2FOncoImmune-Announces-Option-and-License-Agreement-with-Pfizer-Inc.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-97\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-97\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.businesswire.com/news/home/20161222005395/en/Pfizer-Completes-Acquisition-of-Small-Molecule-Anti-Infective-Business-From-AstraZeneca\">\"Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca\"</a> (Press release). Pfizer. December 23, 2016 &#8211; via <a href=\"/wiki/Business_Wire\" title=\"Business Wire\">Business Wire</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Completes+Acquisition+of+Small+Molecule+Anti-Infective+Business+From+AstraZeneca&amp;rft.pub=Pfizer&amp;rft.date=2016-12-23&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20161222005395%2Fen%2FPfizer-Completes-Acquisition-of-Small-Molecule-Anti-Infective-Business-From-AstraZeneca&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-98\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-98\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.genengnews.com/topics/drug-discovery/pfizer-buys-astrazeneca-antibiotics-for-up-to-1-575b/\">\"Pfizer Buys AstraZeneca Antibiotics for Up to $1.575B\"</a>. <i><a href=\"/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Genengnews.com (page does not exist)\">genengnews.com</a></i>. August 24, 2016.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+Buys+AstraZeneca+Antibiotics+for+Up+to+%241.575B&amp;rft.date=2016-08-24&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Ftopics%2Fdrug-discovery%2Fpfizer-buys-astrazeneca-antibiotics-for-up-to-1-575b%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-99\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-99\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFStaton2016\" class=\"citation news cs1\">Staton, Tracy (August 24, 2016). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.fiercepharma.com/pharma/pfizer-grabs-az-antibiotics-1-5b-deal-pre-split-prep-or-just-another-sales-boosting-buy\">\"Pfizer grabs AZ antibiotics in $1.5B deal. Pre-split prep or just another sales-boosting buy?\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Pfizer+grabs+AZ+antibiotics+in+%241.5B+deal.+Pre-split+prep+or+just+another+sales-boosting+buy%3F&amp;rft.date=2016-08-24&amp;rft.aulast=Staton&amp;rft.aufirst=Tracy&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizer-grabs-az-antibiotics-1-5b-deal-pre-split-prep-or-just-another-sales-boosting-buy&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-100\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-100\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFHiltzik2018\" class=\"citation news cs1\"><a href=\"/wiki/Michael_Hiltzik\" title=\"Michael Hiltzik\">Hiltzik, Michael</a> (January 8, 2018). <span class=\"cs1-lock-subscription\" title=\"Paid subscription required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.latimes.com/business/hiltzik/la-fi-hiltzik-pfizer-20180108-story.html\">\"Pfizer, pocketing a big tax cut from Trump, will end investment in Alzheimer's and Parkinson's research\"</a></span>. <i><a href=\"/wiki/Los_Angeles_Times\" title=\"Los Angeles Times\">Los Angeles Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Los+Angeles+Times&amp;rft.atitle=Pfizer%2C+pocketing+a+big+tax+cut+from+Trump%2C+will+end+investment+in+Alzheimer%27s+and+Parkinson%27s+research&amp;rft.date=2018-01-08&amp;rft.aulast=Hiltzik&amp;rft.aufirst=Michael&amp;rft_id=https%3A%2F%2Fwww.latimes.com%2Fbusiness%2Fhiltzik%2Fla-fi-hiltzik-pfizer-20180108-story.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-101\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-101\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-enzalutamide-castration-resistant-prostate-cancer\">\"FDA approves enzalutamide for castration-resistant prostate cancer\"</a> (Press release). <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a>. July 13, 2018.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+approves+enzalutamide+for+castration-resistant+prostate+cancer&amp;rft.pub=Food+and+Drug+Administration&amp;rft.date=2018-07-13&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fdrugs%2Fresources-information-approved-drugs%2Ffda-approves-enzalutamide-castration-resistant-prostate-cancer&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-102\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-102\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://biontechse.gcs-web.com/news-releases/news-release-details/biontech-signs-collaboration-agreement-pfizer-develop-mrna-based\">\"BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza\"</a> (Press release). <a href=\"/wiki/BioNTech\" title=\"BioNTech\">BioNTech</a>. August 16, 2018.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=BioNTech+Signs+Collaboration+Agreement+with+Pfizer+to+Develop+mRNA-based+Vaccines+for+Prevention+of+Influenza&amp;rft.pub=BioNTech&amp;rft.date=2018-08-16&amp;rft_id=https%3A%2F%2Fbiontechse.gcs-web.com%2Fnews-releases%2Fnews-release-details%2Fbiontech-signs-collaboration-agreement-pfizer-develop-mrna-based&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-103\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-103\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFMathiasBanerjee2018\" class=\"citation news cs1\">Mathias, Tamara; Banerjee, Ankur (October 1, 2018). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.reuters.com/article/us-pfizer-ceo/pfizer-to-replace-longtime-ceo-read-with-veteran-bourla-idUSKCN1MB29D\">\"Pfizer to replace longtime CEO Read with veteran Bourla\"</a>. <i><a href=\"/wiki/Reuters\" title=\"Reuters\">Reuters</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+to+replace+longtime+CEO+Read+with+veteran+Bourla&amp;rft.date=2018-10-01&amp;rft.aulast=Mathias&amp;rft.aufirst=Tamara&amp;rft.au=Banerjee%2C+Ankur&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-pfizer-ceo%2Fpfizer-to-replace-longtime-ceo-read-with-veteran-bourla-idUSKCN1MB29D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-104\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-104\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFMaidenberg2018\" class=\"citation news cs1\">Maidenberg, Micah (October 9, 2018). <span class=\"cs1-lock-subscription\" title=\"Paid subscription required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.wsj.com/articles/pfizer-prepares-for-ceo-transition-with-executive-suite-changes-1539095075\">\"Pfizer Prepares for CEO Transition With Executive Suite Changes\"</a></span>. <i><a href=\"/wiki/The_Wall_Street_Journal\" title=\"The Wall Street Journal\">The Wall Street Journal</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=Pfizer+Prepares+for+CEO+Transition+With+Executive+Suite+Changes&amp;rft.date=2018-10-09&amp;rft.aulast=Maidenberg&amp;rft.aufirst=Micah&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2Fpfizer-prepares-for-ceo-transition-with-executive-suite-changes-1539095075&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-105\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-105\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFRamsey2018\" class=\"citation news cs1\">Ramsey, Lydia (October 1, 2018). <span class=\"cs1-lock-subscription\" title=\"Paid subscription required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.businessinsider.com/who-is-albert-bourla-next-pfizer-ceo-2018-10\">\"Pfizer's CEO is stepping down after 8 years — meet the man who will be replacing him\"</a></span>. <i><a href=\"/wiki/Business_Insider\" title=\"Business Insider\">Business Insider</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Business+Insider&amp;rft.atitle=Pfizer%27s+CEO+is+stepping+down+after+8+years+%E2%80%94+meet+the+man+who+will+be+replacing+him&amp;rft.date=2018-10-01&amp;rft.aulast=Ramsey&amp;rft.aufirst=Lydia&amp;rft_id=https%3A%2F%2Fwww.businessinsider.com%2Fwho-is-albert-bourla-next-pfizer-ceo-2018-10&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-106\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-106\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFJarvis2018\" class=\"citation news cs1\">Jarvis, Lisa M. (October 3, 2018). <a rel=\"nofollow\" class=\"external text\" href=\"https://cen.acs.org/pharmaceuticals/Pfizer-unveils-CEO-succession-plan/96/i40\">\"Pfizer unveils CEO succession plan\"</a>. <i><a href=\"/wiki/Chemical_%26_Engineering_News\" title=\"Chemical &amp; Engineering News\">Chemical &amp; Engineering News</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Chemical+%26+Engineering+News&amp;rft.atitle=Pfizer+unveils+CEO+succession+plan&amp;rft.date=2018-10-03&amp;rft.aulast=Jarvis&amp;rft.aufirst=Lisa+M.&amp;rft_id=https%3A%2F%2Fcen.acs.org%2Fpharmaceuticals%2FPfizer-unveils-CEO-succession-plan%2F96%2Fi40&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-107\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-107\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFBakolia2019\" class=\"citation news cs1\">Bakolia, Ravikash (July 1, 2019). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.spglobal.com/marketintelligence/en/news-insights/trending/sWCcSrMgL8UmeCJXuuGp-w2\">\"Pfizer completes acquisition of Therachon to bolster rare disease drug portfolio\"</a>. <i><a href=\"/wiki/S%26P_Global\" title=\"S&amp;P Global\">S&amp;P Global</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=S%26P+Global&amp;rft.atitle=Pfizer+completes+acquisition+of+Therachon+to+bolster+rare+disease+drug+portfolio&amp;rft.date=2019-07-01&amp;rft.aulast=Bakolia&amp;rft.aufirst=Ravikash&amp;rft_id=https%3A%2F%2Fwww.spglobal.com%2Fmarketintelligence%2Fen%2Fnews-insights%2Ftrending%2FsWCcSrMgL8UmeCJXuuGp-w2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-108\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-108\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.businesswire.com/news/home/20190730005590/en/Pfizer-Completes-Acquisition-of-Array-Biopharma\">\"Pfizer Completes Acquisition of Array Biopharma\"</a> (Press release). Pfizer. July 30, 2019 &#8211; via <a href=\"/wiki/Business_Wire\" title=\"Business Wire\">Business Wire</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Completes+Acquisition+of+Array+Biopharma&amp;rft.pub=Pfizer&amp;rft.date=2019-07-30&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20190730005590%2Fen%2FPfizer-Completes-Acquisition-of-Array-Biopharma&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-109\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-109\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.gsk.com/en-gb/media/press-releases/gsk-completes-transaction-with-pfizer-to-form-new-world-leading-consumer-healthcare-joint-venture/\">\"GSK completes transaction with Pfizer to form new world-leading Consumer Healthcare Joint Venture\"</a> (Press release). <a href=\"/wiki/GlaxoSmithKline\" title=\"GlaxoSmithKline\">GlaxoSmithKline</a>. August 1, 2019.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=GSK+completes+transaction+with+Pfizer+to+form+new+world-leading+Consumer+Healthcare+Joint+Venture&amp;rft.pub=GlaxoSmithKline&amp;rft.date=2019-08-01&amp;rft_id=https%3A%2F%2Fwww.gsk.com%2Fen-gb%2Fmedia%2Fpress-releases%2Fgsk-completes-transaction-with-pfizer-to-form-new-world-leading-consumer-healthcare-joint-venture%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-110\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-110\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-plc-and-pfizer-inc-to-form-new-world-leading-consumer-healthcare-joint-venture/\">\"GlaxoSmithKline plc and Pfizer Inc to form new world-leading Consumer Healthcare Joint Venture\"</a> (Press release). <a href=\"/wiki/GlaxoSmithKline\" title=\"GlaxoSmithKline\">GlaxoSmithKline</a>. December 19, 2018.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=GlaxoSmithKline+plc+and+Pfizer+Inc+to+form+new+world-leading+Consumer+Healthcare+Joint+Venture&amp;rft.pub=GlaxoSmithKline&amp;rft.date=2018-12-19&amp;rft_id=https%3A%2F%2Fwww.gsk.com%2Fen-gb%2Fmedia%2Fpress-releases%2Fglaxosmithkline-plc-and-pfizer-inc-to-form-new-world-leading-consumer-healthcare-joint-venture%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-111\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-111\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.pfizer.com/news/press-release/press-release-detail/pfizer_and_glaxosmithkline_announce_joint_venture_to_create_a_premier_global_consumer_healthcare_company\">\"Pfizer and GlaxoSmithKline Announce Joint Venture to Create a Premier Global Consumer Healthcare Company\"</a>. <i>Pfizer</i> (Press release). December 18, 2018.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+and+GlaxoSmithKline+Announce+Joint+Venture+to+Create+a+Premier+Global+Consumer+Healthcare+Company&amp;rft.date=2018-12-18&amp;rft_id=https%3A%2F%2Fwww.pfizer.com%2Fnews%2Fpress-release%2Fpress-release-detail%2Fpfizer_and_glaxosmithkline_announce_joint_venture_to_create_a_premier_global_consumer_healthcare_company&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-112\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-112\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.bbc.co.uk/news/business-46616713\">\"GlaxoSmithKline and Pfizer merge healthcare arms\"</a>. <i><a href=\"/wiki/BBC_News\" title=\"BBC News\">BBC News</a></i>. December 19, 2018.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=GlaxoSmithKline+and+Pfizer+merge+healthcare+arms&amp;rft.date=2018-12-19&amp;rft_id=https%3A%2F%2Fwww.bbc.co.uk%2Fnews%2Fbusiness-46616713&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-113\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-113\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFHelfand2017\" class=\"citation news cs1\">Helfand, Carly (October 16, 2017). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.fiercepharma.com/pharma/reckitt-benckiser-s-still-keen-a-pfizer-otc-buy-but-can-it-afford-one\">\"Reckitt Benckiser's still keen on a Pfizer OTC buy. But can it afford one?\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Reckitt+Benckiser%27s+still+keen+on+a+Pfizer+OTC+buy.+But+can+it+afford+one%3F&amp;rft.date=2017-10-16&amp;rft.aulast=Helfand&amp;rft.aufirst=Carly&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Freckitt-benckiser-s-still-keen-a-pfizer-otc-buy-but-can-it-afford-one&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-114\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-114\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFHelfand2017\" class=\"citation news cs1\">Helfand, Carly (October 26, 2017). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.fiercepharma.com/pharma/sanofi-j-j-could-join-gsk-reckitt-20b-bidding-war-for-pfizer-otc-report\">\"Sanofi, J&amp;J could join GlaxoSmithKline, Reckitt in $20B bidding war for Pfizer OTC: report\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Sanofi%2C+J%26J+could+join+GlaxoSmithKline%2C+Reckitt+in+%2420B+bidding+war+for+Pfizer+OTC%3A+report&amp;rft.date=2017-10-26&amp;rft.aulast=Helfand&amp;rft.aufirst=Carly&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fsanofi-j-j-could-join-gsk-reckitt-20b-bidding-war-for-pfizer-otc-report&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-115\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-115\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFHelfand2017\" class=\"citation news cs1\">Helfand, Carly (October 25, 2017). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.fiercepharma.com/pharma/glaxosmithkline-s-eyeing-pfizer-s-otc-unit-but-will-a-buy-imperil-its-dividend\">\"GlaxoSmithKline eyes Pfizer's OTC unit. But will a buy imperil its dividend?\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=GlaxoSmithKline+eyes+Pfizer%27s+OTC+unit.+But+will+a+buy+imperil+its+dividend%3F&amp;rft.date=2017-10-25&amp;rft.aulast=Helfand&amp;rft.aufirst=Carly&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fglaxosmithkline-s-eyeing-pfizer-s-otc-unit-but-will-a-buy-imperil-its-dividend&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-116\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-116\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.reuters.com/article/us-cstone-pfizer/pfizer-to-buy-9-9-of-cstone-for-200-million-eyes-collaboration-idUKKBN26L01D\">\"Pfizer to buy 9.9% of CStone for $200 million, eyes collaboration\"</a>. <i><a href=\"/wiki/Reuters\" title=\"Reuters\">Reuters</a></i>. September 29, 2020.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+to+buy+9.9%25+of+CStone+for+%24200+million%2C+eyes+collaboration&amp;rft.date=2020-09-29&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-cstone-pfizer%2Fpfizer-to-buy-9-9-of-cstone-for-200-million-eyes-collaboration-idUKKBN26L01D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-117\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-117\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFAl_Idrus2020\" class=\"citation news cs1\">Al Idrus, Amirah (October 22, 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.fiercebiotech.com/biotech/pfizer-snaps-up-antibiotics-maker-arixa-and-its-oral-avycaz-follow-up\">\"Biotech Pfizer snaps up antibiotics maker Arixa and its oral Avycaz follow-up\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Biotech+Pfizer+snaps+up+antibiotics+maker+Arixa+and+its+oral+Avycaz+follow-up&amp;rft.date=2020-10-22&amp;rft.aulast=Al+Idrus&amp;rft.aufirst=Amirah&amp;rft_id=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fpfizer-snaps-up-antibiotics-maker-arixa-and-its-oral-avycaz-follow-up&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-118\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-118\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.businesswire.com/news/home/20201116005378/en/Pfizer-Completes-Transaction-to-Combine-Its-Upjohn-Business-with-Mylan\">\"Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan\"</a> (Press release). Pfizer. November 16, 2020 &#8211; via <a href=\"/wiki/Business_Wire\" title=\"Business Wire\">Business Wire</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Completes+Transaction+to+Combine+Its+Upjohn+Business+with+Mylan&amp;rft.pub=Pfizer&amp;rft.date=2020-11-16&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20201116005378%2Fen%2FPfizer-Completes-Transaction-to-Combine-Its-Upjohn-Business-with-Mylan&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-119\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-119\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.nasdaq.com/articles/pfizer-completes-combination-of-upjohn-and-mylan-viatris-to-begin-trading-on-nov.-17-2020\">\"Pfizer Completes Combination Of Upjohn And Mylan; Viatris To Begin Trading On Nov. 17\"</a>. <i><a href=\"/wiki/Nasdaq\" title=\"Nasdaq\">Nasdaq</a></i>. November 16, 2020.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nasdaq&amp;rft.atitle=Pfizer+Completes+Combination+Of+Upjohn+And+Mylan%3B+Viatris+To+Begin+Trading+On+Nov.+17&amp;rft.date=2020-11-16&amp;rft_id=https%3A%2F%2Fwww.nasdaq.com%2Farticles%2Fpfizer-completes-combination-of-upjohn-and-mylan-viatris-to-begin-trading-on-nov.-17-2020&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-120\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-120\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFSabatini2020\" class=\"citation news cs1\">Sabatini, Patricia (November 16, 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.post-gazette.com/business/healthcare-business/2020/11/16/Mylan-merger-Upjohn-Viatris-bresch-coury-Pfizer-cost-cuts-generic-drugs/stories/202011160111\">\"Mylan completes merger with Upjohn to form Viatris\"</a>. <i><a href=\"/wiki/Pittsburgh_Post-Gazette\" title=\"Pittsburgh Post-Gazette\">Pittsburgh Post-Gazette</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pittsburgh+Post-Gazette&amp;rft.atitle=Mylan+completes+merger+with+Upjohn+to+form+Viatris&amp;rft.date=2020-11-16&amp;rft.aulast=Sabatini&amp;rft.aufirst=Patricia&amp;rft_id=https%3A%2F%2Fwww.post-gazette.com%2Fbusiness%2Fhealthcare-business%2F2020%2F11%2F16%2FMylan-merger-Upjohn-Viatris-bresch-coury-Pfizer-cost-cuts-generic-drugs%2Fstories%2F202011160111&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-121\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-121\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFBruell2021\" class=\"citation news cs1\">Bruell, Alexandra (January 5, 2021). <span class=\"cs1-lock-subscription\" title=\"Paid subscription required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.wsj.com/articles/pfizer-introduces-new-logo-playing-up-role-in-drug-creation-11609844400\">\"Pfizer Introduces New Logo Playing Up Role in Drug Creation\"</a></span>. <i><a href=\"/wiki/The_Wall_Street_Journal\" title=\"The Wall Street Journal\">The Wall Street Journal</a></i>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0099-9660\">0099-9660</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=Pfizer+Introduces+New+Logo+Playing+Up+Role+in+Drug+Creation&amp;rft.date=2021-01-05&amp;rft.issn=0099-9660&amp;rft.aulast=Bruell&amp;rft.aufirst=Alexandra&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2Fpfizer-introduces-new-logo-playing-up-role-in-drug-creation-11609844400&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-122\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-122\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.businesswire.com/news/home/20210428005147/en/Pfizer-Acquires-Amplyx-Pharmaceuticals\">\"Pfizer Acquires Amplyx Pharmaceuticals\"</a> (Press release). Pfizer. April 28, 2021 &#8211; via <a href=\"/wiki/Business_Wire\" title=\"Business Wire\">Business Wire</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Acquires+Amplyx+Pharmaceuticals&amp;rft.pub=Pfizer&amp;rft.date=2021-04-28&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20210428005147%2Fen%2FPfizer-Acquires-Amplyx-Pharmaceuticals&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-123\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-123\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFTaylor2021\" class=\"citation news cs1\">Taylor, Nick Paul (April 28, 2021). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.fiercebiotech.com/biotech/pfizer-buys-amplyx-to-grow-infectious-disease-pipeline\">\"Pfizer buys Amplyx to grow infectious disease pipeline\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Pfizer+buys+Amplyx+to+grow+infectious+disease+pipeline&amp;rft.date=2021-04-28&amp;rft.aulast=Taylor&amp;rft.aufirst=Nick+Paul&amp;rft_id=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fpfizer-buys-amplyx-to-grow-infectious-disease-pipeline&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-124\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-124\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFWosen2021\" class=\"citation news cs1\">Wosen, Jonathan (April 28, 2021). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.sandiegouniontribune.com/business/biotech/story/2021-04-28/pfizer-acquires-fungus-fighting-san-diego-biotech-amplyx\">\"Pfizer acquires fungus-fighting San Diego biotech\"</a>. <i><a href=\"/wiki/The_San_Diego_Union-Tribune\" title=\"The San Diego Union-Tribune\">The San Diego Union-Tribune</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+San+Diego+Union-Tribune&amp;rft.atitle=Pfizer+acquires+fungus-fighting+San+Diego+biotech&amp;rft.date=2021-04-28&amp;rft.aulast=Wosen&amp;rft.aufirst=Jonathan&amp;rft_id=https%3A%2F%2Fwww.sandiegouniontribune.com%2Fbusiness%2Fbiotech%2Fstory%2F2021-04-28%2Fpfizer-acquires-fungus-fighting-san-diego-biotech-amplyx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-125\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-125\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.reuters.com/business/pfizer-buy-trillium-therapeutics-226-bln-deal-2021-08-23/\">\"Pfizer to buy cancer drug developer Trillium in $2.3 BLN deal\"</a>. <i>Reuters</i>. August 23, 2021.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+to+buy+cancer+drug+developer+Trillium+in+%242.3+BLN+deal&amp;rft.date=2021-08-23&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Fbusiness%2Fpfizer-buy-trillium-therapeutics-226-bln-deal-2021-08-23%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-126\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-126\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.biospace.com/article/releases/pfizer-to-acquire-trillium-therapeutics-inc-/?s=79\">\"Pfizer to Acquire Trillium Therapeutics Inc\"</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+to+Acquire+Trillium+Therapeutics+Inc&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Freleases%2Fpfizer-to-acquire-trillium-therapeutics-inc-%2F%3Fs%3D79&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-127\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-127\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.reuters.com/markets/deals/pfizer-acquire-arena-pharmaceuticals-67-bln-deal-2021-12-13\">\"Pfizer bets on Arena's promising bowel disease treatment in $6.7 bln deal\"</a>. <i><a href=\"/wiki/Reuters\" title=\"Reuters\">Reuters</a></i>. December 13, 2021<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">December 13,</span> 2021</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+bets+on+Arena%27s+promising+bowel+disease+treatment+in+%246.7+bln+deal&amp;rft.date=2021-12-13&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Fmarkets%2Fdeals%2Fpfizer-acquire-arena-pharmaceuticals-67-bln-deal-2021-12-13&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-128\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-128\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFWalker2021\" class=\"citation web cs1\">Walker, Joseph (December 13, 2021). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.wsj.com/articles/pfizer-to-acquire-arena-pharmaceuticals-in-6-7-billion-deal-11639414813\">\"Pfizer to Acquire Arena Pharmaceuticals in $6.7 Billion Deal\"</a>. <i><a href=\"/wiki/Wall_Street_Journal\" class=\"mw-redirect\" title=\"Wall Street Journal\">Wall Street Journal</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">December 13,</span> 2021</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Wall+Street+Journal&amp;rft.atitle=Pfizer+to+Acquire+Arena+Pharmaceuticals+in+%246.7+Billion+Deal&amp;rft.date=2021-12-13&amp;rft.aulast=Walker&amp;rft.aufirst=Joseph&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2Fpfizer-to-acquire-arena-pharmaceuticals-in-6-7-billion-deal-11639414813&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-129\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-129\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.pharmaceutical-technology.com/news/pfizer-arena-pharmaceuticals-acquisition/\">\"Pfizer concludes Arena Pharmaceuticals acquisition for $6.7bn\"</a>. <i>Pharmaceutical Technology</i>. March 14, 2022<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">March 14,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Pharmaceutical+Technology&amp;rft.atitle=Pfizer+concludes+Arena+Pharmaceuticals+acquisition+for+%246.7bn&amp;rft.date=2022-03-14&amp;rft_id=https%3A%2F%2Fwww.pharmaceutical-technology.com%2Fnews%2Fpfizer-arena-pharmaceuticals-acquisition%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-130\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-130\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFCzachor2020\" class=\"citation news cs1\">Czachor, Emily (November 9, 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.newsweek.com/pfizer-avoided-rd-funding-trumps-operation-warp-speed-because-bureaucracy-politics-1546110\">\"Pfizer Avoided R&amp;D Funding From Trump's Operation Warp Speed Because of Bureaucracy, Politics\"</a>. <i><a href=\"/wiki/Newsweek\" title=\"Newsweek\">Newsweek</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">May 18,</span> 2021</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Newsweek&amp;rft.atitle=Pfizer+Avoided+R%26D+Funding+From+Trump%27s+Operation+Warp+Speed+Because+of+Bureaucracy%2C+Politics&amp;rft.date=2020-11-09&amp;rft.aulast=Czachor&amp;rft.aufirst=Emily&amp;rft_id=https%3A%2F%2Fwww.newsweek.com%2Fpfizer-avoided-rd-funding-trumps-operation-warp-speed-because-bureaucracy-politics-1546110&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-131\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-131\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFMinkoff2020\" class=\"citation web cs1\">Minkoff, Yoel (May 13, 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://seekingalpha.com/news/3573714-pfizer-sees-expanded-coronavirus-vaccine-trials\">\"Pfizer sees expanded coronavirus vaccine trials\"</a>. <i>Seeking Alpha</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">May 13,</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Seeking+Alpha&amp;rft.atitle=Pfizer+sees+expanded+coronavirus+vaccine+trials&amp;rft.date=2020-05-13&amp;rft.aulast=Minkoff&amp;rft.aufirst=Yoel&amp;rft_id=https%3A%2F%2Fseekingalpha.com%2Fnews%2F3573714-pfizer-sees-expanded-coronavirus-vaccine-trials&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-132\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-132\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.globenewswire.com/news-release/2020/07/13/2061084/0/en/Pfizer-and-BioNTech-Granted-FDA-Fast-Track-Designation-for-Two-Investigational-mRNA-based-Vaccine-Candidates-Against-SARS-CoV-2.html\">\"Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2\"</a> (Press release). BioNTech. July 13, 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">July 15,</span> 2020</span> &#8211; via GlobeNewswire.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+and+BioNTech+Granted+FDA+Fast+Track+Designation+for+Two+Investigational+mRNA-based+Vaccine+Candidates+Against+SARS-CoV-2&amp;rft.pub=BioNTech&amp;rft.date=2020-07-13&amp;rft_id=http%3A%2F%2Fwww.globenewswire.com%2Fnews-release%2F2020%2F07%2F13%2F2061084%2F0%2Fen%2FPfizer-and-BioNTech-Granted-FDA-Fast-Track-Designation-for-Two-Investigational-mRNA-based-Vaccine-Candidates-Against-SARS-CoV-2.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-133\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-133\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFDeArment2020\" class=\"citation web cs1\">DeArment, Alaric (July 13, 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://medcitynews.com/2020/07/pfizer-biontech-get-fast-track-from-fda-for-covid-19-vaccines/\">\"Pfizer, BioNTech get fast-track from FDA for Covid-19 vaccines\"</a>. <i>MedCity News</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">July 15,</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=MedCity+News&amp;rft.atitle=Pfizer%2C+BioNTech+get+fast-track+from+FDA+for+Covid-19+vaccines&amp;rft.date=2020-07-13&amp;rft.aulast=DeArment&amp;rft.aufirst=Alaric&amp;rft_id=https%3A%2F%2Fmedcitynews.com%2F2020%2F07%2Fpfizer-biontech-get-fast-track-from-fda-for-covid-19-vaccines%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-134\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-134\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.wsj.com/articles/pfizer-sales-fall-as-company-races-toward-covid-19-vaccine-11595936314\">\"Pfizer Beats Forecasts as Vaccine Trial Enters Final Stage\"</a>. <i>The Wall Street Journal</i>. July 29, 2020.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=Pfizer+Beats+Forecasts+as+Vaccine+Trial+Enters+Final+Stage&amp;rft.date=2020-07-29&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2Fpfizer-sales-fall-as-company-races-toward-covid-19-vaccine-11595936314&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-135\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-135\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://news.yahoo.com/pfizer-charge-39-per-coronavirus-065224983.html\">\"Pfizer To Charge $39 Per Coronavirus Vaccine Course To All Developed Countries For Similar Volume Commitments As US\"</a>. <i>Benzinga</i>. <a href=\"/wiki/Yahoo!\" title=\"Yahoo!\">Yahoo!</a>. July 29, 2020.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Benzinga&amp;rft.atitle=Pfizer+To+Charge+%2439+Per+Coronavirus+Vaccine+Course+To+All+Developed+Countries+For+Similar+Volume+Commitments+As+US&amp;rft.date=2020-07-29&amp;rft_id=https%3A%2F%2Fnews.yahoo.com%2Fpfizer-charge-39-per-coronavirus-065224983.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-136\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-136\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.barrons.com/articles/pfizer-ceo-says-companies-should-make-profit-on-covid-19-vaccines-51595968611\">\"Pfizer CEO Says Companies Should Make Profit On Covid-19 Vaccines\"</a>. Barron's.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+CEO+Says+Companies+Should+Make+Profit+On+Covid-19+Vaccines&amp;rft.pub=Barron%27s&amp;rft_id=https%3A%2F%2Fwww.barrons.com%2Farticles%2Fpfizer-ceo-says-companies-should-make-profit-on-covid-19-vaccines-51595968611&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-137\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-137\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFKilgore\" class=\"citation web cs1\">Kilgore, Tomi. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.marketwatch.com/story/pfizer-biontech-conclude-talks-over-supplying-eu-with-sars-cov-2-vaccine-candidate-2020-09-09\">\"Pfizer, BioNTech conclude talks over supplying EU with SARS-CoV-2 vaccine candidate\"</a>. <i>MarketWatch</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">September 10,</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=MarketWatch&amp;rft.atitle=Pfizer%2C+BioNTech+conclude+talks+over+supplying+EU+with+SARS-CoV-2+vaccine+candidate&amp;rft.aulast=Kilgore&amp;rft.aufirst=Tomi&amp;rft_id=https%3A%2F%2Fwww.marketwatch.com%2Fstory%2Fpfizer-biontech-conclude-talks-over-supplying-eu-with-sars-cov-2-vaccine-candidate-2020-09-09&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-138\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-138\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-potentially-supply-eu-200-million-doses\">\"Pfizer and BioNTech to Potentially Supply the EU with 200 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2\"</a>. <i>Pfizer</i> (Press release)<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">September 10,</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+and+BioNTech+to+Potentially+Supply+the+EU+with+200+Million+Doses+of+mRNA-based+Vaccine+Candidate+Against+SARS-CoV-2&amp;rft_id=https%3A%2F%2Fwww.pfizer.com%2Fnews%2Fpress-release%2Fpress-release-detail%2Fpfizer-and-biontech-potentially-supply-eu-200-million-doses&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-139\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-139\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.bbc.com/news/health-54873105\">\"Covid vaccine: First 'milestone' vaccine offers 90% protection\"</a>. <i><a href=\"/wiki/BBC_News\" title=\"BBC News\">BBC News</a></i>. November 9, 2020.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Covid+vaccine%3A+First+%27milestone%27+vaccine+offers+90%25+protection&amp;rft.date=2020-11-09&amp;rft_id=https%3A%2F%2Fwww.bbc.com%2Fnews%2Fhealth-54873105&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-:1-140\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:1_140-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:1_140-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFKounang2020\" class=\"citation web cs1\">Kounang, Nadia (November 9, 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.cnn.com/2020/11/18/health/pfizer-coronavirus-vaccine-safety/index.html\">\"Pfizer and BioNTech say final analysis shows coronavirus vaccine is 95% effective with no safety concerns\"</a>. <i>CNN</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">November 9,</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=CNN&amp;rft.atitle=Pfizer+and+BioNTech+say+final+analysis+shows+coronavirus+vaccine+is+95%25+effective+with+no+safety+concerns&amp;rft.date=2020-11-09&amp;rft.aulast=Kounang&amp;rft.aufirst=Nadia&amp;rft_id=https%3A%2F%2Fwww.cnn.com%2F2020%2F11%2F18%2Fhealth%2Fpfizer-coronavirus-vaccine-safety%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-141\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-141\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFThomasGellesZimmer2020\" class=\"citation news cs1\">Thomas, Katie; Gelles, David; Zimmer, Carl (November 9, 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2020/11/09/health/covid-vaccine-pfizer.html\">\"Pfizer's Early Data Shows Vaccine Is More Than 90% Effective\"</a>. <i>The New York Times</i>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0362-4331\">0362-4331</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">May 18,</span> 2021</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer%27s+Early+Data+Shows+Vaccine+Is+More+Than+90%25+Effective&amp;rft.date=2020-11-09&amp;rft.issn=0362-4331&amp;rft.aulast=Thomas&amp;rft.aufirst=Katie&amp;rft.au=Gelles%2C+David&amp;rft.au=Zimmer%2C+Carl&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2020%2F11%2F09%2Fhealth%2Fcovid-vaccine-pfizer.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-142\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-142\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFRoberts2020\" class=\"citation web cs1\">Roberts, Michelle (December 2, 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.bbc.com/news/health-55145696\">\"Covid-19: Pfizer/BioNTech vaccine judged safe for use in UK\"</a>. <i><a href=\"/wiki/BBC_News\" title=\"BBC News\">BBC News</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">December 2,</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BBC+News&amp;rft.atitle=Covid-19%3A+Pfizer%2FBioNTech+vaccine+judged+safe+for+use+in+UK&amp;rft.date=2020-12-02&amp;rft.aulast=Roberts&amp;rft.aufirst=Michelle&amp;rft_id=https%3A%2F%2Fwww.bbc.com%2Fnews%2Fhealth-55145696&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-Bahrain_Approves_Covid-19_Vaccine_(Al_Jazeera)-143\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Bahrain_Approves_Covid-19_Vaccine_(Al_Jazeera)_143-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.aljazeera.com/news/2020/12/4/bahrain-becomes-second-country-to-approve-pfizer-covid-19-vaccine\">\"Bahrain becomes second country to approve Pfizer COVID-19 vaccine\"</a>. <i>www.aljazeera.com</i>. Al Jazeera. December 4, 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">December 11,</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=www.aljazeera.com&amp;rft.atitle=Bahrain+becomes+second+country+to+approve+Pfizer+COVID-19+vaccine&amp;rft.date=2020-12-04&amp;rft_id=https%3A%2F%2Fwww.aljazeera.com%2Fnews%2F2020%2F12%2F4%2Fbahrain-becomes-second-country-to-approve-pfizer-covid-19-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-Canada_Approves_Covid-19_Vaccine_(NYT)-144\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Canada_Approves_Covid-19_Vaccine_(NYT)_144-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFAusten2020\" class=\"citation news cs1\">Austen, Ian (December 9, 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2020/12/09/world/americas/canada-vaccine-approve.html\">\"Canada Approves Vaccine and Could Start Shots Next Week\"</a>. <i>The New York Times</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">December 11,</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Canada+Approves+Vaccine+and+Could+Start+Shots+Next+Week&amp;rft.date=2020-12-09&amp;rft.aulast=Austen&amp;rft.aufirst=Ian&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2020%2F12%2F09%2Fworld%2Famericas%2Fcanada-vaccine-approve.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-Saudi_Arabia_Approves_Covid-19_Vaccine,_Bahrain_To_Distribute_Free_to_Public_(KTLA)-145\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Saudi_Arabia_Approves_Covid-19_Vaccine,_Bahrain_To_Distribute_Free_to_Public_(KTLA)_145-0\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://ktla.com/news/nationworld/saudi-arabia-approves-pfizer-covid-19-vaccine-as-bahrain-plans-to-give-the-public-free-shots/\">\"Saudi Arabia approves Pfizer COVID-19 vaccine as Bahrain plans to give the public free shots\"</a>. <i>KTLA</i>. December 11, 2020<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">December 11,</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=KTLA&amp;rft.atitle=Saudi+Arabia+approves+Pfizer+COVID-19+vaccine+as+Bahrain+plans+to+give+the+public+free+shots&amp;rft.date=2020-12-11&amp;rft_id=https%3A%2F%2Fktla.com%2Fnews%2Fnationworld%2Fsaudi-arabia-approves-pfizer-covid-19-vaccine-as-bahrain-plans-to-give-the-public-free-shots%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-US_FDA_Advisory_Panel_Backs_Covid-19_Vaccine_Approval_(Reuters)-146\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-US_FDA_Advisory_Panel_Backs_Covid-19_Vaccine_Approval_(Reuters)_146-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-US_FDA_Advisory_Panel_Backs_Covid-19_Vaccine_Approval_(Reuters)_146-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFSteenhuysen2020\" class=\"citation news cs1\">Steenhuysen, Manas Mishra, Julie (December 11, 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.reuters.com/article/health-coronavirus-pfizer-vaccine/us-fda-advisers-wrestle-with-ethical-issues-linked-to-authorizing-pfizers-covid-19-vaccine-idUSKBN28K1O5\">\"U.S. FDA advisers overwhelmingly back authorizing Pfizer–BioNTech COVID-19 vaccine\"</a>. <i>Reuters</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">December 11,</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=U.S.+FDA+advisers+overwhelmingly+back+authorizing+Pfizer%E2%80%93BioNTech+COVID-19+vaccine&amp;rft.date=2020-12-11&amp;rft.aulast=Steenhuysen&amp;rft.aufirst=Manas+Mishra%2C+Julie&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fhealth-coronavirus-pfizer-vaccine%2Fus-fda-advisers-wrestle-with-ethical-issues-linked-to-authorizing-pfizers-covid-19-vaccine-idUSKBN28K1O5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-147\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-147\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFThomasLaFraniereWeilandGoodnough2020\" class=\"citation news cs1\">Thomas, Katie; LaFraniere, Sharon; Weiland, Noah; Goodnough, Abby; Haberman, Maggie (December 12, 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2020/12/11/health/pfizer-vaccine-authorized.html\">\"F.D.A. Clears Pfizer Vaccine, and Millions of Doses Will Be Shipped Right Away\"</a>. <i>The New York Times</i>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0362-4331\">0362-4331</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">December 12,</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=F.D.A.+Clears+Pfizer+Vaccine%2C+and+Millions+of+Doses+Will+Be+Shipped+Right+Away&amp;rft.date=2020-12-12&amp;rft.issn=0362-4331&amp;rft.aulast=Thomas&amp;rft.aufirst=Katie&amp;rft.au=LaFraniere%2C+Sharon&amp;rft.au=Weiland%2C+Noah&amp;rft.au=Goodnough%2C+Abby&amp;rft.au=Haberman%2C+Maggie&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2020%2F12%2F11%2Fhealth%2Fpfizer-vaccine-authorized.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-148\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-148\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFAbdullah2020\" class=\"citation news cs1\">Abdullah, Zhaki (December 14, 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.channelnewsasia.com/news/singapore/singapore-approves-pfizer-biontech-covid-19-vaccine-phase-3-13769570\">\"Pfizer–BioNTech COVID-19 vaccine approved by Singapore, first shipment expected by end-December\"</a>. <i>CNA</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNA&amp;rft.atitle=Pfizer%E2%80%93BioNTech+COVID-19+vaccine+approved+by+Singapore%2C+first+shipment+expected+by+end-December&amp;rft.date=2020-12-14&amp;rft.aulast=Abdullah&amp;rft.aufirst=Zhaki&amp;rft_id=https%3A%2F%2Fwww.channelnewsasia.com%2Fnews%2Fsingapore%2Fsingapore-approves-pfizer-biontech-covid-19-vaccine-phase-3-13769570&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-149\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-149\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ema.europa.eu/en/news/ema-recommends-first-covid-19-vaccine-authorisation-eu\">\"EMA recommends first COVID-19 vaccine for authorisation in the EU\"</a>. <i><a href=\"/wiki/Europa_(web_portal)\" title=\"Europa (web portal)\">Europa</a></i>. December 21, 2020.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Europa&amp;rft.atitle=EMA+recommends+first+COVID-19+vaccine+for+authorisation+in+the+EU&amp;rft.date=2020-12-21&amp;rft_id=https%3A%2F%2Fwww.ema.europa.eu%2Fen%2Fnews%2Fema-recommends-first-covid-19-vaccine-authorisation-eu&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-150\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-150\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFHiggins-Dunn2021\" class=\"citation news cs1\">Higgins-Dunn, Noah (May 4, 2021). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.fiercepharma.com/pharma/thanks-to-revved-up-manufacturing-biontech-ceo-estimates-3b-covid-vaccine-doses-2021\">\"BioNTech, with partner Pfizer, on track to make 3B COVID vaccine doses in 2021, CEO says\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">May 18,</span> 2021</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=BioNTech%2C+with+partner+Pfizer%2C+on+track+to+make+3B+COVID+vaccine+doses+in+2021%2C+CEO+says&amp;rft.date=2021-05-04&amp;rft.aulast=Higgins-Dunn&amp;rft.aufirst=Noah&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fthanks-to-revved-up-manufacturing-biontech-ceo-estimates-3b-covid-vaccine-doses-2021&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-bullied-151\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-bullied_151-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-bullied_151-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.aljazeera.com/news/2021/3/11/investigation-pfizer-bullied-latin-american-nations\">\"Investigation: Drugmaker 'bullied' Latin American nations\"</a>. <i><a href=\"/wiki/Al_Jazeera_English\" title=\"Al Jazeera English\">Al Jazeera English</a></i>. March 11, 2021.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Al+Jazeera+English&amp;rft.atitle=Investigation%3A+Drugmaker+%27bullied%27+Latin+American+nations&amp;rft.date=2021-03-11&amp;rft_id=https%3A%2F%2Fwww.aljazeera.com%2Fnews%2F2021%2F3%2F11%2Finvestigation-pfizer-bullied-latin-american-nations&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-152\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-152\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFThacker\" class=\"citation news cs1\">Thacker, Paul. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.bmj.com/content/375/bmj.n2635?utm_term=hootsuite\">\"Covid-19: Researcher blows the whistle on data integrity issues in Pfizer's vaccine trial\"</a>. thebmj<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">November 2,</span> 2021</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Covid-19%3A+Researcher+blows+the+whistle+on+data+integrity+issues+in+Pfizer%27s+vaccine+trial&amp;rft.aulast=Thacker&amp;rft.aufirst=Paul&amp;rft_id=https%3A%2F%2Fwww.bmj.com%2Fcontent%2F375%2Fbmj.n2635%3Futm_term%3Dhootsuite&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-153\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-153\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFEuropean_Medicines_Agency2021\" class=\"citation web cs1\"><a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a> (December 3, 2021). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ema.europa.eu/en/documents/other/ema-reply-letter-members-european-parliament-ms-m-rivasi-mr-p-pedicini-ms-t-metz-concerning-covid-19_en.pdf\">\"Reply letter on the Integrity of clinical data, additional clinical trials and studies, pharmacovigilance and mRNA COVID-19 vaccine safety\"</a> <span class=\"cs1-format\">(PDF)</span><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">February 2,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Reply+letter+on+the+Integrity+of+clinical+data%2C+additional+clinical+trials+and+studies%2C+pharmacovigilance+and+mRNA+COVID-19+vaccine+safety&amp;rft.date=2021-12-03&amp;rft.au=European+Medicines+Agency&amp;rft_id=https%3A%2F%2Fwww.ema.europa.eu%2Fen%2Fdocuments%2Fother%2Fema-reply-letter-members-european-parliament-ms-m-rivasi-mr-p-pedicini-ms-t-metz-concerning-covid-19_en.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-154\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-154\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate\">\"Pfizer's novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR Study\"</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer%27s+novel+COVID-19+Oral+Antiviral+Treatment+Candidate+Reduced+Risk+of+Hospitalization+or+Death+by+89%25+in+Interim+Analysis+of+Phase+2%2F3+EPIC-HR+Study&amp;rft_id=https%3A%2F%2Fwww.pfizer.com%2Fnews%2Fpress-release%2Fpress-release-detail%2Fpfizers-novel-covid-19-oral-antiviral-treatment-candidate&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span><span class=\"cs1-maint citation-comment\"><code class=\"cs1-code\">{{<a href=\"/wiki/Template:Cite_web\" title=\"Template:Cite web\">cite web</a>}}</code>:  CS1 maint: url-status (<a href=\"/wiki/Category:CS1_maint:_url-status\" title=\"Category:CS1 maint: url-status\">link</a>)</span></span>\n</li>\n<li id=\"cite_note-155\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-155\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.israelnationalnews.com/news/320624\">\"Pfizer CEO: Current wave will be last with so many restrictions\"</a>. <i>Israel National News</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">January 17,</span> 2021</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Israel+National+News&amp;rft.atitle=Pfizer+CEO%3A+Current+wave+will+be+last+with+so+many+restrictions&amp;rft_id=https%3A%2F%2Fwww.israelnationalnews.com%2Fnews%2F320624&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-156\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-156\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.livemint.com/companies/news/pfizer-ceo-shares-some-good-news-on-covid-but-cautions-virus-could-circulate-for-years-11642405004050.html\">\"Pfizer CEO shares some good news on covid but cautions virus could circulate for years\"</a>. <i>Mint</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">January 17,</span> 2021</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Mint&amp;rft.atitle=Pfizer+CEO+shares+some+good+news+on+covid+but+cautions+virus+could+circulate+for+years&amp;rft_id=https%3A%2F%2Fwww.livemint.com%2Fcompanies%2Fnews%2Fpfizer-ceo-shares-some-good-news-on-covid-but-cautions-virus-could-circulate-for-years-11642405004050.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-157\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-157\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFKirkpatrick2000\" class=\"citation news cs1\">Kirkpatrick, David D. (May 15, 2000). <a rel=\"nofollow\" class=\"external text\" href=\"https://nymag.com/nymetro/health/features/3122/\">\"Inside the Happiness Business\"</a>. <i><a href=\"/wiki/New_York_(magazine)\" title=\"New York (magazine)\">New York</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+York&amp;rft.atitle=Inside+the+Happiness+Business&amp;rft.date=2000-05-15&amp;rft.aulast=Kirkpatrick&amp;rft.aufirst=David+D.&amp;rft_id=https%3A%2F%2Fnymag.com%2Fnymetro%2Fhealth%2Ffeatures%2F3122%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-158\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-158\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFOldani2002\" class=\"citation journal cs1\">Oldani, Michael (2002). <a rel=\"nofollow\" class=\"external text\" href=\"https://digitalassets.lib.berkeley.edu/anthpubs/ucb/text/kas087-006.pdf\">\"Tales from the Script\"</a> <span class=\"cs1-format\">(PDF)</span>. <i>Kroeber Society Papers</i>. <b>87</b>: 147–176 &#8211; via University of California Berkeley.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Kroeber+Society+Papers&amp;rft.atitle=Tales+from+the+Script&amp;rft.volume=87&amp;rft.pages=147-176&amp;rft.date=2002&amp;rft.aulast=Oldani&amp;rft.aufirst=Michael&amp;rft_id=https%3A%2F%2Fdigitalassets.lib.berkeley.edu%2Fanthpubs%2Fucb%2Ftext%2Fkas087-006.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-159\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-159\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFOldani2004\" class=\"citation journal cs1\">Oldani, Michael J. (2004). \"Thick Prescriptions: Toward an Interpretation of Pharmaceutical Sales Practices\". <i>Medical Anthropology Quarterly</i>. <b>18</b> (3): 325–356. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1525%2Fmaq.2004.18.3.325\">10.1525/maq.2004.18.3.325</a>. <a href=\"/wiki/ISSN_(identifier)\" class=\"mw-redirect\" title=\"ISSN (identifier)\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1548-1387\">1548-1387</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/15484967\">15484967</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Medical+Anthropology+Quarterly&amp;rft.atitle=Thick+Prescriptions%3A+Toward+an+Interpretation+of+Pharmaceutical+Sales+Practices&amp;rft.volume=18&amp;rft.issue=3&amp;rft.pages=325-356&amp;rft.date=2004&amp;rft.issn=1548-1387&amp;rft_id=info%3Apmid%2F15484967&amp;rft_id=info%3Adoi%2F10.1525%2Fmaq.2004.18.3.325&amp;rft.aulast=Oldani&amp;rft.aufirst=Michael+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-160\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-160\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFSteinmanBeroChrenLandefeld2006\" class=\"citation journal cs1\">Steinman MA, Bero LA, Chren MM, Landefeld CS (August 2006). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.7326%2F0003-4819-145-4-200608150-00008\">\"Narrative review: the promotion of gabapentin: an analysis of internal industry documents\"</a>. <i><a href=\"/wiki/Annals_of_Internal_Medicine\" title=\"Annals of Internal Medicine\">Annals of Internal Medicine</a></i>. <b>145</b> (4): 284–93. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.7326%2F0003-4819-145-4-200608150-00008\">10.7326/0003-4819-145-4-200608150-00008</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/16908919\">16908919</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Internal+Medicine&amp;rft.atitle=Narrative+review%3A+the+promotion+of+gabapentin%3A+an+analysis+of+internal+industry+documents&amp;rft.volume=145&amp;rft.issue=4&amp;rft.pages=284-93&amp;rft.date=2006-08&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-145-4-200608150-00008&amp;rft_id=info%3Apmid%2F16908919&amp;rft.aulast=Steinman&amp;rft.aufirst=MA&amp;rft.au=Bero%2C+LA&amp;rft.au=Chren%2C+MM&amp;rft.au=Landefeld%2C+CS&amp;rft_id=%2F%2Fdoi.org%2F10.7326%252F0003-4819-145-4-200608150-00008&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-161\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-161\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFHenney_JE2006\" class=\"citation journal cs1\">Henney JE (August 2006). \"Safeguarding patient welfare: who's in charge?\". <i><a href=\"/wiki/Annals_of_Internal_Medicine\" title=\"Annals of Internal Medicine\">Annals of Internal Medicine</a></i>. <b>145</b> (4): 305–7. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.7326%2F0003-4819-145-4-200608150-00013\">10.7326/0003-4819-145-4-200608150-00013</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/16908923\">16908923</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:39262014\">39262014</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Internal+Medicine&amp;rft.atitle=Safeguarding+patient+welfare%3A+who%27s+in+charge%3F&amp;rft.volume=145&amp;rft.issue=4&amp;rft.pages=305-7&amp;rft.date=2006-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A39262014%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F16908923&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-145-4-200608150-00013&amp;rft.au=Henney+JE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-162\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-162\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFMullenersMcCroryLinde2014\" class=\"citation journal cs1\">Mulleners WM, McCrory DC, Linde M (August 2014). \"Antiepileptics in migraine prophylaxis: An updated Cochrane review\". <i>Cephalalgia</i>. <b>35</b> (1): 51–62. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1177%2F0333102414534325\">10.1177/0333102414534325</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/25115844\">25115844</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:43079346\">43079346</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cephalalgia&amp;rft.atitle=Antiepileptics+in+migraine+prophylaxis%3A+An+updated+Cochrane+review&amp;rft.volume=35&amp;rft.issue=1&amp;rft.pages=51-62&amp;rft.date=2014-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A43079346%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25115844&amp;rft_id=info%3Adoi%2F10.1177%2F0333102414534325&amp;rft.aulast=Mulleners&amp;rft.aufirst=WM&amp;rft.au=McCrory%2C+DC&amp;rft.au=Linde%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-163\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-163\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFLoderBurchRizzoli2012\" class=\"citation journal cs1\">Loder E, Burch R, Rizzoli P (June 2012). <a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1111%2Fj.1526-4610.2012.02185.x\">\"The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines\"</a>. <i>Headache</i>. <b>52</b> (6): 930–45. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1111%2Fj.1526-4610.2012.02185.x\">10.1111/j.1526-4610.2012.02185.x</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/22671714\">22671714</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:540800\">540800</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Headache&amp;rft.atitle=The+2012+AHS%2FAAN+guidelines+for+prevention+of+episodic+migraine%3A+a+summary+and+comparison+with+other+recent+clinical+practice+guidelines&amp;rft.volume=52&amp;rft.issue=6&amp;rft.pages=930-45&amp;rft.date=2012-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A540800%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F22671714&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1526-4610.2012.02185.x&amp;rft.aulast=Loder&amp;rft.aufirst=E&amp;rft.au=Burch%2C+R&amp;rft.au=Rizzoli%2C+P&amp;rft_id=%2F%2Fdoi.org%2F10.1111%252Fj.1526-4610.2012.02185.x&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-164\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-164\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFHarris2009\" class=\"citation news cs1\">Harris, Gardiner (September 2, 2009). <span class=\"cs1-lock-limited\" title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2009/09/03/business/03health.html\">\"Pfizer pays $2.3 billion to settle marketing case\"</a></span>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+pays+%242.3+billion+to+settle+marketing+case&amp;rft.date=2009-09-02&amp;rft.aulast=Harris&amp;rft.aufirst=Gardiner&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2009%2F09%2F03%2Fbusiness%2F03health.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-largestdoj-165\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-largestdoj_165-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-largestdoj_165-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.justice.gov/opa/pr/justice-department-announces-largest-health-care-fraud-settlement-its-history\">\"Justice Department Announces Largest Health Care Fraud Settlement in Its History\"</a> (Press release). <a href=\"/wiki/United_States_Department_of_Justice\" title=\"United States Department of Justice\">United States Department of Justice</a>. September 2, 2009.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Justice+Department+Announces+Largest+Health+Care+Fraud+Settlement+in+Its+History&amp;rft.pub=United+States+Department+of+Justice&amp;rft.date=2009-09-02&amp;rft_id=https%3A%2F%2Fwww.justice.gov%2Fopa%2Fpr%2Fjustice-department-announces-largest-health-care-fraud-settlement-its-history&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-Settle-166\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Settle_166-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Settle_166-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFHarris2009\" class=\"citation news cs1\">Harris, Gardiner (September 3, 2009). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2009/09/03/business/03health.html\">\"Pfizer Pays $2.3 billion to Settle Marketing Case\"</a>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+Pays+%242.3+billion+to+Settle+Marketing+Case&amp;rft.date=2009-09-03&amp;rft.aulast=Harris&amp;rft.aufirst=Gardiner&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2009%2F09%2F03%2Fbusiness%2F03health.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-Improper-167\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Improper_167-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Improper_167-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFJohnson2009\" class=\"citation news cs1\">Johnson, Carrie (September 3, 2009). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.washingtonpost.com/wp-dyn/content/article/2009/09/02/AR2009090201449_pf.html\">\"In Settlement, A Warning To Drugmakers: Pfizer to Pay Record Penalty In Improper-Marketing Case\"</a>. <i><a href=\"/wiki/The_Washington_Post\" title=\"The Washington Post\">The Washington Post</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Washington+Post&amp;rft.atitle=In+Settlement%2C+A+Warning+To+Drugmakers%3A+Pfizer+to+Pay+Record+Penalty+In+Improper-Marketing+Case&amp;rft.date=2009-09-03&amp;rft.aulast=Johnson&amp;rft.aufirst=Carrie&amp;rft_id=https%3A%2F%2Fwww.washingtonpost.com%2Fwp-dyn%2Fcontent%2Farticle%2F2009%2F09%2F02%2FAR2009090201449_pf.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-fine-168\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-fine_168-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-fine_168-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"http://news.bbc.co.uk/2/hi/business/8234533.stm\">\"Pfizer agrees record fraud fine\"</a>. <i><a href=\"/wiki/BBC_News\" title=\"BBC News\">BBC News</a></i>. September 2, 2009.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Pfizer+agrees+record+fraud+fine&amp;rft.date=2009-09-02&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F2%2Fhi%2Fbusiness%2F8234533.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-169\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-169\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://oig.hhs.gov/fraud/cia/agreements/pfizer_inc.pdf\">\"Corporate Integrity Agreement between the Office of the Inspector General of the Department of Health and Human Services and Pfizer Inc\"</a> <span class=\"cs1-format\">(PDF)</span>. <i><a href=\"/wiki/Office_of_Inspector_General_(United_States)\" title=\"Office of Inspector General (United States)\">Office of Inspector General</a></i>. August 31, 2009. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20110715112330/http://oig.hhs.gov/fraud/cia/agreements/pfizer_inc.pdf\">Archived</a> <span class=\"cs1-format\">(PDF)</span> from the original on July 15, 2011.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Office+of+Inspector+General&amp;rft.atitle=Corporate+Integrity+Agreement+between+the+Office+of+the+Inspector+General+of+the+Department+of+Health+and+Human+Services+and+Pfizer+Inc.&amp;rft.date=2009-08-31&amp;rft_id=https%3A%2F%2Foig.hhs.gov%2Ffraud%2Fcia%2Fagreements%2Fpfizer_inc.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-170\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-170\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://casetext.com/case/rost-v-pfizer-2\">\"ROST v. PFIZER, INC\"</a>. Casetext.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=ROST+v.+PFIZER%2C+INC.&amp;rft.pub=Casetext&amp;rft_id=https%3A%2F%2Fcasetext.com%2Fcase%2Frost-v-pfizer-2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-171\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-171\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFBerenson2005\" class=\"citation news cs1\"><a href=\"/wiki/Alex_Berenson\" title=\"Alex Berenson\">Berenson, Alex</a> (June 8, 2005). <span class=\"cs1-lock-limited\" title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2005/06/08/business/at-pfizer-the-isolation-increases-for-a-whistleblower.html\">\"At Pfizer, the Isolation Increases for a Whistle-Blower\"</a></span>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=At+Pfizer%2C+the+Isolation+Increases+for+a+Whistle-Blower&amp;rft.date=2005-06-08&amp;rft.aulast=Berenson&amp;rft.aufirst=Alex&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2005%2F06%2F08%2Fbusiness%2Fat-pfizer-the-isolation-increases-for-a-whistleblower.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-172\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-172\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFStaton2010\" class=\"citation news cs1\">Staton, Tracy (June 14, 2010). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.fiercepharma.com/pharma/congress-joins-probe-into-wyeth-s-rapamune-marketing\">\"Congress joins probe into Wyeth's Rapamune marketing\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Congress+joins+probe+into+Wyeth%27s+Rapamune+marketing&amp;rft.date=2010-06-14&amp;rft.aulast=Staton&amp;rft.aufirst=Tracy&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fcongress-joins-probe-into-wyeth-s-rapamune-marketing&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-173\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-173\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFPalmer2010\" class=\"citation news cs1\">Palmer, Eric (June 14, 2010). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.fiercepharma.com/regulatory/pfizer-settles-more-off-label-marketing-cases-tied-to-rapamune\">\"Pfizer settles more off-label marketing cases tied to Rapamune\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Pfizer+settles+more+off-label+marketing+cases+tied+to+Rapamune&amp;rft.date=2010-06-14&amp;rft.aulast=Palmer&amp;rft.aufirst=Eric&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fregulatory%2Fpfizer-settles-more-off-label-marketing-cases-tied-to-rapamune&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-174\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-174\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFEdwards2010\" class=\"citation news cs1\">Edwards, Jim (June 10, 2010). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.cbsnews.com/news/blue-cross-names-and-shames-pfizer-execs-linked-to-massages-for-prescriptions-push/\">\"Blue Cross Names and Shames Pfizer Execs Linked to Massages-for-Prescriptions Push\"</a>. <i><a href=\"/wiki/CBS_News\" title=\"CBS News\">CBS News</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CBS+News&amp;rft.atitle=Blue+Cross+Names+and+Shames+Pfizer+Execs+Linked+to+Massages-for-Prescriptions+Push&amp;rft.date=2010-06-10&amp;rft.aulast=Edwards&amp;rft.aufirst=Jim&amp;rft_id=https%3A%2F%2Fwww.cbsnews.com%2Fnews%2Fblue-cross-names-and-shames-pfizer-execs-linked-to-massages-for-prescriptions-push%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-175\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-175\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFBounds2010\" class=\"citation news cs1\">Bounds, Jeff (June 10, 2010). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.bizjournals.com/austin/stories/2010/06/07/daily52.html\">\"Blue Cross Blue Shield of Texas sues Pfizer\"</a>. <i><a href=\"/wiki/American_City_Business_Journals\" title=\"American City Business Journals\">American City Business Journals</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+City+Business+Journals&amp;rft.atitle=Blue+Cross+Blue+Shield+of+Texas+sues+Pfizer&amp;rft.date=2010-06-10&amp;rft.aulast=Bounds&amp;rft.aufirst=Jeff&amp;rft_id=https%3A%2F%2Fwww.bizjournals.com%2Faustin%2Fstories%2F2010%2F06%2F07%2Fdaily52.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-176\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-176\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFStaton2010\" class=\"citation news cs1\">Staton, Tracy (June 11, 2010). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.fiercepharma.com/pharma/bcbs-names-pfizer-managers-kickback-suit\">\"BCBS names Pfizer managers in kickback suit\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=BCBS+names+Pfizer+managers+in+kickback+suit&amp;rft.date=2010-06-11&amp;rft.aulast=Staton&amp;rft.aufirst=Tracy&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fbcbs-names-pfizer-managers-kickback-suit&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-177\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-177\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><span class=\"cs1-lock-subscription\" title=\"Paid subscription required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.dallasnews.com/business/2010/06/11/blue-cross-blue-shield-of-texas-sues-pfizer-over-drug-marketing/\">\"Blue Cross Blue Shield of Texas sues Pfizer over drug marketing\"</a></span>. <i><a href=\"/wiki/The_Dallas_Morning_News\" title=\"The Dallas Morning News\">The Dallas Morning News</a></i>. June 11, 2010.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Dallas+Morning+News&amp;rft.atitle=Blue+Cross+Blue+Shield+of+Texas+sues+Pfizer+over+drug+marketing&amp;rft.date=2010-06-11&amp;rft_id=https%3A%2F%2Fwww.dallasnews.com%2Fbusiness%2F2010%2F06%2F11%2Fblue-cross-blue-shield-of-texas-sues-pfizer-over-drug-marketing%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-toobig-178\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-toobig_178-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-toobig_178-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFGriffinSegal2010\" class=\"citation news cs1\">Griffin, Drew; Segal, Andy (April 2, 2010). <a rel=\"nofollow\" class=\"external text\" href=\"https://edition.cnn.com/2010/HEALTH/04/02/pfizer.bextra/index.html\">\"Feds found Pfizer too big to nail\"</a>. <i><a href=\"/wiki/CNN\" title=\"CNN\">CNN</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNN&amp;rft.atitle=Feds+found+Pfizer+too+big+to+nail&amp;rft.date=2010-04-02&amp;rft.aulast=Griffin&amp;rft.aufirst=Drew&amp;rft.au=Segal%2C+Andy&amp;rft_id=https%3A%2F%2Fedition.cnn.com%2F2010%2FHEALTH%2F04%2F02%2Fpfizer.bextra%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-179\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-179\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFSmythe2014\" class=\"citation news cs1\">Smythe, Christie (June 2, 2014). <span class=\"cs1-lock-subscription\" title=\"Paid subscription required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.bloomberg.com/news/2014-06-02/pfizer-agrees-to-325-million-settlment-over-neurontin.html\">\"Pfizer Agrees to $325 Million Neurontin Marketing Accord\"</a></span>. <i><a href=\"/wiki/Bloomberg_News\" title=\"Bloomberg News\">Bloomberg News</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+News&amp;rft.atitle=Pfizer+Agrees+to+%24325+Million+Neurontin+Marketing+Accord&amp;rft.date=2014-06-02&amp;rft.aulast=Smythe&amp;rft.aufirst=Christie&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2F2014-06-02%2Fpfizer-agrees-to-325-million-settlment-over-neurontin.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-180\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-180\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFPetrovich2013\" class=\"citation news cs1\">Petrovich, Dushko (March 15, 2013). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.bookforum.com/culture/-11264\">\"The Art of Making Magazines edited by Victor S. Navasky and Evan Cornog\"</a>. <i><a href=\"/wiki/Bookforum\" title=\"Bookforum\">Bookforum</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bookforum&amp;rft.atitle=The+Art+of+Making+Magazines+edited+by+Victor+S.+Navasky+and+Evan+Cornog&amp;rft.date=2013-03-15&amp;rft.aulast=Petrovich&amp;rft.aufirst=Dushko&amp;rft_id=https%3A%2F%2Fwww.bookforum.com%2Fculture%2F-11264&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-181\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-181\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFKary2013\" class=\"citation news cs1\">Kary, Tiffany (June 27, 2013). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.theday.com/article/20130627/BIZ03/306279581\">\"Pfizer to pay $958M to end asbestos litigation\"</a>. <a href=\"/wiki/Bloomberg_News\" title=\"Bloomberg News\">Bloomberg News</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pfizer+to+pay+%24958M+to+end+asbestos+litigation&amp;rft.date=2013-06-27&amp;rft.aulast=Kary&amp;rft.aufirst=Tiffany&amp;rft_id=https%3A%2F%2Fwww.theday.com%2Farticle%2F20130627%2FBIZ03%2F306279581&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-182\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-182\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFMeier1994\" class=\"citation news cs1\"><a href=\"/wiki/Barry_Meier\" title=\"Barry Meier\">Meier, Barry</a> (July 2, 1994). <span class=\"cs1-lock-limited\" title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/1994/07/02/business/pfizer-unit-to-settle-charges-of-lying-about-heart-valve.html\">\"Pfizer Unit to Settle Charges Of Lying About Heart Valve\"</a></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pfizer+Unit+to+Settle+Charges+Of+Lying+About+Heart+Valve&amp;rft.date=1994-07-02&amp;rft.aulast=Meier&amp;rft.aufirst=Barry&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F1994%2F07%2F02%2Fbusiness%2Fpfizer-unit-to-settle-charges-of-lying-about-heart-valve.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-183\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-183\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.courant.com/news/connecticut/hc-xpm-2010-03-14-hc-pfizer-virus-lawsuit-0314-artmar14-story.html\">\"Ex-Pfizer Worker Cites Genetically Engineered Virus In Lawsuit Over Firing\"</a>. <i><a href=\"/wiki/Hartford_Courant\" title=\"Hartford Courant\">Hartford Courant</a></i>. March 14, 2010. <a rel=\"nofollow\" class=\"external text\" href=\"https://archive.today/20120728144301/http://www.courant.com/news/connecticut/hc-pfizer-virus-lawsuit-0314.artmar14,0,5614508,print.story\">Archived</a> from the original on July 28, 2012.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hartford+Courant&amp;rft.atitle=Ex-Pfizer+Worker+Cites+Genetically+Engineered+Virus+In+Lawsuit+Over+Firing&amp;rft.date=2010-03-14&amp;rft_id=https%3A%2F%2Fwww.courant.com%2Fnews%2Fconnecticut%2Fhc-xpm-2010-03-14-hc-pfizer-virus-lawsuit-0314-artmar14-story.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-184\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-184\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFPollackWilson2010\" class=\"citation news cs1\">Pollack, Andrew; <a href=\"/wiki/Duff_Wilson\" title=\"Duff Wilson\">Wilson, Duff</a> (April 2, 2010). <span class=\"cs1-lock-limited\" title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2010/04/03/business/03pfizer.html\">\"A Pfizer Whistle-Blower Is Awarded $1.4 Million\"</a></span>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=A+Pfizer+Whistle-Blower+Is+Awarded+%241.4+Million&amp;rft.date=2010-04-02&amp;rft.aulast=Pollack&amp;rft.aufirst=Andrew&amp;rft.au=Wilson%2C+Duff&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2010%2F04%2F03%2Fbusiness%2F03pfizer.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-185\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-185\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><span class=\"cs1-lock-limited\" title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2012/05/02/health/pfizer-settles-byu-lawsuit-over-development-of-celebrex.html\">\"Pfizer Settles B.Y.U. Lawsuit Over Development of Celebrex\"</a></span>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>. <a href=\"/wiki/Associated_Press\" title=\"Associated Press\">Associated Press</a>. May 1, 2012.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+Settles+B.Y.U.+Lawsuit+Over+Development+of+Celebrex&amp;rft.date=2012-05-01&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2012%2F05%2F02%2Fhealth%2Fpfizer-settles-byu-lawsuit-over-development-of-celebrex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-186\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-186\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFOldani2016\" class=\"citation cs2\">Oldani, Michael (2016), <a rel=\"nofollow\" class=\"external text\" href=\"http://sk.sagepub.com/reference/the-sage-encyclopedia-of-pharmacology-and-society/i11727.xml\">\"Trovafloxacin (Trovan) Controversy\"</a>, <i>The SAGE Encyclopedia of Pharmacology and Society</i>, SAGE Publications, Inc., pp.&#160;1444–1447, <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.4135%2F9781483349985.n409\">10.4135/9781483349985.n409</a>, <a href=\"/wiki/ISBN_(identifier)\" class=\"mw-redirect\" title=\"ISBN (identifier)\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/9781483350004\" title=\"Special:BookSources/9781483350004\"><bdi>9781483350004</bdi></a><span class=\"reference-accessdate\">, retrieved <span class=\"nowrap\">January 21,</span> 2019</span></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Trovafloxacin+%28Trovan%29+Controversy&amp;rft.btitle=The+SAGE+Encyclopedia+of+Pharmacology+and+Society&amp;rft.pages=1444-1447&amp;rft.pub=SAGE+Publications%2C+Inc.&amp;rft.date=2016&amp;rft_id=info%3Adoi%2F10.4135%2F9781483349985.n409&amp;rft.isbn=9781483350004&amp;rft.aulast=Oldani&amp;rft.aufirst=Michael&amp;rft_id=http%3A%2F%2Fsk.sagepub.com%2Freference%2Fthe-sage-encyclopedia-of-pharmacology-and-society%2Fi11727.xml&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-187\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-187\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFMurray2007\" class=\"citation news cs1\">Murray, Senan (June 20, 2007). <a rel=\"nofollow\" class=\"external text\" href=\"http://news.bbc.co.uk/2/hi/africa/6768799.stm\">\"Anger at deadly Nigerian drug trials\"</a>. <i><a href=\"/wiki/BBC_News\" title=\"BBC News\">BBC News</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Anger+at+deadly+Nigerian+drug+trials&amp;rft.date=2007-06-20&amp;rft.aulast=Murray&amp;rft.aufirst=Senan&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F2%2Fhi%2Fafrica%2F6768799.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-188\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-188\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFRamakrishnanUllandSteinhardtMoïsi2009\" class=\"citation journal cs1\">Ramakrishnan M, Ulland AJ, Steinhardt LC, Moïsi JC, Were F, Levine OS (2009). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2759956\">\"Sequelae due to bacterial meningitis among African children: a systematic literature review\"</a>. <i><a href=\"/wiki/BMC_Medicine\" title=\"BMC Medicine\">BMC Medicine</a></i>. <b>7</b>: 47. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1186%2F1741-7015-7-47\">10.1186/1741-7015-7-47</a>. <a href=\"/wiki/PMC_(identifier)\" class=\"mw-redirect\" title=\"PMC (identifier)\">PMC</a>&#160;<span class=\"cs1-lock-free\" title=\"Freely accessible\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2759956\">2759956</a></span>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/19751516\">19751516</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMC+Medicine&amp;rft.atitle=Sequelae+due+to+bacterial+meningitis+among+African+children%3A+a+systematic+literature+review&amp;rft.volume=7&amp;rft.pages=47&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2759956%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19751516&amp;rft_id=info%3Adoi%2F10.1186%2F1741-7015-7-47&amp;rft.aulast=Ramakrishnan&amp;rft.aufirst=M&amp;rft.au=Ulland%2C+AJ&amp;rft.au=Steinhardt%2C+LC&amp;rft.au=Mo%C3%AFsi%2C+JC&amp;rft.au=Were%2C+F&amp;rft.au=Levine%2C+OS&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2759956&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-189\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-189\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"http://news.bbc.co.uk/2/hi/business/1517171.stm\">\"Nigerians sue Pfizer over test deaths\"</a>. <i><a href=\"/wiki/BBC_News\" title=\"BBC News\">BBC News</a></i>. August 30, 2001.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Nigerians+sue+Pfizer+over+test+deaths&amp;rft.date=2001-08-30&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F2%2Fhi%2Fbusiness%2F1517171.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-DN-190\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-DN_190-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-DN_190-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.democracynow.org/2010/12/17/wikileaks_cables_pfizer_targeted_nigerian_attorney\">\"WikiLeaks Cables: Pfizer Targeted Nigerian Attorney General to Undermine Suit over Fatal Drug Tests\"</a>. <i><a href=\"/wiki/Democracy_Now!\" title=\"Democracy Now!\">Democracy Now!</a></i>. December 17, 2010.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Democracy+Now%21&amp;rft.atitle=WikiLeaks+Cables%3A+Pfizer+Targeted+Nigerian+Attorney+General+to+Undermine+Suit+over+Fatal+Drug+Tests&amp;rft.date=2010-12-17&amp;rft_id=https%3A%2F%2Fwww.democracynow.org%2F2010%2F12%2F17%2Fwikileaks_cables_pfizer_targeted_nigerian_attorney&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-191\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-191\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.washingtonpost.com/wp-dyn/content/article/2006/05/06/AR2006050601338.html\">\"Panel Faults Pfizer in '96 Clinical Trial In Nigeria\"</a>. <i><a href=\"/wiki/The_Washington_Post\" title=\"The Washington Post\">The Washington Post</a></i>. May 7, 2006.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Washington+Post&amp;rft.atitle=Panel+Faults+Pfizer+in+%2796+Clinical+Trial+In+Nigeria&amp;rft.date=2006-05-07&amp;rft_id=https%3A%2F%2Fwww.washingtonpost.com%2Fwp-dyn%2Fcontent%2Farticle%2F2006%2F05%2F06%2FAR2006050601338.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-192\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-192\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFEdwards2011\" class=\"citation news cs1\">Edwards, Jim (February 10, 2011). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.cbsnews.com/news/pfizer-bribed-nigerian-officials-in-fatal-drug-trial-ex-employee-claims/\">\"Pfizer Bribed Nigerian Officials in Fatal Drug Trial, Ex-Employee Claims\"</a>. <i><a href=\"/wiki/CBS_News\" title=\"CBS News\">CBS News</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CBS+News&amp;rft.atitle=Pfizer+Bribed+Nigerian+Officials+in+Fatal+Drug+Trial%2C+Ex-Employee+Claims&amp;rft.date=2011-02-10&amp;rft.aulast=Edwards&amp;rft.aufirst=Jim&amp;rft_id=https%3A%2F%2Fwww.cbsnews.com%2Fnews%2Fpfizer-bribed-nigerian-officials-in-fatal-drug-trial-ex-employee-claims%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-193\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-193\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://cdn.pfizer.com/pfizercom/news/trovan_statement_defense_summary.pdf\">\"Trovan, Kano State Civil Case – Statement Of Defense\"</a> <span class=\"cs1-format\">(PDF)</span>. Pfizer. July 2007.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Trovan%2C+Kano+State+Civil+Case+%E2%80%93+Statement+Of+Defense&amp;rft.pub=Pfizer&amp;rft.date=2007-07&amp;rft_id=https%3A%2F%2Fcdn.pfizer.com%2Fpfizercom%2Fnews%2Ftrovan_statement_defense_summary.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-194\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-194\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"http://news.bbc.co.uk/2/hi/world/us_and_canada/10454982.stm\">\"Pfizer-Nigeria appeal dismissed\"</a>. <i><a href=\"/wiki/BBC_News\" title=\"BBC News\">BBC News</a></i>. June 29, 2010.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Pfizer-Nigeria+appeal+dismissed&amp;rft.date=2010-06-29&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F2%2Fhi%2Fworld%2Fus_and_canada%2F10454982.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-195\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-195\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFBoseley2010\" class=\"citation news cs1\">Boseley, Sarah (December 9, 2010). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.theguardian.com/business/2010/dec/09/wikileaks-cables-pfizer-nigeria\">\"WikiLeaks cables: Pfizer 'used dirty tricks to avoid clinical trial payout'<span class=\"cs1-kern-right\"></span>\"</a>. <i>The Guardian</i>. London.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Guardian&amp;rft.atitle=WikiLeaks+cables%3A+Pfizer+%27used+dirty+tricks+to+avoid+clinical+trial+payout%27&amp;rft.date=2010-12-09&amp;rft.aulast=Boseley&amp;rft.aufirst=Sarah&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fbusiness%2F2010%2Fdec%2F09%2Fwikileaks-cables-pfizer-nigeria&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-196\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-196\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://cdn.pfizer.com/pfizercom/news/the_guardian_nigeria_120910.pdf\">\"Pfizer Statement Regarding Article In The Guardian\"</a> <span class=\"cs1-format\">(PDF)</span> (Press release). Pfizer. December 9, 2010.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Statement+Regarding+Article+In+The+Guardian&amp;rft.pub=Pfizer&amp;rft.date=2010-12-09&amp;rft_id=https%3A%2F%2Fcdn.pfizer.com%2Fpfizercom%2Fnews%2Fthe_guardian_nigeria_120910.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-197\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-197\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFEdwards2011\" class=\"citation news cs1\">Edwards, Jim (January 4, 2011). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.cbsnews.com/news/in-defense-of-blackmail-why-shouldnt-pfizer-dig-dirt-on-crooked-pols/\">\"In Defense of Blackmail: Why Shouldn't Pfizer Dig Dirt on Crooked Pols?\"</a>. <i><a href=\"/wiki/CBS_News\" title=\"CBS News\">CBS News</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CBS+News&amp;rft.atitle=In+Defense+of+Blackmail%3A+Why+Shouldn%27t+Pfizer+Dig+Dirt+on+Crooked+Pols%3F&amp;rft.date=2011-01-04&amp;rft.aulast=Edwards&amp;rft.aufirst=Jim&amp;rft_id=https%3A%2F%2Fwww.cbsnews.com%2Fnews%2Fin-defense-of-blackmail-why-shouldnt-pfizer-dig-dirt-on-crooked-pols%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-198\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-198\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"http://saharareporters.com/2010/07/19/michael-aondoakaa-%E2%80%9Cunfit%E2%80%9D-remain-san-says-cdhr-high-powered-petition\">\"Michael Aondoakaa \"Unfit\" To Remain SAN, Says CDHR In High-Powered Petition\"</a>. <i>Sahara Reporters</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Sahara+Reporters&amp;rft.atitle=Michael+Aondoakaa+%22Unfit%22+To+Remain+SAN%2C+Says+CDHR+In+High-Powered+Petition&amp;rft_id=http%3A%2F%2Fsaharareporters.com%2F2010%2F07%2F19%2Fmichael-aondoakaa-%25E2%2580%259Cunfit%25E2%2580%259D-remain-san-says-cdhr-high-powered-petition&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-199\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-199\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"http://usafricaonline.com/2010/12/12/wikileaks-on-nigerias-oil-corruption-nnpc-shell-us-ambassador-attorney-general-aondoakaa/\">\"Wikileaks on Nigeria's Corrupt Oil Sales at NNPC, Shell, US Ambassador\"</a>. December 12, 2010.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Wikileaks+on+Nigeria%27s+Corrupt+Oil+Sales+at+NNPC%2C+Shell%2C+US+Ambassador&amp;rft.date=2010-12-12&amp;rft_id=http%3A%2F%2Fusafricaonline.com%2F2010%2F12%2F12%2Fwikileaks-on-nigerias-oil-corruption-nnpc-shell-us-ambassador-attorney-general-aondoakaa%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-200\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-200\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFLenzer2011\" class=\"citation journal cs1\">Lenzer, J. (August 16, 2011). \"Pfizer settles with victims of Nigerian drug trial\". <i>BMJ</i>. <b>343</b> (aug16 3): d5268. <a href=\"/wiki/Doi_(identifier)\" class=\"mw-redirect\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1136%2Fbmj.d5268\">10.1136/bmj.d5268</a>. <a href=\"/wiki/PMID_(identifier)\" class=\"mw-redirect\" title=\"PMID (identifier)\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//pubmed.ncbi.nlm.nih.gov/21846712\">21846712</a>. <a href=\"/wiki/S2CID_(identifier)\" class=\"mw-redirect\" title=\"S2CID (identifier)\">S2CID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"https://api.semanticscholar.org/CorpusID:8758603\">8758603</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMJ&amp;rft.atitle=Pfizer+settles+with+victims+of+Nigerian+drug+trial&amp;rft.volume=343&amp;rft.issue=aug16+3&amp;rft.pages=d5268&amp;rft.date=2011-08-16&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A8758603%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F21846712&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.d5268&amp;rft.aulast=Lenzer&amp;rft.aufirst=J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-201\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-201\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.uschamber.com/article/pfizer-implemented-more-4000-greenhouse-gas-reduction-projects-2000\">\"Pfizer Implemented More than 4,000 Greenhouse Gas Reduction Projects Since 2000\"</a>. <i><a href=\"/wiki/United_States_Chamber_of_Commerce\" title=\"United States Chamber of Commerce\">United States Chamber of Commerce</a></i>. November 15, 2019.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=United+States+Chamber+of+Commerce&amp;rft.atitle=Pfizer+Implemented+More+than+4%2C000+Greenhouse+Gas+Reduction+Projects+Since+2000&amp;rft.date=2019-11-15&amp;rft_id=https%3A%2F%2Fwww.uschamber.com%2Farticle%2Fpfizer-implemented-more-4000-greenhouse-gas-reduction-projects-2000&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-202\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-202\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation pressrelease cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.businesswire.com/news/home/20120913006098/en/Pfizer-Recognized-Carbon-Disclosure-Project-Carbon-Performance\">\"Pfizer Recognized by Carbon Disclosure Project for Carbon Performance\"</a> (Press release). Pfizer. September 13, 2012 &#8211; via <a href=\"/wiki/Business_Wire\" title=\"Business Wire\">Business Wire</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Recognized+by+Carbon+Disclosure+Project+for+Carbon+Performance&amp;rft.pub=Pfizer&amp;rft.date=2012-09-13&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20120913006098%2Fen%2FPfizer-Recognized-Carbon-Disclosure-Project-Carbon-Performance&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-203\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-203\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.nj.gov/dep/srp/community/sites/pi/american_cyanamid_fs.pdf\">\"American Cyanamid Superfund Site Fact Sheet\"</a> <span class=\"cs1-format\">(PDF)</span>. <i><a href=\"/wiki/New_Jersey\" title=\"New Jersey\">New Jersey</a></i>. December 2011.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=New+Jersey&amp;rft.atitle=American+Cyanamid+Superfund+Site+Fact+Sheet&amp;rft.date=2011-12&amp;rft_id=https%3A%2F%2Fwww.nj.gov%2Fdep%2Fsrp%2Fcommunity%2Fsites%2Fpi%2Famerican_cyanamid_fs.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-204\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-204\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFPaik2012\" class=\"citation news cs1\">Paik, Eugene (March 9, 2012). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nj.com/news/2012/03/activisits_say_epa_fix_for_pol.html\">\"Activists say EPA $204M fix for polluted American Cyanamid property will not permanently resolve problem\"</a>. <i><a href=\"/wiki/NJ.com\" title=\"NJ.com\">NJ.com</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=NJ.com&amp;rft.atitle=Activists+say+EPA+%24204M+fix+for+polluted+American+Cyanamid+property+will+not+permanently+resolve+problem&amp;rft.date=2012-03-09&amp;rft.aulast=Paik&amp;rft.aufirst=Eugene&amp;rft_id=https%3A%2F%2Fwww.nj.com%2Fnews%2F2012%2F03%2Factivisits_say_epa_fix_for_pol.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-205\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-205\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation news cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.washingtonpost.com/wp-dyn/content/article/2006/05/23/AR2006052301305_pf.html\">\"The tempest\"</a>. <i><a href=\"/wiki/The_Washington_Post\" title=\"The Washington Post\">The Washington Post</a></i>. May 28, 2006.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Washington+Post&amp;rft.atitle=The+tempest&amp;rft.date=2006-05-28&amp;rft_id=https%3A%2F%2Fwww.washingtonpost.com%2Fwp-dyn%2Fcontent%2Farticle%2F2006%2F05%2F23%2FAR2006052301305_pf.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-206\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-206\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.usglc.org/about-us/coalition-members/\">\"U.S. Global Leadership Coalition, Global Trust members\"</a>. <a href=\"/wiki/U.S._Global_Leadership_Coalition\" title=\"U.S. Global Leadership Coalition\">U.S. Global Leadership Coalition</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=U.S.+Global+Leadership+Coalition%2C+Global+Trust+members&amp;rft.pub=U.S.+Global+Leadership+Coalition&amp;rft_id=https%3A%2F%2Fwww.usglc.org%2Fabout-us%2Fcoalition-members%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-207\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-207\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.phrma.org/about\">\"About\"</a>. <i>PhRMA</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://archive.ph/gaGKc\">Archived</a> from the original on April 6, 2022<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">April 6,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=PhRMA&amp;rft.atitle=About&amp;rft_id=https%3A%2F%2Fwww.phrma.org%2Fabout&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-208\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-208\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20180926013616/https://www.phrma.org/about\">\"About\"</a>. <i>PhRMA</i>. Archived from the original on September 26, 2018<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">April 6,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=PhRMA&amp;rft.atitle=About&amp;rft_id=https%3A%2F%2Fwww.phrma.org%2Fabout&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span><span class=\"cs1-maint citation-comment\"><code class=\"cs1-code\">{{<a href=\"/wiki/Template:Cite_web\" title=\"Template:Cite web\">cite web</a>}}</code>:  CS1 maint: unfit URL (<a href=\"/wiki/Category:CS1_maint:_unfit_URL\" title=\"Category:CS1 maint: unfit URL\">link</a>)</span></span>\n</li>\n<li id=\"cite_note-209\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-209\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://nationalhealthcouncil.org/members/\">\"Our Members\"</a>. <i>National Health Council</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20220406081753/https://nationalhealthcouncil.org/members/?m_cat=74&amp;m_key=\">Archived</a> from the original on April 6, 2022<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">April 6,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=National+Health+Council&amp;rft.atitle=Our+Members&amp;rft_id=https%3A%2F%2Fnationalhealthcouncil.org%2Fmembers%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-210\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-210\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.researchamerica.org/about-us/member-organizations\">\"Member Organizations\"</a>. <i>Research!America</i>. September 28, 2007. <a rel=\"nofollow\" class=\"external text\" href=\"https://archive.ph/CR4A7\">Archived</a> from the original on April 6, 2022<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">April 6,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Research%21America&amp;rft.atitle=Member+Organizations&amp;rft.date=2007-09-28&amp;rft_id=https%3A%2F%2Fwww.researchamerica.org%2Fabout-us%2Fmember-organizations&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-211\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-211\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.weforum.org/organizations/pfizer/\">\"Pfizer\"</a>. <i>World Economic Forum</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://archive.ph/gpwLc\">Archived</a> from the original on March 14, 2022<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">April 6,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Economic+Forum&amp;rft.atitle=Pfizer&amp;rft_id=https%3A%2F%2Fwww.weforum.org%2Forganizations%2Fpfizer%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-212\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-212\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFBourla2018\" class=\"citation web cs1\">Bourla, Albert (January 19, 2018). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.weforum.org/agenda/2018/01/this-is-what-the-future-of-healthcare-looks-like/\">\"5 key trends for the future of healthcare\"</a>. <i>World Economic Forum</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://archive.ph/n5PLQ\">Archived</a> from the original on March 14, 2022<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">April 6,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Economic+Forum&amp;rft.atitle=5+key+trends+for+the+future+of+healthcare&amp;rft.date=2018-01-19&amp;rft.aulast=Bourla&amp;rft.aufirst=Albert&amp;rft_id=https%3A%2F%2Fwww.weforum.org%2Fagenda%2F2018%2F01%2Fthis-is-what-the-future-of-healthcare-looks-like%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-213\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-213\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFMishra2019\" class=\"citation news cs1\">Mishra, Manas (July 2, 2019).  Kuber, Shailesh (ed.). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.reuters.com/article/us-pfizer-board-scott-gottlieb/senator-warren-asks-former-fda-chief-gottlieb-to-resign-from-pfizer-board-idUSKCN1TX2IX\">\"Senator Warren asks former FDA chief Gottlieb to resign from Pfizer board\"</a>. <i><a href=\"/wiki/Reuters\" title=\"Reuters\">Reuters</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Senator+Warren+asks+former+FDA+chief+Gottlieb+to+resign+from+Pfizer+board&amp;rft.date=2019-07-02&amp;rft.aulast=Mishra&amp;rft.aufirst=Manas&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-pfizer-board-scott-gottlieb%2Fsenator-warren-asks-former-fda-chief-gottlieb-to-resign-from-pfizer-board-idUSKCN1TX2IX&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-214\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-214\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.personalizedmedicinecoalition.org/Members/Current_Members\">\"Current Members\"</a>. <i>Personalized Medicine Coalition</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20210815032705/https://personalizedmedicinecoalition.org/Members/Current_Members\">Archived</a> from the original on August 15, 2021<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">April 6,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Personalized+Medicine+Coalition&amp;rft.atitle=Current+Members&amp;rft_id=https%3A%2F%2Fwww.personalizedmedicinecoalition.org%2FMembers%2FCurrent_Members&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-215\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-215\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"http://innovativemedicines.ca/about/member-companies/\">\"Member Companies\"</a>. <i>Innovative Medicines Canada</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://archive.ph/nA2q9\">Archived</a> from the original on November 3, 2021<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">March 8,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Innovative+Medicines+Canada&amp;rft.atitle=Member+Companies&amp;rft_id=http%3A%2F%2Finnovativemedicines.ca%2Fabout%2Fmember-companies%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-216\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-216\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://lobbyist.oico.on.ca/Pages/Public/PublicSearch/\">\"Consultant Lobbyist Registration No. CL4899-20200917025456\"</a>. <i>Office of the Integrity Commissioner of Ontario</i>. September 22, 2021. <a rel=\"nofollow\" class=\"external text\" href=\"https://ia601407.us.archive.org/2/items/consultant_lobbyist_registration_no._CL4899-20200917025456/screencapture-lobbyist-oico-on-ca-Pages-Public-PublicSearch-ConsultantLobbyistPreview-aspx-2022-03-08-09_54_13.pdf\">Archived</a> <span class=\"cs1-format\">(PDF)</span> from the original on March 8, 2022<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">March 8,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Office+of+the+Integrity+Commissioner+of+Ontario&amp;rft.atitle=Consultant+Lobbyist+Registration+No.+CL4899-20200917025456&amp;rft.date=2021-09-22&amp;rft_id=https%3A%2F%2Flobbyist.oico.on.ca%2FPages%2FPublic%2FPublicSearch%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-217\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-217\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFMaher2019\" class=\"citation web cs1\">Maher, Stephen (January 29, 2019). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.macleans.ca/politics/for-access-to-the-ford-government-two-names-matter-most/\">\"For access to the Ford government, two names matter most\"</a>. <i>MacLean's</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://archive.ph/LJWg5\">Archived</a> from the original on March 22, 2021<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">March 8,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=MacLean%27s&amp;rft.atitle=For+access+to+the+Ford+government%2C+two+names+matter+most&amp;rft.date=2019-01-29&amp;rft.aulast=Maher&amp;rft.aufirst=Stephen&amp;rft_id=https%3A%2F%2Fwww.macleans.ca%2Fpolitics%2Ffor-access-to-the-ford-government-two-names-matter-most%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-218\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-218\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://2020-annual-report.fnih.org/donors/\">\"2020 Donors\"</a>. <i>FNIH 2020 Annual Report</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20220402180716/https://2020-annual-report.fnih.org/donors/\">Archived</a> from the original on April 2, 2022<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">April 6,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=FNIH+2020+Annual+Report&amp;rft.atitle=2020+Donors&amp;rft_id=https%3A%2F%2F2020-annual-report.fnih.org%2Fdonors%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-219\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-219\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFPfizer2021\" class=\"citation web cs1\">Pfizer (October 1, 2021). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.cnbc.com/advertorial/2021/10/01/for-pfizer-a-covid-19-vaccine-may-just-be-the-beginning-for-the-potential-revolutionary-promise-of-mrna-technology.html\">\"For Pfizer, a COVID-19 vaccine may just be the beginning for the potential revolutionary promise of mRNA technology\"</a>. <i>CNBC</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://archive.ph/N7oE7\">Archived</a> from the original on October 19, 2021<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">March 28,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=CNBC&amp;rft.atitle=For+Pfizer%2C+a+COVID-19+vaccine+may+just+be+the+beginning+for+the+potential+revolutionary+promise+of+mRNA+technology&amp;rft.date=2021-10-01&amp;rft.au=Pfizer&amp;rft_id=https%3A%2F%2Fwww.cnbc.com%2Fadvertorial%2F2021%2F10%2F01%2Ffor-pfizer-a-covid-19-vaccine-may-just-be-the-beginning-for-the-potential-revolutionary-promise-of-mrna-technology.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-220\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-220\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.cpha.ca/sites/default/files/uploads/about/reports/2018-annual-report-web-e.pdf\">\"2018 Annual Report\"</a> <span class=\"cs1-format\">(PDF)</span>. <i>Canadian Public Health Association</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20210608184141/https://www.cpha.ca/sites/default/files/uploads/about/reports/2018-annual-report-web-e.pdf\">Archived</a> <span class=\"cs1-format\">(PDF)</span> from the original on June 8, 2021<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">March 18,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Canadian+Public+Health+Association&amp;rft.atitle=2018+Annual+Report&amp;rft_id=https%3A%2F%2Fwww.cpha.ca%2Fsites%2Fdefault%2Ffiles%2Fuploads%2Fabout%2Freports%2F2018-annual-report-web-e.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-:2-221\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:2_221-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:2_221-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFPublic_Health_Agency_of_Canada2022\" class=\"citation web cs1\">Public Health Agency of Canada (February 25, 2022). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html\">\"National Advisory Committee on Immunization (NACI): Membership and representation\"</a>. <i>Government of Canada</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20220323061520/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html#fn1-rf\">Archived</a> from the original on March 23, 2022<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">March 29,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Government+of+Canada&amp;rft.atitle=National+Advisory+Committee+on+Immunization+%28NACI%29%3A+Membership+and+representation&amp;rft.date=2022-02-25&amp;rft.au=Public+Health+Agency+of+Canada&amp;rft_id=https%3A%2F%2Fwww.canada.ca%2Fen%2Fpublic-health%2Fservices%2Fimmunization%2Fnational-advisory-committee-on-immunization-naci%2Fnaci-membership-representation.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-222\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-222\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFBettinger2020\" class=\"citation web cs1\">Bettinger, Julie (January 24, 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://mediasite.phsa.ca/Mediasite/Catalog/Mobile/FolderPresentation/22912938f963448cab10cf3719de3d5e21/22912938f963448cab10cf3719de3d5e21/b27eb1456cb14e06af5370550b1c5e431d/\">\"Vaccine Hesitancy: It doesn't matter if the vaccine works if nobody gets it\"</a>. <i>Provincial Health Sciences Authority</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20210118225408/https://mediasite.phsa.ca/Mediasite/Catalog/Mobile/FolderPresentation/22912938f963448cab10cf3719de3d5e21/22912938f963448cab10cf3719de3d5e21/b27eb1456cb14e06af5370550b1c5e431d/\">Archived</a> from the original on January 18, 2021<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">March 29,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Provincial+Health+Sciences+Authority&amp;rft.atitle=Vaccine+Hesitancy%3A+It+doesn%27t+matter+if+the+vaccine+works+if+nobody+gets+it&amp;rft.date=2020-01-24&amp;rft.aulast=Bettinger&amp;rft.aufirst=Julie&amp;rft_id=https%3A%2F%2Fmediasite.phsa.ca%2FMediasite%2FCatalog%2FMobile%2FFolderPresentation%2F22912938f963448cab10cf3719de3d5e21%2F22912938f963448cab10cf3719de3d5e21%2Fb27eb1456cb14e06af5370550b1c5e431d%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-223\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-223\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite class=\"citation web cs1\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.cfn-nce.ca/get-involved/our-partners/industry-and-association-partners/\">\"Industry and Association Partners\"</a>. <i>Canadian Frailty Network</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://archive.ph/BkHql\">Archived</a> from the original on March 28, 2022<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">March 28,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Canadian+Frailty+Network&amp;rft.atitle=Industry+and+Association+Partners&amp;rft_id=https%3A%2F%2Fwww.cfn-nce.ca%2Fget-involved%2Four-partners%2Findustry-and-association-partners%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n<li id=\"cite_note-224\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-224\">^</a></b></span> <span class=\"reference-text\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1067248974\"/><cite id=\"CITEREFKim2020\" class=\"citation web cs1\">Kim, Perry (April 7, 2020). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.cfn-nce.ca/wp-content/uploads/2020/04/RFP-Frailty-and-COVID-April-7.pdf\">\"Request for Proposals (RFP) Frailty and COVID-19\"</a> <span class=\"cs1-format\">(PDF)</span>. <i>Canadian Frailty Network</i>. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20220302175728/https://www.cfn-nce.ca/wp-content/uploads/2020/04/RFP-Frailty-and-COVID-April-7.pdf\">Archived</a> <span class=\"cs1-format\">(PDF)</span> from the original on March 2, 2022<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">March 27,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Canadian+Frailty+Network&amp;rft.atitle=Request+for+Proposals+%28RFP%29+Frailty+and+COVID-19&amp;rft.date=2020-04-07&amp;rft.aulast=Kim&amp;rft.aufirst=Perry&amp;rft_id=https%3A%2F%2Fwww.cfn-nce.ca%2Fwp-content%2Fuploads%2F2020%2F04%2FRFP-Frailty-and-COVID-April-7.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\" class=\"Z3988\"></span></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=38\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<table role=\"presentation\" class=\"mbox-small plainlinks sistersitebox\" style=\"background-color:#f9f9f9;border:1px solid #aaa;color:#000\">\n<tbody><tr>\n<td class=\"mbox-image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-Commons-logo.svg.png\" decoding=\"async\" width=\"30\" height=\"40\" class=\"noviewer\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/45px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/59px-Commons-logo.svg.png 2x\" data-file-width=\"1024\" data-file-height=\"1376\" /></td>\n<td class=\"mbox-text plainlist\">Wikimedia Commons has media related to <span style=\"font-weight: bold; font-style: italic;\"><a href=\"https://commons.wikimedia.org/wiki/Category:Pfizer\" class=\"extiw\" title=\"commons:Category:Pfizer\">Pfizer</a></span>.</td></tr>\n</tbody></table>\n<ul><li><span class=\"official-website\"><span class=\"url\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.pfizer.com/\">Official website</a></span></span> <a href=\"https://www.wikidata.org/wiki/Q206921#P856\" title=\"Edit this at Wikidata\"><img alt=\"Edit this at Wikidata\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png\" decoding=\"async\" width=\"10\" height=\"10\" style=\"vertical-align: text-top\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x\" data-file-width=\"20\" data-file-height=\"20\" /></a></li>\n<li>Business data for Pfizer Inc.: <div class=\"hlist hlist-separated inline\"><ul><li><a rel=\"nofollow\" class=\"external text\" href=\"https://www.google.com/finance?q=PFE\">Google Finance</a></li><li><a rel=\"nofollow\" class=\"external text\" href=\"https://finance.yahoo.com/q?s=PFE\">Yahoo! Finance</a></li><li><a rel=\"nofollow\" class=\"external text\" href=\"https://www.bloomberg.com/quote/PFE:US\">Bloomberg</a></li><li><a rel=\"nofollow\" class=\"external text\" href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=PFE\">SEC filings</a></li></ul></div></li></ul>\n<div class=\"navbox-styles nomobile\"><style data-mw-deduplicate=\"TemplateStyles:r1061467846\">.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}</style></div><div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Pharmaceutical_companies_of_the_United_States\" style=\"padding:3px\"><table class=\"nowraplinks hlist mw-collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><style data-mw-deduplicate=\"TemplateStyles:r1063604349\">.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:\"[ \"}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:\" ]\"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}</style><div class=\"navbar plainlinks hlist navbar-mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Pharmaceutical_companies_of_the_United_States\" title=\"Template:Pharmaceutical companies of the United States\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;box-shadow:none;padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Pharmaceutical_companies_of_the_United_States\" title=\"Template talk:Pharmaceutical companies of the United States\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;box-shadow:none;padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"https://en.wikipedia.org/w/index.php?title=Template:Pharmaceutical_companies_of_the_United_States&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;box-shadow:none;padding:0;\">e</abbr></a></li></ul></div><div id=\"Pharmaceutical_companies_of_the_United_States\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Category:Pharmaceutical_companies_of_the_United_States\" title=\"Category:Pharmaceutical companies of the United States\">Pharmaceutical companies of the United States</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Current</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n<ul><li><a href=\"/wiki/Abbott_Laboratories\" title=\"Abbott Laboratories\">Abbott Laboratories</a></li>\n<li><a href=\"/wiki/AbbVie\" title=\"AbbVie\">AbbVie Inc.</a></li>\n<li><a href=\"/wiki/Acorda_Therapeutics\" title=\"Acorda Therapeutics\">Acorda Therapeutics</a></li>\n<li><a href=\"/wiki/Aderis_Pharmaceuticals\" title=\"Aderis Pharmaceuticals\">Aderis</a></li>\n<li><a href=\"/wiki/Advaxis\" title=\"Advaxis\">Advaxis</a></li>\n<li><a href=\"/wiki/Alcon\" title=\"Alcon\">Alcon</a></li>\n<li><a href=\"/wiki/Alexion_Pharmaceuticals\" title=\"Alexion Pharmaceuticals\">Alexion</a></li>\n<li><a href=\"/wiki/Alnylam\" class=\"mw-redirect\" title=\"Alnylam\">Alnylam</a></li>\n<li><a href=\"/wiki/Amgen\" title=\"Amgen\">Amgen</a></li>\n<li><a href=\"/wiki/Amneal_Pharmaceuticals\" title=\"Amneal Pharmaceuticals\">Amneal Pharmaceuticals</a></li>\n<li><a href=\"/wiki/Avax_Technologies\" title=\"Avax Technologies\">Avax Technologies</a></li>\n<li><a href=\"/wiki/Baxter_International\" title=\"Baxter International\">Baxter</a></li>\n<li><a href=\"/wiki/BioCryst_Pharmaceuticals\" title=\"BioCryst Pharmaceuticals\">BioCryst</a></li>\n<li><a href=\"/wiki/Biogen\" title=\"Biogen\">Biogen</a></li>\n<li><a href=\"/wiki/Bioverativ\" title=\"Bioverativ\">Bioverativ</a></li>\n<li><a href=\"/wiki/Biovest\" title=\"Biovest\">Biovest</a></li>\n<li><a href=\"/wiki/Biovista\" title=\"Biovista\">Biovista</a></li>\n<li><a href=\"/wiki/Bristol_Myers_Squibb\" title=\"Bristol Myers Squibb\">Bristol Myers Squibb</a></li>\n<li><a href=\"/wiki/Century_Pharmaceuticals\" title=\"Century Pharmaceuticals\">Century</a></li>\n<li><a href=\"/wiki/Ceragenix_Pharmaceuticals\" title=\"Ceragenix Pharmaceuticals\">Ceragenix</a></li>\n<li><a href=\"/wiki/Combe_Incorporated\" title=\"Combe Incorporated\">Combe</a></li>\n<li><a href=\"/wiki/CytoSport\" title=\"CytoSport\">CytoSport</a></li>\n<li><a href=\"/wiki/CytRx\" title=\"CytRx\">CytRx</a></li>\n<li><a href=\"/wiki/Danco_Laboratories\" title=\"Danco Laboratories\">Danco Laboratories</a></li>\n<li><a href=\"/wiki/Eli_Lilly_and_Company\" title=\"Eli Lilly and Company\">Eli Lilly</a></li>\n<li><a href=\"/wiki/Galena_Biopharma\" title=\"Galena Biopharma\">Galena Biopharma</a></li>\n<li><a href=\"/wiki/Genentech\" title=\"Genentech\">Genentech</a></li>\n<li><a href=\"/wiki/Gilead_Sciences\" title=\"Gilead Sciences\">Gilead Sciences</a></li>\n<li><a href=\"/wiki/Ionis_Pharmaceuticals\" title=\"Ionis Pharmaceuticals\">Ionis</a></li>\n<li><a href=\"/wiki/Institute_for_OneWorld_Health\" class=\"mw-redirect\" title=\"Institute for OneWorld Health\">Institute for OneWorld Health</a></li>\n<li><a href=\"/wiki/Intercept_Pharmaceuticals\" title=\"Intercept Pharmaceuticals\">Intercept</a></li>\n<li><a href=\"/wiki/Johnson_%26_Johnson\" title=\"Johnson &amp; Johnson\">Johnson &amp; Johnson</a>\n<ul><li><a href=\"/wiki/Ethicon_Inc.\" class=\"mw-redirect\" title=\"Ethicon Inc.\">Ethicon</a></li>\n<li><a href=\"/wiki/Janssen_Biotech\" title=\"Janssen Biotech\">Janssen Biotech</a></li>\n<li><a href=\"/wiki/McNeil_Consumer_Healthcare\" title=\"McNeil Consumer Healthcare\">McNeil Consumer Healthcare</a></li>\n<li><a href=\"/wiki/Ortho-McNeil_Pharmaceutical\" title=\"Ortho-McNeil Pharmaceutical\">Ortho-McNeil</a></li></ul></li>\n<li><a href=\"/wiki/Kinetic_Concepts\" title=\"Kinetic Concepts\">Kinetic Concepts</a></li>\n<li><a href=\"/wiki/McKesson_Corporation\" title=\"McKesson Corporation\">McKesson</a></li>\n<li><a href=\"/wiki/Melinta_Therapeutics\" title=\"Melinta Therapeutics\">Melinta Therapeutics</a></li>\n<li><a href=\"/wiki/Melior_Discovery\" title=\"Melior Discovery\">Melior Discovery</a></li>\n<li><a href=\"/wiki/Mentholatum\" title=\"Mentholatum\">Mentholatum</a></li>\n<li><a href=\"/wiki/Merck_%26_Co.\" title=\"Merck &amp; Co.\">Merck &amp; Co.</a></li>\n<li><a href=\"/wiki/Merrimack_Pharmaceuticals\" title=\"Merrimack Pharmaceuticals\">Merrimack Pharmaceuticals</a></li>\n<li><a href=\"/wiki/Myriad_Genetics\" title=\"Myriad Genetics\">Myriad Genetics</a></li>\n<li><a href=\"/wiki/Moderna\" title=\"Moderna\">Moderna</a></li>\n<li><a href=\"/wiki/Northwest_Biotherapeutics\" title=\"Northwest Biotherapeutics\">Northwest Biotherapeutics</a></li>\n<li><a href=\"/wiki/Norwich_Pharma_Services\" title=\"Norwich Pharma Services\">Norwich Pharma</a></li>\n<li><a href=\"/wiki/NovaBay_Pharmaceuticals\" title=\"NovaBay Pharmaceuticals\">NovaBay</a></li>\n<li><a href=\"/wiki/Organon_%26_Co.\" title=\"Organon &amp; Co.\">Organon</a></li>\n<li><a href=\"/wiki/Ovation_Pharmaceuticals\" title=\"Ovation Pharmaceuticals\">Ovation</a></li>\n<li><a class=\"mw-selflink selflink\">Pfizer</a>\n<ul><li><a href=\"/wiki/Hospira\" title=\"Hospira\">Hospira</a></li>\n<li><a href=\"/wiki/G.D._Searle,_LLC\" title=\"G.D. Searle, LLC\">Searle</a></li></ul></li>\n<li><a href=\"/wiki/PPD,_Inc.\" title=\"PPD, Inc.\">Pharmaceutical Product Development</a></li>\n<li><a href=\"/wiki/Prasco_Laboratories\" title=\"Prasco Laboratories\">Prasco Laboratories</a></li>\n<li><a href=\"/wiki/Procter_%26_Gamble\" title=\"Procter &amp; Gamble\">Procter &amp; Gamble</a></li>\n<li><a href=\"/wiki/Proteon_Therapeutics\" title=\"Proteon Therapeutics\">Proteon Therapeutics</a></li>\n<li><a href=\"/wiki/Purdue_Pharma\" title=\"Purdue Pharma\">Purdue Pharma</a></li>\n<li><a href=\"/wiki/Quark_Pharmaceuticals\" title=\"Quark Pharmaceuticals\">Quark</a></li>\n<li><a href=\"/wiki/Regeneron_Pharmaceuticals\" title=\"Regeneron Pharmaceuticals\">Regeneron</a></li>\n<li><a href=\"/wiki/RespireRx\" title=\"RespireRx\">RespireRx</a></li>\n<li><a href=\"/wiki/Sarepta_Therapeutics\" title=\"Sarepta Therapeutics\">Sarepta Therapeutics</a></li>\n<li><a href=\"/wiki/Sheffield_Pharmaceuticals\" title=\"Sheffield Pharmaceuticals\">Sheffield</a></li>\n<li><a href=\"/wiki/Spectrum_Pharmaceuticals\" title=\"Spectrum Pharmaceuticals\">Spectrum</a></li>\n<li><a href=\"/wiki/Tec_Laboratories\" title=\"Tec Laboratories\">Tec Laboratories</a></li>\n<li><a href=\"/wiki/Titan_Pharmaceuticals\" title=\"Titan Pharmaceuticals\">Titan</a></li>\n<li><a href=\"/wiki/Trevena_Inc\" title=\"Trevena Inc\">Trevena Inc</a></li>\n<li><a href=\"/wiki/Ultragenyx\" title=\"Ultragenyx\">Ultragenyx</a></li>\n<li><a href=\"/wiki/Upsher-Smith_Laboratories\" title=\"Upsher-Smith Laboratories\">Upsher-Smith</a></li>\n<li><a href=\"/wiki/Ventria_Bioscience\" title=\"Ventria Bioscience\">Ventria Bioscience</a></li>\n<li><a href=\"/wiki/Vertex_Pharmaceuticals\" title=\"Vertex Pharmaceuticals\">Vertex</a></li>\n<li><a href=\"/wiki/Viatris\" title=\"Viatris\">Viatris</a></li>\n<li><a href=\"/wiki/West_Pharmaceutical_Services\" title=\"West Pharmaceutical Services\">West Pharmaceutical Services</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Former</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th id=\"Tax_inversion\" scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Tax_inversion\" title=\"Tax inversion\">Tax inversion</a></th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n<ul><li><a href=\"/wiki/Actavis\" title=\"Actavis\">Actavis</a> (<a href=\"/wiki/Corporation_tax_in_the_Republic_of_Ireland#List_of_inversions\" title=\"Corporation tax in the Republic of Ireland\">Ireland</a>, 2013)</li>\n<li><a href=\"/wiki/Alkermes_(company)\" title=\"Alkermes (company)\">Alkermes</a> (<a href=\"/wiki/Corporation_tax_in_the_Republic_of_Ireland#List_of_inversions\" title=\"Corporation tax in the Republic of Ireland\">Ireland</a>, 2011)</li>\n<li><a href=\"/wiki/Allergan\" title=\"Allergan\">Allergan</a> (<a href=\"/wiki/Corporation_tax_in_the_Republic_of_Ireland#List_of_inversions\" title=\"Corporation tax in the Republic of Ireland\">Ireland</a>, 2015)</li>\n<li><a href=\"/wiki/Covidien\" title=\"Covidien\">Covidien</a> (<a href=\"/wiki/Corporation_tax_in_the_Republic_of_Ireland#List_of_inversions\" title=\"Corporation tax in the Republic of Ireland\">Ireland</a>, 2007)</li>\n<li><a href=\"/wiki/Endo_International\" title=\"Endo International\">Endo International</a> (<a href=\"/wiki/Corporation_tax_in_the_Republic_of_Ireland#List_of_inversions\" title=\"Corporation tax in the Republic of Ireland\">Ireland</a>, 2014)</li>\n<li><a href=\"/wiki/Horizon_Therapeutics\" title=\"Horizon Therapeutics\">Horizon Therapeutics</a> (<a href=\"/wiki/Corporation_tax_in_the_Republic_of_Ireland#List_of_inversions\" title=\"Corporation tax in the Republic of Ireland\">Ireland</a>, 2014)</li>\n<li><a href=\"/wiki/Jazz_Pharmaceuticals\" title=\"Jazz Pharmaceuticals\">Jazz Pharmaceuticals</a> (<a href=\"/wiki/Corporation_tax_in_the_Republic_of_Ireland#List_of_inversions\" title=\"Corporation tax in the Republic of Ireland\">Ireland</a>, 2012)</li>\n<li><a href=\"/wiki/Mallinckrodt\" title=\"Mallinckrodt\">Mallinckrodt</a> (<a href=\"/wiki/Corporation_tax_in_the_Republic_of_Ireland#List_of_inversions\" title=\"Corporation tax in the Republic of Ireland\">Ireland</a>, 2013)</li>\n<li><a href=\"/wiki/Perrigo\" title=\"Perrigo\">Perrigo</a> (<a href=\"/wiki/Corporation_tax_in_the_Republic_of_Ireland#List_of_inversions\" title=\"Corporation tax in the Republic of Ireland\">Ireland</a>, 2013)</li>\n<li><a href=\"/wiki/Bausch_Health\" title=\"Bausch Health\">Valeant</a> (Canada, 2010)</li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Other</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n<ul><li><a href=\"/wiki/ALZA\" class=\"mw-redirect\" title=\"ALZA\">ALZA</a></li>\n<li><a href=\"/wiki/Allergan,_Inc.\" title=\"Allergan, Inc.\">Allergan, Inc.</a></li>\n<li><a href=\"/wiki/Amylin_Pharmaceuticals\" title=\"Amylin Pharmaceuticals\">Amylin</a></li>\n<li><a href=\"/wiki/ARIAD_Pharmaceuticals\" title=\"ARIAD Pharmaceuticals\">ARIAD</a></li>\n<li><a href=\"/wiki/Barr_Pharmaceuticals\" title=\"Barr Pharmaceuticals\">Barr</a></li>\n<li><a href=\"/wiki/Biolex\" title=\"Biolex\">Biolex</a></li>\n<li><a href=\"/wiki/Bradley_Pharmaceuticals\" title=\"Bradley Pharmaceuticals\">Bradley</a></li>\n<li><a href=\"/wiki/CancerVax\" title=\"CancerVax\">CancerVax</a></li>\n<li><a href=\"/wiki/Cephalon\" title=\"Cephalon\">Cephalon</a></li>\n<li><a href=\"/wiki/CoTherix\" class=\"mw-redirect\" title=\"CoTherix\">CoTherix</a></li>\n<li><a href=\"/wiki/Covance\" class=\"mw-redirect\" title=\"Covance\">Covance</a></li>\n<li><a href=\"/wiki/Cubist_Pharmaceuticals\" title=\"Cubist Pharmaceuticals\">Cubist</a></li>\n<li><a href=\"/wiki/Cutter_Laboratories\" title=\"Cutter Laboratories\">Cutter Laboratories</a></li>\n<li><a href=\"/wiki/DNAPrint_Genomics\" title=\"DNAPrint Genomics\">DNAPrint Genomics</a></li>\n<li><a href=\"/wiki/Epix_Pharmaceuticals\" title=\"Epix Pharmaceuticals\">Epix</a></li>\n<li><a href=\"/wiki/Forest_Laboratories\" title=\"Forest Laboratories\">Forest Laboratories</a></li>\n<li><a href=\"/wiki/Genta_(company)\" title=\"Genta (company)\">Genta</a></li>\n<li><a href=\"/wiki/ImClone_Systems\" title=\"ImClone Systems\">ImClone Systems</a></li>\n<li><a href=\"/wiki/ISTA_Pharmaceuticals\" title=\"ISTA Pharmaceuticals\">ISTA</a></li>\n<li><a href=\"/wiki/King_Pharmaceuticals\" title=\"King Pharmaceuticals\">King</a></li>\n<li><a href=\"/wiki/KV_Pharmaceutical\" title=\"KV Pharmaceutical\">KV</a></li>\n<li><a href=\"/wiki/Leiner_Health_Products\" title=\"Leiner Health Products\">Leiner Health Products</a></li>\n<li><a href=\"/wiki/Martek_Biosciences_Corporation\" title=\"Martek Biosciences Corporation\">Martek Biosciences</a></li>\n<li><a href=\"/wiki/S._E._Massengill_Company\" title=\"S. E. Massengill Company\">Massengill</a></li>\n<li><a href=\"/wiki/Miles_Laboratories\" title=\"Miles Laboratories\">Miles Laboratories</a></li>\n<li><a href=\"/wiki/Mylan\" title=\"Mylan\">Mylan</a></li>\n<li><a href=\"/wiki/Naurex\" class=\"mw-redirect\" title=\"Naurex\">Naurex</a></li>\n<li><a href=\"/wiki/Nereus_Pharmaceuticals\" title=\"Nereus Pharmaceuticals\">Nereus</a></li>\n<li><a href=\"/wiki/Nuvelo\" title=\"Nuvelo\">Nuvelo</a></li>\n<li><a href=\"/wiki/Ortho_Pharmaceutical\" title=\"Ortho Pharmaceutical\">Ortho</a></li>\n<li><a href=\"/wiki/OSI_Pharmaceuticals\" title=\"OSI Pharmaceuticals\">OSI</a></li>\n<li><a href=\"/wiki/Parke-Davis\" title=\"Parke-Davis\">Parke-Davis</a></li>\n<li><a href=\"/wiki/Repros_Therapeutics\" title=\"Repros Therapeutics\">Repros Therapeutics</a></li>\n<li><a href=\"/wiki/Qualitest\" title=\"Qualitest\">Qualitest</a></li>\n<li><a href=\"/wiki/Melinta_Therapeutics\" title=\"Melinta Therapeutics\">Rib-X</a></li>\n<li><a href=\"/wiki/Schering-Plough\" title=\"Schering-Plough\">Schering-Plough</a></li>\n<li><a href=\"/wiki/Smith,_Kline_%26_French\" title=\"Smith, Kline &amp; French\">Smith, Kline &amp; French</a></li>\n<li><a href=\"/wiki/Sterling_Drug\" title=\"Sterling Drug\">Sterling Drug</a></li>\n<li><a href=\"/wiki/Tanox\" title=\"Tanox\">Tanox</a></li>\n<li><a href=\"/wiki/TAP_Pharmaceutical_Products\" class=\"mw-redirect\" title=\"TAP Pharmaceutical Products\">TAP</a></li>\n<li><a href=\"/wiki/Trubion\" title=\"Trubion\">Trubion</a></li>\n<li><a href=\"/wiki/Upjohn\" title=\"Upjohn\">Upjohn</a></li>\n<li><a href=\"/wiki/Verus_Pharmaceuticals\" title=\"Verus Pharmaceuticals\">Verus</a></li>\n<li><a href=\"/wiki/Vion_Pharmaceuticals,_Inc.\" class=\"mw-redirect\" title=\"Vion Pharmaceuticals, Inc.\">Vion</a></li>\n<li><a href=\"/wiki/ViroPharma\" title=\"ViroPharma\">ViroPharma</a></li>\n<li><a href=\"/wiki/Wyeth\" title=\"Wyeth\">Wyeth</a></li>\n<li><a href=\"/wiki/Zonite_Products_Corporation\" title=\"Zonite Products Corporation\">Zonite</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><td class=\"navbox-abovebelow\" colspan=\"2\"><div>\n<ul><li><a href=\"/wiki/List_of_pharmaceutical_companies\" title=\"List of pharmaceutical companies\">List of pharmaceutical companies</a></li></ul>\n</div></td></tr></tbody></table></div>\n<div class=\"navbox-styles nomobile\"><link rel=\"mw-deduplicated-inline-style\" href=\"mw-data:TemplateStyles:r1061467846\"/></div><div role=\"navigation\" class=\"navbox authority-control\" aria-labelledby=\"Authority_control_frameless&amp;#124;text-top&amp;#124;10px&amp;#124;alt=Edit_this_at_Wikidata&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q206921#identifiers&amp;#124;class=noprint&amp;#124;Edit_this_at_Wikidata\" style=\"padding:3px\"><table class=\"nowraplinks hlist mw-collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div id=\"Authority_control_frameless&amp;#124;text-top&amp;#124;10px&amp;#124;alt=Edit_this_at_Wikidata&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q206921#identifiers&amp;#124;class=noprint&amp;#124;Edit_this_at_Wikidata\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Help:Authority_control\" title=\"Help:Authority control\">Authority control</a> <a href=\"https://www.wikidata.org/wiki/Q206921#identifiers\" title=\"Edit this at Wikidata\"><img alt=\"Edit this at Wikidata\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png\" decoding=\"async\" width=\"10\" height=\"10\" style=\"vertical-align: text-top\" class=\"noprint\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x\" data-file-width=\"20\" data-file-height=\"20\" /></a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">General</th><td class=\"navbox-list-with-group navbox-list navbox-odd\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n<ul><li><a href=\"/wiki/ISNI_(identifier)\" class=\"mw-redirect\" title=\"ISNI (identifier)\">ISNI</a>\n<ul><li><span class=\"uid\"><a rel=\"nofollow\" class=\"external text\" href=\"https://isni.org/isni/0000000088007493\">1</a></span></li></ul></li>\n<li><span class=\"uid\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.worldcat.org/identities/lccn-n85014186/\">WorldCat</a></span></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">National libraries</th><td class=\"navbox-list-with-group navbox-list navbox-even\" style=\"width:100%;padding:0\"><div style=\"padding:0 0.25em\">\n<ul><li><span class=\"uid\"><a rel=\"nofollow\" class=\"external text\" href=\"https://d-nb.info/gnd/2064146-1\">Germany</a></span></li>\n<li><span class=\"uid\"><a rel=\"nofollow\" class=\"external text\" href=\"http://uli.nli.org.il/F/?func=find-b&amp;local_base=NLX10&amp;find_code=UID&amp;request=987007257758205171\">Israel</a></span></li>\n<li><span class=\"uid\"><a rel=\"nofollow\" class=\"external text\" href=\"https://id.loc.gov/authorities/names/n85014186\">United States</a></span></li>\n<li><span class=\"uid\"><a rel=\"nofollow\" class=\"external text\" href=\"https://aleph.nkp.cz/F/?func=find-c&amp;local_base=aut&amp;ccl_term=ica=ko2010557126&amp;CON_LNG=ENG\">Czech Republic</a></span></li>\n<li><span class=\"uid\"><a rel=\"nofollow\" class=\"external text\" href=\"https://nla.gov.au/anbd.aut-an35802451\">Australia</a></span></li></ul>\n</div></td></tr></tbody></table></div>\n<!-- \nNewPP limit report\nParsed by mw1429\nCached time: 20220406185917\nCache expiry: 86400\nReduced expiry: true\nComplications: [vary‐revision‐sha1]\nCPU time usage: 2.343 seconds\nReal time usage: 2.569 seconds\nPreprocessor visited node count: 11582/1000000\nPost‐expand include size: 425654/2097152 bytes\nTemplate argument size: 5383/2097152 bytes\nHighest expansion depth: 16/100\nExpensive parser function count: 17/500\nUnstrip recursion depth: 1/20\nUnstrip post‐expand size: 667427/5000000 bytes\nLua time usage: 1.367/10.000 seconds\nLua memory usage: 16345398/52428800 bytes\nLua Profile:\n    Scribunto_LuaSandboxCallback::callParserFunction                 220 ms       15.7%\n    ?                                                                200 ms       14.3%\n    Scribunto_LuaSandboxCallback::gsub                               120 ms        8.6%\n    type                                                             100 ms        7.1%\n    recursiveClone <mwInit.lua:41>                                   100 ms        7.1%\n    <mw.lua:690>                                                      80 ms        5.7%\n    Scribunto_LuaSandboxCallback::getExpandedArgument                 80 ms        5.7%\n    dataWrapper <mw.lua:668>                                          60 ms        4.3%\n    Scribunto_LuaSandboxCallback::plain                               40 ms        2.9%\n    makeMessage <mw.message.lua:76>                                   40 ms        2.9%\n    [others]                                                         360 ms       25.7%\nNumber of Wikibase entities loaded: 1/400\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00% 2217.874      1 -total\n 58.59% 1299.434      1 Template:Reflist\n 24.94%  553.177    128 Template:Cite_news\n 14.27%  316.417     57 Template:Cite_web\n 11.71%  259.687      1 Template:Infobox_company\n 11.11%  246.478      1 Template:Infobox\n  4.27%   94.741      1 Template:Short_description\n  3.78%   83.798     22 Template:Cite_press_release\n  3.46%   76.811     13 Template:Cite_journal\n  3.37%   74.794      1 Template:Official_URL\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:62304-0!canonical and timestamp 20220406185914 and revision id 1081304371. Serialized with JSON.\n -->\n</div><noscript><img src=\"//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1\" alt=\"\" title=\"\" width=\"1\" height=\"1\" style=\"border: none; position: absolute;\" /></noscript>\n<div class=\"printfooter\">Retrieved from \"<a dir=\"ltr\" href=\"https://en.wikipedia.org/w/index.php?title=Pfizer&amp;oldid=1081304371\">https://en.wikipedia.org/w/index.php?title=Pfizer&amp;oldid=1081304371</a>\"</div></div>\n\t\t<div id=\"catlinks\" class=\"catlinks\" data-mw=\"interface\"><div id=\"mw-normal-catlinks\" class=\"mw-normal-catlinks\"><a href=\"/wiki/Help:Category\" title=\"Help:Category\">Categories</a>: <ul><li><a href=\"/wiki/Category:Pfizer\" title=\"Category:Pfizer\">Pfizer</a></li><li><a href=\"/wiki/Category:Companies_listed_on_the_New_York_Stock_Exchange\" title=\"Category:Companies listed on the New York Stock Exchange\">Companies listed on the New York Stock Exchange</a></li><li><a href=\"/wiki/Category:1849_establishments_in_New_York_(state)\" title=\"Category:1849 establishments in New York (state)\">1849 establishments in New York (state)</a></li><li><a href=\"/wiki/Category:Clinical_trial_organizations\" title=\"Category:Clinical trial organizations\">Clinical trial organizations</a></li><li><a href=\"/wiki/Category:Companies_based_in_Manhattan\" title=\"Category:Companies based in Manhattan\">Companies based in Manhattan</a></li><li><a href=\"/wiki/Category:American_brands\" title=\"Category:American brands\">American brands</a></li><li><a href=\"/wiki/Category:American_companies_established_in_1849\" title=\"Category:American companies established in 1849\">American companies established in 1849</a></li><li><a href=\"/wiki/Category:Former_components_of_the_Dow_Jones_Industrial_Average\" title=\"Category:Former components of the Dow Jones Industrial Average\">Former components of the Dow Jones Industrial Average</a></li><li><a href=\"/wiki/Category:Multinational_companies_based_in_New_York_City\" title=\"Category:Multinational companies based in New York City\">Multinational companies based in New York City</a></li><li><a href=\"/wiki/Category:Pharmaceutical_companies_of_the_United_States\" title=\"Category:Pharmaceutical companies of the United States\">Pharmaceutical companies of the United States</a></li><li><a href=\"/wiki/Category:Publicly_traded_companies_based_in_New_York_City\" title=\"Category:Publicly traded companies based in New York City\">Publicly traded companies based in New York City</a></li><li><a href=\"/wiki/Category:Research_and_development_in_the_United_States\" title=\"Category:Research and development in the United States\">Research and development in the United States</a></li><li><a href=\"/wiki/Category:Companies_listed_on_the_Bombay_Stock_Exchange\" title=\"Category:Companies listed on the Bombay Stock Exchange\">Companies listed on the Bombay Stock Exchange</a></li><li><a href=\"/wiki/Category:Orphan_drug_companies\" title=\"Category:Orphan drug companies\">Orphan drug companies</a></li><li><a href=\"/wiki/Category:Life_sciences_industry\" title=\"Category:Life sciences industry\">Life sciences industry</a></li><li><a href=\"/wiki/Category:Pharmaceutical_companies_established_in_1849\" title=\"Category:Pharmaceutical companies established in 1849\">Pharmaceutical companies established in 1849</a></li><li><a href=\"/wiki/Category:Vaccine_producers\" title=\"Category:Vaccine producers\">Vaccine producers</a></li><li><a href=\"/wiki/Category:COVID-19_vaccine_producers\" title=\"Category:COVID-19 vaccine producers\">COVID-19 vaccine producers</a></li></ul></div><div id=\"mw-hidden-catlinks\" class=\"mw-hidden-catlinks mw-hidden-cats-hidden\">Hidden categories: <ul><li><a href=\"/wiki/Category:CS1_maint:_url-status\" title=\"Category:CS1 maint: url-status\">CS1 maint: url-status</a></li><li><a href=\"/wiki/Category:CS1:_long_volume_value\" title=\"Category:CS1: long volume value\">CS1: long volume value</a></li><li><a href=\"/wiki/Category:CS1_maint:_unfit_URL\" title=\"Category:CS1 maint: unfit URL\">CS1 maint: unfit URL</a></li><li><a href=\"/wiki/Category:Articles_with_short_description\" title=\"Category:Articles with short description\">Articles with short description</a></li><li><a href=\"/wiki/Category:Short_description_matches_Wikidata\" title=\"Category:Short description matches Wikidata\">Short description matches Wikidata</a></li><li><a href=\"/wiki/Category:Use_American_English_from_November_2015\" title=\"Category:Use American English from November 2015\">Use American English from November 2015</a></li><li><a href=\"/wiki/Category:All_Wikipedia_articles_written_in_American_English\" title=\"Category:All Wikipedia articles written in American English\">All Wikipedia articles written in American English</a></li><li><a href=\"/wiki/Category:Use_mdy_dates_from_November_2015\" title=\"Category:Use mdy dates from November 2015\">Use mdy dates from November 2015</a></li><li><a href=\"/wiki/Category:Coordinates_not_on_Wikidata\" title=\"Category:Coordinates not on Wikidata\">Coordinates not on Wikidata</a></li><li><a href=\"/wiki/Category:Commons_category_link_from_Wikidata\" title=\"Category:Commons category link from Wikidata\">Commons category link from Wikidata</a></li><li><a href=\"/wiki/Category:Articles_with_ISNI_identifiers\" title=\"Category:Articles with ISNI identifiers\">Articles with ISNI identifiers</a></li><li><a href=\"/wiki/Category:Articles_with_WORLDCATID_identifiers\" title=\"Category:Articles with WORLDCATID identifiers\">Articles with WORLDCATID identifiers</a></li><li><a href=\"/wiki/Category:Articles_with_GND_identifiers\" title=\"Category:Articles with GND identifiers\">Articles with GND identifiers</a></li><li><a href=\"/wiki/Category:Articles_with_J9U_identifiers\" title=\"Category:Articles with J9U identifiers\">Articles with J9U identifiers</a></li><li><a href=\"/wiki/Category:Articles_with_LCCN_identifiers\" title=\"Category:Articles with LCCN identifiers\">Articles with LCCN identifiers</a></li><li><a href=\"/wiki/Category:Articles_with_NKC_identifiers\" title=\"Category:Articles with NKC identifiers\">Articles with NKC identifiers</a></li><li><a href=\"/wiki/Category:Articles_with_NLA_identifiers\" title=\"Category:Articles with NLA identifiers\">Articles with NLA identifiers</a></li></ul></div></div>\n\t</div>\n</div>\n<div id='mw-data-after-content'>\n\t<div class=\"read-more-container\"></div>\n</div>\n\n<div id=\"mw-navigation\">\n\t<h2>Navigation menu</h2>\n\t<div id=\"mw-head\">\n\t\t\n<nav id=\"p-personal\" class=\"mw-portlet mw-portlet-personal vector-user-menu-legacy vector-menu\" aria-labelledby=\"p-personal-label\" role=\"navigation\" \n\t >\n\t<label id=\"p-personal-label\" aria-label=\"\" class=\"vector-menu-heading\">\n\t\t<span class=\"vector-menu-heading-label\">Personal tools</span>\n\t</label>\n\t<div class=\"vector-menu-content\">\n\t\t\n\t\t<ul class=\"vector-menu-content-list\"><li id=\"pt-anonuserpage\" class=\"mw-list-item\"><span>Not logged in</span></li><li id=\"pt-anontalk\" class=\"mw-list-item\"><a href=\"/wiki/Special:MyTalk\" title=\"Discussion about edits from this IP address [n]\" accesskey=\"n\"><span>Talk</span></a></li><li id=\"pt-anoncontribs\" class=\"mw-list-item\"><a href=\"/wiki/Special:MyContributions\" title=\"A list of edits made from this IP address [y]\" accesskey=\"y\"><span>Contributions</span></a></li><li id=\"pt-createaccount\" class=\"mw-list-item\"><a href=\"/w/index.php?title=Special:CreateAccount&amp;returnto=Pfizer\" title=\"You are encouraged to create an account and log in; however, it is not mandatory\"><span>Create account</span></a></li><li id=\"pt-login\" class=\"mw-list-item\"><a href=\"/w/index.php?title=Special:UserLogin&amp;returnto=Pfizer\" title=\"You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]\" accesskey=\"o\"><span>Log in</span></a></li></ul>\n\t\t\n\t</div>\n</nav>\n\n\t\t<div id=\"left-navigation\">\n\t\t\t\n<nav id=\"p-namespaces\" class=\"mw-portlet mw-portlet-namespaces vector-menu vector-menu-tabs\" aria-labelledby=\"p-namespaces-label\" role=\"navigation\" \n\t >\n\t<label id=\"p-namespaces-label\" aria-label=\"\" class=\"vector-menu-heading\">\n\t\t<span class=\"vector-menu-heading-label\">Namespaces</span>\n\t</label>\n\t<div class=\"vector-menu-content\">\n\t\t\n\t\t<ul class=\"vector-menu-content-list\"><li id=\"ca-nstab-main\" class=\"selected mw-list-item\"><a href=\"/wiki/Pfizer\" title=\"View the content page [c]\" accesskey=\"c\"><span>Article</span></a></li><li id=\"ca-talk\" class=\"mw-list-item\"><a href=\"/wiki/Talk:Pfizer\" rel=\"discussion\" title=\"Discuss improvements to the content page [t]\" accesskey=\"t\"><span>Talk</span></a></li></ul>\n\t\t\n\t</div>\n</nav>\n\n\t\t\t\n<nav id=\"p-variants\" class=\"mw-portlet mw-portlet-variants emptyPortlet vector-menu-dropdown-noicon vector-menu vector-menu-dropdown\" aria-labelledby=\"p-variants-label\" role=\"navigation\" \n\t >\n\t<input type=\"checkbox\"\n\t\tid=\"p-variants-checkbox\"\n\t\trole=\"button\"\n\t\taria-haspopup=\"true\"\n\t\tdata-event-name=\"ui.dropdown-p-variants\"\n\t\tclass=\"vector-menu-checkbox\" aria-labelledby=\"p-variants-label\" />\n\t<label id=\"p-variants-label\" aria-label=\"Change language variant\" class=\"vector-menu-heading\">\n\t\t<span class=\"vector-menu-heading-label\">English</span>\n\t</label>\n\t<div class=\"vector-menu-content\">\n\t\t\n\t\t<ul class=\"vector-menu-content-list\"></ul>\n\t\t\n\t</div>\n</nav>\n\n\t\t</div>\n\t\t<div id=\"right-navigation\">\n\t\t\t\n<nav id=\"p-views\" class=\"mw-portlet mw-portlet-views vector-menu vector-menu-tabs\" aria-labelledby=\"p-views-label\" role=\"navigation\" \n\t >\n\t<label id=\"p-views-label\" aria-label=\"\" class=\"vector-menu-heading\">\n\t\t<span class=\"vector-menu-heading-label\">Views</span>\n\t</label>\n\t<div class=\"vector-menu-content\">\n\t\t\n\t\t<ul class=\"vector-menu-content-list\"><li id=\"ca-view\" class=\"selected mw-list-item\"><a href=\"/wiki/Pfizer\"><span>Read</span></a></li><li id=\"ca-edit\" class=\"mw-list-item\"><a href=\"/w/index.php?title=Pfizer&amp;action=edit\" title=\"Edit this page [e]\" accesskey=\"e\"><span>Edit</span></a></li><li id=\"ca-history\" class=\"mw-list-item\"><a href=\"/w/index.php?title=Pfizer&amp;action=history\" title=\"Past revisions of this page [h]\" accesskey=\"h\"><span>View history</span></a></li></ul>\n\t\t\n\t</div>\n</nav>\n\n\t\t\t\n<nav id=\"p-cactions\" class=\"mw-portlet mw-portlet-cactions emptyPortlet vector-menu-dropdown-noicon vector-menu vector-menu-dropdown\" aria-labelledby=\"p-cactions-label\" role=\"navigation\"  title=\"More options\"\n\t >\n\t<input type=\"checkbox\"\n\t\tid=\"p-cactions-checkbox\"\n\t\trole=\"button\"\n\t\taria-haspopup=\"true\"\n\t\tdata-event-name=\"ui.dropdown-p-cactions\"\n\t\tclass=\"vector-menu-checkbox\" aria-labelledby=\"p-cactions-label\" />\n\t<label id=\"p-cactions-label\" aria-label=\"\" class=\"vector-menu-heading\">\n\t\t<span class=\"vector-menu-heading-label\">More</span>\n\t</label>\n\t<div class=\"vector-menu-content\">\n\t\t\n\t\t<ul class=\"vector-menu-content-list\"></ul>\n\t\t\n\t</div>\n</nav>\n\n\t\t\t\n<div id=\"p-search\" role=\"search\" class=\"vector-search-box-vue  vector-search-box-show-thumbnail vector-search-box-auto-expand-width vector-search-box\">\n\t<div>\n\t\t\t<h3 >\n\t\t\t\t<label for=\"searchInput\">Search</label>\n\t\t\t</h3>\n\t\t<form action=\"/w/index.php\" id=\"searchform\"\n\t\t\tclass=\"vector-search-box-form\">\n\t\t\t<div id=\"simpleSearch\"\n\t\t\t\tclass=\"vector-search-box-inner\"\n\t\t\t\t data-search-loc=\"header-navigation\">\n\t\t\t\t<input class=\"vector-search-box-input\"\n\t\t\t\t\t type=\"search\" name=\"search\" placeholder=\"Search Wikipedia\" aria-label=\"Search Wikipedia\" autocapitalize=\"sentences\" title=\"Search Wikipedia [f]\" accesskey=\"f\" id=\"searchInput\"\n\t\t\t\t/>\n\t\t\t\t<input type=\"hidden\" name=\"title\" value=\"Special:Search\"/>\n\t\t\t\t<input id=\"mw-searchButton\"\n\t\t\t\t\t class=\"searchButton mw-fallbackSearchButton\" type=\"submit\" name=\"fulltext\" title=\"Search Wikipedia for this text\" value=\"Search\" />\n\t\t\t\t<input id=\"searchButton\"\n\t\t\t\t\t class=\"searchButton\" type=\"submit\" name=\"go\" title=\"Go to a page with this exact name if it exists\" value=\"Go\" />\n\t\t\t</div>\n\t\t</form>\n\t</div>\n</div>\n\n\t\t</div>\n\t</div>\n\t\n\n<div id=\"mw-panel\">\n\t<div id=\"p-logo\" role=\"banner\">\n\t\t<a class=\"mw-wiki-logo\" href=\"/wiki/Main_Page\"\n\t\t\ttitle=\"Visit the main page\"></a>\n\t</div>\n\t\n<nav id=\"p-navigation\" class=\"mw-portlet mw-portlet-navigation vector-menu vector-menu-portal portal\" aria-labelledby=\"p-navigation-label\" role=\"navigation\" \n\t >\n\t<label id=\"p-navigation-label\" aria-label=\"\" class=\"vector-menu-heading\">\n\t\t<span class=\"vector-menu-heading-label\">Navigation</span>\n\t</label>\n\t<div class=\"vector-menu-content\">\n\t\t\n\t\t<ul class=\"vector-menu-content-list\"><li id=\"n-mainpage-description\" class=\"mw-list-item\"><a href=\"/wiki/Main_Page\" icon=\"home\" title=\"Visit the main page [z]\" accesskey=\"z\"><span>Main page</span></a></li><li id=\"n-contents\" class=\"mw-list-item\"><a href=\"/wiki/Wikipedia:Contents\" title=\"Guides to browsing Wikipedia\"><span>Contents</span></a></li><li id=\"n-currentevents\" class=\"mw-list-item\"><a href=\"/wiki/Portal:Current_events\" title=\"Articles related to current events\"><span>Current events</span></a></li><li id=\"n-randompage\" class=\"mw-list-item\"><a href=\"/wiki/Special:Random\" icon=\"die\" title=\"Visit a randomly selected article [x]\" accesskey=\"x\"><span>Random article</span></a></li><li id=\"n-aboutsite\" class=\"mw-list-item\"><a href=\"/wiki/Wikipedia:About\" title=\"Learn about Wikipedia and how it works\"><span>About Wikipedia</span></a></li><li id=\"n-contactpage\" class=\"mw-list-item\"><a href=\"//en.wikipedia.org/wiki/Wikipedia:Contact_us\" title=\"How to contact Wikipedia\"><span>Contact us</span></a></li><li id=\"n-sitesupport\" class=\"mw-list-item\"><a href=\"https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en\" title=\"Support us by donating to the Wikimedia Foundation\"><span>Donate</span></a></li></ul>\n\t\t\n\t</div>\n</nav>\n\n\t\n<nav id=\"p-interaction\" class=\"mw-portlet mw-portlet-interaction vector-menu vector-menu-portal portal\" aria-labelledby=\"p-interaction-label\" role=\"navigation\" \n\t >\n\t<label id=\"p-interaction-label\" aria-label=\"\" class=\"vector-menu-heading\">\n\t\t<span class=\"vector-menu-heading-label\">Contribute</span>\n\t</label>\n\t<div class=\"vector-menu-content\">\n\t\t\n\t\t<ul class=\"vector-menu-content-list\"><li id=\"n-help\" class=\"mw-list-item\"><a href=\"/wiki/Help:Contents\" icon=\"help\" title=\"Guidance on how to use and edit Wikipedia\"><span>Help</span></a></li><li id=\"n-introduction\" class=\"mw-list-item\"><a href=\"/wiki/Help:Introduction\" title=\"Learn how to edit Wikipedia\"><span>Learn to edit</span></a></li><li id=\"n-portal\" class=\"mw-list-item\"><a href=\"/wiki/Wikipedia:Community_portal\" title=\"The hub for editors\"><span>Community portal</span></a></li><li id=\"n-recentchanges\" class=\"mw-list-item\"><a href=\"/wiki/Special:RecentChanges\" icon=\"recentChanges\" title=\"A list of recent changes to Wikipedia [r]\" accesskey=\"r\"><span>Recent changes</span></a></li><li id=\"n-upload\" class=\"mw-list-item\"><a href=\"/wiki/Wikipedia:File_Upload_Wizard\" title=\"Add images or other media for use on Wikipedia\"><span>Upload file</span></a></li></ul>\n\t\t\n\t</div>\n</nav>\n\n<nav id=\"p-tb\" class=\"mw-portlet mw-portlet-tb vector-menu vector-menu-portal portal\" aria-labelledby=\"p-tb-label\" role=\"navigation\" \n\t >\n\t<label id=\"p-tb-label\" aria-label=\"\" class=\"vector-menu-heading\">\n\t\t<span class=\"vector-menu-heading-label\">Tools</span>\n\t</label>\n\t<div class=\"vector-menu-content\">\n\t\t\n\t\t<ul class=\"vector-menu-content-list\"><li id=\"t-whatlinkshere\" class=\"mw-list-item\"><a href=\"/wiki/Special:WhatLinksHere/Pfizer\" title=\"List of all English Wikipedia pages containing links to this page [j]\" accesskey=\"j\"><span>What links here</span></a></li><li id=\"t-recentchangeslinked\" class=\"mw-list-item\"><a href=\"/wiki/Special:RecentChangesLinked/Pfizer\" rel=\"nofollow\" title=\"Recent changes in pages linked from this page [k]\" accesskey=\"k\"><span>Related changes</span></a></li><li id=\"t-upload\" class=\"mw-list-item\"><a href=\"/wiki/Wikipedia:File_Upload_Wizard\" title=\"Upload files [u]\" accesskey=\"u\"><span>Upload file</span></a></li><li id=\"t-specialpages\" class=\"mw-list-item\"><a href=\"/wiki/Special:SpecialPages\" title=\"A list of all special pages [q]\" accesskey=\"q\"><span>Special pages</span></a></li><li id=\"t-permalink\" class=\"mw-list-item\"><a href=\"/w/index.php?title=Pfizer&amp;oldid=1081304371\" title=\"Permanent link to this revision of this page\"><span>Permanent link</span></a></li><li id=\"t-info\" class=\"mw-list-item\"><a href=\"/w/index.php?title=Pfizer&amp;action=info\" title=\"More information about this page\"><span>Page information</span></a></li><li id=\"t-cite\" class=\"mw-list-item\"><a href=\"/w/index.php?title=Special:CiteThisPage&amp;page=Pfizer&amp;id=1081304371&amp;wpFormIdentifier=titleform\" title=\"Information on how to cite this page\"><span>Cite this page</span></a></li><li id=\"t-wikibase\" class=\"mw-list-item\"><a href=\"https://www.wikidata.org/wiki/Special:EntityPage/Q206921\" title=\"Structured data on this page hosted by Wikidata [g]\" accesskey=\"g\"><span>Wikidata item</span></a></li></ul>\n\t\t\n\t</div>\n</nav>\n\n<nav id=\"p-coll-print_export\" class=\"mw-portlet mw-portlet-coll-print_export vector-menu vector-menu-portal portal\" aria-labelledby=\"p-coll-print_export-label\" role=\"navigation\" \n\t >\n\t<label id=\"p-coll-print_export-label\" aria-label=\"\" class=\"vector-menu-heading\">\n\t\t<span class=\"vector-menu-heading-label\">Print/export</span>\n\t</label>\n\t<div class=\"vector-menu-content\">\n\t\t\n\t\t<ul class=\"vector-menu-content-list\"><li id=\"coll-download-as-rl\" class=\"mw-list-item\"><a href=\"/w/index.php?title=Special:DownloadAsPdf&amp;page=Pfizer&amp;action=show-download-screen\" title=\"Download this page as a PDF file\"><span>Download as PDF</span></a></li><li id=\"t-print\" class=\"mw-list-item\"><a href=\"/w/index.php?title=Pfizer&amp;printable=yes\" title=\"Printable version of this page [p]\" accesskey=\"p\"><span>Printable version</span></a></li></ul>\n\t\t\n\t</div>\n</nav>\n\n<nav id=\"p-wikibase-otherprojects\" class=\"mw-portlet mw-portlet-wikibase-otherprojects vector-menu vector-menu-portal portal\" aria-labelledby=\"p-wikibase-otherprojects-label\" role=\"navigation\" \n\t >\n\t<label id=\"p-wikibase-otherprojects-label\" aria-label=\"\" class=\"vector-menu-heading\">\n\t\t<span class=\"vector-menu-heading-label\">In other projects</span>\n\t</label>\n\t<div class=\"vector-menu-content\">\n\t\t\n\t\t<ul class=\"vector-menu-content-list\"><li class=\"wb-otherproject-link wb-otherproject-commons mw-list-item\"><a href=\"https://commons.wikimedia.org/wiki/Category:Pfizer\" hreflang=\"en\"><span>Wikimedia Commons</span></a></li><li class=\"wb-otherproject-link wb-otherproject-wikinews mw-list-item\"><a href=\"https://en.wikinews.org/wiki/Category:Pfizer\" hreflang=\"en\"><span>Wikinews</span></a></li></ul>\n\t\t\n\t</div>\n</nav>\n\n\t\n<nav id=\"p-lang\" class=\"mw-portlet mw-portlet-lang vector-menu vector-menu-portal portal\" aria-labelledby=\"p-lang-label\" role=\"navigation\" \n\t >\n\t<label id=\"p-lang-label\" aria-label=\"\" class=\"vector-menu-heading\">\n\t\t<span class=\"vector-menu-heading-label\">Languages</span>\n\t</label>\n\t<div class=\"vector-menu-content\">\n\t\t\n\t\t<ul class=\"vector-menu-content-list\"><li class=\"interlanguage-link interwiki-af mw-list-item\"><a href=\"https://af.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Afrikaans\" lang=\"af\" hreflang=\"af\" class=\"interlanguage-link-target\"><span>Afrikaans</span></a></li><li class=\"interlanguage-link interwiki-ar mw-list-item\"><a href=\"https://ar.wikipedia.org/wiki/%D9%81%D8%A7%D9%8A%D8%B2%D8%B1\" title=\"فايزر – Arabic\" lang=\"ar\" hreflang=\"ar\" class=\"interlanguage-link-target\"><span>العربية</span></a></li><li class=\"interlanguage-link interwiki-ast mw-list-item\"><a href=\"https://ast.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Asturian\" lang=\"ast\" hreflang=\"ast\" class=\"interlanguage-link-target\"><span>Asturianu</span></a></li><li class=\"interlanguage-link interwiki-az mw-list-item\"><a href=\"https://az.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Azerbaijani\" lang=\"az\" hreflang=\"az\" class=\"interlanguage-link-target\"><span>Azərbaycanca</span></a></li><li class=\"interlanguage-link interwiki-azb mw-list-item\"><a href=\"https://azb.wikipedia.org/wiki/%D9%81%D8%A7%DB%8C%D8%B2%D8%B1\" title=\"فایزر – South Azerbaijani\" lang=\"azb\" hreflang=\"azb\" class=\"interlanguage-link-target\"><span>تۆرکجه</span></a></li><li class=\"interlanguage-link interwiki-bn mw-list-item\"><a href=\"https://bn.wikipedia.org/wiki/%E0%A6%AB%E0%A6%BE%E0%A6%87%E0%A6%9C%E0%A6%BE%E0%A6%B0\" title=\"ফাইজার – Bangla\" lang=\"bn\" hreflang=\"bn\" class=\"interlanguage-link-target\"><span>বাংলা</span></a></li><li class=\"interlanguage-link interwiki-zh-min-nan mw-list-item\"><a href=\"https://zh-min-nan.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Chinese (Min Nan)\" lang=\"nan\" hreflang=\"nan\" class=\"interlanguage-link-target\"><span>Bân-lâm-gú</span></a></li><li class=\"interlanguage-link interwiki-bg mw-list-item\"><a href=\"https://bg.wikipedia.org/wiki/%D0%A4%D0%B0%D0%B9%D0%B7%D1%8A%D1%80\" title=\"Файзър – Bulgarian\" lang=\"bg\" hreflang=\"bg\" class=\"interlanguage-link-target\"><span>Български</span></a></li><li class=\"interlanguage-link interwiki-bs mw-list-item\"><a href=\"https://bs.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Bosnian\" lang=\"bs\" hreflang=\"bs\" class=\"interlanguage-link-target\"><span>Bosanski</span></a></li><li class=\"interlanguage-link interwiki-ca mw-list-item\"><a href=\"https://ca.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Catalan\" lang=\"ca\" hreflang=\"ca\" class=\"interlanguage-link-target\"><span>Català</span></a></li><li class=\"interlanguage-link interwiki-cs mw-list-item\"><a href=\"https://cs.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Czech\" lang=\"cs\" hreflang=\"cs\" class=\"interlanguage-link-target\"><span>Čeština</span></a></li><li class=\"interlanguage-link interwiki-da mw-list-item\"><a href=\"https://da.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Danish\" lang=\"da\" hreflang=\"da\" class=\"interlanguage-link-target\"><span>Dansk</span></a></li><li class=\"interlanguage-link interwiki-de mw-list-item\"><a href=\"https://de.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – German\" lang=\"de\" hreflang=\"de\" class=\"interlanguage-link-target\"><span>Deutsch</span></a></li><li class=\"interlanguage-link interwiki-et mw-list-item\"><a href=\"https://et.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Estonian\" lang=\"et\" hreflang=\"et\" class=\"interlanguage-link-target\"><span>Eesti</span></a></li><li class=\"interlanguage-link interwiki-el mw-list-item\"><a href=\"https://el.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Greek\" lang=\"el\" hreflang=\"el\" class=\"interlanguage-link-target\"><span>Ελληνικά</span></a></li><li class=\"interlanguage-link interwiki-es mw-list-item\"><a href=\"https://es.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Spanish\" lang=\"es\" hreflang=\"es\" class=\"interlanguage-link-target\"><span>Español</span></a></li><li class=\"interlanguage-link interwiki-eo mw-list-item\"><a href=\"https://eo.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Esperanto\" lang=\"eo\" hreflang=\"eo\" class=\"interlanguage-link-target\"><span>Esperanto</span></a></li><li class=\"interlanguage-link interwiki-eu mw-list-item\"><a href=\"https://eu.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Basque\" lang=\"eu\" hreflang=\"eu\" class=\"interlanguage-link-target\"><span>Euskara</span></a></li><li class=\"interlanguage-link interwiki-fa mw-list-item\"><a href=\"https://fa.wikipedia.org/wiki/%D9%81%D8%A7%DB%8C%D8%B2%D8%B1\" title=\"فایزر – Persian\" lang=\"fa\" hreflang=\"fa\" class=\"interlanguage-link-target\"><span>فارسی</span></a></li><li class=\"interlanguage-link interwiki-fr mw-list-item\"><a href=\"https://fr.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – French\" lang=\"fr\" hreflang=\"fr\" class=\"interlanguage-link-target\"><span>Français</span></a></li><li class=\"interlanguage-link interwiki-gl mw-list-item\"><a href=\"https://gl.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Galician\" lang=\"gl\" hreflang=\"gl\" class=\"interlanguage-link-target\"><span>Galego</span></a></li><li class=\"interlanguage-link interwiki-ko mw-list-item\"><a href=\"https://ko.wikipedia.org/wiki/%ED%99%94%EC%9D%B4%EC%9E%90\" title=\"화이자 – Korean\" lang=\"ko\" hreflang=\"ko\" class=\"interlanguage-link-target\"><span>한국어</span></a></li><li class=\"interlanguage-link interwiki-hy mw-list-item\"><a href=\"https://hy.wikipedia.org/wiki/%D5%8A%D6%86%D5%A1%D5%B5%D5%A6%D5%A5%D6%80\" title=\"Պֆայզեր – Armenian\" lang=\"hy\" hreflang=\"hy\" class=\"interlanguage-link-target\"><span>Հայերեն</span></a></li><li class=\"interlanguage-link interwiki-hi mw-list-item\"><a href=\"https://hi.wikipedia.org/wiki/%E0%A4%AB%E0%A4%BE%E0%A4%87%E0%A4%9C%E0%A4%B0\" title=\"फाइजर – Hindi\" lang=\"hi\" hreflang=\"hi\" class=\"interlanguage-link-target\"><span>हिन्दी</span></a></li><li class=\"interlanguage-link interwiki-hr mw-list-item\"><a href=\"https://hr.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Croatian\" lang=\"hr\" hreflang=\"hr\" class=\"interlanguage-link-target\"><span>Hrvatski</span></a></li><li class=\"interlanguage-link interwiki-id mw-list-item\"><a href=\"https://id.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Indonesian\" lang=\"id\" hreflang=\"id\" class=\"interlanguage-link-target\"><span>Bahasa Indonesia</span></a></li><li class=\"interlanguage-link interwiki-it mw-list-item\"><a href=\"https://it.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Italian\" lang=\"it\" hreflang=\"it\" class=\"interlanguage-link-target\"><span>Italiano</span></a></li><li class=\"interlanguage-link interwiki-he mw-list-item\"><a href=\"https://he.wikipedia.org/wiki/%D7%A4%D7%99%D7%99%D7%96%D7%A8\" title=\"פייזר – Hebrew\" lang=\"he\" hreflang=\"he\" class=\"interlanguage-link-target\"><span>עברית</span></a></li><li class=\"interlanguage-link interwiki-kn mw-list-item\"><a href=\"https://kn.wikipedia.org/wiki/%E0%B2%AB%E0%B3%88%E0%B2%9D%E0%B2%B0%E0%B3%8D\" title=\"ಫೈಝರ್ – Kannada\" lang=\"kn\" hreflang=\"kn\" class=\"interlanguage-link-target\"><span>ಕನ್ನಡ</span></a></li><li class=\"interlanguage-link interwiki-sw mw-list-item\"><a href=\"https://sw.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Swahili\" lang=\"sw\" hreflang=\"sw\" class=\"interlanguage-link-target\"><span>Kiswahili</span></a></li><li class=\"interlanguage-link interwiki-lv mw-list-item\"><a href=\"https://lv.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Latvian\" lang=\"lv\" hreflang=\"lv\" class=\"interlanguage-link-target\"><span>Latviešu</span></a></li><li class=\"interlanguage-link interwiki-lt mw-list-item\"><a href=\"https://lt.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Lithuanian\" lang=\"lt\" hreflang=\"lt\" class=\"interlanguage-link-target\"><span>Lietuvių</span></a></li><li class=\"interlanguage-link interwiki-hu mw-list-item\"><a href=\"https://hu.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Hungarian\" lang=\"hu\" hreflang=\"hu\" class=\"interlanguage-link-target\"><span>Magyar</span></a></li><li class=\"interlanguage-link interwiki-ml mw-list-item\"><a href=\"https://ml.wikipedia.org/wiki/%E0%B4%AB%E0%B5%88%E0%B4%B8%E0%B5%BC\" title=\"ഫൈസർ – Malayalam\" lang=\"ml\" hreflang=\"ml\" class=\"interlanguage-link-target\"><span>മലയാളം</span></a></li><li class=\"interlanguage-link interwiki-xmf mw-list-item\"><a href=\"https://xmf.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Mingrelian\" lang=\"xmf\" hreflang=\"xmf\" class=\"interlanguage-link-target\"><span>მარგალური</span></a></li><li class=\"interlanguage-link interwiki-arz mw-list-item\"><a href=\"https://arz.wikipedia.org/wiki/%D9%81%D8%A7%D9%8A%D8%B2%D8%B1\" title=\"فايزر – Egyptian Arabic\" lang=\"arz\" hreflang=\"arz\" class=\"interlanguage-link-target\"><span>مصرى</span></a></li><li class=\"interlanguage-link interwiki-ms mw-list-item\"><a href=\"https://ms.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Malay\" lang=\"ms\" hreflang=\"ms\" class=\"interlanguage-link-target\"><span>Bahasa Melayu</span></a></li><li class=\"interlanguage-link interwiki-my mw-list-item\"><a href=\"https://my.wikipedia.org/wiki/%E1%80%96%E1%80%AD%E1%80%AF%E1%80%84%E1%80%BA%E1%80%87%E1%80%AC\" title=\"ဖိုင်ဇာ – Burmese\" lang=\"my\" hreflang=\"my\" class=\"interlanguage-link-target\"><span>မြန်မာဘာသာ</span></a></li><li class=\"interlanguage-link interwiki-nl mw-list-item\"><a href=\"https://nl.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Dutch\" lang=\"nl\" hreflang=\"nl\" class=\"interlanguage-link-target\"><span>Nederlands</span></a></li><li class=\"interlanguage-link interwiki-ja mw-list-item\"><a href=\"https://ja.wikipedia.org/wiki/%E3%83%95%E3%82%A1%E3%82%A4%E3%82%B6%E3%83%BC\" title=\"ファイザー – Japanese\" lang=\"ja\" hreflang=\"ja\" class=\"interlanguage-link-target\"><span>日本語</span></a></li><li class=\"interlanguage-link interwiki-no mw-list-item\"><a href=\"https://no.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Norwegian Bokmål\" lang=\"nb\" hreflang=\"nb\" class=\"interlanguage-link-target\"><span>Norsk bokmål</span></a></li><li class=\"interlanguage-link interwiki-uz mw-list-item\"><a href=\"https://uz.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Uzbek\" lang=\"uz\" hreflang=\"uz\" class=\"interlanguage-link-target\"><span>Oʻzbekcha/ўзбекча</span></a></li><li class=\"interlanguage-link interwiki-pnb mw-list-item\"><a href=\"https://pnb.wikipedia.org/wiki/%D9%81%D8%A7%D8%A6%D8%B2%D8%B1\" title=\"فائزر – Western Punjabi\" lang=\"pnb\" hreflang=\"pnb\" class=\"interlanguage-link-target\"><span>پنجابی</span></a></li><li class=\"interlanguage-link interwiki-pl mw-list-item\"><a href=\"https://pl.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Polish\" lang=\"pl\" hreflang=\"pl\" class=\"interlanguage-link-target\"><span>Polski</span></a></li><li class=\"interlanguage-link interwiki-pt mw-list-item\"><a href=\"https://pt.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Portuguese\" lang=\"pt\" hreflang=\"pt\" class=\"interlanguage-link-target\"><span>Português</span></a></li><li class=\"interlanguage-link interwiki-ro mw-list-item\"><a href=\"https://ro.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Romanian\" lang=\"ro\" hreflang=\"ro\" class=\"interlanguage-link-target\"><span>Română</span></a></li><li class=\"interlanguage-link interwiki-ru mw-list-item\"><a href=\"https://ru.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Russian\" lang=\"ru\" hreflang=\"ru\" class=\"interlanguage-link-target\"><span>Русский</span></a></li><li class=\"interlanguage-link interwiki-sah mw-list-item\"><a href=\"https://sah.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Sakha\" lang=\"sah\" hreflang=\"sah\" class=\"interlanguage-link-target\"><span>Саха тыла</span></a></li><li class=\"interlanguage-link interwiki-simple mw-list-item\"><a href=\"https://simple.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Simple English\" lang=\"en-simple\" hreflang=\"en-simple\" class=\"interlanguage-link-target\"><span>Simple English</span></a></li><li class=\"interlanguage-link interwiki-sl mw-list-item\"><a href=\"https://sl.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Slovenian\" lang=\"sl\" hreflang=\"sl\" class=\"interlanguage-link-target\"><span>Slovenščina</span></a></li><li class=\"interlanguage-link interwiki-ckb mw-list-item\"><a href=\"https://ckb.wikipedia.org/wiki/%D9%81%D8%A7%DB%8C%D8%B2%DB%95%D8%B1\" title=\"فایزەر – Central Kurdish\" lang=\"ckb\" hreflang=\"ckb\" class=\"interlanguage-link-target\"><span>کوردی</span></a></li><li class=\"interlanguage-link interwiki-sr mw-list-item\"><a href=\"https://sr.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Serbian\" lang=\"sr\" hreflang=\"sr\" class=\"interlanguage-link-target\"><span>Српски / srpski</span></a></li><li class=\"interlanguage-link interwiki-sh mw-list-item\"><a href=\"https://sh.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Serbo-Croatian\" lang=\"sh\" hreflang=\"sh\" class=\"interlanguage-link-target\"><span>Srpskohrvatski / српскохрватски</span></a></li><li class=\"interlanguage-link interwiki-fi mw-list-item\"><a href=\"https://fi.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Finnish\" lang=\"fi\" hreflang=\"fi\" class=\"interlanguage-link-target\"><span>Suomi</span></a></li><li class=\"interlanguage-link interwiki-sv mw-list-item\"><a href=\"https://sv.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Swedish\" lang=\"sv\" hreflang=\"sv\" class=\"interlanguage-link-target\"><span>Svenska</span></a></li><li class=\"interlanguage-link interwiki-tl mw-list-item\"><a href=\"https://tl.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Tagalog\" lang=\"tl\" hreflang=\"tl\" class=\"interlanguage-link-target\"><span>Tagalog</span></a></li><li class=\"interlanguage-link interwiki-ta mw-list-item\"><a href=\"https://ta.wikipedia.org/wiki/%E0%AE%AA%E0%AF%88%E0%AE%9A%E0%AE%B0%E0%AF%8D\" title=\"பைசர் – Tamil\" lang=\"ta\" hreflang=\"ta\" class=\"interlanguage-link-target\"><span>தமிழ்</span></a></li><li class=\"interlanguage-link interwiki-te mw-list-item\"><a href=\"https://te.wikipedia.org/wiki/%E0%B0%AB%E0%B1%88%E0%B0%9C%E0%B0%B0%E0%B1%8D\" title=\"ఫైజర్ – Telugu\" lang=\"te\" hreflang=\"te\" class=\"interlanguage-link-target\"><span>తెలుగు</span></a></li><li class=\"interlanguage-link interwiki-th mw-list-item\"><a href=\"https://th.wikipedia.org/wiki/%E0%B9%84%E0%B8%9F%E0%B9%80%E0%B8%8B%E0%B8%AD%E0%B8%A3%E0%B9%8C\" title=\"ไฟเซอร์ – Thai\" lang=\"th\" hreflang=\"th\" class=\"interlanguage-link-target\"><span>ไทย</span></a></li><li class=\"interlanguage-link interwiki-tr mw-list-item\"><a href=\"https://tr.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Turkish\" lang=\"tr\" hreflang=\"tr\" class=\"interlanguage-link-target\"><span>Türkçe</span></a></li><li class=\"interlanguage-link interwiki-uk mw-list-item\"><a href=\"https://uk.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Ukrainian\" lang=\"uk\" hreflang=\"uk\" class=\"interlanguage-link-target\"><span>Українська</span></a></li><li class=\"interlanguage-link interwiki-ur mw-list-item\"><a href=\"https://ur.wikipedia.org/wiki/%D9%81%D8%A7%D8%A6%D8%B2%D8%B1\" title=\"فائزر – Urdu\" lang=\"ur\" hreflang=\"ur\" class=\"interlanguage-link-target\"><span>اردو</span></a></li><li class=\"interlanguage-link interwiki-vi mw-list-item\"><a href=\"https://vi.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Vietnamese\" lang=\"vi\" hreflang=\"vi\" class=\"interlanguage-link-target\"><span>Tiếng Việt</span></a></li><li class=\"interlanguage-link interwiki-wuu mw-list-item\"><a href=\"https://wuu.wikipedia.org/wiki/%E8%BE%89%E7%91%9E\" title=\"辉瑞 – Wu Chinese\" lang=\"wuu\" hreflang=\"wuu\" class=\"interlanguage-link-target\"><span>吴语</span></a></li><li class=\"interlanguage-link interwiki-yi mw-list-item\"><a href=\"https://yi.wikipedia.org/wiki/%D7%A4%D7%99%D7%99%D7%96%D7%A2%D7%A8\" title=\"פייזער – Yiddish\" lang=\"yi\" hreflang=\"yi\" class=\"interlanguage-link-target\"><span>ייִדיש</span></a></li><li class=\"interlanguage-link interwiki-zh-yue mw-list-item\"><a href=\"https://zh-yue.wikipedia.org/wiki/%E8%BC%9D%E7%91%9E\" title=\"輝瑞 – Cantonese\" lang=\"yue\" hreflang=\"yue\" class=\"interlanguage-link-target\"><span>粵語</span></a></li><li class=\"interlanguage-link interwiki-bat-smg mw-list-item\"><a href=\"https://bat-smg.wikipedia.org/wiki/Pfizer\" title=\"Pfizer – Samogitian\" lang=\"sgs\" hreflang=\"sgs\" class=\"interlanguage-link-target\"><span>Žemaitėška</span></a></li><li class=\"interlanguage-link interwiki-zh mw-list-item\"><a href=\"https://zh.wikipedia.org/wiki/%E8%BC%9D%E7%91%9E\" title=\"輝瑞 – Chinese\" lang=\"zh\" hreflang=\"zh\" class=\"interlanguage-link-target\"><span>中文</span></a></li></ul>\n\t\t<div class=\"after-portlet after-portlet-lang\"><span class=\"wb-langlinks-edit wb-langlinks-link\"><a href=\"https://www.wikidata.org/wiki/Special:EntityPage/Q206921#sitelinks-wikipedia\" title=\"Edit interlanguage links\" class=\"wbc-editpage\">Edit links</a></span></div>\n\t</div>\n</nav>\n\n</div>\n\n</div>\n\n<footer id=\"footer\" class=\"mw-footer\" role=\"contentinfo\" >\n\t<ul id=\"footer-info\">\n\t<li id=\"footer-info-lastmod\"> This page was last edited on 6 April 2022, at 16:37<span class=\"anonymous-show\">&#160;(UTC)</span>.</li>\n\t<li id=\"footer-info-copyright\">Text is available under the <a rel=\"license\" href=\"//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License\">Creative Commons Attribution-ShareAlike License 3.0</a><a rel=\"license\" href=\"//creativecommons.org/licenses/by-sa/3.0/\" style=\"display:none;\"></a>;\nadditional terms may apply.  By using this site, you agree to the <a href=\"//foundation.wikimedia.org/wiki/Terms_of_Use\">Terms of Use</a> and <a href=\"//foundation.wikimedia.org/wiki/Privacy_policy\">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href=\"//www.wikimediafoundation.org/\">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>\n</ul>\n\n\t<ul id=\"footer-places\">\n\t<li id=\"footer-places-privacy\"><a href=\"https://foundation.wikimedia.org/wiki/Privacy_policy\" class=\"extiw\" title=\"wmf:Privacy policy\">Privacy policy</a></li>\n\t<li id=\"footer-places-about\"><a href=\"/wiki/Wikipedia:About\" title=\"Wikipedia:About\">About Wikipedia</a></li>\n\t<li id=\"footer-places-disclaimer\"><a href=\"/wiki/Wikipedia:General_disclaimer\" title=\"Wikipedia:General disclaimer\">Disclaimers</a></li>\n\t<li id=\"footer-places-contact\"><a href=\"//en.wikipedia.org/wiki/Wikipedia:Contact_us\">Contact Wikipedia</a></li>\n\t<li id=\"footer-places-mobileview\"><a href=\"//en.m.wikipedia.org/w/index.php?title=Pfizer&amp;mobileaction=toggle_view_mobile\" class=\"noprint stopMobileRedirectToggle\">Mobile view</a></li>\n\t<li id=\"footer-places-developers\"><a href=\"https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute\">Developers</a></li>\n\t<li id=\"footer-places-statslink\"><a href=\"https://stats.wikimedia.org/#/en.wikipedia.org\">Statistics</a></li>\n\t<li id=\"footer-places-cookiestatement\"><a href=\"https://foundation.wikimedia.org/wiki/Cookie_statement\">Cookie statement</a></li>\n</ul>\n\n\t<ul id=\"footer-icons\" class=\"noprint\">\n\t<li id=\"footer-copyrightico\"><a href=\"https://wikimediafoundation.org/\"><img src=\"/static/images/footer/wikimedia-button.png\" srcset=\"/static/images/footer/wikimedia-button-1.5x.png 1.5x, /static/images/footer/wikimedia-button-2x.png 2x\" width=\"88\" height=\"31\" alt=\"Wikimedia Foundation\" loading=\"lazy\" /></a></li>\n\t<li id=\"footer-poweredbyico\"><a href=\"https://www.mediawiki.org/\"><img src=\"/static/images/footer/poweredby_mediawiki_88x31.png\" alt=\"Powered by MediaWiki\" srcset=\"/static/images/footer/poweredby_mediawiki_132x47.png 1.5x, /static/images/footer/poweredby_mediawiki_176x62.png 2x\" width=\"88\" height=\"31\" loading=\"lazy\"/></a></li>\n</ul>\n\n</footer>\n\n<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({\"wgPageParseReport\":{\"limitreport\":{\"cputime\":\"2.343\",\"walltime\":\"2.569\",\"ppvisitednodes\":{\"value\":11582,\"limit\":1000000},\"postexpandincludesize\":{\"value\":425654,\"limit\":2097152},\"templateargumentsize\":{\"value\":5383,\"limit\":2097152},\"expansiondepth\":{\"value\":16,\"limit\":100},\"expensivefunctioncount\":{\"value\":17,\"limit\":500},\"unstrip-depth\":{\"value\":1,\"limit\":20},\"unstrip-size\":{\"value\":667427,\"limit\":5000000},\"entityaccesscount\":{\"value\":1,\"limit\":400},\"timingprofile\":[\"100.00% 2217.874      1 -total\",\" 58.59% 1299.434      1 Template:Reflist\",\" 24.94%  553.177    128 Template:Cite_news\",\" 14.27%  316.417     57 Template:Cite_web\",\" 11.71%  259.687      1 Template:Infobox_company\",\" 11.11%  246.478      1 Template:Infobox\",\"  4.27%   94.741      1 Template:Short_description\",\"  3.78%   83.798     22 Template:Cite_press_release\",\"  3.46%   76.811     13 Template:Cite_journal\",\"  3.37%   74.794      1 Template:Official_URL\"]},\"scribunto\":{\"limitreport-timeusage\":{\"value\":\"1.367\",\"limit\":\"10.000\"},\"limitreport-memusage\":{\"value\":16345398,\"limit\":52428800},\"limitreport-profile\":[[\"Scribunto_LuaSandboxCallback::callParserFunction\",\"220\",\"15.7\"],[\"?\",\"200\",\"14.3\"],[\"Scribunto_LuaSandboxCallback::gsub\",\"120\",\"8.6\"],[\"type\",\"100\",\"7.1\"],[\"recursiveClone \\u003CmwInit.lua:41\\u003E\",\"100\",\"7.1\"],[\"\\u003Cmw.lua:690\\u003E\",\"80\",\"5.7\"],[\"Scribunto_LuaSandboxCallback::getExpandedArgument\",\"80\",\"5.7\"],[\"dataWrapper \\u003Cmw.lua:668\\u003E\",\"60\",\"4.3\"],[\"Scribunto_LuaSandboxCallback::plain\",\"40\",\"2.9\"],[\"makeMessage \\u003Cmw.message.lua:76\\u003E\",\"40\",\"2.9\"],[\"[others]\",\"360\",\"25.7\"]]},\"cachereport\":{\"origin\":\"mw1429\",\"timestamp\":\"20220406185917\",\"ttl\":86400,\"transientcontent\":true}}});});</script>\n<script type=\"application/ld+json\">{\"@context\":\"https:\\/\\/schema.org\",\"@type\":\"Article\",\"name\":\"Pfizer\",\"url\":\"https:\\/\\/en.wikipedia.org\\/wiki\\/Pfizer\",\"sameAs\":\"http:\\/\\/www.wikidata.org\\/entity\\/Q206921\",\"mainEntity\":\"http:\\/\\/www.wikidata.org\\/entity\\/Q206921\",\"author\":{\"@type\":\"Organization\",\"name\":\"Contributors to Wikimedia projects\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"Wikimedia Foundation, Inc.\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\/\\/www.wikimedia.org\\/static\\/images\\/wmf-hor-googpub.png\"}},\"datePublished\":\"2002-07-15T03:25:40Z\",\"dateModified\":\"2022-04-06T16:37:59Z\",\"image\":\"https:\\/\\/upload.wikimedia.org\\/wikipedia\\/commons\\/9\\/94\\/Pfizer_World_Headquarters_Entrance.jpg\",\"headline\":\"American multinational pharmaceutical corporation\"}</script>\n<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({\"wgBackendResponseTime\":205,\"wgHostname\":\"mw1354\"});});</script>\n</body>\n</html>","oembed":false,"readabilityObject":{"title":"Pfizer","content":"<div id=\"readability-page-1\" class=\"page\"><div id=\"mw-content-text\" lang=\"en\" dir=\"ltr\">\n\n<p>\n\n<span><span id=\"coordinates\"><a href=\"/wiki/Geographic_coordinate_system\" title=\"Geographic coordinate system\">Coordinates</a>: <span><a href=\"//geohack.toolforge.org/geohack.php?pagename=Pfizer&amp;params=40_45_01_N_73_58_21_W_\"><span><span title=\"Maps, aerial photos, and other data for this location\"><span>40°45′01″N</span> <span>73°58′21″W</span></span></span><span>﻿ / ﻿</span><span><span title=\"Maps, aerial photos, and other data for this location\">40.75028°N 73.97250°W</span></span></a></span></span></span>\n</p>\n<table><caption>Pfizer Inc.</caption><tbody><tr><td colspan=\"2\"><a href=\"/wiki/File:Pfizer_(2021).svg\"><img alt=\"Pfizer (2021).svg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/57/Pfizer_%282021%29.svg/220px-Pfizer_%282021%29.svg.png\" decoding=\"async\" width=\"220\" height=\"90\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/57/Pfizer_%282021%29.svg/330px-Pfizer_%282021%29.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/57/Pfizer_%282021%29.svg/440px-Pfizer_%282021%29.svg.png 2x\" data-file-width=\"1000\" data-file-height=\"409\"></a></td></tr><tr><td colspan=\"2\"><a href=\"/wiki/File:Pfizer_World_Headquarters_Entrance.jpg\"><img alt=\"Pfizer World Headquarters Entrance.jpg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/94/Pfizer_World_Headquarters_Entrance.jpg/250px-Pfizer_World_Headquarters_Entrance.jpg\" decoding=\"async\" width=\"250\" height=\"170\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/94/Pfizer_World_Headquarters_Entrance.jpg/375px-Pfizer_World_Headquarters_Entrance.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/94/Pfizer_World_Headquarters_Entrance.jpg/500px-Pfizer_World_Headquarters_Entrance.jpg 2x\" data-file-width=\"4908\" data-file-height=\"3330\"></a><div><p>Pfizer <a href=\"/wiki/Headquarters\" title=\"Headquarters\">headquarters</a> on <a href=\"/wiki/42nd_Street_(Manhattan)\" title=\"42nd Street (Manhattan)\">42nd Street</a> in Midtown Manhattan</p></div></td></tr><tr><th scope=\"row\">Type</th><td><a href=\"/wiki/Public_company\" title=\"Public company\">Public</a></td></tr><tr><th scope=\"row\"><div><p><a href=\"/wiki/Ticker_symbol\" title=\"Ticker symbol\">Traded as</a></p></div></th><td><div><ul><li><a href=\"/wiki/New_York_Stock_Exchange\" title=\"New York Stock Exchange\">NYSE</a>:&nbsp;<a rel=\"nofollow\" href=\"https://www.nyse.com/quote/XNYS:PFE\">PFE</a></li><li><a href=\"/wiki/S%26P_100\" title=\"S&amp;P 100\">S&amp;P 100</a> component</li><li><a href=\"/wiki/S%26P_500\" title=\"S&amp;P 500\">S&amp;P 500</a> component</li><li><a href=\"/wiki/Russell_1000_Index\" title=\"Russell 1000 Index\">Russell 1000 Index</a> component</li></ul></div></td></tr><tr><th scope=\"row\">Industry</th><td><div><ul><li><a href=\"/wiki/Pharmaceutical_industry\" title=\"Pharmaceutical industry\">Pharmaceutical</a></li><li><a href=\"/wiki/Biotechnology\" title=\"Biotechnology\">Biotechnology</a></li></ul></div></td></tr><tr><th scope=\"row\">Founded</th><td>1849<span>; 173&nbsp;years ago</span> in New York City</td></tr><tr><th scope=\"row\">Founders</th><td><div><ul><li><a href=\"/wiki/Charles_Pfizer\" title=\"Charles Pfizer\">Charles Pfizer</a></li><li><a href=\"/wiki/Charles_F._Erhart\" title=\"Charles F. Erhart\">Charles F. Erhart</a></li></ul></div></td></tr><tr><th scope=\"row\">Headquarters</th><td>235 East 42nd Street, <p>New York City</p>, <p>U.S.</p></td></tr><tr><th scope=\"row\"><p>Area served</p></th><td>Worldwide</td></tr><tr><th scope=\"row\"><p>Key people</p></th><td><a href=\"/wiki/Albert_Bourla\" title=\"Albert Bourla\">Albert Bourla</a>, <a href=\"/wiki/CEO\" title=\"CEO\">CEO</a><br>Frank A. D’Amelio, <a href=\"/wiki/CFO\" title=\"CFO\">CFO</a><br><a href=\"/wiki/Scott_Gottlieb\" title=\"Scott Gottlieb\">Scott Gottlieb</a>, Director<br><a href=\"/wiki/Helen_Hobbs\" title=\"Helen Hobbs\">Helen Hobbs</a>, Director<br><a href=\"/wiki/Susan_Hockfield\" title=\"Susan Hockfield\">Susan Hockfield</a>, Director<br><a href=\"/wiki/Dan_Littman\" title=\"Dan Littman\">Dan Littman</a>, Director<br><a href=\"/wiki/Shantanu_Narayen\" title=\"Shantanu Narayen\">Shantanu Narayen</a>, Director<br><a href=\"/wiki/Suzanne_Nora_Johnson\" title=\"Suzanne Nora Johnson\">Suzanne Nora Johnson</a>, Director<br><a href=\"/wiki/James_Quincey\" title=\"James Quincey\">James Quincey</a>, Director<br><a href=\"/wiki/Jim_Smith_(business_executive)\" title=\"Jim Smith (business executive)\">Jim Smith</a>, Director</td></tr><tr><th scope=\"row\">Products</th><td><div><ul><li><a href=\"/wiki/Pharmaceutical\" title=\"Pharmaceutical\">Pharmaceuticals</a></li><li><a href=\"/wiki/Vaccine\" title=\"Vaccine\">vaccines</a></li></ul></div></td></tr><tr><th scope=\"row\">Revenue</th><td><img alt=\"Increase\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png\" decoding=\"async\" title=\"Increase\" width=\"11\" height=\"11\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x\" data-file-width=\"300\" data-file-height=\"300\"> $41.908 billion&nbsp;(2020)</td></tr><tr><th scope=\"row\"><div><p><a href=\"/wiki/Earnings_before_interest_and_taxes\" title=\"Earnings before interest and taxes\">Operating income</a></p></div></th><td><img alt=\"Decrease\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/11px-Decrease2.svg.png\" decoding=\"async\" title=\"Decrease\" width=\"11\" height=\"11\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/17px-Decrease2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/22px-Decrease2.svg.png 2x\" data-file-width=\"300\" data-file-height=\"300\"> $7.497 billion&nbsp;(2020)</td></tr><tr><th scope=\"row\"><div><p><a href=\"/wiki/Net_income\" title=\"Net income\">Net income</a></p></div></th><td><img alt=\"Decrease\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/11px-Decrease2.svg.png\" decoding=\"async\" title=\"Decrease\" width=\"11\" height=\"11\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/17px-Decrease2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/22px-Decrease2.svg.png 2x\" data-file-width=\"300\" data-file-height=\"300\"> $9.616 billion&nbsp;(2020)</td></tr><tr><th scope=\"row\"><span><a href=\"/wiki/Asset\" title=\"Asset\">Total assets</a></span></th><td><img alt=\"Decrease\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/11px-Decrease2.svg.png\" decoding=\"async\" title=\"Decrease\" width=\"11\" height=\"11\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/17px-Decrease2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/22px-Decrease2.svg.png 2x\" data-file-width=\"300\" data-file-height=\"300\"> $154.229 billion&nbsp;(2020)</td></tr><tr><th scope=\"row\"><span><a href=\"/wiki/Equity_(finance)\" title=\"Equity (finance)\">Total equity</a></span></th><td><img alt=\"Increase\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png\" decoding=\"async\" title=\"Increase\" width=\"11\" height=\"11\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x\" data-file-width=\"300\" data-file-height=\"300\"> $63.473 billion&nbsp;(2020)</td></tr><tr><th scope=\"row\"><p>Number of employees</p></th><td>78,500&nbsp;(2020)</td></tr><tr><th scope=\"row\">Website</th><td><span><a rel=\"nofollow\" href=\"https://www.pfizer.com/\">www<wbr>.pfizer<wbr>.com</a></span> <a href=\"https://www.wikidata.org/wiki/Q206921#P856\" title=\"Edit this at Wikidata\"><img alt=\"Edit this at Wikidata\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png\" decoding=\"async\" width=\"10\" height=\"10\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x\" data-file-width=\"20\" data-file-height=\"20\"></a></td></tr><tr><td colspan=\"2\"><b>Footnotes&nbsp;/ references</b><br><sup id=\"cite_ref-10K_1-0\"><a href=\"#cite_note-10K-1\">[1]</a></sup></td></tr></tbody></table>\n<div><p><a href=\"/wiki/File:Shinjuku_Bunka_Quint_Building.jpg\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/36/Shinjuku_Bunka_Quint_Building.jpg/170px-Shinjuku_Bunka_Quint_Building.jpg\" decoding=\"async\" width=\"170\" height=\"227\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/36/Shinjuku_Bunka_Quint_Building.jpg/255px-Shinjuku_Bunka_Quint_Building.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/36/Shinjuku_Bunka_Quint_Building.jpg/340px-Shinjuku_Bunka_Quint_Building.jpg 2x\" data-file-width=\"600\" data-file-height=\"800\"></a></p><div><p>The headquarters of Pfizer In Tokyo, Japan</p></div></div>\n<p><b>Pfizer Inc.</b> ( <a href=\"/wiki/Help:Pronunciation_respelling_key\" title=\"Help:Pronunciation respelling key\"><i title=\"English pronunciation respelling\"><span>FY</span>-zər</i></a>)<sup id=\"cite_ref-2\"><a href=\"#cite_note-2\">[2]</a></sup> is an American <a href=\"/wiki/Multinational_corporation\" title=\"Multinational corporation\">multinational</a> <a href=\"/wiki/Pharmaceutical_industry\" title=\"Pharmaceutical industry\">pharmaceutical</a> and <a href=\"/wiki/Biotechnology\" title=\"Biotechnology\">biotechnology</a> corporation headquartered on <a href=\"/wiki/42nd_Street_(Manhattan)\" title=\"42nd Street (Manhattan)\">42nd Street</a> in <a href=\"/wiki/Manhattan\" title=\"Manhattan\">Manhattan, New York City</a>. The company was established in 1849 in New York by two German immigrants, <a href=\"/wiki/Charles_Pfizer\" title=\"Charles Pfizer\">Charles Pfizer</a> (1824–1906) and his cousin <a href=\"/wiki/Charles_F._Erhart\" title=\"Charles F. Erhart\">Charles F. Erhart</a> (1821–1891).\n</p><p>Pfizer develops and produces <a href=\"/wiki/Medicine\" title=\"Medicine\">medicines</a> and <a href=\"/wiki/Vaccine\" title=\"Vaccine\">vaccines</a> for <a href=\"/wiki/Immunology\" title=\"Immunology\">immunology</a>, <a href=\"/wiki/Oncology\" title=\"Oncology\">oncology</a>, <a href=\"/wiki/Cardiology\" title=\"Cardiology\">cardiology</a>, <a href=\"/wiki/Endocrinology\" title=\"Endocrinology\">endocrinology</a>, and <a href=\"/wiki/Neurology\" title=\"Neurology\">neurology</a>. The company has several <a href=\"/wiki/Medication#Blockbuster_drug\" title=\"Medication\">blockbuster drugs</a> or products that each generate more than <span>US$1</span><span>&nbsp;</span>billion in annual revenues.<sup id=\"cite_ref-10K_1-1\"><a href=\"#cite_note-10K-1\">[1]</a></sup> In 2020, 52% of the company's revenues came from the United States, 6% came from each of China and Japan, and 36% came from other countries.<sup id=\"cite_ref-10K_1-2\"><a href=\"#cite_note-10K-1\">[1]</a></sup>\n</p><p>Pfizer was a component of the <a href=\"/wiki/Dow_Jones_Industrial_Average\" title=\"Dow Jones Industrial Average\">Dow Jones Industrial Average</a> <a href=\"/wiki/Stock_market_index\" title=\"Stock market index\">stock market index</a> from 2004 to August 2020.<sup id=\"cite_ref-3\"><a href=\"#cite_note-3\">[3]</a></sup><sup id=\"cite_ref-4\"><a href=\"#cite_note-4\">[4]</a></sup><sup id=\"cite_ref-5\"><a href=\"#cite_note-5\">[5]</a></sup><sup id=\"cite_ref-6\"><a href=\"#cite_note-6\">[6]</a></sup> The company ranks 64th on the <a href=\"/wiki/Fortune_500\" title=\"Fortune 500\">Fortune 500</a><sup id=\"cite_ref-7\"><a href=\"#cite_note-7\">[7]</a></sup> and 49th on the <a href=\"/wiki/Forbes_Global_2000\" title=\"Forbes Global 2000\">Forbes Global 2000</a>.<sup id=\"cite_ref-8\"><a href=\"#cite_note-8\">[8]</a></sup>\n</p>\n\n\n<h2><span id=\"History\">History</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=1\" title=\"Edit section: History\">edit</a><span>]</span></span></h2>\n<div><p><a href=\"/wiki/File:Charlespfizer.jpg\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/30/Charlespfizer.jpg/170px-Charlespfizer.jpg\" decoding=\"async\" width=\"170\" height=\"220\" srcset=\"//upload.wikimedia.org/wikipedia/commons/3/30/Charlespfizer.jpg 1.5x\" data-file-width=\"190\" data-file-height=\"246\"></a></p><div><p>Charles Pfizer (1824–1906)</p></div></div>\n<h3><span id=\"1849.E2.80.931950:_Early_history\"></span><span id=\"1849–1950:_Early_history\">1849–1950: Early history</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=2\" title=\"Edit section: 1849–1950: Early history\">edit</a><span>]</span></span></h3>\n<p>Pfizer was founded in 1849 by <a href=\"/wiki/Charles_Pfizer\" title=\"Charles Pfizer\">Charles Pfizer</a> and <a href=\"/wiki/Charles_F._Erhart\" title=\"Charles F. Erhart\">Charles F. Erhart</a>, two cousins who had immigrated to the United States from <a href=\"/wiki/Ludwigsburg\" title=\"Ludwigsburg\">Ludwigsburg, Germany</a>, the year before. The business produced chemical compounds, and was headquartered on Bartlett Street<sup id=\"cite_ref-Citycyclopedia_9-0\"><a href=\"#cite_note-Citycyclopedia-9\">[9]</a></sup> in <a href=\"/wiki/Williamsburg,_Brooklyn\" title=\"Williamsburg, Brooklyn\">Williamsburgh, New York</a>, where they produced an <a href=\"/wiki/Antiparasitic\" title=\"Antiparasitic\">antiparasitic</a> called <a href=\"/wiki/Santonin\" title=\"Santonin\">santonin</a>. This was an immediate success, although it was production of <a href=\"/wiki/Citric_acid\" title=\"Citric acid\">citric acid</a> that led to Pfizer's growth in the 1880s. Pfizer continued to buy property in the area (by now the Williamsburg district of the city of <a href=\"/wiki/Brooklyn,_New_York\" title=\"Brooklyn, New York\">Brooklyn, New York</a> and, beginning in 1898, the <a href=\"/wiki/City_of_Greater_New_York\" title=\"City of Greater New York\">City of Greater New York</a>) to expand its lab and factory, retaining offices on Flushing Avenue until the 1960s; the Brooklyn plant ultimately closed in 2009.<sup id=\"cite_ref-10\"><a href=\"#cite_note-10\">[10]</a></sup> Following the success of citric acid, Pfizer (at the now-demolished 295 Washington Avenue) and Erhart (at 280 Washington Avenue) established their main residences in the nearby <a href=\"/wiki/Clinton_Hill,_Brooklyn\" title=\"Clinton Hill, Brooklyn\">Clinton Hill</a> district, known for its concentration of <a href=\"/wiki/Gilded_Age\" title=\"Gilded Age\">Gilded Age</a> wealth. Pfizer spent summers in similarly exclusive <a href=\"/wiki/Newport,_Rhode_Island\" title=\"Newport, Rhode Island\">Newport, Rhode Island</a>, where he died in 1906.\n</p><p>In 1881, Pfizer moved its administrative headquarters to 81 Maiden Lane in <a href=\"/wiki/Manhattan\" title=\"Manhattan\">Manhattan</a>, presaging the company's expansion to <a href=\"/wiki/Chicago,_Illinois\" title=\"Chicago, Illinois\">Chicago, Illinois</a> a year later.<sup id=\"cite_ref-Citycyclopedia_9-1\"><a href=\"#cite_note-Citycyclopedia-9\">[9]</a></sup><sup id=\"cite_ref-collection_11-0\"><a href=\"#cite_note-collection-11\">[11]</a></sup> By 1906, sales exceeded $3<span>&nbsp;</span>million.<sup id=\"cite_ref-history_12-0\"><a href=\"#cite_note-history-12\">[12]</a></sup>\n</p><p><a href=\"/wiki/World_War_I\" title=\"World War I\">World War I</a> caused a shortage of <a href=\"/wiki/Calcium_citrate\" title=\"Calcium citrate\">calcium citrate</a>, which Pfizer imported from Italy for the manufacture of citric acid, and the company began a search for an alternative supply. Pfizer chemists learned of a fungus that ferments sugar to citric acid, and they were able to commercialize production of citric acid from this source in 1919. The company developed expertise in fermentation technology as a result. These skills were applied to the mass production of <a href=\"/wiki/Penicillin\" title=\"Penicillin\">penicillin</a>, an <a href=\"/wiki/Antibiotic\" title=\"Antibiotic\">antibiotic</a>, during <a href=\"/wiki/World_War_II\" title=\"World War II\">World War II</a> in response to the need to treat injured Allied soldiers.<sup id=\"cite_ref-Fermentation_13-0\"><a href=\"#cite_note-Fermentation-13\">[13]</a></sup>\n</p><p>On June 2, 1942, the company incorporated in <a href=\"/wiki/Delaware\" title=\"Delaware\">Delaware</a>.<sup id=\"cite_ref-10K_1-3\"><a href=\"#cite_note-10K-1\">[1]</a></sup>\n</p>\n<h3><span id=\"1950.E2.80.931980:_Pivot_to_pharmaceutical_research_and_global_expansion\"></span><span id=\"1950–1980:_Pivot_to_pharmaceutical_research_and_global_expansion\">1950–1980: Pivot to pharmaceutical research and global expansion</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=3\" title=\"Edit section: 1950–1980: Pivot to pharmaceutical research and global expansion\">edit</a><span>]</span></span></h3>\n<p>Due to price declines for <a href=\"/wiki/Penicillin\" title=\"Penicillin\">penicillin</a>, Pfizer searched for new antibiotics with greater profit potential. Pfizer discovered <a href=\"/wiki/Oxytetracycline\" title=\"Oxytetracycline\">oxytetracycline</a> in 1950, and this changed the company from a manufacturer of <a href=\"/wiki/Fine_chemical\" title=\"Fine chemical\">fine chemicals</a> to a research-based pharmaceutical company. Pfizer developed a <a href=\"/wiki/Drug_discovery\" title=\"Drug discovery\">drug discovery</a> program focused on in vitro synthesis to augment its research in fermentation technology. In 1959, the company established an <a href=\"/wiki/Animal_health\" title=\"Animal health\">animal health</a> division with a 700-acre (2.8&nbsp;km<sup>2</sup>) farm and research facility in <a href=\"/wiki/Terre_Haute,_Indiana\" title=\"Terre Haute, Indiana\">Terre Haute, Indiana</a>.<sup id=\"cite_ref-Fermentation_13-1\"><a href=\"#cite_note-Fermentation-13\">[13]</a></sup>\n</p><p>By the 1950s, Pfizer had established offices in <a href=\"/wiki/Belgium\" title=\"Belgium\">Belgium</a>, <a href=\"/wiki/Brazil\" title=\"Brazil\">Brazil</a>, <a href=\"/wiki/Canada\" title=\"Canada\">Canada</a>, <a href=\"/wiki/Cuba\" title=\"Cuba\">Cuba</a>, <a href=\"/wiki/Mexico\" title=\"Mexico\">Mexico</a>, <a href=\"/wiki/Panama\" title=\"Panama\">Panama</a>, <a href=\"/wiki/Puerto_Rico\" title=\"Puerto Rico\">Puerto Rico</a>, and the <a href=\"/wiki/United_Kingdom\" title=\"United Kingdom\">United Kingdom</a>. In 1960, the company moved its medical research laboratory operations out of <a href=\"/wiki/New_York_City\" title=\"New York City\">New York City</a> to a new facility in <a href=\"/wiki/Groton,_Connecticut\" title=\"Groton, Connecticut\">Groton, Connecticut</a>. In 1980, Pfizer launched <i>Feldene</i> (<a href=\"/wiki/Piroxicam\" title=\"Piroxicam\">piroxicam</a>), a prescription anti-inflammatory medication that became Pfizer's first product to reach $1<span>&nbsp;</span>billion in revenue.<sup id=\"cite_ref-history_12-1\"><a href=\"#cite_note-history-12\">[12]</a></sup>\n</p><p>In 1965, John Powers, Jr. became <a href=\"/wiki/Chief_executive_officer\" title=\"Chief executive officer\">chief executive officer</a> of the company, succeeding John McKeen.<sup id=\"cite_ref-history_12-2\"><a href=\"#cite_note-history-12\">[12]</a></sup>\n</p><p>As the area surrounding its <a href=\"/wiki/Brooklyn\" title=\"Brooklyn\">Brooklyn</a> plant fell into decline in the 1970s and 1980s, the company formed a public-private partnership with New York City that encompassed the construction of low- and middle-income housing, the refurbishment of apartment buildings for the homeless and the establishment of a <a href=\"/wiki/Charter_school\" title=\"Charter school\">charter school</a>.<sup id=\"cite_ref-collection_11-1\"><a href=\"#cite_note-collection-11\">[11]</a></sup>\n</p><p>In 1972, <a href=\"/wiki/Edmund_T._Pratt_Jr.\" title=\"Edmund T. Pratt Jr.\">Edmund T. Pratt Jr.</a> became <a href=\"/wiki/Chief_executive_officer\" title=\"Chief executive officer\">chief executive officer</a> of the company, succeeding John Powers, Jr.<sup id=\"cite_ref-history_12-3\"><a href=\"#cite_note-history-12\">[12]</a></sup>\n</p>\n<h3><span id=\"1980.E2.80.932000:_Development_of_Viagra.2C_Zoloft.2C_and_Lipitor\"></span><span id=\"1980–2000:_Development_of_Viagra,_Zoloft,_and_Lipitor\">1980–2000: Development of Viagra, Zoloft, and Lipitor</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=4\" title=\"Edit section: 1980–2000: Development of Viagra, Zoloft, and Lipitor\">edit</a><span>]</span></span></h3>\n<p>In 1981, the company received approval for <i>Diflucan</i> (<a href=\"/wiki/Fluconazole\" title=\"Fluconazole\">fluconazole</a>), the first oral treatment for severe <a href=\"/wiki/Fungal_infection\" title=\"Fungal infection\">fungal infections</a> including <a href=\"/wiki/Candidiasis\" title=\"Candidiasis\">candidiasis</a>, <a href=\"/wiki/Blastomycosis\" title=\"Blastomycosis\">blastomycosis</a>, <a href=\"/wiki/Coccidiodomycosis\" title=\"Coccidiodomycosis\">coccidiodomycosis</a>, <a href=\"/wiki/Cryptococcosis\" title=\"Cryptococcosis\">cryptococcosis</a>, <a href=\"/wiki/Histoplasmosis\" title=\"Histoplasmosis\">histoplasmosis</a>, <a href=\"/wiki/Dermatophytosis\" title=\"Dermatophytosis\">dermatophytosis</a>, and <a href=\"/wiki/Pityriasis_versicolor\" title=\"Pityriasis versicolor\">pityriasis versicolor</a>.<sup id=\"cite_ref-14\"><a href=\"#cite_note-14\">[14]</a></sup>\n</p><p>In 1986, Pfizer acquired the worldwide rights to <i>Zithromax</i> (<a href=\"/wiki/Azithromycin\" title=\"Azithromycin\">azithromycin</a>), a macrolide antibiotic that is recommended by the <a href=\"/wiki/Infectious_Disease_Society_of_America\" title=\"Infectious Disease Society of America\">Infectious Disease Society of America</a> as a first line treatment for certain cases of community-acquired pneumonia, from <a href=\"/wiki/Pliva\" title=\"Pliva\">Pliva</a>.<sup id=\"cite_ref-best_15-0\"><a href=\"#cite_note-best-15\">[15]</a></sup><sup id=\"cite_ref-16\"><a href=\"#cite_note-16\">[16]</a></sup>\n</p><p>In 1989, Pfizer scientists Peter Dunn and Albert Wood created <i>Viagra</i> (<a href=\"/wiki/Sildenafil\" title=\"Sildenafil\">sildenafil</a>) for treating <a href=\"/wiki/High_blood_pressure\" title=\"High blood pressure\">high blood pressure</a> and <a href=\"/wiki/Angina\" title=\"Angina\">angina</a>, a chest pain associated with <a href=\"/wiki/Coronary_artery_disease\" title=\"Coronary artery disease\">coronary artery disease</a>. In 1991, it was patented in the United Kingdom as a heart medication. Early trials for the medication showed that it did not work for the treatment of heart disease, but volunteers in the clinical trials had increased <a href=\"/wiki/Erection\" title=\"Erection\">erections</a> several days after taking the drug. It was patented in the United States in 1996 and received approval by the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> in March 1998. In December 1998, Pfizer hired <a href=\"/wiki/Bob_Dole\" title=\"Bob Dole\">Bob Dole</a> as a spokesperson for the drug.<sup id=\"cite_ref-17\"><a href=\"#cite_note-17\">[17]</a></sup> The patents for Viagra expired in 2020.<sup id=\"cite_ref-18\"><a href=\"#cite_note-18\">[18]</a></sup>\n</p><p>In 1991, <a href=\"/wiki/William_C._Steere,_Jr.\" title=\"William C. Steere, Jr.\">William C. Steere, Jr.</a> became <a href=\"/wiki/Chief_executive_officer\" title=\"Chief executive officer\">chief executive officer</a> of the company, succeeding <a href=\"/wiki/Edmund_T._Pratt_Jr.\" title=\"Edmund T. Pratt Jr.\">Edmund T. Pratt Jr.</a><sup id=\"cite_ref-19\"><a href=\"#cite_note-19\">[19]</a></sup>\n</p><p>In 1991 Pfizer also began marketing <i>Zoloft</i> (<a href=\"/wiki/Sertraline\" title=\"Sertraline\">sertraline</a>), an <a href=\"/wiki/Antidepressant\" title=\"Antidepressant\">antidepressant</a> of the <a href=\"/wiki/Selective_serotonin_reuptake_inhibitor\" title=\"Selective serotonin reuptake inhibitor\">selective serotonin reuptake inhibitor</a> (SSRI) class developed nine years earlier by Pfizer chemists <a href=\"/wiki/Kenneth_Koe\" title=\"Kenneth Koe\">Kenneth Koe</a> and Willard Welch. Sertraline is primarily prescribed for <a href=\"/wiki/Major_depressive_disorder\" title=\"Major depressive disorder\">major depressive disorder</a> in adult <a href=\"/wiki/Outpatients\" title=\"Outpatients\">outpatients</a> as well as <a href=\"/wiki/Obsessive-compulsive_disorder\" title=\"Obsessive-compulsive disorder\">obsessive-compulsive disorder</a>, <a href=\"/wiki/Panic_disorder\" title=\"Panic disorder\">panic disorder</a>, and <a href=\"/wiki/Social_anxiety_disorder\" title=\"Social anxiety disorder\">social anxiety disorder</a> in both adults and children. In 2005, the year before it became a generic drug, sales were over $3<span>&nbsp;</span>billion and over 100<span>&nbsp;</span>million people had been treated with the drug.<sup id=\"cite_ref-20\"><a href=\"#cite_note-20\">[20]</a></sup> The patent for Zoloft expired in the summer of 2006.<sup id=\"cite_ref-21\"><a href=\"#cite_note-21\">[21]</a></sup>\n</p><p>In 1996, <a href=\"/wiki/Eisai_(company)\" title=\"Eisai (company)\">Eisai</a>, in partnership with Pfizer, received <a href=\"/wiki/Approved_drug\" title=\"Approved drug\">approval</a> from the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> for <a href=\"/wiki/Donepezil\" title=\"Donepezil\">donepezil</a> under the brand Aricept for treatment of <a href=\"/wiki/Alzheimer%27s_disease\" title=\"Alzheimer's disease\">Alzheimer's disease</a>;<sup id=\"cite_ref-22\"><a href=\"#cite_note-22\">[22]</a></sup> Pfizer also received approval for <i>Norvasc</i> (<a href=\"/wiki/Amlodipine\" title=\"Amlodipine\">amlodipine</a>), an <a href=\"/wiki/Antihypertensive\" title=\"Antihypertensive\">antihypertensive</a> drug of the dihydropyridine calcium channel blocker class.<sup id=\"cite_ref-23\"><a href=\"#cite_note-23\">[23]</a></sup>\n</p>\n<div><p><a href=\"/wiki/File:Zoloft_bottles.jpg\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/48/Zoloft_bottles.jpg/220px-Zoloft_bottles.jpg\" decoding=\"async\" width=\"220\" height=\"196\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/48/Zoloft_bottles.jpg/330px-Zoloft_bottles.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/48/Zoloft_bottles.jpg/440px-Zoloft_bottles.jpg 2x\" data-file-width=\"1223\" data-file-height=\"1088\"></a></p></div>\n<p>In 1997, the company entered into a co-marketing agreement with <a href=\"/wiki/Warner%E2%80%93Lambert\" title=\"Warner–Lambert\">Warner–Lambert</a> for <i>Lipitor</i> (<a href=\"/wiki/Atorvastatin\" title=\"Atorvastatin\">atorvastatin</a>), a <a href=\"/wiki/Statin\" title=\"Statin\">statin</a> for the treatment of <a href=\"/wiki/Hypercholesterolemia\" title=\"Hypercholesterolemia\">hypercholesterolemia</a>. Although atorvastatin was the fifth <a href=\"/wiki/Statin\" title=\"Statin\">statin</a> to be developed, clinical trials showed that atorvastatin caused a more dramatic reduction in <a href=\"/wiki/Low-density_lipoprotein\" title=\"Low-density lipoprotein\">low-density lipoprotein</a> pattern C (LDL-C) than the other statin drugs. Upon its patent expiration in 2011, Lipitor was the best-selling drug ever, with approximately $125<span>&nbsp;</span>billion in sales over 14.5 years.<sup id=\"cite_ref-24\"><a href=\"#cite_note-24\">[24]</a></sup>\n</p>\n<h3><span id=\"2000.E2.80.932010:_Further_expansion\"></span><span id=\"2000–2010:_Further_expansion\">2000–2010: Further expansion</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=5\" title=\"Edit section: 2000–2010: Further expansion\">edit</a><span>]</span></span></h3>\n<p>In 2001, <a href=\"/wiki/Henry_McKinnell\" title=\"Henry McKinnell\">Henry McKinnell</a> became <a href=\"/wiki/Chief_executive_officer\" title=\"Chief executive officer\">chief executive officer</a> of the company, replacing <a href=\"/wiki/William_C._Steere,_Jr.\" title=\"William C. Steere, Jr.\">William C. Steere, Jr.</a><sup id=\"cite_ref-longshot_25-0\"><a href=\"#cite_note-longshot-25\">[25]</a></sup>\n</p><p>In 2004, the company received approval for <i>Lyrica</i> (<a href=\"/wiki/Pregabalin\" title=\"Pregabalin\">pregabalin</a>), an <a href=\"/wiki/Anticonvulsant\" title=\"Anticonvulsant\">anticonvulsant</a> and <a href=\"/wiki/Anxiolytic\" title=\"Anxiolytic\">anxiolytic</a> medication used to treat <a href=\"/wiki/Epilepsy\" title=\"Epilepsy\">epilepsy</a>, <a href=\"/wiki/Neuropathic_pain\" title=\"Neuropathic pain\">neuropathic pain</a>, <a href=\"/wiki/Fibromyalgia\" title=\"Fibromyalgia\">fibromyalgia</a>, <a href=\"/wiki/Restless_leg_syndrome\" title=\"Restless leg syndrome\">restless leg syndrome</a>, and <a href=\"/wiki/Generalized_anxiety_disorder\" title=\"Generalized anxiety disorder\">generalized anxiety disorder</a>.<sup id=\"cite_ref-26\"><a href=\"#cite_note-26\">[26]</a></sup><sup id=\"cite_ref-27\"><a href=\"#cite_note-27\">[27]</a></sup><sup id=\"cite_ref-28\"><a href=\"#cite_note-28\">[28]</a></sup> The United States patent on Lyrica was challenged by generic manufacturers and was upheld in 2014, extending the expiration date to 2018.<sup id=\"cite_ref-29\"><a href=\"#cite_note-29\">[29]</a></sup> In 2016, the drug had sales of $4.2 billion.<sup id=\"cite_ref-30\"><a href=\"#cite_note-30\">[30]</a></sup>\n</p><p>In July 2006, <a href=\"/wiki/Jeff_Kindler\" title=\"Jeff Kindler\">Jeff Kindler</a> was named <a href=\"/wiki/Chief_executive_officer\" title=\"Chief executive officer\">chief executive officer</a> of the company, replacing <a href=\"/wiki/Henry_McKinnell\" title=\"Henry McKinnell\">Henry McKinnell</a>.<sup id=\"cite_ref-longshot_25-1\"><a href=\"#cite_note-longshot-25\">[25]</a></sup><sup id=\"cite_ref-31\"><a href=\"#cite_note-31\">[31]</a></sup>\n</p><p>On December 3, 2006, Pfizer ceased development of <a href=\"/wiki/Torcetrapib\" title=\"Torcetrapib\">torcetrapib</a>, a drug that increases production of <a href=\"/wiki/High_density_lipoprotein\" title=\"High density lipoprotein\">HDL</a>, or \"good cholesterol\", which reduces <a href=\"/wiki/Low_density_lipoprotein\" title=\"Low density lipoprotein\">LDL</a> thought to be correlated to heart disease. During a <a href=\"/wiki/Phase_III_clinical_trial\" title=\"Phase III clinical trial\">Phase III clinical trial</a> involving 15,000 patients, more deaths than expected occurred in the group that took the medicine, and the <a href=\"/wiki/Mortality_rate\" title=\"Mortality rate\">mortality rate</a> of patients taking the combination of torcetrapib and Lipitor (82 deaths during the study) was 60% higher than those taking Lipitor alone (52 deaths during the study). Lipitor alone was not implicated in the results, but Pfizer lost nearly $1<span>&nbsp;</span>billion developing the failed drug and its stock price dropped 11% on the day of the announcement.<sup id=\"cite_ref-32\"><a href=\"#cite_note-32\">[32]</a></sup><sup id=\"cite_ref-33\"><a href=\"#cite_note-33\">[33]</a></sup><sup id=\"cite_ref-34\"><a href=\"#cite_note-34\">[34]</a></sup><sup id=\"cite_ref-35\"><a href=\"#cite_note-35\">[35]</a></sup>\n</p><p>Between 2007 and 2010, Pfizer spent $3.3<span>&nbsp;</span>million on investigations and legal fees and recovered about $5.1<span>&nbsp;</span>million, and had another $5<span>&nbsp;</span>million of pending recoveries from civil lawsuits against makers of <a href=\"/wiki/Counterfeit\" title=\"Counterfeit\">counterfeit</a> prescription drugs. Pfizer has hired customs and narcotics experts worldwide to track down fakes and assemble evidence that can be used to pursue civil suits for <a href=\"/wiki/Trademark_infringement\" title=\"Trademark infringement\">trademark infringement</a>.<sup id=\"cite_ref-36\"><a href=\"#cite_note-36\">[36]</a></sup>\n</p><p>In July 2008, Pfizer announced 275 job cuts at its manufacturing facility in <a href=\"/wiki/Kalamazoo,_Michigan\" title=\"Kalamazoo, Michigan\">Kalamazoo, Michigan</a>. Kalamazoo was previously the world headquarters of <a href=\"/wiki/Upjohn_Company\" title=\"Upjohn Company\">Upjohn Company</a>, which had been acquired as part of Pharmacia.<sup id=\"cite_ref-37\"><a href=\"#cite_note-37\">[37]</a></sup><sup id=\"cite_ref-:0_38-0\"><a href=\"#cite_note-:0-38\">[38]</a></sup>\n</p>\n<h4><span id=\"Acquisitions_and_mergers\">Acquisitions and mergers</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=6\" title=\"Edit section: Acquisitions and mergers\">edit</a><span>]</span></span></h4>\n<p>In June 2000, Pfizer acquired Warner-Lambert outright for $116<span>&nbsp;</span>billion. To satisfy conditions imposed by antitrust regulators at the <a href=\"/wiki/Federal_Trade_Commission\" title=\"Federal Trade Commission\">Federal Trade Commission</a>, Pfizer sold off or transferred stakes in several minor products, including RID (a shampoo for treatment of <a href=\"/wiki/Head_lice_infestation\" title=\"Head lice infestation\">head lice</a>, sold to <a href=\"/wiki/Bayer\" title=\"Bayer\">Bayer</a>) and Warner-Lambert's antidepressant <a href=\"/wiki/Celexa\" title=\"Celexa\">Celexa</a> (which competes with Zoloft).<sup id=\"cite_ref-39\"><a href=\"#cite_note-39\">[39]</a></sup> The acquisition created what was, at the time, the second-largest pharmaceutical company worldwide.<sup id=\"cite_ref-40\"><a href=\"#cite_note-40\">[40]</a></sup>\n</p><p>In 2003, Pfizer merged with <a href=\"/wiki/Pharmacia\" title=\"Pharmacia\">Pharmacia</a>, and in the process acquired <a href=\"/wiki/G.D._Searle,_LLC\" title=\"G.D. Searle, LLC\">Searle</a> and <a href=\"/wiki/SUGEN\" title=\"SUGEN\">SUGEN</a>. Searle had developed <i>Flagyl</i> (<a href=\"/wiki/Metronidazole\" title=\"Metronidazole\">metronidazole</a>), a <a href=\"/wiki/Nitroimidazole\" title=\"Nitroimidazole\">nitroimidazole</a> antibiotic medication used particularly for <a href=\"/wiki/Anaerobe\" title=\"Anaerobe\">anaerobic</a> <a href=\"/wiki/Bacterium\" title=\"Bacterium\">bacteria</a> and <a href=\"/wiki/Protozoa\" title=\"Protozoa\">protozoa</a>.<sup id=\"cite_ref-:0_38-1\"><a href=\"#cite_note-:0-38\">[38]</a></sup><sup id=\"cite_ref-41\"><a href=\"#cite_note-41\">[41]</a></sup> Searle also developed <a href=\"/wiki/Celecoxib\" title=\"Celecoxib\">celecoxib</a> (<i>Celebrex</i>) a <a href=\"/wiki/COX-2_inhibitor\" title=\"COX-2 inhibitor\">COX-2 inhibitor</a> and <a href=\"/wiki/Nonsteroidal_anti-inflammatory_drug\" title=\"Nonsteroidal anti-inflammatory drug\">nonsteroidal anti-inflammatory drug</a> (NSAID) used to treat the <a href=\"/wiki/Pain\" title=\"Pain\">pain</a> and <a href=\"/wiki/Inflammation\" title=\"Inflammation\">inflammation</a> in <a href=\"/wiki/Osteoarthritis\" title=\"Osteoarthritis\">osteoarthritis</a>, <a href=\"/wiki/Acute_pain\" title=\"Acute pain\">acute pain</a> in adults, <a href=\"/wiki/Rheumatoid_arthritis\" title=\"Rheumatoid arthritis\">rheumatoid arthritis</a>, <a href=\"/wiki/Ankylosing_spondylitis\" title=\"Ankylosing spondylitis\">ankylosing spondylitis</a>, <a href=\"/wiki/Painful_menstruation\" title=\"Painful menstruation\">painful menstruation</a>, and <a href=\"/wiki/Juvenile_rheumatoid_arthritis\" title=\"Juvenile rheumatoid arthritis\">juvenile rheumatoid arthritis</a>.<sup id=\"cite_ref-42\"><a href=\"#cite_note-42\">[42]</a></sup> <a href=\"/wiki/SUGEN\" title=\"SUGEN\">SUGEN</a>, a company focused on <a href=\"/wiki/Protein_kinase\" title=\"Protein kinase\">protein kinase</a> inhibitors, had pioneered the use of ATP-mimetic small molecules to block <a href=\"/wiki/Signal_transduction\" title=\"Signal transduction\">signal transduction</a>. The <a href=\"/wiki/SUGEN\" title=\"SUGEN\">SUGEN</a> facility was shut down in 2003 by Pfizer, with the loss of more than 300 jobs, and several programs were transferred to Pfizer. These included <a href=\"/wiki/Sunitinib\" title=\"Sunitinib\">sunitinib</a> (<i>Sutent</i>), a cancer medication which was approved for human use by the FDA in January 2006.<sup id=\"cite_ref-43\"><a href=\"#cite_note-43\">[43]</a></sup><sup id=\"cite_ref-44\"><a href=\"#cite_note-44\">[44]</a></sup> A related compound, SU11654 (<a href=\"/wiki/Toceranib\" title=\"Toceranib\">Toceranib</a>), was also approved for <a href=\"/wiki/Cancer_in_dogs\" title=\"Cancer in dogs\">cancer in dogs</a>, and the <a href=\"/wiki/ALK_inhibitor\" title=\"ALK inhibitor\">ALK inhibitor</a> <a href=\"/wiki/Crizotinib\" title=\"Crizotinib\">Crizotinib</a> also grew out of a SUGEN program.<sup id=\"cite_ref-45\"><a href=\"#cite_note-45\">[45]</a></sup><sup id=\"cite_ref-46\"><a href=\"#cite_note-46\">[46]</a></sup>\n</p><p>In October 2006, the company announced it would acquire PowerMed.<sup id=\"cite_ref-47\"><a href=\"#cite_note-47\">[47]</a></sup>\n</p><p>On October 15, 2009, Pfizer acquired <a href=\"/wiki/Wyeth\" title=\"Wyeth\">Wyeth</a> for $68<span>&nbsp;</span>billion in cash and stock, including the assumption of debt, making Pfizer the largest pharmaceutical company in the world.<sup id=\"cite_ref-48\"><a href=\"#cite_note-48\">[48]</a></sup><sup id=\"cite_ref-49\"><a href=\"#cite_note-49\">[49]</a></sup><sup id=\"cite_ref-50\"><a href=\"#cite_note-50\">[50]</a></sup><sup id=\"cite_ref-worst_51-0\"><a href=\"#cite_note-worst-51\">[51]</a></sup><sup id=\"cite_ref-wyethpr_52-0\"><a href=\"#cite_note-wyethpr-52\">[52]</a></sup> The acquisition of Wyeth provided Pfizer with a <a href=\"/wiki/Pneumococcal_conjugate_vaccine\" title=\"Pneumococcal conjugate vaccine\">pneumococcal conjugate vaccine</a>, trademarked <a href=\"/wiki/Pneumococcal_conjugate_vaccine#Prevnar\" title=\"Pneumococcal conjugate vaccine\">Prevnar 13</a>; this is used for the prevention of invasive pneumococcal infections. The introduction of the original, 7-valent version of the vaccine, developed by <a href=\"/wiki/Wyeth\" title=\"Wyeth\">Wyeth</a> in February 2000, led to a 75% reduction in the incidence of invasive pneumococcal infections among children under age<span>&nbsp;</span>5 in the United States. Pfizer introduced an improved version of the vaccine in 2010, for which it was granted a patent in India in 2017. Prevnar 13 provides coverage of 13 bacterial variants, expanding beyond the original 7-valent version.<sup id=\"cite_ref-wyethpr_52-1\"><a href=\"#cite_note-wyethpr-52\">[52]</a></sup> By 2012, the rate of invasive infections among children under age<span>&nbsp;</span>5 had been reduced by an additional 50%.<sup id=\"cite_ref-cdc.gov_53-0\"><a href=\"#cite_note-cdc.gov-53\">[53]</a></sup><sup id=\"cite_ref-54\"><a href=\"#cite_note-54\">[54]</a></sup>\n</p>\n<h3><span id=\"2010.E2.80.932020:_Further_discoveries_and_acquisitions\"></span><span id=\"2010–2020:_Further_discoveries_and_acquisitions\">2010–2020: Further discoveries and acquisitions</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=7\" title=\"Edit section: 2010–2020: Further discoveries and acquisitions\">edit</a><span>]</span></span></h3>\n<p>In 2010, <a href=\"/wiki/Ian_Read\" title=\"Ian Read\">Ian Read</a> was named <a href=\"/wiki/Chief_executive_officer\" title=\"Chief executive officer\">chief executive officer</a> of the company.<sup id=\"cite_ref-55\"><a href=\"#cite_note-55\">[55]</a></sup>\n</p><p>In February 2011, Pfizer announced the closure of its UK research and development facility (formerly also a manufacturing plant) in <a href=\"/wiki/Sandwich,_Kent\" title=\"Sandwich, Kent\">Sandwich, Kent</a>, which at the time employed 2,400 people.<sup id=\"cite_ref-56\"><a href=\"#cite_note-56\">[56]</a></sup> In March 2011, Pfizer acquired <a href=\"/wiki/King_Pharmaceuticals\" title=\"King Pharmaceuticals\">King Pharmaceuticals</a> for $3.6<span>&nbsp;</span>billion in cash. King produced emergency injectables such as the <a href=\"/wiki/EpiPen\" title=\"EpiPen\">EpiPen</a>.<sup id=\"cite_ref-57\"><a href=\"#cite_note-57\">[57]</a></sup>\n</p><p>On September 4, 2012, the FDA approved <a href=\"/wiki/Bosutinib\" title=\"Bosutinib\">bosutinib</a> (<i>Bosulif</i>) for <a href=\"/wiki/Chronic_myelogenous_leukemia\" title=\"Chronic myelogenous leukemia\">chronic myelogenous leukemia</a> (CML), a rare type of <a href=\"/wiki/Leukemia\" title=\"Leukemia\">leukemia</a> and a blood and <a href=\"/wiki/Bone_marrow\" title=\"Bone marrow\">bone marrow</a> disease that affects primarily older adults.<sup id=\"cite_ref-58\"><a href=\"#cite_note-58\">[58]</a></sup> In November 2012, Pfizer received approval from the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> for Xeljanz, a <a href=\"/wiki/Tofacitinib\" title=\"Tofacitinib\">tofacitinib</a>, for <a href=\"/wiki/Rheumatoid_arthritis\" title=\"Rheumatoid arthritis\">rheumatoid arthritis</a> and <a href=\"/wiki/Ulcerative_colitis\" title=\"Ulcerative colitis\">ulcerative colitis</a>.<sup id=\"cite_ref-59\"><a href=\"#cite_note-59\">[59]</a></sup> The drug had sales of $1.77<span>&nbsp;</span>billion in 2018, and in January 2019, it was the top drug in the United States for <a href=\"/wiki/Direct-to-consumer_advertising\" title=\"Direct-to-consumer advertising\">direct-to-consumer advertising</a>, passing <a href=\"/wiki/Adalimumab\" title=\"Adalimumab\">adalimumab</a> (<i>Humira</i>).<sup id=\"cite_ref-60\"><a href=\"#cite_note-60\">[60]</a></sup>\n</p><p>On February 1, 2013, <a href=\"/wiki/Zoetis\" title=\"Zoetis\">Zoetis</a>, the Agriculture Division of Pfizer and later Pfizer Animal Health, became a <a href=\"/wiki/Public_company\" title=\"Public company\">public company</a> via an <a href=\"/wiki/Initial_public_offering\" title=\"Initial public offering\">initial public offering</a>, raising $2.2<span>&nbsp;</span>billion.<sup id=\"cite_ref-61\"><a href=\"#cite_note-61\">[61]</a></sup><sup id=\"cite_ref-62\"><a href=\"#cite_note-62\">[62]</a></sup><sup id=\"cite_ref-63\"><a href=\"#cite_note-63\">[63]</a></sup><sup id=\"cite_ref-64\"><a href=\"#cite_note-64\">[64]</a></sup> Later in 2013, Pfizer completed the <a href=\"/wiki/Corporate_spin-off\" title=\"Corporate spin-off\">corporate spin-off</a> of its remaining stake in <a href=\"/wiki/Zoetis\" title=\"Zoetis\">Zoetis</a>.<sup id=\"cite_ref-65\"><a href=\"#cite_note-65\">[65]</a></sup><sup id=\"cite_ref-66\"><a href=\"#cite_note-66\">[66]</a></sup>\n</p><p>In September 2014, the company acquired Innopharma for $225<span>&nbsp;</span>million, plus up to $135<span>&nbsp;</span>million in milestone payments, in a deal that expanded Pfizer's range of generic and injectable drugs.<sup id=\"cite_ref-67\"><a href=\"#cite_note-67\">[67]</a></sup><sup id=\"cite_ref-68\"><a href=\"#cite_note-68\">[68]</a></sup>\n</p><p>On January 5, 2015, the company announced it would acquire a controlling interest in Redvax, expanding its vaccine portfolio targeting human <a href=\"/wiki/Cytomegalovirus\" title=\"Cytomegalovirus\">cytomegalovirus</a>.<sup id=\"cite_ref-69\"><a href=\"#cite_note-69\">[69]</a></sup> In February 2015, the company received approval from the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> for <a href=\"/wiki/Palbociclib\" title=\"Palbociclib\">palbociclib</a> (<i>Ibrance</i>) for treatment of certain types of <a href=\"/wiki/Breast_cancer\" title=\"Breast cancer\">breast cancer</a>.<sup id=\"cite_ref-70\"><a href=\"#cite_note-70\">[70]</a></sup><sup id=\"cite_ref-71\"><a href=\"#cite_note-71\">[71]</a></sup> In March 2015, the company announced it would restart its collaboration with <a href=\"/wiki/Eli_Lilly_and_Company\" title=\"Eli Lilly and Company\">Eli Lilly and Company</a> surrounding the <a href=\"/wiki/Phase_III_trial\" title=\"Phase III trial\">Phase III trial</a> of <a href=\"/wiki/Tanezumab\" title=\"Tanezumab\">Tanezumab</a>.<sup id=\"cite_ref-72\"><a href=\"#cite_note-72\">[72]</a></sup> In May 2015, Pfizer and a <a href=\"/wiki/Bar-Ilan_University\" title=\"Bar-Ilan University\">Bar-Ilan University</a> laboratory announced a partnership based on the development of medical <a href=\"/wiki/DNA_nanotechnology\" title=\"DNA nanotechnology\">DNA nanotechnology</a>.<sup id=\"cite_ref-73\"><a href=\"#cite_note-73\">[73]</a></sup> In June 2015, the company acquired <i>Nimenrix</i> and <i>Mencevax</i>, <a href=\"/wiki/Meningococcal_vaccine\" title=\"Meningococcal vaccine\">meningococcal vaccines</a>, from GlaxoSmithKline for around $130<span>&nbsp;</span>million.<sup id=\"cite_ref-74\"><a href=\"#cite_note-74\">[74]</a></sup> In September 2015, Pfizer acquired <a href=\"/wiki/Hospira\" title=\"Hospira\">Hospira</a> for $17<span>&nbsp;</span>billion, including the assumption of debt.<sup id=\"cite_ref-75\"><a href=\"#cite_note-75\">[75]</a></sup><sup id=\"cite_ref-76\"><a href=\"#cite_note-76\">[76]</a></sup><sup id=\"cite_ref-77\"><a href=\"#cite_note-77\">[77]</a></sup><sup id=\"cite_ref-78\"><a href=\"#cite_note-78\">[78]</a></sup><sup id=\"cite_ref-79\"><a href=\"#cite_note-79\">[79]</a></sup><sup id=\"cite_ref-80\"><a href=\"#cite_note-80\">[80]</a></sup> <a href=\"/wiki/Hospira\" title=\"Hospira\">Hospira</a> was the largest producer of generic injectable pharmaceuticals in the world.<sup id=\"cite_ref-81\"><a href=\"#cite_note-81\">[81]</a></sup> On November 23, 2015, Pfizer and <a href=\"/wiki/Allergan\" title=\"Allergan\">Allergan</a> announced a planned $160<span>&nbsp;</span>billion merger, in the largest pharmaceutical deal ever and the third largest corporate merger in history. The proposed transaction contemplated that the merged company maintain Allergan's <a href=\"/wiki/Republic_of_Ireland\" title=\"Republic of Ireland\">Republic of Ireland</a> domicile, resulting in the new company being subject to <a href=\"/wiki/Corporation_tax\" title=\"Corporation tax\">corporation tax</a> at the relatively low rate of 12.5%.<sup id=\"cite_ref-82\"><a href=\"#cite_note-82\">[82]</a></sup> The deal was to constitute a <a href=\"/wiki/Reverse_merger\" title=\"Reverse merger\">reverse merger</a>, whereby Allergan acquired Pfizer, with the new company then changing its name to \"Pfizer, plc\".<sup id=\"cite_ref-83\"><a href=\"#cite_note-83\">[83]</a></sup><sup id=\"cite_ref-84\"><a href=\"#cite_note-84\">[84]</a></sup><sup id=\"cite_ref-85\"><a href=\"#cite_note-85\">[85]</a></sup> On April 6, 2016, Pfizer and Allergan terminated the merger agreement after the <a href=\"/wiki/Obama_administration\" title=\"Obama administration\">Obama administration</a> and the <a href=\"/wiki/United_States_Department_of_the_Treasury\" title=\"United States Department of the Treasury\">United States Department of the Treasury</a> introduced new laws intended to limit <a href=\"/wiki/Corporate_inversion\" title=\"Corporate inversion\">corporate inversions</a> (the extent to which companies could move their headquarters overseas in order to reduce the amount of taxes they pay).<sup id=\"cite_ref-86\"><a href=\"#cite_note-86\">[86]</a></sup><sup id=\"cite_ref-87\"><a href=\"#cite_note-87\">[87]</a></sup>\n</p><p>In June 2016, the company acquired <a href=\"/wiki/Anacor_Pharmaceuticals\" title=\"Anacor Pharmaceuticals\">Anacor Pharmaceuticals</a> for $5.2<span>&nbsp;</span>billion, expanding its portfolio in both inflammation and immunology drugs areas.<sup id=\"cite_ref-88\"><a href=\"#cite_note-88\">[88]</a></sup><sup id=\"cite_ref-89\"><a href=\"#cite_note-89\">[89]</a></sup> In August 2016, the company made a $40<span>&nbsp;</span>million bid for the assets of BIND Therapeutics, which was in <a href=\"/wiki/Bankruptcy\" title=\"Bankruptcy\">bankruptcy</a>.<sup id=\"cite_ref-90\"><a href=\"#cite_note-90\">[90]</a></sup> The same month, the company acquired Bamboo Therapeutics for $645<span>&nbsp;</span>million, expanding its gene therapy offerings.<sup id=\"cite_ref-91\"><a href=\"#cite_note-91\">[91]</a></sup> In September 2016, the company acquired cancer drug-maker <a href=\"/wiki/Medivation\" title=\"Medivation\">Medivation</a> for $14<span>&nbsp;</span>billion.<sup id=\"cite_ref-92\"><a href=\"#cite_note-92\">[92]</a></sup><sup id=\"cite_ref-93\"><a href=\"#cite_note-93\">[93]</a></sup><sup id=\"cite_ref-94\"><a href=\"#cite_note-94\">[94]</a></sup> In October 2016, the company licensed the anti-<a href=\"/wiki/CTLA4\" title=\"CTLA4\">CTLA4</a> monoclonal antibody, ONC-392, from OncoImmune.<sup id=\"cite_ref-95\"><a href=\"#cite_note-95\">[95]</a></sup><sup id=\"cite_ref-96\"><a href=\"#cite_note-96\">[96]</a></sup> In December 2016, Pfizer acquired <a href=\"/wiki/AstraZeneca\" title=\"AstraZeneca\">AstraZeneca</a>'s small-molecule antibiotics business for $1.575 billion.<sup id=\"cite_ref-97\"><a href=\"#cite_note-97\">[97]</a></sup><sup id=\"cite_ref-98\"><a href=\"#cite_note-98\">[98]</a></sup><sup id=\"cite_ref-99\"><a href=\"#cite_note-99\">[99]</a></sup>\n</p><p>In January 2018, Pfizer announced that it would end its work on research into treatments for <a href=\"/wiki/Alzheimer%27s_disease\" title=\"Alzheimer's disease\">Alzheimer's disease</a> and <a href=\"/wiki/Parkinsonism\" title=\"Parkinsonism\">Parkinsonism</a> (a symptom of <a href=\"/wiki/Parkinson%27s_disease\" title=\"Parkinson's disease\">Parkinson's disease</a> and other conditions). The company said about 300 researchers would lose their jobs.<sup id=\"cite_ref-100\"><a href=\"#cite_note-100\">[100]</a></sup> In July 2018, the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> approved <a href=\"/wiki/Enzalutamide\" title=\"Enzalutamide\">enzalutamide</a>, developed by Pfizer and <a href=\"/wiki/Astellas_Pharma\" title=\"Astellas Pharma\">Astellas Pharma</a> for patients with <a href=\"/wiki/Castration\" title=\"Castration\">castration</a>-resistant <a href=\"/wiki/Prostate_cancer\" title=\"Prostate cancer\">prostate cancer</a>.<sup id=\"cite_ref-101\"><a href=\"#cite_note-101\">[101]</a></sup> In August 2018, Pfizer signed an agreement with <a href=\"/wiki/BioNTech\" title=\"BioNTech\">BioNTech</a> to conduct joint research and development activities regarding <a href=\"/wiki/MRNA\" title=\"MRNA\">mRNA</a>-based <a href=\"/wiki/Influenza_vaccine\" title=\"Influenza vaccine\">influenza vaccines</a>.<sup id=\"cite_ref-102\"><a href=\"#cite_note-102\">[102]</a></sup> In October 2018, effective January 1, 2019, <a href=\"/wiki/Albert_Bourla\" title=\"Albert Bourla\">Albert Bourla</a> was promoted to <a href=\"/wiki/Chief_executive_officer\" title=\"Chief executive officer\">chief executive officer</a>, succeeding <a href=\"/wiki/Ian_Read\" title=\"Ian Read\">Ian Read</a>, his mentor.<sup id=\"cite_ref-103\"><a href=\"#cite_note-103\">[103]</a></sup><sup id=\"cite_ref-104\"><a href=\"#cite_note-104\">[104]</a></sup><sup id=\"cite_ref-105\"><a href=\"#cite_note-105\">[105]</a></sup><sup id=\"cite_ref-106\"><a href=\"#cite_note-106\">[106]</a></sup>\n</p><p>In July 2019, the company acquired Therachon for up to $810<span>&nbsp;</span>million, expanding its rare disease portfolio through Therachon's recombinant human fibroblast growth factor receptor 3 compound, aimed at treating conditions such as <a href=\"/wiki/Achondroplasia\" title=\"Achondroplasia\">achondroplasia</a>.<sup id=\"cite_ref-107\"><a href=\"#cite_note-107\">[107]</a></sup> Also in July, Pfizer acquired <a href=\"/wiki/Array_Biopharma\" title=\"Array Biopharma\">Array Biopharma</a> for $10.6<span>&nbsp;</span>billion, boosting its oncology pipeline.<sup id=\"cite_ref-108\"><a href=\"#cite_note-108\">[108]</a></sup> In August 2019, Pfizer merged its consumer health business with that of GlaxoSmithKline, into a <a href=\"/wiki/Joint_venture\" title=\"Joint venture\">joint venture</a> owned 68% by GlaxoSmithKline and 32% by Pfizer, with plans to make it a <a href=\"/wiki/Public_company\" title=\"Public company\">public company</a>. The transaction built on a 2018 transaction where GlaxoSmithKline acquired <a href=\"/wiki/Novartis\" title=\"Novartis\">Novartis</a>' stake in the GSK-Novartis consumer healthcare joint business.<sup id=\"cite_ref-109\"><a href=\"#cite_note-109\">[109]</a></sup><sup id=\"cite_ref-110\"><a href=\"#cite_note-110\">[110]</a></sup><sup id=\"cite_ref-111\"><a href=\"#cite_note-111\">[111]</a></sup><sup id=\"cite_ref-112\"><a href=\"#cite_note-112\">[112]</a></sup> The transaction followed negotiations with other companies including <a href=\"/wiki/Reckitt_Benckiser\" title=\"Reckitt Benckiser\">Reckitt Benckiser</a>,<sup id=\"cite_ref-113\"><a href=\"#cite_note-113\">[113]</a></sup> <a href=\"/wiki/Sanofi\" title=\"Sanofi\">Sanofi</a>, <a href=\"/wiki/Johnson_%26_Johnson\" title=\"Johnson &amp; Johnson\">Johnson &amp; Johnson</a>,<sup id=\"cite_ref-114\"><a href=\"#cite_note-114\">[114]</a></sup> and <a href=\"/wiki/Procter_%26_Gamble\" title=\"Procter &amp; Gamble\">Procter &amp; Gamble</a>.<sup id=\"cite_ref-115\"><a href=\"#cite_note-115\">[115]</a></sup>\n</p><p>In September 2020, the company acquired a 9.9% stake in <a href=\"/w/index.php?title=CStone_Pharmaceuticals&amp;action=edit&amp;redlink=1\" title=\"CStone Pharmaceuticals (page does not exist)\">CStone Pharmaceuticals</a> for $200<span>&nbsp;</span>million (HK$1.55<span>&nbsp;</span>billion), helping to commercialise its anti-<a href=\"/wiki/PD-L1\" title=\"PD-L1\">PD-L1</a> monoclonal antibody, CS1001.<sup id=\"cite_ref-116\"><a href=\"#cite_note-116\">[116]</a></sup> In October 2020, the company acquired Arixa Pharmaceuticals.<sup id=\"cite_ref-117\"><a href=\"#cite_note-117\">[117]</a></sup> In November 2020, using a <a href=\"/wiki/Reverse_Morris_Trust\" title=\"Reverse Morris Trust\">Reverse Morris Trust</a> structure, Pfizer merged its off-patent branded and <a href=\"/wiki/Generic_drug\" title=\"Generic drug\">generic drug</a> business, known as Upjohn, with <a href=\"/wiki/Mylan\" title=\"Mylan\">Mylan</a> to form <a href=\"/wiki/Viatris\" title=\"Viatris\">Viatris</a>, owned 57% by Pfizer shareholders.<sup id=\"cite_ref-118\"><a href=\"#cite_note-118\">[118]</a></sup><sup id=\"cite_ref-119\"><a href=\"#cite_note-119\">[119]</a></sup><sup id=\"cite_ref-120\"><a href=\"#cite_note-120\">[120]</a></sup>\n</p>\n<h3><span id=\"2021.E2.80.93onwards:_Corporate_developments_and_acquisitions\"></span><span id=\"2021–onwards:_Corporate_developments_and_acquisitions\">2021–onwards: Corporate developments and acquisitions</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=8\" title=\"Edit section: 2021–onwards: Corporate developments and acquisitions\">edit</a><span>]</span></span></h3>\n<p>On January 5, 2021, Pfizer introduced a new <a href=\"/wiki/Logo\" title=\"Logo\">logo</a>.<sup id=\"cite_ref-121\"><a href=\"#cite_note-121\">[121]</a></sup> In April 2021, Pfizer acquired Amplyx Pharmaceuticals and its anti-fungal compound Fosmanogepix (APX001).<sup id=\"cite_ref-122\"><a href=\"#cite_note-122\">[122]</a></sup><sup id=\"cite_ref-123\"><a href=\"#cite_note-123\">[123]</a></sup><sup id=\"cite_ref-124\"><a href=\"#cite_note-124\">[124]</a></sup> In August, the company announced it would acquire Trillium Therapeutics Inc and its immuno-oncology portfolio for $2.3 billion ($18.50 per share).<sup id=\"cite_ref-125\"><a href=\"#cite_note-125\">[125]</a></sup><sup id=\"cite_ref-126\"><a href=\"#cite_note-126\">[126]</a></sup> In December, Pfizer announced that it had agreed to acquire <a href=\"/wiki/Arena_Pharmaceuticals\" title=\"Arena Pharmaceuticals\">Arena Pharmaceuticals</a> for $6.7 billion in cash.<sup id=\"cite_ref-127\"><a href=\"#cite_note-127\">[127]</a></sup><sup id=\"cite_ref-128\"><a href=\"#cite_note-128\">[128]</a></sup> In March 2022, it was announced the acquisition of Arena Pharmaceuticals had been concluded.<sup id=\"cite_ref-129\"><a href=\"#cite_note-129\">[129]</a></sup>\n</p>\n<h3><span id=\"Acquisition_history\">Acquisition history</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=9\" title=\"Edit section: Acquisition history\">edit</a><span>]</span></span></h3>\n<div><p>Pfizer acquisitions</p><div>\n<ul><li><b>Pfizer</b> <small>(Founded 1849 as Charles Pfizer &amp; Company)</small>\n<ul><li><a href=\"/wiki/Warner%E2%80%93Lambert\" title=\"Warner–Lambert\">Warner–Lambert</a>\n<ul><li>William R. Warner <small>(Founded 1856, merged 1955)</small></li>\n<li>Lambert Pharmacal Company <small>(Merged 1955)</small></li>\n<li>Parke-Davis <small>(Founded 1860, Acq 1976)</small></li>\n<li>Wilkinson Sword <small>(Acq 1993, divested 2003)</small></li>\n<li>Agouron <small>(Acq 1999)</small></li></ul></li>\n<li><a href=\"/wiki/Pharmacia\" title=\"Pharmacia\">Pharmacia</a> <small>(Acq 2002)</small>\n<ul><li><a href=\"/wiki/Pharmacia_%26_Upjohn\" title=\"Pharmacia &amp; Upjohn\">Pharmacia &amp; Upjohn</a> <small>(Merged 2000)</small>\n<ul><li><a href=\"/wiki/Pharmacia\" title=\"Pharmacia\">Pharmacia</a> <small>(Merged 1995)</small>\n<ul><li>Farmitalia Carlo Erba</li>\n<li>Kabi Pharmacia</li>\n<li>Pharmacia Aktiebolaget</li></ul></li>\n<li><a href=\"/wiki/The_Upjohn_Company\" title=\"The Upjohn Company\">The Upjohn Company</a> <small>(Merged 1995)</small></li>\n<li><a href=\"/wiki/Monsanto\" title=\"Monsanto\">Monsanto</a> <small>(Merged 2000, divested 2002)</small></li>\n<li><a href=\"/wiki/G.D._Searle,_LLC\" title=\"G.D. Searle, LLC\">Searle</a> <small>(Merged 2000)</small></li></ul></li></ul></li>\n<li>Esperion Therapeutics <small>(Acq 2003, divested 2008)</small></li>\n<li>Meridica <small>(Acq 2004)</small></li>\n<li>Vicuron Pharmaceuticals <small>(Acq 2005)</small></li>\n<li>Idun <small>(Acq 2005)</small></li>\n<li>Angiosyn <small>(Acq 2005)</small></li>\n<li>Powermed <small>(Acq 2006)</small></li>\n<li>Rinat <small>(Acq 2006)</small></li>\n<li>Coley Pharmaceutical Group <small>(Acq 2007)</small></li>\n<li>CovX <small>(Acq 2007)</small></li>\n<li>Encysive Pharmaceuticals Inc <small>(Acq 2008)</small></li>\n<li><a href=\"/wiki/Wyeth\" title=\"Wyeth\">Wyeth</a> <small>(Acq 2009)</small>\n<ul><li><a href=\"/wiki/Chef_Boyardee\" title=\"Chef Boyardee\">Chef Boyardee</a> <small>(Acq 1946, divested 1996 with food div)</small></li>\n<li>S.M.A. Corporation</li>\n<li>Ayerst Laboratories <small>(Acq 1943)</small></li>\n<li>Fort Dodge Serum Company <small>(Acq 1945)</small></li>\n<li><a href=\"/wiki/Bristol-Myers\" title=\"Bristol-Myers\">Bristol-Myers</a> <small>(Animal Health div)</small></li>\n<li><a href=\"/wiki/Parke-Davis\" title=\"Parke-Davis\">Parke-Davis</a> <small>(Animal Health div)</small></li>\n<li>A.H. Robins</li>\n<li>Sherwood Medical <small>(Acq 1982)</small></li>\n<li><a href=\"/wiki/Genetics_Institute,_Inc.\" title=\"Genetics Institute, Inc.\">Genetics Institute, Inc.</a> <small>(Acq 1992)</small></li>\n<li><a href=\"/wiki/American_Cyanamid\" title=\"American Cyanamid\">American Cyanamid</a> <small>(Acq 1994)</small></li>\n<li>Lederle Laboratories</li>\n<li><a href=\"/wiki/Solvay_S.A.\" title=\"Solvay S.A.\">Solvay</a> <small>(Acq 1995, Animal Health div)</small></li></ul></li>\n<li><a href=\"/wiki/King_Pharmaceuticals\" title=\"King Pharmaceuticals\">King Pharmaceuticals</a> <small>(Acq 2010)</small>\n<ul><li>Monarch Pharmaceuticals, Inc.</li>\n<li>King Pharmaceuticals Research and Development, Inc.</li>\n<li>Meridian Medical Technologies, Inc.</li>\n<li>Parkedale Pharmaceuticals, Inc.</li>\n<li>King Pharmaceuticals Canada Inc.</li>\n<li>Monarch Pharmaceuticals Ireland Limited</li></ul></li>\n<li>Synbiotics Corporation <small>(Acq 2011)</small></li>\n<li>Icagen <small>(Acq 2011)</small></li>\n<li>Ferrosan <small>(Consumer Health div, Acq 2011)</small></li>\n<li>Excaliard Pharmaceuticals <small>(Acq 2011)</small></li>\n<li>Alacer Corp <small>(Acq 2012)</small></li>\n<li>NextWave Pharmaceuticals, Inc <small>(Acq 2012)</small></li>\n<li>Innopharma <small>(Acq 2014)</small></li>\n<li>Redvax GmbH <small>(Acq 2014)</small></li>\n<li>Hospira <small>(Spun off from Abbott Laboratories 2004, Acq 2015)</small> \n<ul><li>Mayne Pharma Ltd <small>(Acq 2007)</small></li>\n<li>Pliva-Croatia</li>\n<li><a href=\"/wiki/Orchid_Chemicals_%26_Pharmaceuticals_Ltd.\" title=\"Orchid Chemicals &amp; Pharmaceuticals Ltd.\">Orchid Chemicals &amp; Pharmaceuticals Ltd.</a> <small>(Generics &amp; Injectables div, Acq 2009)</small> </li>\n<li>Javelin Pharmaceuticals, Inc. <small>(Acq 2010)</small></li>\n<li>TheraDoc <small>(Acq 2010)</small></li>\n<li>Arixa Pharmaceuticals <small>(Acq 2020)</small></li></ul></li>\n<li><a href=\"/wiki/Anacor_Pharmaceuticals\" title=\"Anacor Pharmaceuticals\">Anacor Pharmaceuticals</a> <small>(Acq 2016)</small></li>\n<li>Bamboo Therapeutics <small>(Acq 2016)</small></li>\n<li><a href=\"/wiki/Medivation\" title=\"Medivation\">Medivation</a> <small>(Acq 2016)</small></li>\n<li><a href=\"/wiki/AstraZeneca\" title=\"AstraZeneca\">AstraZeneca</a> <small>(Small molecule antibiotic div, Acq 2016)</small></li>\n<li><a href=\"/wiki/Array_BioPharma\" title=\"Array BioPharma\">Array BioPharma</a> <small>(Acq 2019)</small></li>\n<li>Amplyx Pharmaceuticals <small>(Acq 2021)</small></li>\n<li>Trillium Therapeutics <small>(Acq 2021)</small></li>\n<li><a href=\"/wiki/Arena_Pharmaceuticals\" title=\"Arena Pharmaceuticals\">Arena Pharmaceuticals</a> <small>(Acq TBA)</small></li></ul></li></ul>\n</div></div>\n\n<div><p><a href=\"/wiki/File:Covid19_vaccine_biontech_pfizer_2.jpg\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/5b/Covid19_vaccine_biontech_pfizer_2.jpg/220px-Covid19_vaccine_biontech_pfizer_2.jpg\" decoding=\"async\" width=\"220\" height=\"113\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/5b/Covid19_vaccine_biontech_pfizer_2.jpg/330px-Covid19_vaccine_biontech_pfizer_2.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/5b/Covid19_vaccine_biontech_pfizer_2.jpg/440px-Covid19_vaccine_biontech_pfizer_2.jpg 2x\" data-file-width=\"2909\" data-file-height=\"1496\"></a></p></div>\n<h3><span id=\"COVID-19_vaccine_and_other_initiatives\">COVID-19 vaccine and other initiatives</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=10\" title=\"Edit section: COVID-19 vaccine and other initiatives\">edit</a><span>]</span></span></h3>\n<h4><span id=\"COVID-19_pandemic_and_vaccine_development\">COVID-19 pandemic and vaccine development</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=11\" title=\"Edit section: COVID-19 pandemic and vaccine development\">edit</a><span>]</span></span></h4>\n\n<h5><span id=\"Initial_development_and_testing\">Initial development and testing</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=12\" title=\"Edit section: Initial development and testing\">edit</a><span>]</span></span></h5>\n<p>In March 2020, as the scale of the <a href=\"/wiki/COVID-19_pandemic\" title=\"COVID-19 pandemic\">COVID-19 pandemic</a> became apparent, Pfizer partnered with BioNTech to study and develop <a href=\"/wiki/COVID-19\" title=\"COVID-19\">COVID-19</a> mRNA vaccine candidates. Unlike many of its competitors, Pfizer took no initial research funds from the United States' <a href=\"/wiki/Operation_Warp_Speed\" title=\"Operation Warp Speed\">Operation Warp Speed</a> vaccine development program, instead choosing to invest roughly $2 billion of its own funds. Pfizer CEO Albert Bourla has said that he declined money from Operation Warp Speed to avoid government intervention, stating later that \"when you get money from someone that always comes with strings. They want to see how we are going to progress, what type of moves you are going to do. They want reports. And also, I wanted to keep Pfizer out of politics, by the way.\"<sup id=\"cite_ref-130\"><a href=\"#cite_note-130\">[130]</a></sup>\n</p><p>In May 2020, Pfizer began testing four different <a href=\"/wiki/COVID-19_vaccine\" title=\"COVID-19 vaccine\">COVID-19 vaccine</a> variations. Vaccines were injected into the first human participants in the U.S. in early May.<sup id=\"cite_ref-131\"><a href=\"#cite_note-131\">[131]</a></sup> In July 2020, Pfizer and BioNTech announced that two of the partners' four <a href=\"/wiki/Messenger_RNA\" title=\"Messenger RNA\">mRNA</a> vaccine candidates had won fast track designation from the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">FDA</a>.<sup id=\"cite_ref-132\"><a href=\"#cite_note-132\">[132]</a></sup><sup id=\"cite_ref-133\"><a href=\"#cite_note-133\">[133]</a></sup> The company began Phase<span>&nbsp;</span>II-III testing on 30,000 people in the last week of July 2020 and was slated to be paid $1.95<span>&nbsp;</span>billion for 100<span>&nbsp;</span>million doses of the vaccine by the US government.<sup id=\"cite_ref-134\"><a href=\"#cite_note-134\">[134]</a></sup> The U.S. deal priced two doses at $39, and the company stated that it would not lower the rates for other countries until the outbreak is no longer a pandemic.<sup id=\"cite_ref-135\"><a href=\"#cite_note-135\">[135]</a></sup> Pfizer's CEO stated the companies in the private sector producing a vaccine should make a profit.<sup id=\"cite_ref-136\"><a href=\"#cite_note-136\">[136]</a></sup> In September 2020, Pfizer and BioNTech announced that they had completed talks with the European Commission to provide an initial 200<span>&nbsp;</span>million vaccine doses to the EU, with the option to supply another 100<span>&nbsp;</span>million doses at a later date.<sup id=\"cite_ref-137\"><a href=\"#cite_note-137\">[137]</a></sup><sup id=\"cite_ref-138\"><a href=\"#cite_note-138\">[138]</a></sup>\n</p>\n<h5><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=13\" title=\"Edit section: Efficacy results and authorization\">edit</a><span>]</span></span></h5>\n\n<p>On November 9, 2020, Pfizer announced that BioNTech's COVID-19 vaccine, tested on 43,500 people, was found to be 90% effective at preventing symptomatic COVID-19.<sup id=\"cite_ref-139\"><a href=\"#cite_note-139\">[139]</a></sup> The efficacy was updated to 95% a week later.<sup id=\"cite_ref-:1_140-0\"><a href=\"#cite_note-:1-140\">[140]</a></sup> Akiko Iwasaki, an immunologist interviewed by the <i>New York Times</i>, described the efficacy figure as \"really a spectacular number.\"<sup id=\"cite_ref-141\"><a href=\"#cite_note-141\">[141]</a></sup> The announcement made Pfizer and BioNTech the first companies to develop and test a working vaccine for COVID-19.<sup id=\"cite_ref-:1_140-1\"><a href=\"#cite_note-:1-140\">[140]</a></sup>\n</p><p>Over the following month and a half, regulators in various countries approved Pfizer's vaccine for emergency use. The United Kingdom approved the vaccine first, on December 2,<sup id=\"cite_ref-142\"><a href=\"#cite_note-142\">[142]</a></sup> followed by <a href=\"/wiki/Bahrain\" title=\"Bahrain\">Bahrain</a> on December 4,<sup id=\"cite_ref-Bahrain_Approves_Covid-19_Vaccine_(Al_Jazeera)_143-0\"><a href=\"#cite_note-Bahrain_Approves_Covid-19_Vaccine_(Al_Jazeera)-143\">[143]</a></sup> Canada on December 9,<sup id=\"cite_ref-Canada_Approves_Covid-19_Vaccine_(NYT)_144-0\"><a href=\"#cite_note-Canada_Approves_Covid-19_Vaccine_(NYT)-144\">[144]</a></sup> and Saudi Arabia on December 10.<sup id=\"cite_ref-Saudi_Arabia_Approves_Covid-19_Vaccine,_Bahrain_To_Distribute_Free_to_Public_(KTLA)_145-0\"><a href=\"#cite_note-Saudi_Arabia_Approves_Covid-19_Vaccine,_Bahrain_To_Distribute_Free_to_Public_(KTLA)-145\">[145]</a></sup> On December 10, 2020, the United States FDA held an advisory committee meeting to discuss authorization of the vaccine.<sup id=\"cite_ref-US_FDA_Advisory_Panel_Backs_Covid-19_Vaccine_Approval_(Reuters)_146-0\"><a href=\"#cite_note-US_FDA_Advisory_Panel_Backs_Covid-19_Vaccine_Approval_(Reuters)-146\">[146]</a></sup> The next day, the US officially became the 5th country to approve use of Pfizer's vaccine under an Emergency Use Authorization (EUA), with an independent panel voting 17–4 in support of approval.<sup id=\"cite_ref-US_FDA_Advisory_Panel_Backs_Covid-19_Vaccine_Approval_(Reuters)_146-1\"><a href=\"#cite_note-US_FDA_Advisory_Panel_Backs_Covid-19_Vaccine_Approval_(Reuters)-146\">[146]</a></sup><sup id=\"cite_ref-147\"><a href=\"#cite_note-147\">[147]</a></sup> On December 14, Singapore became one of the first in Asia to approve the vaccine through the <a href=\"/wiki/Health_Sciences_Authority\" title=\"Health Sciences Authority\">Health Sciences Authority</a>.<sup id=\"cite_ref-148\"><a href=\"#cite_note-148\">[148]</a></sup> On December 21, the <a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a> (EMA) recommended granting a conditional marketing authorisation for the vaccine in the <a href=\"/wiki/European_Union\" title=\"European Union\">European Union</a>, under the brand name \"Comirnaty.\"<sup id=\"cite_ref-149\"><a href=\"#cite_note-149\">[149]</a></sup>\n</p>\n<h5><span id=\"Manufacturing_and_distribution\">Manufacturing and distribution</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=14\" title=\"Edit section: Manufacturing and distribution\">edit</a><span>]</span></span></h5>\n\n<p>As of early May 2021, Pfizer and BioNTech had manufactured at least 430 million vaccine doses, which have been distributed to 91 countries and territories. The companies have said they expect to manufacture nearly 3 billion total vaccine doses in 2021.<sup id=\"cite_ref-150\"><a href=\"#cite_note-150\">[150]</a></sup>\n</p>\n<h5><span id=\"Controversy\">Controversy</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=15\" title=\"Edit section: Controversy\">edit</a><span>]</span></span></h5>\n<p>In February 2021, after a year long investigation relying on unnamed officials, Pfizer was accused by <a href=\"/wiki/The_Bureau_of_Investigative_Journalism\" title=\"The Bureau of Investigative Journalism\">The Bureau of Investigative Journalism</a> (TBIJ) of employing \"high-level bullying\" against at least two <a href=\"/wiki/Latin_America\" title=\"Latin America\">Latin American</a> countries during negotiations to acquire COVID-19 vaccines, including requesting that the countries put sovereign assets as <a href=\"/wiki/Collateral_(finance)\" title=\"Collateral (finance)\">collateral</a> for payments.<sup id=\"cite_ref-bullied_151-0\"><a href=\"#cite_note-bullied-151\">[151]</a></sup> According to TBIJ, these negotiation tactics resulted in a months long delay in Pfizer reaching a vaccine agreement with one country and a complete failure to reach agreements with two other countries, including <a href=\"/wiki/Argentina\" title=\"Argentina\">Argentina</a> and Brazil.<sup id=\"cite_ref-bullied_151-1\"><a href=\"#cite_note-bullied-151\">[151]</a></sup>\n</p><p>On 2 November 2021, <a href=\"/wiki/The_BMJ\" title=\"The BMJ\">The BMJ</a> published an article after obtaining information from a <a href=\"/wiki/Whistleblower\" title=\"Whistleblower\">whistleblower</a> from the Ventavia Research Group. Ventavia was hired by Pfizer as a research subcontractor. The company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in <a href=\"/wiki/Pfizer%E2%80%93BioNTech_COVID-19_vaccine#Clinical_trials\" title=\"Pfizer–BioNTech COVID-19 vaccine\">Pfizer’s pivotal phase III trial</a>. The regional director, Brook Jackson, emailed a complaint to the US <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA). Ventavia fired her later the same day.<sup id=\"cite_ref-152\"><a href=\"#cite_note-152\">[152]</a></sup> The <a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a> (EMA) stated in a response to the <a href=\"/wiki/European_Parliament\" title=\"European Parliament\">European Parliament</a>, that \"the deficiencies identified do not jeopardize the quality and integrity of the data from the main Comirnaty trial and have no impact on the benefit-risk assessment or on the conclusions on the safety, effectiveness and quality of the vaccine”.<sup id=\"cite_ref-153\"><a href=\"#cite_note-153\">[153]</a></sup>\n</p>\n<h4><span id=\"Other_initiatives\">Other initiatives</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=16\" title=\"Edit section: Other initiatives\">edit</a><span>]</span></span></h4>\n<p>In November 2021 Pfizer started a new COVID-19 oral antivirus treatment, known as <a href=\"/wiki/Nirmatrelvir/ritonavir\" title=\"Nirmatrelvir/ritonavir\">Paxlovid</a>, which according to a recent study reduces the risk of hospitalisation or death by 89%.<sup id=\"cite_ref-154\"><a href=\"#cite_note-154\">[154]</a></sup> In January 2022, the Pfizer CEO <a href=\"/wiki/Albert_Bourla\" title=\"Albert Bourla\">Albert Bourla</a> confirmed that the trial results of a fourth dose were pending until March 2022. He also said that the firm was setting up a collaboration to develop an anti-Covid pill treatment along with French company, <a href=\"/wiki/Novasep\" title=\"Novasep\">Novasep</a>. He also said the Covid vaccine was “safe and efficient” for children.<sup id=\"cite_ref-155\"><a href=\"#cite_note-155\">[155]</a></sup> <sup id=\"cite_ref-156\"><a href=\"#cite_note-156\">[156]</a></sup>\n</p>\n<h2><span id=\"Legal_issues\">Legal issues</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=17\" title=\"Edit section: Legal issues\">edit</a><span>]</span></span></h2>\n<h3><span id=\"Aggressive_pharmaceutical_marketing\">Aggressive pharmaceutical marketing</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=18\" title=\"Edit section: Aggressive pharmaceutical marketing\">edit</a><span>]</span></span></h3>\n\n<p>Pfizer has been accused of aggressive <a href=\"/wiki/Pharmaceutical_marketing\" title=\"Pharmaceutical marketing\">pharmaceutical marketing</a>.<sup id=\"cite_ref-157\"><a href=\"#cite_note-157\">[157]</a></sup><sup id=\"cite_ref-158\"><a href=\"#cite_note-158\">[158]</a></sup><sup id=\"cite_ref-159\"><a href=\"#cite_note-159\">[159]</a></sup>\n</p>\n<h4><span id=\"Illegal_marketing_of_gabapentin_for_off-label_uses\">Illegal marketing of gabapentin for off-label uses</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=19\" title=\"Edit section: Illegal marketing of gabapentin for off-label uses\">edit</a><span>]</span></span></h4>\n<p>In 1993, the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA) approved <a href=\"/wiki/Gabapentin\" title=\"Gabapentin\">gabapentin</a> only for treatment of <a href=\"/wiki/Seizures\" title=\"Seizures\">seizures</a>. <a href=\"/wiki/Warner%E2%80%93Lambert\" title=\"Warner–Lambert\">Warner–Lambert</a>, which merged with Pfizer in 2000, used <a href=\"/wiki/Continuing_medical_education\" title=\"Continuing medical education\">continuing medical education</a> and <a href=\"/wiki/Medical_research\" title=\"Medical research\">medical research</a>, sponsored articles about the drug for the medical literature, and alleged suppression of unfavorable study results, to promote gabapentin. Within five years, the drug was being widely used for <a href=\"/wiki/Off-label_use\" title=\"Off-label use\">off-label uses</a> such as treatment of pain and psychiatric conditions. Warner–Lambert admitted to violating FDA regulations by promoting the drug for pain, psychiatric conditions, migraine, and other unapproved uses.<sup id=\"cite_ref-160\"><a href=\"#cite_note-160\">[160]</a></sup> In 2004, the company paid $430<span>&nbsp;</span>million in one of the largest settlements to resolve criminal and civil health care liability charges. It was the first off-label promotion case successfully brought under the <a href=\"/wiki/False_Claims_Act\" title=\"False Claims Act\">False Claims Act</a>.<sup id=\"cite_ref-161\"><a href=\"#cite_note-161\">[161]</a></sup> A Cochrane review concluded that gabapentin is ineffective in migraine prophylaxis.<sup id=\"cite_ref-162\"><a href=\"#cite_note-162\">[162]</a></sup> The <a href=\"/wiki/American_Academy_of_Neurology\" title=\"American Academy of Neurology\">American Academy of Neurology</a> rates it as having unproven efficacy, while the <a href=\"/wiki/Canadian_Headache_Society\" title=\"Canadian Headache Society\">Canadian Headache Society</a> and the <a href=\"/wiki/European_Federation_of_Neurological_Societies\" title=\"European Federation of Neurological Societies\">European Federation of Neurological Societies</a> rate its use as being supported by moderate and low-quality evidence.<sup id=\"cite_ref-163\"><a href=\"#cite_note-163\">[163]</a></sup>\n</p>\n<h4><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=20\" title=\"Edit section: Illegal marketing of Bextra\">edit</a><span>]</span></span></h4>\n<p>In September 2009, Pfizer pleaded guilty to the illegal marketing of <a href=\"/wiki/Arthritis\" title=\"Arthritis\">arthritis</a> drug <a href=\"/wiki/Valdecoxib\" title=\"Valdecoxib\">valdecoxib</a> (<i>Bextra</i>) and agreed to a $2.3<span>&nbsp;</span>billion settlement, the largest <a href=\"/wiki/Health_care_fraud\" title=\"Health care fraud\">health care fraud</a> settlement at that time. Pfizer promoted the sale of the drug for several uses and dosages that the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> specifically declined to approve due to safety concerns. The drug was pulled from the market in 2005.<sup id=\"cite_ref-164\"><a href=\"#cite_note-164\">[164]</a></sup><sup id=\"cite_ref-largestdoj_165-0\"><a href=\"#cite_note-largestdoj-165\">[165]</a></sup> It was Pfizer's fourth such settlement in a decade.<sup id=\"cite_ref-Settle_166-0\"><a href=\"#cite_note-Settle-166\">[166]</a></sup><sup id=\"cite_ref-Improper_167-0\"><a href=\"#cite_note-Improper-167\">[167]</a></sup><sup id=\"cite_ref-fine_168-0\"><a href=\"#cite_note-fine-168\">[168]</a></sup> The payment included $1.3<span>&nbsp;</span>billion in criminal penalties for felony violations of the <a href=\"/wiki/Federal_Food,_Drug,_and_Cosmetic_Act\" title=\"Federal Food, Drug, and Cosmetic Act\">Federal Food, Drug, and Cosmetic Act</a>, and $1.0<span>&nbsp;</span>billion to settle allegations it had illegally promoted the drugs for uses that were not approved by the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA) leading to violations under the <a href=\"/wiki/False_Claims_Act\" title=\"False Claims Act\">False Claims Act</a> as reimbursements were requested from Federal and State programs. The criminal fine was the largest ever assessed in the United States to date.<sup id=\"cite_ref-largestdoj_165-1\"><a href=\"#cite_note-largestdoj-165\">[165]</a></sup><sup id=\"cite_ref-Settle_166-1\"><a href=\"#cite_note-Settle-166\">[166]</a></sup><sup id=\"cite_ref-Improper_167-1\"><a href=\"#cite_note-Improper-167\">[167]</a></sup><sup id=\"cite_ref-fine_168-1\"><a href=\"#cite_note-fine-168\">[168]</a></sup> Pfizer entered a <a href=\"/wiki/Corporate_integrity_agreement\" title=\"Corporate integrity agreement\">corporate integrity agreement</a> with the <a href=\"/wiki/Office_of_Inspector_General_(United_States)\" title=\"Office of Inspector General (United States)\">Office of Inspector General</a> that required it to make substantial structural reforms within the company, and publish to its website its post approval commitments and a searchable database of all payments to physicians made by the company.<sup id=\"cite_ref-169\"><a href=\"#cite_note-169\">[169]</a></sup>\n</p>\n<h4><span id=\"Termination_of_Peter_Rost\">Termination of Peter Rost</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=21\" title=\"Edit section: Termination of Peter Rost\">edit</a><span>]</span></span></h4>\n<p><a href=\"/wiki/Peter_Rost_(doctor)\" title=\"Peter Rost (doctor)\">Peter Rost</a> was vice president in charge of the <a href=\"/wiki/Endocrinology\" title=\"Endocrinology\">endocrinology</a> division at <a href=\"/wiki/Pharmacia\" title=\"Pharmacia\">Pharmacia</a> before its acquisition by Pfizer. During that time he raised concerns internally about <a href=\"/wiki/Kickback_(bribery)\" title=\"Kickback (bribery)\">kickbacks</a> and off-label marketing of Genotropin, Pharmacia's <a href=\"/wiki/Human_growth_hormone\" title=\"Human growth hormone\">human growth hormone</a> drug. Pfizer reported the Pharmacia marketing practices to the FDA and Department of Justice; Rost was unaware of this and filed an FCA lawsuit against Pfizer. Pfizer kept him employed, but isolated him until the FCA suit was unsealed in 2005. The Justice Department declined to intervene, and Pfizer fired him, and he filed a wrongful termination suit against Pfizer. Pfizer won a summary dismissal of the case, with the court ruling that the evidence showed Pfizer had decided to fire Rost prior to learning of his whistleblower activities.<sup id=\"cite_ref-170\"><a href=\"#cite_note-170\">[170]</a></sup><sup id=\"cite_ref-171\"><a href=\"#cite_note-171\">[171]</a></sup>\n</p>\n<h4><span id=\"Illegal_marketing_of_Rapamune\">Illegal marketing of Rapamune</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=22\" title=\"Edit section: Illegal marketing of Rapamune\">edit</a><span>]</span></span></h4>\n<p>A \"whistleblower suit\" was filed in 2005 against <a href=\"/wiki/Wyeth\" title=\"Wyeth\">Wyeth</a>, which was acquired by Pfizer in 2009, alleging that the company illegally marketed <a href=\"/wiki/Sirolimus\" title=\"Sirolimus\">sirolimus</a> (<i>Rapamune</i>) for <a href=\"/wiki/Off-label_use\" title=\"Off-label use\">off-label uses</a>, targeted specific doctors and medical facilities to increase sales of Rapamune, tried to get transplant patients to change from their transplant drugs to Rapamune, and specifically targeted <a href=\"/wiki/African-Americans\" title=\"African-Americans\">African-Americans</a>. According to the whistleblowers, Wyeth also provided doctors and hospitals that prescribed the drug with kickbacks such as grants, donations, and other money.<sup id=\"cite_ref-172\"><a href=\"#cite_note-172\">[172]</a></sup> In 2013, the company pleaded guilty to criminal mis-branding violations under the <a href=\"/wiki/Federal_Food,_Drug,_and_Cosmetic_Act\" title=\"Federal Food, Drug, and Cosmetic Act\">Federal Food, Drug, and Cosmetic Act</a>. By August 2014, it had paid $491<span>&nbsp;</span>million in civil and criminal penalties related to Rapamune.<sup id=\"cite_ref-173\"><a href=\"#cite_note-173\">[173]</a></sup>\n</p>\n<h4><span id=\"Illegal_marketing\">Illegal marketing</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=23\" title=\"Edit section: Illegal marketing\">edit</a><span>]</span></span></h4>\n<p>In June 2010, health insurance network <a href=\"/wiki/Blue_Cross_Blue_Shield\" title=\"Blue Cross Blue Shield\">Blue Cross Blue Shield</a> (BCBS) filed a lawsuit against Pfizer for allegedly illegally marketing drugs Bextra, Geodon and Lyrica. BCBS alleged that Pfizer used kickbacks and wrongly persuaded doctors to prescribe the drugs.<sup id=\"cite_ref-174\"><a href=\"#cite_note-174\">[174]</a></sup><sup id=\"cite_ref-175\"><a href=\"#cite_note-175\">[175]</a></sup> According to the lawsuit, Pfizer handed out 'misleading' materials on <a href=\"/wiki/Off-label_use\" title=\"Off-label use\">off-label uses</a>, sent over 5,000 doctors on trips to the <a href=\"/wiki/Caribbean\" title=\"Caribbean\">Caribbean</a> or around the United States, and paid them $2,000 honoraria in return for listening to lectures about Bextra.<sup id=\"cite_ref-176\"><a href=\"#cite_note-176\">[176]</a></sup><sup id=\"cite_ref-177\"><a href=\"#cite_note-177\">[177]</a></sup> Despite Pfizer's claims that \"the company's intent was pure\" in fostering a legal exchange of information among doctors, an internal marketing plan revealed that Pfizer intended to train physicians \"to serve as public relations spokespeople.\"<sup id=\"cite_ref-toobig_178-0\"><a href=\"#cite_note-toobig-178\">[178]</a></sup> The case was settled in 2014 for $325<span>&nbsp;</span>million.<sup id=\"cite_ref-179\"><a href=\"#cite_note-179\">[179]</a></sup> Fearing that Pfizer is \"<a href=\"/wiki/Too_big_to_fail\" title=\"Too big to fail\">too big to fail</a>\" and that prosecuting the company would result in disruptions to <a href=\"/wiki/Medicare_(United_States)\" title=\"Medicare (United States)\">Medicare</a> and <a href=\"/wiki/Medicaid\" title=\"Medicaid\">Medicaid</a>, federal prosecutors instead charged a subsidiary of a subsidiary of a subsidiary of Pfizer, which is \"nothing more than a shell company whose only function is to plead guilty.\"<sup id=\"cite_ref-toobig_178-1\"><a href=\"#cite_note-toobig-178\">[178]</a></sup>\n</p>\n<h3><span id=\"Removal_of_ads_after_unflattering_article\">Removal of ads after unflattering article</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=24\" title=\"Edit section: Removal of ads after unflattering article\">edit</a><span>]</span></span></h3>\n<p>According to <i><a href=\"/wiki/Harper%27s_Magazine\" title=\"Harper's Magazine\">Harper's Magazine</a></i> publisher <a href=\"/wiki/John_R._MacArthur\" title=\"John R. MacArthur\">John R. MacArthur</a>, Pfizer withdrew \"between $400,000 and a million dollars\" worth of ads from <i><a href=\"/wiki/Harper%27s_Magazine\" title=\"Harper's Magazine\">Harper's Magazine</a></i> following an unflattering article on depression medication.<sup id=\"cite_ref-180\"><a href=\"#cite_note-180\">[180]</a></sup>\n</p>\n<h3><span id=\"Quigley_Company_asbestos\">Quigley Company asbestos</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=25\" title=\"Edit section: Quigley Company asbestos\">edit</a><span>]</span></span></h3>\n<p>The Quigley Company, which sold <a href=\"/wiki/Asbestos\" title=\"Asbestos\">asbestos</a>-containing insulation products until the early 1970s, was acquired by Pfizer in 1968. In June 2013, asbestos victims and Pfizer negotiated a settlement that required Pfizer to pay a total of $964<span>&nbsp;</span>million: $430<span>&nbsp;</span>million to 80% of existing plaintiffs and place an additional $535<span>&nbsp;</span>million into a settlement trust that will compensate future plaintiffs as well as the remaining 20% of plaintiffs with claims against Pfizer and Quigley. Of that $535<span>&nbsp;</span>million, $405<span>&nbsp;</span>million is in a 40-year note from Pfizer, while $100<span>&nbsp;</span>million is from insurance policies.<sup id=\"cite_ref-181\"><a href=\"#cite_note-181\">[181]</a></sup>\n</p>\n<h3><span id=\"Shiley_defective_heart_valves\">Shiley defective heart valves</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=26\" title=\"Edit section: Shiley defective heart valves\">edit</a><span>]</span></span></h3>\n<p>Pfizer purchased Shiley in 1979, at the onset of its Convexo-Concave valve ordeal, involving the <a href=\"/wiki/Bjork%E2%80%93Shiley_valve\" title=\"Bjork–Shiley valve\">Bjork–Shiley valve</a>. Approximately 500 people died when defective <a href=\"/wiki/Heart_valve\" title=\"Heart valve\">heart valves</a> fractured and, in 1994, Pfizer agreed to pay $10.75<span>&nbsp;</span>million to settle claims by the <a href=\"/wiki/United_States_Department_of_Justice\" title=\"United States Department of Justice\">United States Department of Justice</a> that the company lied to get approval for the valves.<sup id=\"cite_ref-182\"><a href=\"#cite_note-182\">[182]</a></sup>\n</p>\n<h3><span id=\"Firing_of_employee_that_filed_suit\">Firing of employee that filed suit</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=27\" title=\"Edit section: Firing of employee that filed suit\">edit</a><span>]</span></span></h3>\n<p>A federal lawsuit was filed by a scientist claiming she got an infection by a genetically modified <a href=\"/wiki/Lentivirus\" title=\"Lentivirus\">lentivirus</a> while working for Pfizer, resulting in intermittent <a href=\"/wiki/Paralysis\" title=\"Paralysis\">paralysis</a>.<sup id=\"cite_ref-183\"><a href=\"#cite_note-183\">[183]</a></sup> A judge dismissed the case citing a lack of evidence that the illness was caused by the virus but the jury ruled that by firing the employee, Pfizer violated laws protecting <a href=\"/wiki/Freedom_of_speech\" title=\"Freedom of speech\">freedom of speech</a> and <a href=\"/wiki/Whistleblower\" title=\"Whistleblower\">whistleblowers</a> and awarded her $1.37<span>&nbsp;</span>million.<sup id=\"cite_ref-184\"><a href=\"#cite_note-184\">[184]</a></sup>\n</p>\n<h3><span id=\"Celebrex_intellectual_property\">Celebrex intellectual property</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=28\" title=\"Edit section: Celebrex intellectual property\">edit</a><span>]</span></span></h3>\n<p><a href=\"/wiki/Brigham_Young_University\" title=\"Brigham Young University\">Brigham Young University</a> (BYU) said a professor of chemistry, Dr. <a href=\"/wiki/Daniel_L._Simmons\" title=\"Daniel L. Simmons\">Daniel L. Simmons</a>, discovered an enzyme in the 1990s that led towards development of <a href=\"/wiki/Celebrex\" title=\"Celebrex\">Celebrex</a>. BYU was originally seeking a 15% royalty on sales, equating to $9.7<span>&nbsp;</span>billion. A research agreement had been made between BYU and <a href=\"/wiki/Monsanto\" title=\"Monsanto\">Monsanto</a>, whose pharmaceutical business was later acquired by Pfizer, to develop a better <a href=\"/wiki/Aspirin\" title=\"Aspirin\">aspirin</a>. The enzyme Dr. Simmons claims to have discovered would induce pain and inflammation while causing gastrointestinal problems and Celebrex is used to reduce those issues. A six-year battle ensued because BYU claimed that Pfizer did not give Dr. Simmons credit or compensation, while Pfizer claimed that it had met all obligations regarding the Monsanto agreement. In May 2012, Pfizer settled the allegations, agreeing to pay $450<span>&nbsp;</span>million.<sup id=\"cite_ref-185\"><a href=\"#cite_note-185\">[185]</a></sup>\n</p>\n<h3><span id=\"Nigeria_Trovafloxacin_lawsuit\">Nigeria Trovafloxacin lawsuit</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=29\" title=\"Edit section: Nigeria Trovafloxacin lawsuit\">edit</a><span>]</span></span></h3>\n\n<p>In 1996, an outbreak of measles, cholera, and bacterial meningitis occurred in Nigeria. Pfizer representatives and personnel from a contract research organization (CRO) traveled to <a href=\"/wiki/Kano_(city)\" title=\"Kano (city)\">Kano</a> to set up a clinical trial and administer an experimental <a href=\"/wiki/Antibiotic\" title=\"Antibiotic\">antibiotic</a>, <a href=\"/wiki/Trovafloxacin\" title=\"Trovafloxacin\">trovafloxacin</a>, to approximately 200 children.<sup id=\"cite_ref-186\"><a href=\"#cite_note-186\">[186]</a></sup> Local Kano officials reported that more than fifty children died in the experiment, while many others developed mental and physical deformities.<sup id=\"cite_ref-187\"><a href=\"#cite_note-187\">[187]</a></sup> The nature and frequency of both fatalities and other adverse outcomes were similar to those historically found among pediatric patients treated for meningitis in sub-Saharan Africa.<sup id=\"cite_ref-188\"><a href=\"#cite_note-188\">[188]</a></sup> In 2001, families of the children, as well as the governments of Kano and Nigeria, filed lawsuits regarding the treatment.<sup id=\"cite_ref-189\"><a href=\"#cite_note-189\">[189]</a></sup> According to <i><a href=\"/wiki/Democracy_Now!\" title=\"Democracy Now!\">Democracy Now!</a></i>, \"[r]esearchers did not obtain signed consent forms, and medical personnel said Pfizer did not tell parents their children were getting the experimental drug.\"<sup id=\"cite_ref-DN_190-0\"><a href=\"#cite_note-DN-190\">[190]</a></sup> The lawsuits also accused Pfizer of using the outbreak to perform unapproved human testing, as well as allegedly under-dosing a control group being treated with traditional antibiotics in order to skew the results of the trial in favor of Trovan. Nigerian medical personnel as well as at least one Pfizer physician said the trial was conducted without regulatory approval.<sup id=\"cite_ref-191\"><a href=\"#cite_note-191\">[191]</a></sup><sup id=\"cite_ref-192\"><a href=\"#cite_note-192\">[192]</a></sup>\n</p><p>In 2007, Pfizer published a Statement of Defense letter.<sup id=\"cite_ref-193\"><a href=\"#cite_note-193\">[193]</a></sup> The letter stated that the drug's oral form was safer and easier to administer, that Trovan had been used safely in more than five thousand Americans prior to the Nigerian trial, that mortality in the patients treated by Pfizer was lower than that observed historically in African meningitis epidemics, and that no unusual side effects, unrelated to meningitis, were observed after four weeks.\n</p><p>In June 2010, the US Supreme Court rejected Pfizer's appeal against a ruling allowing lawsuits by the Nigerian families to proceed.<sup id=\"cite_ref-194\"><a href=\"#cite_note-194\">[194]</a></sup>\n</p><p>In December 2010, a <a href=\"/wiki/United_States_diplomatic_cables_leak\" title=\"United States diplomatic cables leak\">United States diplomatic cables leak</a> was released by <a href=\"/wiki/WikiLeaks\" title=\"WikiLeaks\">WikiLeaks</a> indicating that Pfizer hired investigators to find evidence of corruption against Nigerian attorney general Aondoakaa to persuade him to drop legal action.<sup id=\"cite_ref-195\"><a href=\"#cite_note-195\">[195]</a></sup> <i><a href=\"/wiki/The_Washington_Post\" title=\"The Washington Post\">The Washington Post</a></i> reporter Joe Stephens, who helped break the story in 2000, called these actions \"dangerously close to blackmail\".<sup id=\"cite_ref-DN_190-1\"><a href=\"#cite_note-DN-190\">[190]</a></sup> In response, the company released a press statement describing the allegations as \"preposterous\" and saying that it acted in good faith.<sup id=\"cite_ref-196\"><a href=\"#cite_note-196\">[196]</a></sup> Aondoakka, who had allegedly demanded bribes from Pfizer in return for a settlement of the case,<sup id=\"cite_ref-197\"><a href=\"#cite_note-197\">[197]</a></sup> was declared unfit for office and had his U.S. visa revoked in association with corruption charges in 2010.<sup id=\"cite_ref-198\"><a href=\"#cite_note-198\">[198]</a></sup><sup id=\"cite_ref-199\"><a href=\"#cite_note-199\">[199]</a></sup>\n</p><p>The lawsuits were eventually settled out of court. Pfizer committed to paying US$35 million \"to compensate the families of children in the study\", another US$30 million to \"support healthcare initiatives in Kano\", and 10 million to cover legal costs. Payouts began in 2011.<sup id=\"cite_ref-200\"><a href=\"#cite_note-200\">[200]</a></sup>\n</p>\n<h2><span id=\"Environmental_record\">Environmental record</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=30\" title=\"Edit section: Environmental record\">edit</a><span>]</span></span></h2>\n<p>Since 2000, the company has implemented more than 4,000 <a href=\"/wiki/Greenhouse_gas\" title=\"Greenhouse gas\">greenhouse gas</a> reduction projects.<sup id=\"cite_ref-201\"><a href=\"#cite_note-201\">[201]</a></sup>\n</p><p>In 2012, the company was named to the <a href=\"/wiki/Carbon_Disclosure_Project\" title=\"Carbon Disclosure Project\">Carbon Disclosure Project</a>'s Carbon Leadership Index in recognition of its efforts to reduce <a href=\"/wiki/Greenhouse_gas_emissions\" title=\"Greenhouse gas emissions\">greenhouse gas emissions</a>.<sup id=\"cite_ref-202\"><a href=\"#cite_note-202\">[202]</a></sup>\n</p><p>Pfizer has inherited Wyeth's liabilities in the <a href=\"/wiki/American_Cyanamid\" title=\"American Cyanamid\">American Cyanamid</a> site in <a href=\"/wiki/Bridgewater_Township,_New_Jersey\" title=\"Bridgewater Township, New Jersey\">Bridgewater Township, New Jersey</a>, a highly toxic EPA <a href=\"/wiki/Superfund\" title=\"Superfund\">Superfund</a> site. Pfizer has since attempted to remediate this land in order to clean and develop it for future profits and potential public uses.<sup id=\"cite_ref-203\"><a href=\"#cite_note-203\">[203]</a></sup> The <a href=\"/wiki/Sierra_Club\" title=\"Sierra Club\">Sierra Club</a> and the <a href=\"/wiki/Edison_Wetlands_Association\" title=\"Edison Wetlands Association\">Edison Wetlands Association</a> have opposed the cleanup plan, arguing that the area is subject to flooding, which could cause pollutants to leach. The EPA considers the plan the most reasonable from considerations of safety and cost-effectiveness, arguing that an alternative plan involving trucking <a href=\"/wiki/Contaminated_soil\" title=\"Contaminated soil\">contaminated soil</a> off site could expose cleanup workers. The EPA's position is backed by the environmental watchdog group CRISIS.<sup id=\"cite_ref-204\"><a href=\"#cite_note-204\">[204]</a></sup>\n</p><p>In June 2002, a chemical explosion at the Groton plant injured 7 people and caused the evacuation of more than 100 homes in the surrounding area.<sup id=\"cite_ref-205\"><a href=\"#cite_note-205\">[205]</a></sup>\n</p>\n<h2><span id=\"Outreach\">Outreach</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=31\" title=\"Edit section: Outreach\">edit</a><span>]</span></span></h2>\n<h3><span id=\"Political_lobbying\">Political lobbying</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=32\" title=\"Edit section: Political lobbying\">edit</a><span>]</span></span></h3>\n<p>Pfizer is a member of the <a href=\"/wiki/U.S._Global_Leadership_Coalition\" title=\"U.S. Global Leadership Coalition\">U.S. Global Leadership Coalition</a>, a Washington D.C.-based coalition of more than 400 major companies and NGOs that advocates for a larger International Affairs budget, which funds American diplomatic, humanitarian, and development efforts abroad.<sup id=\"cite_ref-206\"><a href=\"#cite_note-206\">[206]</a></sup>\n</p><p>Pfizer is a member company of <a href=\"/wiki/Pharmaceutical_Research_and_Manufacturers_of_America\" title=\"Pharmaceutical Research and Manufacturers of America\">Pharmaceutical Research and Manufacturers of America</a> (PhRMA), a trade association that lobbies the <a href=\"/wiki/U.S._Government\" title=\"U.S. Government\">U.S. Government</a> on behalf of the <a href=\"/wiki/Pharmaceutical_industry\" title=\"Pharmaceutical industry\">pharmaceutical industry</a>.<sup id=\"cite_ref-207\"><a href=\"#cite_note-207\">[207]</a></sup> PhRMA has offices in <a href=\"/wiki/Washington,_D.C.\" title=\"Washington, D.C.\">Washington, D.C.</a>, <a href=\"/wiki/Japan\" title=\"Japan\">Japan</a> and the <a href=\"/wiki/United_Arab_Emirates\" title=\"United Arab Emirates\">United Arab Emirates</a>.<sup id=\"cite_ref-208\"><a href=\"#cite_note-208\">[208]</a></sup>\n</p><p>Pfizer is a member organization of the <a href=\"/wiki/National_Health_Council\" title=\"National Health Council\">National Health Council</a>, a non-profit organization that lobbies the <a href=\"/wiki/U.S._Government\" title=\"U.S. Government\">U.S. Government</a> on issues related to <a href=\"/wiki/Healthcare_reform_in_the_United_States\" title=\"Healthcare reform in the United States\">healthcare reform</a>.<sup id=\"cite_ref-209\"><a href=\"#cite_note-209\">[209]</a></sup>\n</p><p>Pfizer is a member organization of Research!America, a medical research advocacy group.<sup id=\"cite_ref-210\"><a href=\"#cite_note-210\">[210]</a></sup>\n</p><p>Pfizer is a partner organization of the <a href=\"/wiki/World_Economic_Forum\" title=\"World Economic Forum\">World Economic Forum</a>,<sup id=\"cite_ref-211\"><a href=\"#cite_note-211\">[211]</a></sup> through which CEO <a href=\"/wiki/Albert_Bourla\" title=\"Albert Bourla\">Albert Bourla</a> wrote in 2018 about the need to explore the consequences of tech-based personalized health care through filters of society, economy and politics.<sup id=\"cite_ref-212\"><a href=\"#cite_note-212\">[212]</a></sup>\n</p><p><a href=\"/wiki/Scott_Gottlieb\" title=\"Scott Gottlieb\">Scott Gottlieb</a>, who resigned as <a href=\"/wiki/FDA_commissioner\" title=\"FDA commissioner\">FDA commissioner</a> in April 2019, joined the Pfizer <a href=\"/wiki/Board_of_directors\" title=\"Board of directors\">board of directors</a> three months later, in July 2019.<sup id=\"cite_ref-213\"><a href=\"#cite_note-213\">[213]</a></sup>\n</p><p>Pfizer is a member of the Personalized Medicine Coalition, a lobbying group with ties to members of the <a href=\"/wiki/United_States_Congress\" title=\"United States Congress\">United States Congress</a>.<sup id=\"cite_ref-214\"><a href=\"#cite_note-214\">[214]</a></sup>\n</p><p>Pfizer is a member company of Innovative Medicines Canada, an association of pharmaceutical companies doing business in Canada.<sup id=\"cite_ref-215\"><a href=\"#cite_note-215\">[215]</a></sup> The group lobbies the <a href=\"/wiki/Government_of_Ontario\" title=\"Government of Ontario\">Government of Ontario</a> through Rubicon Strategy, a firm owned by <a href=\"/wiki/Progressive_Conservative_Party_of_Ontario\" title=\"Progressive Conservative Party of Ontario\">Progressive Conservative Party of Ontario</a> campaign manager <a href=\"/wiki/Kory_Teneycke\" title=\"Kory Teneycke\">Kory Teneycke</a>.<sup id=\"cite_ref-216\"><a href=\"#cite_note-216\">[216]</a></sup><sup id=\"cite_ref-217\"><a href=\"#cite_note-217\">[217]</a></sup>\n</p><p>Pfizer has donated between $5,000,000 and $9,999,999 to the <a href=\"/wiki/Foundation_for_the_National_Institutes_of_Health\" title=\"Foundation for the National Institutes of Health\">Foundation for the National Institutes of Health</a> between 1997 and 2020.<sup id=\"cite_ref-218\"><a href=\"#cite_note-218\">[218]</a></sup>\n</p>\n<h3><span id=\"Media\">Media</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=33\" title=\"Edit section: Media\">edit</a><span>]</span></span></h3>\n<p>During the <a href=\"/wiki/COVID-19_pandemic\" title=\"COVID-19 pandemic\">COVID-19 pandemic</a>, Pfizer engaged many forms of media to promote their <a href=\"/wiki/Pfizer_COVID-19_vaccine\" title=\"Pfizer COVID-19 vaccine\">COVID-19 vaccine</a>, including paid editorial content on <a href=\"/wiki/CNBC\" title=\"CNBC\">CNBC</a> and a commissioned <a href=\"/wiki/National_Geographic\" title=\"National Geographic\">National Geographic</a> documentary.<sup id=\"cite_ref-219\"><a href=\"#cite_note-219\">[219]</a></sup>\n</p>\n<h3><span id=\"Public_health\">Public health</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=34\" title=\"Edit section: Public health\">edit</a><span>]</span></span></h3>\n<p>Pfizer is one of several pharmaceutical companies disclosed as supporters of the <a href=\"/wiki/Canadian_Public_Health_Association\" title=\"Canadian Public Health Association\">Canadian Public Health Association</a> in their 2018 annual report.<sup id=\"cite_ref-220\"><a href=\"#cite_note-220\">[220]</a></sup> \n</p><p>Pfizer has provided funding to the <a href=\"/wiki/Canadian_Paediatric_Society\" title=\"Canadian Paediatric Society\">Canadian Paediatric Society</a>, the organization that administers the Canadian Immunization Monitoring Program, Active (IMPACT) vaccine safety program.<sup id=\"cite_ref-:2_221-0\"><a href=\"#cite_note-:2-221\">[221]</a></sup> \n</p><p>Pfizer sponsored a presentation in January 2020 delivered through the <a href=\"/wiki/Provincial_Health_Services_Authority\" title=\"Provincial Health Services Authority\">Provincial Health Services Authority</a> titled \"Vaccine hesitancy: It doesn't matter if the vaccine works if nobody gets it.\"<sup id=\"cite_ref-:2_221-1\"><a href=\"#cite_note-:2-221\">[221]</a></sup><sup id=\"cite_ref-222\"><a href=\"#cite_note-222\">[222]</a></sup> \n</p>\n<h3><span id=\"Medical_research\">Medical research</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=35\" title=\"Edit section: Medical research\">edit</a><span>]</span></span></h3>\n<p>Pfizer is an Industry Partner of the Canadian Frailty Network,<sup id=\"cite_ref-223\"><a href=\"#cite_note-223\">[223]</a></sup> which has provided research grants related to <a href=\"/wiki/COVID-19\" title=\"COVID-19\">COVID-19</a>.<sup id=\"cite_ref-224\"><a href=\"#cite_note-224\">[224]</a></sup>\n</p>\n<h2><span id=\"See_also\">See also</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=36\" title=\"Edit section: See also\">edit</a><span>]</span></span></h2>\n\n<ul><li><a href=\"/wiki/Biotech_and_pharmaceutical_companies_in_the_New_York_metropolitan_area\" title=\"Biotech and pharmaceutical companies in the New York metropolitan area\">Biotech and pharmaceutical companies in the New York metropolitan area</a></li>\n<li><a href=\"/wiki/Companies_of_the_United_States_with_untaxed_profits\" title=\"Companies of the United States with untaxed profits\">Companies of the United States with untaxed profits</a></li>\n<li><a href=\"/wiki/Fire_in_the_Blood_(2013_film)\" title=\"Fire in the Blood (2013 film)\">Fire in the Blood (2013 film)</a></li>\n<li><a href=\"/wiki/List_of_pharmaceutical_companies\" title=\"List of pharmaceutical companies\">List of pharmaceutical companies</a></li></ul>\n<h2><span id=\"References\">References</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=37\" title=\"Edit section: References\">edit</a><span>]</span></span></h2>\n<div><ol>\n<li id=\"cite_note-10K-1\"><span>^ <a href=\"#cite_ref-10K_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-10K_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-10K_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-10K_1-3\"><sup><i><b>d</b></i></sup></a></span> <span><cite><a rel=\"nofollow\" href=\"https://s21.q4cdn.com/317678438/files/doc_financials/2020/ar/PFE-2020-Form-10K-FINAL.pdf\">\"Pfizer Inc. 2020 Form 10-K Annual Report\"</a> <span>(PDF)</span>. Pfizer.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Inc.+2020+Form+10-K+Annual+Report&amp;rft.pub=Pfizer&amp;rft_id=https%3A%2F%2Fs21.q4cdn.com%2F317678438%2Ffiles%2Fdoc_financials%2F2020%2Far%2FPFE-2020-Form-10K-FINAL.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-2\"><span><b><a href=\"#cite_ref-2\">^</a></b></span> <span><cite id=\"CITEREFWells2008\">Wells, John C. (2008), <i>Longman Pronunciation Dictionary</i> (3rd&nbsp;ed.), <a href=\"/wiki/Longman\" title=\"Longman\">Longman</a>, <a href=\"/wiki/ISBN_(identifier)\" title=\"ISBN (identifier)\">ISBN</a>&nbsp;<a href=\"/wiki/Special:BookSources/9781405881180\" title=\"Special:BookSources/9781405881180\"><bdi>9781405881180</bdi></a></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Longman+Pronunciation+Dictionary&amp;rft.edition=3rd&amp;rft.pub=Longman&amp;rft.date=2008&amp;rft.isbn=9781405881180&amp;rft.aulast=Wells&amp;rft.aufirst=John+C.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-3\"><span><b><a href=\"#cite_ref-3\">^</a></b></span> <span><cite id=\"CITEREFBomey2020\">Bomey, Nathan (August 25, 2020). <a rel=\"nofollow\" href=\"https://www.usatoday.com/story/money/2020/08/25/exxon-pfizer-dow-jones-industrial-average-salesforce-djia/5630916002/\">\"Exxon Mobil, Pfizer removed from Dow Jones Industrial Average; Salesforce, Honeywell added\"</a>. <i><a href=\"/wiki/USA_Today\" title=\"USA Today\">USA Today</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=USA+Today&amp;rft.atitle=Exxon+Mobil%2C+Pfizer+removed+from+Dow+Jones+Industrial+Average%3B+Salesforce%2C+Honeywell+added&amp;rft.date=2020-08-25&amp;rft.aulast=Bomey&amp;rft.aufirst=Nathan&amp;rft_id=https%3A%2F%2Fwww.usatoday.com%2Fstory%2Fmoney%2F2020%2F08%2F25%2Fexxon-pfizer-dow-jones-industrial-average-salesforce-djia%2F5630916002%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-4\"><span><b><a href=\"#cite_ref-4\">^</a></b></span> <span><cite id=\"CITEREFStevens2020\">Stevens, Pippa (August 24, 2020). <a rel=\"nofollow\" href=\"https://www.cnbc.com/2020/08/24/salesforce-amgen-and-honeywell-added-to-dow-in-major-shakeup-to-the-average.html\">\"Salesforce, Amgen and Honeywell added to Dow in major shake-up to the average\"</a>. <i><a href=\"/wiki/CNBC\" title=\"CNBC\">CNBC</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNBC&amp;rft.atitle=Salesforce%2C+Amgen+and+Honeywell+added+to+Dow+in+major+shake-up+to+the+average&amp;rft.date=2020-08-24&amp;rft.aulast=Stevens&amp;rft.aufirst=Pippa&amp;rft_id=https%3A%2F%2Fwww.cnbc.com%2F2020%2F08%2F24%2Fsalesforce-amgen-and-honeywell-added-to-dow-in-major-shakeup-to-the-average.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-5\"><span><b><a href=\"#cite_ref-5\">^</a></b></span> <span><cite id=\"CITEREFPonczekGreifeld2020\">Ponczek, Sarah; Greifeld, Katherine (August 24, 2020). <span title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" href=\"https://www.bloomberg.com/news/articles/2020-08-24/dow-industrials-kicks-out-exxon-in-biggest-shakeup-since-2013\">\"Exxon Booted from Dow Industrials in Major Embrace of Tech\"</a></span>. <i><a href=\"/wiki/Bloomberg_News\" title=\"Bloomberg News\">Bloomberg News</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+News&amp;rft.atitle=Exxon+Booted+from+Dow+Industrials+in+Major+Embrace+of+Tech&amp;rft.date=2020-08-24&amp;rft.aulast=Ponczek&amp;rft.aufirst=Sarah&amp;rft.au=Greifeld%2C+Katherine&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2020-08-24%2Fdow-industrials-kicks-out-exxon-in-biggest-shakeup-since-2013&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-6\"><span><b><a href=\"#cite_ref-6\">^</a></b></span> <span>\n<cite id=\"CITEREFLevisohn2020\">Levisohn, Ben (August 25, 2020). <span title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" href=\"https://www.barrons.com/articles/exxon-and-pfizer-just-got-booted-from-the-dow-jones-industrial-average-heres-whats-replacing-them-51598307204\">\"Exxon and Pfizer Just Got Booted From the Dow. Here's What's Replacing Them\"</a></span>. <i><a href=\"/wiki/Barron%27s_(newspaper)\" title=\"Barron's (newspaper)\">Barron's</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Barron%27s&amp;rft.atitle=Exxon+and+Pfizer+Just+Got+Booted+From+the+Dow.+Here%27s+What%27s+Replacing+Them.&amp;rft.date=2020-08-25&amp;rft.aulast=Levisohn&amp;rft.aufirst=Ben&amp;rft_id=https%3A%2F%2Fwww.barrons.com%2Farticles%2Fexxon-and-pfizer-just-got-booted-from-the-dow-jones-industrial-average-heres-whats-replacing-them-51598307204&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-7\"><span><b><a href=\"#cite_ref-7\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://fortune.com/company/pfizer/fortune500/\">\"Fortune 500: Pfizer\"</a>. <a href=\"/wiki/Fortune_(magazine)\" title=\"Fortune (magazine)\">Fortune</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Fortune+500%3A+Pfizer&amp;rft.pub=Fortune&amp;rft_id=https%3A%2F%2Ffortune.com%2Fcompany%2Fpfizer%2Ffortune500%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-8\"><span><b><a href=\"#cite_ref-8\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.forbes.com/companies/pfizer/?sh=67d299422d6b\">\"Forbes Global 2000: Pfizer\"</a>. <i><a href=\"/wiki/Forbes\" title=\"Forbes\">Forbes</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Forbes&amp;rft.atitle=Forbes+Global+2000%3A+Pfizer&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fcompanies%2Fpfizer%2F%3Fsh%3D67d299422d6b&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-Citycyclopedia-9\"><span>^ <a href=\"#cite_ref-Citycyclopedia_9-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Citycyclopedia_9-1\"><sup><i><b>b</b></i></sup></a></span> <span>Kenneth T. Jackson. <i>The Encyclopedia of New York City</i>. The New York Historical Society; Yale University Press; September 1995. P. 895. <a href=\"/wiki/ISBN_(identifier)\" title=\"ISBN (identifier)\">ISBN</a>&nbsp;<a href=\"/wiki/Special:BookSources/978-0-300-05536-8\" title=\"Special:BookSources/978-0-300-05536-8\">978-0-300-05536-8</a></span>\n</li>\n<li id=\"cite_note-10\"><span><b><a href=\"#cite_ref-10\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.nytimes.com/2007/01/28/nyregion/28pfizer.html\">\"Pfizer's Birthplace, Soon Without Pfizer\"</a>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>. January 28, 2007.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer%27s+Birthplace%2C+Soon+Without+Pfizer&amp;rft.date=2007-01-28&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2007%2F01%2F28%2Fnyregion%2F28pfizer.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-collection-11\"><span>^ <a href=\"#cite_ref-collection_11-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-collection_11-1\"><sup><i><b>b</b></i></sup></a></span> <span><cite><a rel=\"nofollow\" href=\"http://dlib.nyu.edu/findingaids/html/bhs/arc_084_pfizer/bioghist.html\">\"Guide to the Pfizer Inc. collection ARC.084\"</a>. <a href=\"/wiki/Brooklyn_Public_Library\" title=\"Brooklyn Public Library\">Brooklyn Public Library</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Guide+to+the+Pfizer+Inc.+collection+ARC.084&amp;rft.pub=Brooklyn+Public+Library&amp;rft_id=http%3A%2F%2Fdlib.nyu.edu%2Ffindingaids%2Fhtml%2Fbhs%2Farc_084_pfizer%2Fbioghist.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-history-12\"><span>^ <a href=\"#cite_ref-history_12-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-history_12-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-history_12-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-history_12-3\"><sup><i><b>d</b></i></sup></a></span> <span><cite><a rel=\"nofollow\" href=\"https://www.pfizer.com/people/history\">\"Our People – The Journey\"</a>. <i>Pfizer</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Pfizer&amp;rft.atitle=Our+People+%E2%80%93+The+Journey&amp;rft_id=https%3A%2F%2Fwww.pfizer.com%2Fpeople%2Fhistory&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span><span><code>{{<a href=\"/wiki/Template:Cite_web\" title=\"Template:Cite web\">cite web</a>}}</code>:  CS1 maint: url-status (<a href=\"/wiki/Category:CS1_maint:_url-status\" title=\"Category:CS1 maint: url-status\">link</a>)</span></span>\n</li>\n<li id=\"cite_note-Fermentation-13\"><span>^ <a href=\"#cite_ref-Fermentation_13-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Fermentation_13-1\"><sup><i><b>b</b></i></sup></a></span> <span><cite><a rel=\"nofollow\" href=\"https://www.acs.org/content/acs/en/education/whatischemistry/landmarks/penicillin.html\">\"Penicillin Production through Deep-tank Fermentation – National Historic Chemical Landmark\"</a>. <a href=\"/wiki/American_Chemical_Society\" title=\"American Chemical Society\">American Chemical Society</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Penicillin+Production+through+Deep-tank+Fermentation+%E2%80%93+National+Historic+Chemical+Landmark&amp;rft.pub=American+Chemical+Society&amp;rft_id=https%3A%2F%2Fwww.acs.org%2Fcontent%2Facs%2Fen%2Feducation%2Fwhatischemistry%2Flandmarks%2Fpenicillin.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-14\"><span><b><a href=\"#cite_ref-14\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.drugs.com/monograph/fluconazole.html\">\"Fluconazole\"</a>. The American Society of Health-System Pharmacists. <a rel=\"nofollow\" href=\"https://web.archive.org/web/20161220231218/https://www.drugs.com/monograph/fluconazole.html\">Archived</a> from the original on December 20, 2016.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Fluconazole&amp;rft.pub=The+American+Society+of+Health-System+Pharmacists&amp;rft_id=https%3A%2F%2Fwww.drugs.com%2Fmonograph%2Ffluconazole.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-best-15\"><span><b><a href=\"#cite_ref-best_15-0\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.wipo.int/ipadvantage/en/details.jsp?id=906\">\"Azithromycin: A world best-selling Antibiotic\"</a>. <a href=\"/wiki/World_Intellectual_Property_Organization\" title=\"World Intellectual Property Organization\">World Intellectual Property Organization</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Azithromycin%3A+A+world+best-selling+Antibiotic&amp;rft.pub=World+Intellectual+Property+Organization&amp;rft_id=https%3A%2F%2Fwww.wipo.int%2Fipadvantage%2Fen%2Fdetails.jsp%3Fid%3D906&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-16\"><span><b><a href=\"#cite_ref-16\">^</a></b></span> <span><cite id=\"CITEREFMandellWunderinkAnzueto2007\">Mandell LA, Wunderink RG, Anzueto A,  et&nbsp;al. (March 2007). <a rel=\"nofollow\" href=\"https://www.thoracic.org/statements/resources/mtpi/idsaats-cap.pdf\">\"Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults\"</a> <span>(PDF)</span>. <i>Clin. Infect. Dis</i>. 44 Suppl 2: S27–72. <a href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" href=\"https://doi.org/10.1086%2F511159\">10.1086/511159</a>. <a href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a>&nbsp;<span title=\"Freely accessible\"><a rel=\"nofollow\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC7107997\">7107997</a></span>. <a href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a>&nbsp;<a rel=\"nofollow\" href=\"//pubmed.ncbi.nlm.nih.gov/17278083\">17278083</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin.+Infect.+Dis.&amp;rft.atitle=Infectious+Diseases+Society+of+America%2FAmerican+Thoracic+Society+consensus+guidelines+on+the+management+of+community-acquired+pneumonia+in+adults&amp;rft.volume=44+Suppl+2&amp;rft.pages=S27-72&amp;rft.date=2007-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7107997%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F17278083&amp;rft_id=info%3Adoi%2F10.1086%2F511159&amp;rft.aulast=Mandell&amp;rft.aufirst=LA&amp;rft.au=Wunderink%2C+RG&amp;rft.au=Anzueto%2C+A&amp;rft_id=https%3A%2F%2Fwww.thoracic.org%2Fstatements%2Fresources%2Fmtpi%2Fidsaats-cap.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-17\"><span><b><a href=\"#cite_ref-17\">^</a></b></span> <span><cite id=\"CITEREFWilson2013\">Wilson, Jacque (March 27, 2013). <a rel=\"nofollow\" href=\"https://www.cnn.com/2013/03/27/health/viagra-anniversary-timeline/index.html\">\"Viagra: The little blue pill that could\"</a>. <i><a href=\"/wiki/CNN\" title=\"CNN\">CNN</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNN&amp;rft.atitle=Viagra%3A+The+little+blue+pill+that+could&amp;rft.date=2013-03-27&amp;rft.aulast=Wilson&amp;rft.aufirst=Jacque&amp;rft_id=https%3A%2F%2Fwww.cnn.com%2F2013%2F03%2F27%2Fhealth%2Fviagra-anniversary-timeline%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-18\"><span><b><a href=\"#cite_ref-18\">^</a></b></span> <span><cite id=\"CITEREFCox2019\">Cox, David (June 9, 2019). <a rel=\"nofollow\" href=\"https://www.theguardian.com/science/2019/jun/09/race-to-replace-viagra-patents-erectile-dysfunction-drug-medical-research-cialis-eroxon\">\"The race to replace Viagra\"</a>. <i><a href=\"/wiki/The_Guardian\" title=\"The Guardian\">The Guardian</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Guardian&amp;rft.atitle=The+race+to+replace+Viagra&amp;rft.date=2019-06-09&amp;rft.aulast=Cox&amp;rft.aufirst=David&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fscience%2F2019%2Fjun%2F09%2Frace-to-replace-viagra-patents-erectile-dysfunction-drug-medical-research-cialis-eroxon&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-19\"><span><b><a href=\"#cite_ref-19\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.latimes.com/archives/la-xpm-1991-03-29-fi-903-story.html\">\"Pfizer Inc., New York, has elected its...\"</a> <i><a href=\"/wiki/Los_Angeles_Times\" title=\"Los Angeles Times\">Los Angeles Times</a></i>. March 29, 1991.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Los+Angeles+Times&amp;rft.atitle=Pfizer+Inc.%2C+New+York%2C+has+elected+its...&amp;rft.date=1991-03-29&amp;rft_id=https%3A%2F%2Fwww.latimes.com%2Farchives%2Fla-xpm-1991-03-29-fi-903-story.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-20\"><span><b><a href=\"#cite_ref-20\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.reed.edu/reed-magazine/in-memoriam/obituaries/_online_only/kenneth-koe-1945.html\">\"Kenneth Koe '45\"</a>. <i>Reed Magazine</i>. <a href=\"/wiki/Reed_College\" title=\"Reed College\">Reed College</a>. December 2015<span>. Retrieved <span>May 18,</span> 2021</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Reed+Magazine&amp;rft.atitle=Kenneth+Koe+%2745&amp;rft.date=2015-12&amp;rft_id=https%3A%2F%2Fwww.reed.edu%2Freed-magazine%2Fin-memoriam%2Fobituaries%2F_online_only%2Fkenneth-koe-1945.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span><span><code>{{<a href=\"/wiki/Template:Cite_web\" title=\"Template:Cite web\">cite web</a>}}</code>:  CS1 maint: url-status (<a href=\"/wiki/Category:CS1_maint:_url-status\" title=\"Category:CS1 maint: url-status\">link</a>)</span></span>\n</li>\n<li id=\"cite_note-21\"><span><b><a href=\"#cite_ref-21\">^</a></b></span> <span><cite id=\"CITEREFSmith2006\">Smith, Aaron (April 4, 2006). <a rel=\"nofollow\" href=\"https://money.cnn.com/2006/04/04/news/companies/antidepressants/\">\"Who stands to gain when Zoloft goes generic?\"</a>. <i><a href=\"/wiki/CNN_Money\" title=\"CNN Money\">CNN Money</a></i><span>. Retrieved <span>May 18,</span> 2021</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNN+Money&amp;rft.atitle=Who+stands+to+gain+when+Zoloft+goes+generic%3F&amp;rft.date=2006-04-04&amp;rft.aulast=Smith&amp;rft.aufirst=Aaron&amp;rft_id=https%3A%2F%2Fmoney.cnn.com%2F2006%2F04%2F04%2Fnews%2Fcompanies%2Fantidepressants%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-22\"><span><b><a href=\"#cite_ref-22\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020690s035,021720s008,022568s005lbl.pdf\">\"Highlights of Prescribing Information\"</a> <span>(PDF)</span>. <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Highlights+of+Prescribing+Information&amp;rft.pub=Food+and+Drug+Administration&amp;rft_id=https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2012%2F020690s035%2C021720s008%2C022568s005lbl.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-23\"><span><b><a href=\"#cite_ref-23\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.accessdata.fda.gov/drugsatfda_docs/nda/96/19-787s007_Amlodipine.cfm\">\"Drug Approval Package\"</a>. <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Drug+Approval+Package&amp;rft.pub=Food+and+Drug+Administration&amp;rft_id=https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Fnda%2F96%2F19-787s007_Amlodipine.cfm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-24\"><span><b><a href=\"#cite_ref-24\">^</a></b></span> <span><cite id=\"CITEREFMehta2011\">Mehta, Praful (November 29, 2011). <a rel=\"nofollow\" href=\"https://ihsmarkit.com/research-analysis/lipitor-patent-expiration-atorvastatin-sales.html\">\"Lipitor Patent Expiration - The End of an Era for Atorvastatin Sales\"</a>. <i><a href=\"/wiki/IHS_Markit\" title=\"IHS Markit\">IHS Markit</a></i><span>. Retrieved <span>May 18,</span> 2021</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=IHS+Markit&amp;rft.atitle=Lipitor+Patent+Expiration+-+The+End+of+an+Era+for+Atorvastatin+Sales&amp;rft.date=2011-11-29&amp;rft.aulast=Mehta&amp;rft.aufirst=Praful&amp;rft_id=https%3A%2F%2Fihsmarkit.com%2Fresearch-analysis%2Flipitor-patent-expiration-atorvastatin-sales.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-longshot-25\"><span>^ <a href=\"#cite_ref-longshot_25-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-longshot_25-1\"><sup><i><b>b</b></i></sup></a></span> <span><cite id=\"CITEREFBerenson2006\"><a href=\"/wiki/Alex_Berenson\" title=\"Alex Berenson\">Berenson, Alex</a> (July 29, 2006). <span title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" href=\"https://www.nytimes.com/2006/07/29/business/29pfizer.html\">\"A Long Shot Becomes Pfizer's Latest Chief Executive\"</a></span>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=A+Long+Shot+Becomes+Pfizer%27s+Latest+Chief+Executive&amp;rft.date=2006-07-29&amp;rft.aulast=Berenson&amp;rft.aufirst=Alex&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2006%2F07%2F29%2Fbusiness%2F29pfizer.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-26\"><span><b><a href=\"#cite_ref-26\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.drugs.com/monograph/pregabalin.html\">\"Pregabalin\"</a>. <a href=\"/wiki/American_Society_of_Health-System_Pharmacists\" title=\"American Society of Health-System Pharmacists\">American Society of Health-System Pharmacists</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pregabalin&amp;rft.pub=American+Society+of+Health-System+Pharmacists&amp;rft_id=https%3A%2F%2Fwww.drugs.com%2Fmonograph%2Fpregabalin.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-27\"><span><b><a href=\"#cite_ref-27\">^</a></b></span> <span><cite id=\"CITEREFFrampton2014\">Frampton, James E. (September 2014). \"Pregabalin: A Review of its Use in Adults with Generalized Anxiety Disorder\". <i>CNS Drugs</i>. <b>28</b> (9): 835–854. <a href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" href=\"https://doi.org/10.1007%2Fs40263-014-0192-0\">10.1007/s40263-014-0192-0</a>. <a href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a>&nbsp;<a rel=\"nofollow\" href=\"//pubmed.ncbi.nlm.nih.gov/25149863\">25149863</a>. <a href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a>&nbsp;<a rel=\"nofollow\" href=\"https://api.semanticscholar.org/CorpusID:5349255\">5349255</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNS+Drugs&amp;rft.atitle=Pregabalin%3A+A+Review+of+its+Use+in+Adults+with+Generalized+Anxiety+Disorder&amp;rft.volume=28&amp;rft.issue=9&amp;rft.pages=835-854&amp;rft.date=2014-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A5349255%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25149863&amp;rft_id=info%3Adoi%2F10.1007%2Fs40263-014-0192-0&amp;rft.aulast=Frampton&amp;rft.aufirst=James+E.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-28\"><span><b><a href=\"#cite_ref-28\">^</a></b></span> <span><cite id=\"CITEREFIftikharAlghothaniTrotti2017\">Iftikhar, I. H.; Alghothani, L.; Trotti, L. M. (December 2017). \"Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis\". <i>European Journal of Neurology</i>. <b>24</b> (12): 1446–1456. <a href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" href=\"https://doi.org/10.1111%2Fene.13449\">10.1111/ene.13449</a>. <a href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a>&nbsp;<a rel=\"nofollow\" href=\"//pubmed.ncbi.nlm.nih.gov/28888061\">28888061</a>. <a href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a>&nbsp;<a rel=\"nofollow\" href=\"https://api.semanticscholar.org/CorpusID:22262972\">22262972</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Neurology&amp;rft.atitle=Gabapentin+enacarbil%2C+pregabalin+and+rotigotine+are+equally+effective+in+restless+legs+syndrome%3A+a+comparative+meta-analysis&amp;rft.volume=24&amp;rft.issue=12&amp;rft.pages=1446-1456&amp;rft.date=2017-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22262972%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28888061&amp;rft_id=info%3Adoi%2F10.1111%2Fene.13449&amp;rft.aulast=Iftikhar&amp;rft.aufirst=I.+H.&amp;rft.au=Alghothani%2C+L.&amp;rft.au=Trotti%2C+L.+M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-29\"><span><b><a href=\"#cite_ref-29\">^</a></b></span> <span><cite id=\"CITEREFDecker2014\">Decker, Susan (February 6, 2014). <span title=\"Paid subscription required\"><a rel=\"nofollow\" href=\"https://www.bloomberg.com/news/2014-02-06/pfizer-wins-ruling-to-block-generic-lyrica-until-2018.html\">\"Pfizer Wins Ruling to Block Generic Lyrica Until 2018\"</a></span>. <i><a href=\"/wiki/Bloomberg_News\" title=\"Bloomberg News\">Bloomberg News</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+News&amp;rft.atitle=Pfizer+Wins+Ruling+to+Block+Generic+Lyrica+Until+2018&amp;rft.date=2014-02-06&amp;rft.aulast=Decker&amp;rft.aufirst=Susan&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2F2014-02-06%2Fpfizer-wins-ruling-to-block-generic-lyrica-until-2018.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-30\"><span><b><a href=\"#cite_ref-30\">^</a></b></span> <span><cite id=\"CITEREFSpeights2017\">Speights, Keith (April 17, 2017). <a rel=\"nofollow\" href=\"https://www.fool.com/investing/2017/04/17/how-pfizer-inc-makes-most-of-its-money.aspx\">\"How Pfizer Inc. Makes Most of Its Money\"</a>. <i><a href=\"/wiki/The_Motley_Fool\" title=\"The Motley Fool\">The Motley Fool</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Motley+Fool&amp;rft.atitle=How+Pfizer+Inc.+Makes+Most+of+Its+Money&amp;rft.date=2017-04-17&amp;rft.aulast=Speights&amp;rft.aufirst=Keith&amp;rft_id=https%3A%2F%2Fwww.fool.com%2Finvesting%2F2017%2F04%2F17%2Fhow-pfizer-inc-makes-most-of-its-money.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-31\"><span><b><a href=\"#cite_ref-31\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://money.cnn.com/2006/07/28/news/companies/pfizer_ceo/index.htm\">\"Pfizer names new CEO\"</a>. <i><a href=\"/wiki/CNN\" title=\"CNN\">CNN</a></i>. July 28, 2006.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNN&amp;rft.atitle=Pfizer+names+new+CEO&amp;rft.date=2006-07-28&amp;rft_id=https%3A%2F%2Fmoney.cnn.com%2F2006%2F07%2F28%2Fnews%2Fcompanies%2Fpfizer_ceo%2Findex.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-32\"><span><b><a href=\"#cite_ref-32\">^</a></b></span> <span><cite id=\"CITEREFBerensonPollack2006\">Berenson, Alex; Pollack, Andrew (December 5, 2006). <span title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" href=\"https://www.nytimes.com/2006/12/05/health/05pfizer.html\">\"Pfizer Shares Plummet on Loss of a Promising Heart Drug\"</a></span>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+Shares+Plummet+on+Loss+of+a+Promising+Heart+Drug&amp;rft.date=2006-12-05&amp;rft.aulast=Berenson&amp;rft.aufirst=Alex&amp;rft.au=Pollack%2C+Andrew&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2006%2F12%2F05%2Fhealth%2F05pfizer.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-33\"><span><b><a href=\"#cite_ref-33\">^</a></b></span> <span><cite id=\"CITEREFBerenson2006\"><a href=\"/wiki/Alex_Berenson\" title=\"Alex Berenson\">Berenson, Alex</a> (December 3, 2006). <span title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" href=\"https://www.nytimes.com/2006/12/03/health/03pfizer.html\">\"Pfizer Ends Studies on Drug for Heart Disease\"</a></span>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+Ends+Studies+on+Drug+for+Heart+Disease&amp;rft.date=2006-12-03&amp;rft.aulast=Berenson&amp;rft.aufirst=Alex&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2006%2F12%2F03%2Fhealth%2F03pfizer.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-34\"><span><b><a href=\"#cite_ref-34\">^</a></b></span> <span><cite id=\"CITEREFAgovino2006\">Agovino, Theresa (December 3, 2006). <a rel=\"nofollow\" href=\"https://www.seattletimes.com/nation-world/cholesterol-drug-trials-are-halted/\">\"Pfizer ends cholesterol drug development\"</a>. <a href=\"/wiki/The_Seattle_Times\" title=\"The Seattle Times\">The Seattle Times</a>. <a href=\"/wiki/Associated_Press\" title=\"Associated Press\">Associated Press</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pfizer+ends+cholesterol+drug+development&amp;rft.date=2006-12-03&amp;rft.aulast=Agovino&amp;rft.aufirst=Theresa&amp;rft_id=https%3A%2F%2Fwww.seattletimes.com%2Fnation-world%2Fcholesterol-drug-trials-are-halted%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-35\"><span><b><a href=\"#cite_ref-35\">^</a></b></span> <span><cite id=\"CITEREFTanne2006\">Tanne, Janice Hopkins (December 16, 2006). <a rel=\"nofollow\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1702474\">\"Pfizer stops clinical trials of heart drug\"</a>. <i>BMJ</i>. <b>333</b> (7581): 1237.2–1237. <a href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" href=\"https://doi.org/10.1136%2Fbmj.39059.438044.DB\">10.1136/bmj.39059.438044.DB</a>. <a href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a>&nbsp;<span title=\"Freely accessible\"><a rel=\"nofollow\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1702474\">1702474</a></span>. <a href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a>&nbsp;<a rel=\"nofollow\" href=\"//pubmed.ncbi.nlm.nih.gov/17170401\">17170401</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMJ&amp;rft.atitle=Pfizer+stops+clinical+trials+of+heart+drug&amp;rft.volume=333&amp;rft.issue=7581&amp;rft.pages=1237.2-1237&amp;rft.date=2006-12-16&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1702474%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F17170401&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.39059.438044.DB&amp;rft.aulast=Tanne&amp;rft.aufirst=Janice+Hopkins&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1702474&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-36\"><span><b><a href=\"#cite_ref-36\">^</a></b></span> <span><cite id=\"CITEREFBennett2010\">Bennett, Simeon (July 8, 2010). <span title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" href=\"https://www.bloomberg.com/news/articles/2010-07-08/pfizer-civil-suits-for-drug-counterfeiters\">\"Pfizer: Civil Suits for Drug Counterfeiters\"</a></span>. <i><a href=\"/wiki/Bloomberg_Businessweek\" title=\"Bloomberg Businessweek\">Bloomberg Businessweek</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+Businessweek&amp;rft.atitle=Pfizer%3A+Civil+Suits+for+Drug+Counterfeiters&amp;rft.date=2010-07-08&amp;rft.aulast=Bennett&amp;rft.aufirst=Simeon&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2010-07-08%2Fpfizer-civil-suits-for-drug-counterfeiters&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-37\"><span><b><a href=\"#cite_ref-37\">^</a></b></span> <span><cite id=\"CITEREFJones2008\">Jones, Al (July 15, 2008). <a rel=\"nofollow\" href=\"https://www.mlive.com/kzgazette/2008/07/pfizer_job_cuts_dont_equal_a_r.html\">\"Pfizer job cuts don't equal a reduction in work load, says company spokesman\"</a>. <i><a href=\"/wiki/Booth_Newspapers\" title=\"Booth Newspapers\">Booth Newspapers</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Booth+Newspapers&amp;rft.atitle=Pfizer+job+cuts+don%27t+equal+a+reduction+in+work+load%2C+says+company+spokesman&amp;rft.date=2008-07-15&amp;rft.aulast=Jones&amp;rft.aufirst=Al&amp;rft_id=https%3A%2F%2Fwww.mlive.com%2Fkzgazette%2F2008%2F07%2Fpfizer_job_cuts_dont_equal_a_r.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-:0-38\"><span>^ <a href=\"#cite_ref-:0_38-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:0_38-1\"><sup><i><b>b</b></i></sup></a></span> <span><cite><a rel=\"nofollow\" href=\"https://money.cnn.com/2003/04/16/news/companies/pfizer_pharma/\">\"It's official: Pfizer buys Pharmacia\"</a>. <i><a href=\"/wiki/CNN\" title=\"CNN\">CNN</a></i>. April 16, 2003.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNN&amp;rft.atitle=It%27s+official%3A+Pfizer+buys+Pharmacia&amp;rft.date=2003-04-16&amp;rft_id=https%3A%2F%2Fmoney.cnn.com%2F2003%2F04%2F16%2Fnews%2Fcompanies%2Fpfizer_pharma%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-39\"><span><b><a href=\"#cite_ref-39\">^</a></b></span> <span><cite id=\"CITEREFHensley2000\">Hensley, Scott (June 20, 2000). <span title=\"Paid subscription required\"><a rel=\"nofollow\" href=\"https://www.wsj.com/articles/SB961456765639278103\">\"Pfizer Completes Stormy Takeover Of Warner-Lambert for $116 Billion\"</a></span>. <i><a href=\"/wiki/The_Wall_Street_Journal\" title=\"The Wall Street Journal\">The Wall Street Journal</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=Pfizer+Completes+Stormy+Takeover+Of+Warner-Lambert+for+%24116+Billion&amp;rft.date=2000-06-20&amp;rft.aulast=Hensley&amp;rft.aufirst=Scott&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2FSB961456765639278103&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-40\"><span><b><a href=\"#cite_ref-40\">^</a></b></span> <span><cite id=\"CITEREFCampbell2017\">Campbell, Todd (May 15, 2017). <a rel=\"nofollow\" href=\"https://www.businessinsider.com/here-are-the-7-biggest-mergers-of-all-time-2017-5#6-warner-lambert-warms-up-to-pfizer-89-billion-2\">\"Here are the 7 biggest mergers of all time\"</a>. <a href=\"/wiki/Business_Insider\" title=\"Business Insider\">Business Insider</a>. <a href=\"/wiki/The_Motley_Fool\" title=\"The Motley Fool\">The Motley Fool</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Here+are+the+7+biggest+mergers+of+all+time&amp;rft.date=2017-05-15&amp;rft.aulast=Campbell&amp;rft.aufirst=Todd&amp;rft_id=https%3A%2F%2Fwww.businessinsider.com%2Fhere-are-the-7-biggest-mergers-of-all-time-2017-5%236-warner-lambert-warms-up-to-pfizer-89-billion-2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-41\"><span><b><a href=\"#cite_ref-41\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.drugs.com/monograph/metronidazole.html\">\"Metronidazole Monograph for Professionals\"</a>. <a href=\"/wiki/Drugs.com\" title=\"Drugs.com\">Drugs.com</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Metronidazole+Monograph+for+Professionals&amp;rft.pub=Drugs.com&amp;rft_id=https%3A%2F%2Fwww.drugs.com%2Fmonograph%2Fmetronidazole.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-42\"><span><b><a href=\"#cite_ref-42\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.drugs.com/monograph/celecoxib.html\">\"Celecoxib Monograph for Professionals\"</a>. <i>Drugs.com</i>. American Society of Health-System Pharmacists. November 11, 2019.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Drugs.com&amp;rft.atitle=Celecoxib+Monograph+for+Professionals&amp;rft.date=2019-11-11&amp;rft_id=https%3A%2F%2Fwww.drugs.com%2Fmonograph%2Fcelecoxib.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-43\"><span><b><a href=\"#cite_ref-43\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.bloomberg.com/news/articles/2005-11-20/the-spirit-of-a-startup-lives-on\">\"The Spirit Of A Startup Lives On\"</a>. <i><a href=\"/wiki/Bloomberg_Businessweek\" title=\"Bloomberg Businessweek\">Bloomberg Businessweek</a></i>. November 21, 2005.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+Businessweek&amp;rft.atitle=The+Spirit+Of+A+Startup+Lives+On&amp;rft.date=2005-11-21&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2005-11-20%2Fthe-spirit-of-a-startup-lives-on&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-44\"><span><b><a href=\"#cite_ref-44\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.bizjournals.com/sanfrancisco/stories/2003/04/28/daily24.html\">\"Pfizer expects to shutter South City biotech outpost\"</a>. <i><a href=\"/wiki/American_City_Business_Journals\" title=\"American City Business Journals\">American City Business Journals</a></i>. April 30, 2003.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+City+Business+Journals&amp;rft.atitle=Pfizer+expects+to+shutter+South+City+biotech+outpost&amp;rft.date=2003-04-30&amp;rft_id=https%3A%2F%2Fwww.bizjournals.com%2Fsanfrancisco%2Fstories%2F2003%2F04%2F28%2Fdaily24.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-45\"><span><b><a href=\"#cite_ref-45\">^</a></b></span> <span><cite id=\"CITEREFRockoff2011\">Rockoff, Jonathan D. (August 26, 2011). <span title=\"Paid subscription required\"><a rel=\"nofollow\" href=\"https://www.wsj.com/articles/SB10001424053111904009304576532892704206326\">\"FDA Approves Pfizer Lung-Cancer Drug\"</a></span>. <i><a href=\"/wiki/The_Wall_Street_Journal\" title=\"The Wall Street Journal\">The Wall Street Journal</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=FDA+Approves+Pfizer+Lung-Cancer+Drug&amp;rft.date=2011-08-26&amp;rft.aulast=Rockoff&amp;rft.aufirst=Jonathan+D.&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2FSB10001424053111904009304576532892704206326&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-46\"><span><b><a href=\"#cite_ref-46\">^</a></b></span> <span><cite id=\"CITEREFMortlockWilsonKettleGoldberg2017\">Mortlock, A.A.; Wilson, D.M.; Kettle, J.G.; Goldberg, F.W.; Foote, K.M. (2017). \"Selective Kinase Inhibitors in Cancer\". <i>Comprehensive Medicinal Chemistry III</i>. pp.&nbsp;39–75. <a href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" href=\"https://doi.org/10.1016%2FB978-0-12-409547-2.12391-1\">10.1016/B978-0-12-409547-2.12391-1</a>. <a href=\"/wiki/ISBN_(identifier)\" title=\"ISBN (identifier)\">ISBN</a>&nbsp;<a href=\"/wiki/Special:BookSources/978-0-12-803201-5\" title=\"Special:BookSources/978-0-12-803201-5\"><bdi>978-0-12-803201-5</bdi></a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Selective+Kinase+Inhibitors+in+Cancer&amp;rft.btitle=Comprehensive+Medicinal+Chemistry+III&amp;rft.pages=39-75&amp;rft.date=2017&amp;rft_id=info%3Adoi%2F10.1016%2FB978-0-12-409547-2.12391-1&amp;rft.isbn=978-0-12-803201-5&amp;rft.aulast=Mortlock&amp;rft.aufirst=A.A.&amp;rft.au=Wilson%2C+D.M.&amp;rft.au=Kettle%2C+J.G.&amp;rft.au=Goldberg%2C+F.W.&amp;rft.au=Foote%2C+K.M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-47\"><span><b><a href=\"#cite_ref-47\">^</a></b></span> <span><cite id=\"CITEREFBarriaux2006\">Barriaux, Marianne (October 9, 2006). <a rel=\"nofollow\" href=\"https://www.theguardian.com/business/2006/oct/09/money5\">\"Pfizer buys vaccine developer PowderMed\"</a>. <i><a href=\"/wiki/The_Guardian\" title=\"The Guardian\">The Guardian</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Guardian&amp;rft.atitle=Pfizer+buys+vaccine+developer+PowderMed&amp;rft.date=2006-10-09&amp;rft.aulast=Barriaux&amp;rft.aufirst=Marianne&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fbusiness%2F2006%2Foct%2F09%2Fmoney5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-48\"><span><b><a href=\"#cite_ref-48\">^</a></b></span> <span><cite id=\"CITEREFSorkinWilson2009\"><a href=\"/wiki/Andrew_Ross_Sorkin\" title=\"Andrew Ross Sorkin\">Sorkin, Andrew Ross</a>; <a href=\"/wiki/Duff_Wilson\" title=\"Duff Wilson\">Wilson, Duff</a> (January 25, 2009). <span title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" href=\"https://www.nytimes.com/2009/01/26/business/26drug.html\">\"Pfizer Agrees to Pay $68 Billion for Rival Drug Maker Wyeth\"</a></span>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>. <a href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a>&nbsp;<a rel=\"nofollow\" href=\"//www.worldcat.org/issn/0362-4331\">0362-4331</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+Agrees+to+Pay+%2468+Billion+for+Rival+Drug+Maker+Wyeth&amp;rft.date=2009-01-25&amp;rft.issn=0362-4331&amp;rft.aulast=Sorkin&amp;rft.aufirst=Andrew+Ross&amp;rft.au=Wilson%2C+Duff&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2009%2F01%2F26%2Fbusiness%2F26drug.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-49\"><span><b><a href=\"#cite_ref-49\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.reuters.com/article/instant-article/idUSTRE59E4S320091015\">\"Pfizer completes $67 billion deal for rival Wyeth\"</a>. <i><a href=\"/wiki/Reuters\" title=\"Reuters\">Reuters</a></i>. October 15, 2009.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+completes+%2467+billion+deal+for+rival+Wyeth&amp;rft.date=2009-10-15&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Finstant-article%2FidUSTRE59E4S320091015&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-50\"><span><b><a href=\"#cite_ref-50\">^</a></b></span> <span><cite id=\"CITEREFKarnitschnigRockoff2009\">Karnitschnig, Matthew; Rockoff, Jonathan D. (January 23, 2009). <span title=\"Paid subscription required\"><a rel=\"nofollow\" href=\"https://www.wsj.com/articles/SB123268511212809429\">\"Pfizer in Talks to Buy Wyeth\"</a></span>. <i><a href=\"/wiki/The_Wall_Street_Journal\" title=\"The Wall Street Journal\">The Wall Street Journal</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=Pfizer+in+Talks+to+Buy+Wyeth&amp;rft.date=2009-01-23&amp;rft.aulast=Karnitschnig&amp;rft.aufirst=Matthew&amp;rft.au=Rockoff%2C+Jonathan+D.&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2FSB123268511212809429&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-worst-51\"><span><b><a href=\"#cite_ref-worst_51-0\">^</a></b></span> <span><cite id=\"CITEREFEdwards2009\">Edwards, Jim (January 23, 2009). <a rel=\"nofollow\" href=\"https://www.cbsnews.com/news/the-pfizer-wyeth-deal-worst-case-scenario/\">\"The Pfizer–Wyeth Deal Worst-Case Scenario\"</a>. <i><a href=\"/wiki/CBS_News\" title=\"CBS News\">CBS News</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CBS+News&amp;rft.atitle=The+Pfizer%E2%80%93Wyeth+Deal+Worst-Case+Scenario&amp;rft.date=2009-01-23&amp;rft.aulast=Edwards&amp;rft.aufirst=Jim&amp;rft_id=https%3A%2F%2Fwww.cbsnews.com%2Fnews%2Fthe-pfizer-wyeth-deal-worst-case-scenario%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-wyethpr-52\"><span>^ <a href=\"#cite_ref-wyethpr_52-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-wyethpr_52-1\"><sup><i><b>b</b></i></sup></a></span> <span><cite><a rel=\"nofollow\" href=\"https://www.pfizer.com/news/press-release/press-release-detail/pfizer_completes_acquisition_of_wyeth\">\"PFIZER COMPLETES ACQUISITION OF WYETH\"</a> (Press release). Pfizer. October 14, 2009.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=PFIZER+COMPLETES+ACQUISITION+OF+WYETH&amp;rft.pub=Pfizer&amp;rft.date=2009-10-14&amp;rft_id=https%3A%2F%2Fwww.pfizer.com%2Fnews%2Fpress-release%2Fpress-release-detail%2Fpfizer_completes_acquisition_of_wyeth&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-cdc.gov-53\"><span><b><a href=\"#cite_ref-cdc.gov_53-0\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.cdc.gov/abcs/reports-findings/surv-reports.html\">\"CDC – ABCs: Surveillance Reports main page – Active Bacterial Core surveillance\"</a>. April 5, 2019.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=CDC+%E2%80%93+ABCs%3A+Surveillance+Reports+main+page+%E2%80%93+Active+Bacterial+Core+surveillance&amp;rft.date=2019-04-05&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fabcs%2Freports-findings%2Fsurv-reports.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-54\"><span><b><a href=\"#cite_ref-54\">^</a></b></span> <span><cite id=\"CITEREFHerper2020\">Herper, Matthew (August 24, 2020). <a rel=\"nofollow\" href=\"https://www.statnews.com/2020/08/24/pfizer-edge-in-the-race-for-a-covid-19-vaccine-could-be-a-scientist-with-two-best-sellers-to-her-credit/\">\"In the race for a Covid-19 vaccine, Pfizer turns to a scientist with a history of defying skeptics – and getting results\"</a>. <i><a href=\"/wiki/Stat_(website)\" title=\"Stat (website)\">Stat</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Stat&amp;rft.atitle=In+the+race+for+a+Covid-19+vaccine%2C+Pfizer+turns+to+a+scientist+with+a+history+of+defying+skeptics+%E2%80%93+and+getting+results&amp;rft.date=2020-08-24&amp;rft.aulast=Herper&amp;rft.aufirst=Matthew&amp;rft_id=https%3A%2F%2Fwww.statnews.com%2F2020%2F08%2F24%2Fpfizer-edge-in-the-race-for-a-covid-19-vaccine-could-be-a-scientist-with-two-best-sellers-to-her-credit%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-55\"><span><b><a href=\"#cite_ref-55\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.businesswire.com/news/home/20190927005072/en/Ian-Read-to-Retire-as-Executive-Chairman-of-Pfizer%E2%80%99s-Board-of-Directors-Chief-Executive-Officer-Dr.-Albert-Bourla-Named-Chairman\">\"Ian Read to Retire as Executive Chairman of Pfizer's Board of Directors; Chief Executive Officer Dr. Albert Bourla Named Chairman\"</a> (Press release). <a href=\"/wiki/Business_Wire\" title=\"Business Wire\">Business Wire</a>. September 27, 2019.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Ian+Read+to+Retire+as+Executive+Chairman+of+Pfizer%27s+Board+of+Directors%3B+Chief+Executive+Officer+Dr.+Albert+Bourla+Named+Chairman&amp;rft.pub=Business+Wire&amp;rft.date=2019-09-27&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20190927005072%2Fen%2FIan-Read-to-Retire-as-Executive-Chairman-of-Pfizer%25E2%2580%2599s-Board-of-Directors-Chief-Executive-Officer-Dr.-Albert-Bourla-Named-Chairman&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-56\"><span><b><a href=\"#cite_ref-56\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.bbc.co.uk/news/business-12335801\">\"Pfizer to close UK research site\"</a>. <i><a href=\"/wiki/BBC_News\" title=\"BBC News\">BBC News</a></i>. February 1, 2011.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Pfizer+to+close+UK+research+site&amp;rft.date=2011-02-01&amp;rft_id=https%3A%2F%2Fwww.bbc.co.uk%2Fnews%2Fbusiness-12335801&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-57\"><span><b><a href=\"#cite_ref-57\">^</a></b></span> <span><cite id=\"CITEREFMckinney2011\">Mckinney, Maureen (March 1, 2011). <a rel=\"nofollow\" href=\"https://www.modernhealthcare.com/article/20110301/NEWS/303019922/pfizer-closes-king-pharmaceuticals-acquisition\">\"Pfizer closes King Pharmaceuticals acquisition\"</a>. <i><a href=\"/wiki/Modern_Healthcare\" title=\"Modern Healthcare\">Modern Healthcare</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Modern+Healthcare&amp;rft.atitle=Pfizer+closes+King+Pharmaceuticals+acquisition&amp;rft.date=2011-03-01&amp;rft.aulast=Mckinney&amp;rft.aufirst=Maureen&amp;rft_id=https%3A%2F%2Fwww.modernhealthcare.com%2Farticle%2F20110301%2FNEWS%2F303019922%2Fpfizer-closes-king-pharmaceuticals-acquisition&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-58\"><span><b><a href=\"#cite_ref-58\">^</a></b></span> <span><cite id=\"CITEREFYukhananov2012\">Yukhananov, Anna (September 4, 2012). <a rel=\"nofollow\" href=\"https://www.reuters.com/article/us-pfizer-leukemia/fda-approves-pfizer-leukemia-drug-idUSBRE88314720120904\">\"FDA approves Pfizer leukemia drug\"</a>. <i><a href=\"/wiki/Reuters\" title=\"Reuters\">Reuters</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=FDA+approves+Pfizer+leukemia+drug&amp;rft.date=2012-09-04&amp;rft.aulast=Yukhananov&amp;rft.aufirst=Anna&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-pfizer-leukemia%2Ffda-approves-pfizer-leukemia-drug-idUSBRE88314720120904&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-59\"><span><b><a href=\"#cite_ref-59\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/203214orig1s000toc.cfm\">\"Drug Approval Package\"</a>. <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Drug+Approval+Package&amp;rft.pub=Food+and+Drug+Administration&amp;rft_id=https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Fnda%2F2012%2F203214orig1s000toc.cfm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-60\"><span><b><a href=\"#cite_ref-60\">^</a></b></span> <span><cite id=\"CITEREFSagonowsky2019\">Sagonowsky, Eric (February 20, 2019). <a rel=\"nofollow\" href=\"https://www.fiercepharma.com/pharma/postmarketing-study-pfizer-switches-ra-patients-to-lower-xeljanz-dose-safety-concerns\">\"Pfizer switches RA patients to lower dose of fast-growing Xeljanz as safety issues arise in postmarketing study\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Pfizer+switches+RA+patients+to+lower+dose+of+fast-growing+Xeljanz+as+safety+issues+arise+in+postmarketing+study&amp;rft.date=2019-02-20&amp;rft.aulast=Sagonowsky&amp;rft.aufirst=Eric&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpostmarketing-study-pfizer-switches-ra-patients-to-lower-xeljanz-dose-safety-concerns&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-61\"><span><b><a href=\"#cite_ref-61\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.zoetisus.com/news-and-media/zoetis-files-ipo-registration-statement.aspx\">\"Zoetis™ Files IPO Registration Statement\"</a> (Press release). <a href=\"/wiki/Business_Wire\" title=\"Business Wire\">Business Wire</a>. August 13, 2012.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Zoetis%E2%84%A2+Files+IPO+Registration+Statement&amp;rft.pub=Business+Wire&amp;rft.date=2012-08-13&amp;rft_id=https%3A%2F%2Fwww.zoetisus.com%2Fnews-and-media%2Fzoetis-files-ipo-registration-statement.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-62\"><span><b><a href=\"#cite_ref-62\">^</a></b></span> <span><cite id=\"CITEREFJ._de_la_Merced2013\">J. de la Merced, Michael (February 1, 2013). <span title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" href=\"https://dealbook.nytimes.com/2013/02/01/shares-of-zoetis-surge-on-debut/\">\"Shares of Zoetis Surge on Debut\"</a></span>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Shares+of+Zoetis+Surge+on+Debut&amp;rft.date=2013-02-01&amp;rft.aulast=J.+de+la+Merced&amp;rft.aufirst=Michael&amp;rft_id=https%3A%2F%2Fdealbook.nytimes.com%2F2013%2F02%2F01%2Fshares-of-zoetis-surge-on-debut%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-63\"><span><b><a href=\"#cite_ref-63\">^</a></b></span> <span><cite id=\"CITEREFDieterich2013\">Dieterich, Chris (January 31, 2013). <span title=\"Paid subscription required\"><a rel=\"nofollow\" href=\"https://www.wsj.com/articles/SB10001424127887323701904578276530830057770\">\"Zoetis Raises $2.2 Billion in IPO\"</a></span>. <i><a href=\"/wiki/The_Wall_Street_Journal\" title=\"The Wall Street Journal\">The Wall Street Journal</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=Zoetis+Raises+%242.2+Billion+in+IPO&amp;rft.date=2013-01-31&amp;rft.aulast=Dieterich&amp;rft.aufirst=Chris&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2FSB10001424127887323701904578276530830057770&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-64\"><span><b><a href=\"#cite_ref-64\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.cbsnews.com/news/shares-of-animal-health-company-zoetis-soar-in-ipo/\">\"Shares of animal health company Zoetis soar in IPO\"</a>. <a href=\"/wiki/CBS_News\" title=\"CBS News\">CBS News</a>. <a href=\"/wiki/Associated_Press\" title=\"Associated Press\">Associated Press</a>. February 1, 2013.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Shares+of+animal+health+company+Zoetis+soar+in+IPO&amp;rft.date=2013-02-01&amp;rft_id=https%3A%2F%2Fwww.cbsnews.com%2Fnews%2Fshares-of-animal-health-company-zoetis-soar-in-ipo%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-65\"><span><b><a href=\"#cite_ref-65\">^</a></b></span> <span><cite id=\"CITEREFLoftus2013\">Loftus, Peter (May 22, 2013). <a rel=\"nofollow\" href=\"https://www.wsj.com/articles/SB10001424127887323975004578498994013821124\">\"Pfizer to Spin Off Remaining Zoetis Stake\"</a>. <i><a href=\"/wiki/The_Wall_Street_Journal\" title=\"The Wall Street Journal\">The Wall Street Journal</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=Pfizer+to+Spin+Off+Remaining+Zoetis+Stake&amp;rft.date=2013-05-22&amp;rft.aulast=Loftus&amp;rft.aufirst=Peter&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2FSB10001424127887323975004578498994013821124&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-66\"><span><b><a href=\"#cite_ref-66\">^</a></b></span> <span><cite id=\"CITEREFHumerPierson2013\">Humer, Caroline; Pierson, Ransdell (May 22, 2013). <a rel=\"nofollow\" href=\"https://www.reuters.com/article/us-pfizer-zoetis/pfizer-to-spin-off-zoetis-stake-to-shareholders-idUSBRE94L0JB20130522\">\"Pfizer to spin off Zoetis stake to shareholders\"</a>. <i><a href=\"/wiki/Reuters\" title=\"Reuters\">Reuters</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+to+spin+off+Zoetis+stake+to+shareholders&amp;rft.date=2013-05-22&amp;rft.aulast=Humer&amp;rft.aufirst=Caroline&amp;rft.au=Pierson%2C+Ransdell&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-pfizer-zoetis%2Fpfizer-to-spin-off-zoetis-stake-to-shareholders-idUSBRE94L0JB20130522&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-67\"><span><b><a href=\"#cite_ref-67\">^</a></b></span> <span><cite id=\"CITEREFWasserman2014\">Wasserman, Emily (September 29, 2014). <a rel=\"nofollow\" href=\"https://www.fiercepharma.com/pharma/pfizer-completes-acquisition-of-innopharma\">\"Pfizer Completes Acquisition Of InnoPharma\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Pfizer+Completes+Acquisition+Of+InnoPharma&amp;rft.date=2014-09-29&amp;rft.aulast=Wasserman&amp;rft.aufirst=Emily&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizer-completes-acquisition-of-innopharma&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-68\"><span><b><a href=\"#cite_ref-68\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.genengnews.com/news/pfizer-to-acquire-innopharma-for-up-to-360m/\">\"Pfizer to Acquire InnoPharma for Up to $360M\"</a>. <i><a href=\"/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1\" title=\"Genengnews.com (page does not exist)\">genengnews.com</a></i>. July 16, 2014.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+to+Acquire+InnoPharma+for+Up+to+%24360M&amp;rft.date=2014-07-16&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fnews%2Fpfizer-to-acquire-innopharma-for-up-to-360m%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-69\"><span><b><a href=\"#cite_ref-69\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.genengnews.com/topics/drug-discovery/pfizer-buys-redvax-boosting-vaccine-portfolio/\">\"Pfizer Buys Redvax, Boosting Vaccine Portfolio\"</a>. <i><a href=\"/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1\" title=\"Genengnews.com (page does not exist)\">genengnews.com</a></i>. January 5, 2015.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+Buys+Redvax%2C+Boosting+Vaccine+Portfolio&amp;rft.date=2015-01-05&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Ftopics%2Fdrug-discovery%2Fpfizer-buys-redvax-boosting-vaccine-portfolio%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-70\"><span><b><a href=\"#cite_ref-70\">^</a></b></span> <span><cite id=\"CITEREFBeaverAmiri-KordestaniCharlabChen2015\">Beaver, Julia A.; Amiri-Kordestani, Laleh; Charlab, Rosane; Chen, Wei; Palmby, Todd; Tilley, Amy; Zirkelbach, Jeanne Fourie; Yu, Jingyu; Liu, Qi; Zhao, Liang; Crich, Joyce; Chen, Xiao Hong; Hughes, Minerva; Bloomquist, Erik; Tang, Shenghui; Sridhara, Rajeshwari; Kluetz, Paul G.; Kim, Geoffrey; Ibrahim, Amna; Pazdur, Richard; Cortazar, Patricia (November 1, 2015). <a rel=\"nofollow\" href=\"https://doi.org/10.1158%2F1078-0432.CCR-15-1185\">\"FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor–Positive, HER2-Negative Metastatic Breast Cancer\"</a>. <i>Clinical Cancer Research</i>. <b>21</b> (21): 4760–4766. <a href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span title=\"Freely accessible\"><a rel=\"nofollow\" href=\"https://doi.org/10.1158%2F1078-0432.CCR-15-1185\">10.1158/1078-0432.CCR-15-1185</a></span>. <a href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a>&nbsp;<a rel=\"nofollow\" href=\"//pubmed.ncbi.nlm.nih.gov/26324739\">26324739</a>. <a href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a>&nbsp;<a rel=\"nofollow\" href=\"https://api.semanticscholar.org/CorpusID:24762535\">24762535</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Cancer+Research&amp;rft.atitle=FDA+Approval%3A+Palbociclib+for+the+Treatment+of+Postmenopausal+Patients+with+Estrogen+Receptor%E2%80%93Positive%2C+HER2-Negative+Metastatic+Breast+Cancer&amp;rft.volume=21&amp;rft.issue=21&amp;rft.pages=4760-4766&amp;rft.date=2015-11-01&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A24762535%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F26324739&amp;rft_id=info%3Adoi%2F10.1158%2F1078-0432.CCR-15-1185&amp;rft.aulast=Beaver&amp;rft.aufirst=Julia+A.&amp;rft.au=Amiri-Kordestani%2C+Laleh&amp;rft.au=Charlab%2C+Rosane&amp;rft.au=Chen%2C+Wei&amp;rft.au=Palmby%2C+Todd&amp;rft.au=Tilley%2C+Amy&amp;rft.au=Zirkelbach%2C+Jeanne+Fourie&amp;rft.au=Yu%2C+Jingyu&amp;rft.au=Liu%2C+Qi&amp;rft.au=Zhao%2C+Liang&amp;rft.au=Crich%2C+Joyce&amp;rft.au=Chen%2C+Xiao+Hong&amp;rft.au=Hughes%2C+Minerva&amp;rft.au=Bloomquist%2C+Erik&amp;rft.au=Tang%2C+Shenghui&amp;rft.au=Sridhara%2C+Rajeshwari&amp;rft.au=Kluetz%2C+Paul+G.&amp;rft.au=Kim%2C+Geoffrey&amp;rft.au=Ibrahim%2C+Amna&amp;rft.au=Pazdur%2C+Richard&amp;rft.au=Cortazar%2C+Patricia&amp;rft_id=%2F%2Fdoi.org%2F10.1158%252F1078-0432.CCR-15-1185&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-71\"><span><b><a href=\"#cite_ref-71\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.fda.gov/drugs/resources-information-approved-drugs/palbociclib-ibrance\">\"Palbociclib (IBRANCE)\"</a>. <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a>. February 9, 2019.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Palbociclib+%28IBRANCE%29&amp;rft.pub=Food+and+Drug+Administration&amp;rft.date=2019-02-09&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fdrugs%2Fresources-information-approved-drugs%2Fpalbociclib-ibrance&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-72\"><span><b><a href=\"#cite_ref-72\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.genengnews.com/topics/drug-discovery/pfizer-lilly-to-resume-phase-iii-tanezumab-clinical-program/\">\"Pfizer, Lilly to Resume Phase III Tanezumab Clinical Program\"</a>. <i><a href=\"/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1\" title=\"Genengnews.com (page does not exist)\">genengnews.com</a></i>. March 23, 2015.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer%2C+Lilly+to+Resume+Phase+III+Tanezumab+Clinical+Program&amp;rft.date=2015-03-23&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Ftopics%2Fdrug-discovery%2Fpfizer-lilly-to-resume-phase-iii-tanezumab-clinical-program%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-73\"><span><b><a href=\"#cite_ref-73\">^</a></b></span> <span><cite id=\"CITEREFGali2015\">Gali, Weinreb (May 14, 2015). <a rel=\"nofollow\" href=\"https://en.globes.co.il/en/article-pfizer-to-collaborate-on-bar-ilan-dna-robots-1001036703\">\"Pfizer to collaborate on Bar-Ilan DNA robots\"</a>. <i><a href=\"/wiki/Globes_(newspaper)\" title=\"Globes (newspaper)\">Globes</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Globes&amp;rft.atitle=Pfizer+to+collaborate+on+Bar-Ilan+DNA+robots&amp;rft.date=2015-05-14&amp;rft.aulast=Gali&amp;rft.aufirst=Weinreb&amp;rft_id=https%3A%2F%2Fen.globes.co.il%2Fen%2Farticle-pfizer-to-collaborate-on-bar-ilan-dna-robots-1001036703&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-74\"><span><b><a href=\"#cite_ref-74\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.genengnews.com/topics/drug-discovery/pfizer-buys-two-gsk-meningitis-vaccines-for-130m/\">\"Pfizer Buys Two GSK Meningitis Vaccines for $130M\"</a>. <i><a href=\"/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1\" title=\"Genengnews.com (page does not exist)\">genengnews.com</a></i>. June 22, 2015.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+Buys+Two+GSK+Meningitis+Vaccines+for+%24130M&amp;rft.date=2015-06-22&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Ftopics%2Fdrug-discovery%2Fpfizer-buys-two-gsk-meningitis-vaccines-for-130m%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-75\"><span><b><a href=\"#cite_ref-75\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.businesswire.com/news/home/20150903005752/en/Pfizer-Completes-Acquisition-of-Hospira\">\"Pfizer Completes Acquisition of Hospira\"</a> (Press release). Pfizer. September 3, 2015 – via <a href=\"/wiki/Business_Wire\" title=\"Business Wire\">Business Wire</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Completes+Acquisition+of+Hospira&amp;rft.pub=Pfizer&amp;rft.date=2015-09-03&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20150903005752%2Fen%2FPfizer-Completes-Acquisition-of-Hospira&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-76\"><span><b><a href=\"#cite_ref-76\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.thepharmaletter.com/article/pfizer-completes-17-billion-hospira-acquisition\">\"Pfizer completes $17-billion Hospira acquisition\"</a>. <i><a href=\"/wiki/The_Pharma_Letter\" title=\"The Pharma Letter\">The Pharma Letter</a></i>. September 4, 2015.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Pharma+Letter&amp;rft.atitle=Pfizer+completes+%2417-billion+Hospira+acquisition&amp;rft.date=2015-09-04&amp;rft_id=https%3A%2F%2Fwww.thepharmaletter.com%2Farticle%2Fpfizer-completes-17-billion-hospira-acquisition&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-77\"><span><b><a href=\"#cite_ref-77\">^</a></b></span> <span><cite id=\"CITEREFGellesThomas2015\">Gelles, David; Thomas, Katie (February 5, 2015). <span title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" href=\"https://dealbook.nytimes.com/2015/02/05/pfizer-to-buy-hospira-a-drug-maker-for-15-2-billion-in-cash\">\"Pfizer Bets $15 Billion on New Class of Generic Drugs\"</a></span>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+Bets+%2415+Billion+on+New+Class+of+Generic+Drugs&amp;rft.date=2015-02-05&amp;rft.aulast=Gelles&amp;rft.aufirst=David&amp;rft.au=Thomas%2C+Katie&amp;rft_id=https%3A%2F%2Fdealbook.nytimes.com%2F2015%2F02%2F05%2Fpfizer-to-buy-hospira-a-drug-maker-for-15-2-billion-in-cash&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-78\"><span><b><a href=\"#cite_ref-78\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.sec.gov/Archives/edgar/data/78003/000119312515037588/d866443d8k.htm\">\"8-K\"</a>. <a href=\"/wiki/U.S._Securities_and_Exchange_Commission\" title=\"U.S. Securities and Exchange Commission\">U.S. Securities and Exchange Commission</a>. February 6, 2015.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=8-K&amp;rft.pub=U.S.+Securities+and+Exchange+Commission&amp;rft.date=2015-02-06&amp;rft_id=https%3A%2F%2Fwww.sec.gov%2FArchives%2Fedgar%2Fdata%2F78003%2F000119312515037588%2Fd866443d8k.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-79\"><span><b><a href=\"#cite_ref-79\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.pfizer.com/news/press-release/press-release-detail/pfizer_to_acquire_hospira\">\"Pfizer to Acquire Hospira\"</a>. <i>Pfizer</i> (Press release).</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+to+Acquire+Hospira&amp;rft_id=https%3A%2F%2Fwww.pfizer.com%2Fnews%2Fpress-release%2Fpress-release-detail%2Fpfizer_to_acquire_hospira&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-80\"><span><b><a href=\"#cite_ref-80\">^</a></b></span> <span><cite id=\"CITEREFNeilan2015\">Neilan, Catherine (February 5, 2015). <a rel=\"nofollow\" href=\"https://www.cityam.com/pfizer-hospira-share-prices-soar-after-17bn-deal-announced/\">\"Pfizer, Hospira share prices to soar after $17bn deal announced\"</a>. <i><a href=\"/wiki/City_A.M.\" title=\"City A.M.\">City A.M.</a></i></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=City+A.M.&amp;rft.atitle=Pfizer%2C+Hospira+share+prices+to+soar+after+%2417bn+deal+announced&amp;rft.date=2015-02-05&amp;rft.aulast=Neilan&amp;rft.aufirst=Catherine&amp;rft_id=https%3A%2F%2Fwww.cityam.com%2Fpfizer-hospira-share-prices-soar-after-17bn-deal-announced%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-81\"><span><b><a href=\"#cite_ref-81\">^</a></b></span> <span><cite id=\"CITEREFBhallaSingh2009\">Bhalla, Mohit; Singh, Khomba (December 16, 2009). <a rel=\"nofollow\" href=\"https://m.economictimes.com/industry/healthcare/biotech/pharmaceuticals/us-based-hospira-to-buy-orchid-chemicals-injectables-biz-for-400-mn/articleshow/5342003.cms\">\"US-based Hospira to buy Orchid Chemicals' injectables biz for $400 mn\"</a>. <i><a href=\"/wiki/The_Economic_Times\" title=\"The Economic Times\">The Economic Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Economic+Times&amp;rft.atitle=US-based+Hospira+to+buy+Orchid+Chemicals%27+injectables+biz+for+%24400+mn&amp;rft.date=2009-12-16&amp;rft.aulast=Bhalla&amp;rft.aufirst=Mohit&amp;rft.au=Singh%2C+Khomba&amp;rft_id=https%3A%2F%2Fm.economictimes.com%2Findustry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fus-based-hospira-to-buy-orchid-chemicals-injectables-biz-for-400-mn%2Farticleshow%2F5342003.cms&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-82\"><span><b><a href=\"#cite_ref-82\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.bbc.co.uk/news/business-34900344\">\"Pfizer seals $160bn Allergan deal to create drugs giant\"</a>. <i><a href=\"/wiki/BBC_News\" title=\"BBC News\">BBC News</a></i>. November 23, 2015.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Pfizer+seals+%24160bn+Allergan+deal+to+create+drugs+giant&amp;rft.date=2015-11-23&amp;rft_id=https%3A%2F%2Fwww.bbc.co.uk%2Fnews%2Fbusiness-34900344&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-83\"><span><b><a href=\"#cite_ref-83\">^</a></b></span> <span><cite id=\"CITEREFPiersonBerkrot2015\">Pierson, Ransdell; Berkrot, Bill (November 24, 2015). <a rel=\"nofollow\" href=\"https://www.reuters.com/article/us-allergan-m-a-pfizer/pfizer-to-buy-allergan-in-160-billion-deal-idUSKBN0TB0UT20151124\">\"Pfizer to buy Allergan in $160 billion deal\"</a>. <i><a href=\"/wiki/Reuters\" title=\"Reuters\">Reuters</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+to+buy+Allergan+in+%24160+billion+deal&amp;rft.date=2015-11-24&amp;rft.aulast=Pierson&amp;rft.aufirst=Ransdell&amp;rft.au=Berkrot%2C+Bill&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-allergan-m-a-pfizer%2Fpfizer-to-buy-allergan-in-160-billion-deal-idUSKBN0TB0UT20151124&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-84\"><span><b><a href=\"#cite_ref-84\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.genengnews.com/news/pfizer-to-acquire-allergan-for-160b/\">\"Pfizer to Acquire Allergan for $160B\"</a>. <i><a href=\"/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1\" title=\"Genengnews.com (page does not exist)\">genengnews.com</a></i>. November 23, 2015.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+to+Acquire+Allergan+for+%24160B&amp;rft.date=2015-11-23&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fnews%2Fpfizer-to-acquire-allergan-for-160b%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-85\"><span><b><a href=\"#cite_ref-85\">^</a></b></span> <span><cite id=\"CITEREFKoons2015\">Koons, Cynthia (November 22, 2015). <span title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" href=\"https://www.bloomberg.com/news/articles/2015-11-22/pfizer-allergan-said-to-be-close-to-150-billion-merger\">\"Pfizer and Allergan to Combine With Joint Value of $160 Billion\"</a></span>. <i><a href=\"/wiki/Bloomberg_News\" title=\"Bloomberg News\">Bloomberg News</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+News&amp;rft.atitle=Pfizer+and+Allergan+to+Combine+With+Joint+Value+of+%24160+Billion&amp;rft.date=2015-11-22&amp;rft.aulast=Koons&amp;rft.aufirst=Cynthia&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2015-11-22%2Fpfizer-allergan-said-to-be-close-to-150-billion-merger&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-86\"><span><b><a href=\"#cite_ref-86\">^</a></b></span> <span><cite id=\"CITEREFBray2016\">Bray, Chad (April 6, 2016). <span title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" href=\"https://www.nytimes.com/2016/04/07/business/dealbook/pfizer-allergan-merger.html\">\"Pfizer and Allergan Call Off Merger After Tax-Rule Changes\"</a></span>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+and+Allergan+Call+Off+Merger+After+Tax-Rule+Changes&amp;rft.date=2016-04-06&amp;rft.aulast=Bray&amp;rft.aufirst=Chad&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2016%2F04%2F07%2Fbusiness%2Fdealbook%2Fpfizer-allergan-merger.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-87\"><span><b><a href=\"#cite_ref-87\">^</a></b></span> <span><cite id=\"CITEREFHumerBanerjee2016\">Humer, Caroline; Banerjee, Ankur (April 6, 2016). <a rel=\"nofollow\" href=\"https://www.reuters.com/article/us-allergan-m-a-pfizer-idUSKCN0X3188\">\"Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change\"</a>. <i><a href=\"/wiki/Reuters\" title=\"Reuters\">Reuters</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer%2C+Allergan+scrap+%24160+billion+deal+after+U.S.+tax+rule+change&amp;rft.date=2016-04-06&amp;rft.aulast=Humer&amp;rft.aufirst=Caroline&amp;rft.au=Banerjee%2C+Ankur&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-allergan-m-a-pfizer-idUSKCN0X3188&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-88\"><span><b><a href=\"#cite_ref-88\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.businesswire.com/news/home/20160624005299/en/Pfizer-Completes-Acquisition-of-Anacor\">\"Pfizer Completes Acquisition of Anacor\"</a> (Press release). Pfizer. June 24, 2016 – via <a href=\"/wiki/Business_Wire\" title=\"Business Wire\">Business Wire</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Completes+Acquisition+of+Anacor&amp;rft.pub=Pfizer&amp;rft.date=2016-06-24&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20160624005299%2Fen%2FPfizer-Completes-Acquisition-of-Anacor&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-89\"><span><b><a href=\"#cite_ref-89\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.genengnews.com/news/pfizer-to-acquire-anacor-pharmaceuticals-for-5-2b/\">\"Pfizer to Acquire Anacor Pharmaceuticals for $5.2B\"</a>. <i><a href=\"/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1\" title=\"Genengnews.com (page does not exist)\">genengnews.com</a></i>. May 16, 2016.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+to+Acquire+Anacor+Pharmaceuticals+for+%245.2B&amp;rft.date=2016-05-16&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fnews%2Fpfizer-to-acquire-anacor-pharmaceuticals-for-5-2b%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-90\"><span><b><a href=\"#cite_ref-90\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.genengnews.com/news/pfizer-places-high-bid-of-40m-for-bind-therapeutics/\">\"Pfizer Places High Bid of $40M for BIND Therapeutics\"</a>. <i><a href=\"/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1\" title=\"Genengnews.com (page does not exist)\">genengnews.com</a></i>. July 27, 2016.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+Places+High+Bid+of+%2440M+for+BIND+Therapeutics&amp;rft.date=2016-07-27&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fnews%2Fpfizer-places-high-bid-of-40m-for-bind-therapeutics%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-91\"><span><b><a href=\"#cite_ref-91\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.genengnews.com/news/pfizer-acquires-bamboo-therapeutics-in-a-645m-deal/\">\"Pfizer Acquires Bamboo Therapeutics in a $645M Deal\"</a>. <i><a href=\"/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1\" title=\"Genengnews.com (page does not exist)\">genengnews.com</a></i>. August 1, 2016.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+Acquires+Bamboo+Therapeutics+in+a+%24645M+Deal&amp;rft.date=2016-08-01&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fnews%2Fpfizer-acquires-bamboo-therapeutics-in-a-645m-deal%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-92\"><span><b><a href=\"#cite_ref-92\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.genengnews.com/news/pfizer-to-acquire-medivation-for-14b/\">\"Pfizer to Acquire Medivation for $14B\"</a>. <i><a href=\"/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1\" title=\"Genengnews.com (page does not exist)\">genengnews.com</a></i>. August 22, 2016.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+to+Acquire+Medivation+for+%2414B&amp;rft.date=2016-08-22&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fnews%2Fpfizer-to-acquire-medivation-for-14b%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-93\"><span><b><a href=\"#cite_ref-93\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.bbc.co.uk/news/business-37150531\">\"Pfizer to buy cancer drug firm Medivation for $14bn\"</a>. <i><a href=\"/wiki/BBC_News\" title=\"BBC News\">BBC News</a></i>. August 22, 2016.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Pfizer+to+buy+cancer+drug+firm+Medivation+for+%2414bn&amp;rft.date=2016-08-22&amp;rft_id=https%3A%2F%2Fwww.bbc.co.uk%2Fnews%2Fbusiness-37150531&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-94\"><span><b><a href=\"#cite_ref-94\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.businesswire.com/news/home/20160928005824/en/\">\"Pfizer Completes Acquisition of Medivation\"</a> (Press release). OncoImmune. September 28, 2016 – via <a href=\"/wiki/Business_Wire\" title=\"Business Wire\">Business Wire</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Completes+Acquisition+of+Medivation&amp;rft.pub=OncoImmune&amp;rft.date=2016-09-28&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20160928005824%2Fen%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-95\"><span><b><a href=\"#cite_ref-95\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.genengnews.com/topics/drug-discovery/oncoimmune-licenses-onc-392-to-pfizer-for-up-to-250m/\">\"OncoImmune Licenses ONC-392 to Pfizer for Up to $250M\"</a>. <i><a href=\"/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1\" title=\"Genengnews.com (page does not exist)\">genengnews.com</a></i>. October 15, 2016.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=OncoImmune+Licenses+ONC-392+to+Pfizer+for+Up+to+%24250M&amp;rft.date=2016-10-15&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Ftopics%2Fdrug-discovery%2Foncoimmune-licenses-onc-392-to-pfizer-for-up-to-250m%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-96\"><span><b><a href=\"#cite_ref-96\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.businesswire.com/news/home/20160915005151/en/OncoImmune-Announces-Option-and-License-Agreement-with-Pfizer-Inc.\">\"OncoImmune Announces Option and License Agreement with Pfizer Inc\"</a> (Press release). Pfizer. September 15, 2016 – via <a href=\"/wiki/Business_Wire\" title=\"Business Wire\">Business Wire</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=OncoImmune+Announces+Option+and+License+Agreement+with+Pfizer+Inc.&amp;rft.pub=Pfizer&amp;rft.date=2016-09-15&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20160915005151%2Fen%2FOncoImmune-Announces-Option-and-License-Agreement-with-Pfizer-Inc.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-97\"><span><b><a href=\"#cite_ref-97\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.businesswire.com/news/home/20161222005395/en/Pfizer-Completes-Acquisition-of-Small-Molecule-Anti-Infective-Business-From-AstraZeneca\">\"Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca\"</a> (Press release). Pfizer. December 23, 2016 – via <a href=\"/wiki/Business_Wire\" title=\"Business Wire\">Business Wire</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Completes+Acquisition+of+Small+Molecule+Anti-Infective+Business+From+AstraZeneca&amp;rft.pub=Pfizer&amp;rft.date=2016-12-23&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20161222005395%2Fen%2FPfizer-Completes-Acquisition-of-Small-Molecule-Anti-Infective-Business-From-AstraZeneca&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-98\"><span><b><a href=\"#cite_ref-98\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.genengnews.com/topics/drug-discovery/pfizer-buys-astrazeneca-antibiotics-for-up-to-1-575b/\">\"Pfizer Buys AstraZeneca Antibiotics for Up to $1.575B\"</a>. <i><a href=\"/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1\" title=\"Genengnews.com (page does not exist)\">genengnews.com</a></i>. August 24, 2016.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+Buys+AstraZeneca+Antibiotics+for+Up+to+%241.575B&amp;rft.date=2016-08-24&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Ftopics%2Fdrug-discovery%2Fpfizer-buys-astrazeneca-antibiotics-for-up-to-1-575b%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-99\"><span><b><a href=\"#cite_ref-99\">^</a></b></span> <span><cite id=\"CITEREFStaton2016\">Staton, Tracy (August 24, 2016). <a rel=\"nofollow\" href=\"https://www.fiercepharma.com/pharma/pfizer-grabs-az-antibiotics-1-5b-deal-pre-split-prep-or-just-another-sales-boosting-buy\">\"Pfizer grabs AZ antibiotics in $1.5B deal. Pre-split prep or just another sales-boosting buy?\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Pfizer+grabs+AZ+antibiotics+in+%241.5B+deal.+Pre-split+prep+or+just+another+sales-boosting+buy%3F&amp;rft.date=2016-08-24&amp;rft.aulast=Staton&amp;rft.aufirst=Tracy&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizer-grabs-az-antibiotics-1-5b-deal-pre-split-prep-or-just-another-sales-boosting-buy&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-100\"><span><b><a href=\"#cite_ref-100\">^</a></b></span> <span><cite id=\"CITEREFHiltzik2018\"><a href=\"/wiki/Michael_Hiltzik\" title=\"Michael Hiltzik\">Hiltzik, Michael</a> (January 8, 2018). <span title=\"Paid subscription required\"><a rel=\"nofollow\" href=\"https://www.latimes.com/business/hiltzik/la-fi-hiltzik-pfizer-20180108-story.html\">\"Pfizer, pocketing a big tax cut from Trump, will end investment in Alzheimer's and Parkinson's research\"</a></span>. <i><a href=\"/wiki/Los_Angeles_Times\" title=\"Los Angeles Times\">Los Angeles Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Los+Angeles+Times&amp;rft.atitle=Pfizer%2C+pocketing+a+big+tax+cut+from+Trump%2C+will+end+investment+in+Alzheimer%27s+and+Parkinson%27s+research&amp;rft.date=2018-01-08&amp;rft.aulast=Hiltzik&amp;rft.aufirst=Michael&amp;rft_id=https%3A%2F%2Fwww.latimes.com%2Fbusiness%2Fhiltzik%2Fla-fi-hiltzik-pfizer-20180108-story.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-101\"><span><b><a href=\"#cite_ref-101\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-enzalutamide-castration-resistant-prostate-cancer\">\"FDA approves enzalutamide for castration-resistant prostate cancer\"</a> (Press release). <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a>. July 13, 2018.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+approves+enzalutamide+for+castration-resistant+prostate+cancer&amp;rft.pub=Food+and+Drug+Administration&amp;rft.date=2018-07-13&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fdrugs%2Fresources-information-approved-drugs%2Ffda-approves-enzalutamide-castration-resistant-prostate-cancer&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-102\"><span><b><a href=\"#cite_ref-102\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://biontechse.gcs-web.com/news-releases/news-release-details/biontech-signs-collaboration-agreement-pfizer-develop-mrna-based\">\"BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza\"</a> (Press release). <a href=\"/wiki/BioNTech\" title=\"BioNTech\">BioNTech</a>. August 16, 2018.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=BioNTech+Signs+Collaboration+Agreement+with+Pfizer+to+Develop+mRNA-based+Vaccines+for+Prevention+of+Influenza&amp;rft.pub=BioNTech&amp;rft.date=2018-08-16&amp;rft_id=https%3A%2F%2Fbiontechse.gcs-web.com%2Fnews-releases%2Fnews-release-details%2Fbiontech-signs-collaboration-agreement-pfizer-develop-mrna-based&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-103\"><span><b><a href=\"#cite_ref-103\">^</a></b></span> <span><cite id=\"CITEREFMathiasBanerjee2018\">Mathias, Tamara; Banerjee, Ankur (October 1, 2018). <a rel=\"nofollow\" href=\"https://www.reuters.com/article/us-pfizer-ceo/pfizer-to-replace-longtime-ceo-read-with-veteran-bourla-idUSKCN1MB29D\">\"Pfizer to replace longtime CEO Read with veteran Bourla\"</a>. <i><a href=\"/wiki/Reuters\" title=\"Reuters\">Reuters</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+to+replace+longtime+CEO+Read+with+veteran+Bourla&amp;rft.date=2018-10-01&amp;rft.aulast=Mathias&amp;rft.aufirst=Tamara&amp;rft.au=Banerjee%2C+Ankur&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-pfizer-ceo%2Fpfizer-to-replace-longtime-ceo-read-with-veteran-bourla-idUSKCN1MB29D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-104\"><span><b><a href=\"#cite_ref-104\">^</a></b></span> <span><cite id=\"CITEREFMaidenberg2018\">Maidenberg, Micah (October 9, 2018). <span title=\"Paid subscription required\"><a rel=\"nofollow\" href=\"https://www.wsj.com/articles/pfizer-prepares-for-ceo-transition-with-executive-suite-changes-1539095075\">\"Pfizer Prepares for CEO Transition With Executive Suite Changes\"</a></span>. <i><a href=\"/wiki/The_Wall_Street_Journal\" title=\"The Wall Street Journal\">The Wall Street Journal</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=Pfizer+Prepares+for+CEO+Transition+With+Executive+Suite+Changes&amp;rft.date=2018-10-09&amp;rft.aulast=Maidenberg&amp;rft.aufirst=Micah&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2Fpfizer-prepares-for-ceo-transition-with-executive-suite-changes-1539095075&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-105\"><span><b><a href=\"#cite_ref-105\">^</a></b></span> <span><cite id=\"CITEREFRamsey2018\">Ramsey, Lydia (October 1, 2018). <span title=\"Paid subscription required\"><a rel=\"nofollow\" href=\"https://www.businessinsider.com/who-is-albert-bourla-next-pfizer-ceo-2018-10\">\"Pfizer's CEO is stepping down after 8 years — meet the man who will be replacing him\"</a></span>. <i><a href=\"/wiki/Business_Insider\" title=\"Business Insider\">Business Insider</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Business+Insider&amp;rft.atitle=Pfizer%27s+CEO+is+stepping+down+after+8+years+%E2%80%94+meet+the+man+who+will+be+replacing+him&amp;rft.date=2018-10-01&amp;rft.aulast=Ramsey&amp;rft.aufirst=Lydia&amp;rft_id=https%3A%2F%2Fwww.businessinsider.com%2Fwho-is-albert-bourla-next-pfizer-ceo-2018-10&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-106\"><span><b><a href=\"#cite_ref-106\">^</a></b></span> <span><cite id=\"CITEREFJarvis2018\">Jarvis, Lisa M. (October 3, 2018). <a rel=\"nofollow\" href=\"https://cen.acs.org/pharmaceuticals/Pfizer-unveils-CEO-succession-plan/96/i40\">\"Pfizer unveils CEO succession plan\"</a>. <i><a href=\"/wiki/Chemical_%26_Engineering_News\" title=\"Chemical &amp; Engineering News\">Chemical &amp; Engineering News</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Chemical+%26+Engineering+News&amp;rft.atitle=Pfizer+unveils+CEO+succession+plan&amp;rft.date=2018-10-03&amp;rft.aulast=Jarvis&amp;rft.aufirst=Lisa+M.&amp;rft_id=https%3A%2F%2Fcen.acs.org%2Fpharmaceuticals%2FPfizer-unveils-CEO-succession-plan%2F96%2Fi40&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-107\"><span><b><a href=\"#cite_ref-107\">^</a></b></span> <span><cite id=\"CITEREFBakolia2019\">Bakolia, Ravikash (July 1, 2019). <a rel=\"nofollow\" href=\"https://www.spglobal.com/marketintelligence/en/news-insights/trending/sWCcSrMgL8UmeCJXuuGp-w2\">\"Pfizer completes acquisition of Therachon to bolster rare disease drug portfolio\"</a>. <i><a href=\"/wiki/S%26P_Global\" title=\"S&amp;P Global\">S&amp;P Global</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=S%26P+Global&amp;rft.atitle=Pfizer+completes+acquisition+of+Therachon+to+bolster+rare+disease+drug+portfolio&amp;rft.date=2019-07-01&amp;rft.aulast=Bakolia&amp;rft.aufirst=Ravikash&amp;rft_id=https%3A%2F%2Fwww.spglobal.com%2Fmarketintelligence%2Fen%2Fnews-insights%2Ftrending%2FsWCcSrMgL8UmeCJXuuGp-w2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-108\"><span><b><a href=\"#cite_ref-108\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.businesswire.com/news/home/20190730005590/en/Pfizer-Completes-Acquisition-of-Array-Biopharma\">\"Pfizer Completes Acquisition of Array Biopharma\"</a> (Press release). Pfizer. July 30, 2019 – via <a href=\"/wiki/Business_Wire\" title=\"Business Wire\">Business Wire</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Completes+Acquisition+of+Array+Biopharma&amp;rft.pub=Pfizer&amp;rft.date=2019-07-30&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20190730005590%2Fen%2FPfizer-Completes-Acquisition-of-Array-Biopharma&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-109\"><span><b><a href=\"#cite_ref-109\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.gsk.com/en-gb/media/press-releases/gsk-completes-transaction-with-pfizer-to-form-new-world-leading-consumer-healthcare-joint-venture/\">\"GSK completes transaction with Pfizer to form new world-leading Consumer Healthcare Joint Venture\"</a> (Press release). <a href=\"/wiki/GlaxoSmithKline\" title=\"GlaxoSmithKline\">GlaxoSmithKline</a>. August 1, 2019.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=GSK+completes+transaction+with+Pfizer+to+form+new+world-leading+Consumer+Healthcare+Joint+Venture&amp;rft.pub=GlaxoSmithKline&amp;rft.date=2019-08-01&amp;rft_id=https%3A%2F%2Fwww.gsk.com%2Fen-gb%2Fmedia%2Fpress-releases%2Fgsk-completes-transaction-with-pfizer-to-form-new-world-leading-consumer-healthcare-joint-venture%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-110\"><span><b><a href=\"#cite_ref-110\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-plc-and-pfizer-inc-to-form-new-world-leading-consumer-healthcare-joint-venture/\">\"GlaxoSmithKline plc and Pfizer Inc to form new world-leading Consumer Healthcare Joint Venture\"</a> (Press release). <a href=\"/wiki/GlaxoSmithKline\" title=\"GlaxoSmithKline\">GlaxoSmithKline</a>. December 19, 2018.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=GlaxoSmithKline+plc+and+Pfizer+Inc+to+form+new+world-leading+Consumer+Healthcare+Joint+Venture&amp;rft.pub=GlaxoSmithKline&amp;rft.date=2018-12-19&amp;rft_id=https%3A%2F%2Fwww.gsk.com%2Fen-gb%2Fmedia%2Fpress-releases%2Fglaxosmithkline-plc-and-pfizer-inc-to-form-new-world-leading-consumer-healthcare-joint-venture%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-111\"><span><b><a href=\"#cite_ref-111\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.pfizer.com/news/press-release/press-release-detail/pfizer_and_glaxosmithkline_announce_joint_venture_to_create_a_premier_global_consumer_healthcare_company\">\"Pfizer and GlaxoSmithKline Announce Joint Venture to Create a Premier Global Consumer Healthcare Company\"</a>. <i>Pfizer</i> (Press release). December 18, 2018.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+and+GlaxoSmithKline+Announce+Joint+Venture+to+Create+a+Premier+Global+Consumer+Healthcare+Company&amp;rft.date=2018-12-18&amp;rft_id=https%3A%2F%2Fwww.pfizer.com%2Fnews%2Fpress-release%2Fpress-release-detail%2Fpfizer_and_glaxosmithkline_announce_joint_venture_to_create_a_premier_global_consumer_healthcare_company&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-112\"><span><b><a href=\"#cite_ref-112\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.bbc.co.uk/news/business-46616713\">\"GlaxoSmithKline and Pfizer merge healthcare arms\"</a>. <i><a href=\"/wiki/BBC_News\" title=\"BBC News\">BBC News</a></i>. December 19, 2018.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=GlaxoSmithKline+and+Pfizer+merge+healthcare+arms&amp;rft.date=2018-12-19&amp;rft_id=https%3A%2F%2Fwww.bbc.co.uk%2Fnews%2Fbusiness-46616713&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-113\"><span><b><a href=\"#cite_ref-113\">^</a></b></span> <span><cite id=\"CITEREFHelfand2017\">Helfand, Carly (October 16, 2017). <a rel=\"nofollow\" href=\"https://www.fiercepharma.com/pharma/reckitt-benckiser-s-still-keen-a-pfizer-otc-buy-but-can-it-afford-one\">\"Reckitt Benckiser's still keen on a Pfizer OTC buy. But can it afford one?\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Reckitt+Benckiser%27s+still+keen+on+a+Pfizer+OTC+buy.+But+can+it+afford+one%3F&amp;rft.date=2017-10-16&amp;rft.aulast=Helfand&amp;rft.aufirst=Carly&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Freckitt-benckiser-s-still-keen-a-pfizer-otc-buy-but-can-it-afford-one&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-114\"><span><b><a href=\"#cite_ref-114\">^</a></b></span> <span><cite id=\"CITEREFHelfand2017\">Helfand, Carly (October 26, 2017). <a rel=\"nofollow\" href=\"https://www.fiercepharma.com/pharma/sanofi-j-j-could-join-gsk-reckitt-20b-bidding-war-for-pfizer-otc-report\">\"Sanofi, J&amp;J could join GlaxoSmithKline, Reckitt in $20B bidding war for Pfizer OTC: report\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Sanofi%2C+J%26J+could+join+GlaxoSmithKline%2C+Reckitt+in+%2420B+bidding+war+for+Pfizer+OTC%3A+report&amp;rft.date=2017-10-26&amp;rft.aulast=Helfand&amp;rft.aufirst=Carly&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fsanofi-j-j-could-join-gsk-reckitt-20b-bidding-war-for-pfizer-otc-report&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-115\"><span><b><a href=\"#cite_ref-115\">^</a></b></span> <span><cite id=\"CITEREFHelfand2017\">Helfand, Carly (October 25, 2017). <a rel=\"nofollow\" href=\"https://www.fiercepharma.com/pharma/glaxosmithkline-s-eyeing-pfizer-s-otc-unit-but-will-a-buy-imperil-its-dividend\">\"GlaxoSmithKline eyes Pfizer's OTC unit. But will a buy imperil its dividend?\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=GlaxoSmithKline+eyes+Pfizer%27s+OTC+unit.+But+will+a+buy+imperil+its+dividend%3F&amp;rft.date=2017-10-25&amp;rft.aulast=Helfand&amp;rft.aufirst=Carly&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fglaxosmithkline-s-eyeing-pfizer-s-otc-unit-but-will-a-buy-imperil-its-dividend&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-116\"><span><b><a href=\"#cite_ref-116\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.reuters.com/article/us-cstone-pfizer/pfizer-to-buy-9-9-of-cstone-for-200-million-eyes-collaboration-idUKKBN26L01D\">\"Pfizer to buy 9.9% of CStone for $200 million, eyes collaboration\"</a>. <i><a href=\"/wiki/Reuters\" title=\"Reuters\">Reuters</a></i>. September 29, 2020.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+to+buy+9.9%25+of+CStone+for+%24200+million%2C+eyes+collaboration&amp;rft.date=2020-09-29&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-cstone-pfizer%2Fpfizer-to-buy-9-9-of-cstone-for-200-million-eyes-collaboration-idUKKBN26L01D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-117\"><span><b><a href=\"#cite_ref-117\">^</a></b></span> <span><cite id=\"CITEREFAl_Idrus2020\">Al Idrus, Amirah (October 22, 2020). <a rel=\"nofollow\" href=\"https://www.fiercebiotech.com/biotech/pfizer-snaps-up-antibiotics-maker-arixa-and-its-oral-avycaz-follow-up\">\"Biotech Pfizer snaps up antibiotics maker Arixa and its oral Avycaz follow-up\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Biotech+Pfizer+snaps+up+antibiotics+maker+Arixa+and+its+oral+Avycaz+follow-up&amp;rft.date=2020-10-22&amp;rft.aulast=Al+Idrus&amp;rft.aufirst=Amirah&amp;rft_id=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fpfizer-snaps-up-antibiotics-maker-arixa-and-its-oral-avycaz-follow-up&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-118\"><span><b><a href=\"#cite_ref-118\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.businesswire.com/news/home/20201116005378/en/Pfizer-Completes-Transaction-to-Combine-Its-Upjohn-Business-with-Mylan\">\"Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan\"</a> (Press release). Pfizer. November 16, 2020 – via <a href=\"/wiki/Business_Wire\" title=\"Business Wire\">Business Wire</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Completes+Transaction+to+Combine+Its+Upjohn+Business+with+Mylan&amp;rft.pub=Pfizer&amp;rft.date=2020-11-16&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20201116005378%2Fen%2FPfizer-Completes-Transaction-to-Combine-Its-Upjohn-Business-with-Mylan&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-119\"><span><b><a href=\"#cite_ref-119\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.nasdaq.com/articles/pfizer-completes-combination-of-upjohn-and-mylan-viatris-to-begin-trading-on-nov.-17-2020\">\"Pfizer Completes Combination Of Upjohn And Mylan; Viatris To Begin Trading On Nov. 17\"</a>. <i><a href=\"/wiki/Nasdaq\" title=\"Nasdaq\">Nasdaq</a></i>. November 16, 2020.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nasdaq&amp;rft.atitle=Pfizer+Completes+Combination+Of+Upjohn+And+Mylan%3B+Viatris+To+Begin+Trading+On+Nov.+17&amp;rft.date=2020-11-16&amp;rft_id=https%3A%2F%2Fwww.nasdaq.com%2Farticles%2Fpfizer-completes-combination-of-upjohn-and-mylan-viatris-to-begin-trading-on-nov.-17-2020&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-120\"><span><b><a href=\"#cite_ref-120\">^</a></b></span> <span><cite id=\"CITEREFSabatini2020\">Sabatini, Patricia (November 16, 2020). <a rel=\"nofollow\" href=\"https://www.post-gazette.com/business/healthcare-business/2020/11/16/Mylan-merger-Upjohn-Viatris-bresch-coury-Pfizer-cost-cuts-generic-drugs/stories/202011160111\">\"Mylan completes merger with Upjohn to form Viatris\"</a>. <i><a href=\"/wiki/Pittsburgh_Post-Gazette\" title=\"Pittsburgh Post-Gazette\">Pittsburgh Post-Gazette</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pittsburgh+Post-Gazette&amp;rft.atitle=Mylan+completes+merger+with+Upjohn+to+form+Viatris&amp;rft.date=2020-11-16&amp;rft.aulast=Sabatini&amp;rft.aufirst=Patricia&amp;rft_id=https%3A%2F%2Fwww.post-gazette.com%2Fbusiness%2Fhealthcare-business%2F2020%2F11%2F16%2FMylan-merger-Upjohn-Viatris-bresch-coury-Pfizer-cost-cuts-generic-drugs%2Fstories%2F202011160111&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-121\"><span><b><a href=\"#cite_ref-121\">^</a></b></span> <span><cite id=\"CITEREFBruell2021\">Bruell, Alexandra (January 5, 2021). <span title=\"Paid subscription required\"><a rel=\"nofollow\" href=\"https://www.wsj.com/articles/pfizer-introduces-new-logo-playing-up-role-in-drug-creation-11609844400\">\"Pfizer Introduces New Logo Playing Up Role in Drug Creation\"</a></span>. <i><a href=\"/wiki/The_Wall_Street_Journal\" title=\"The Wall Street Journal\">The Wall Street Journal</a></i>. <a href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a>&nbsp;<a rel=\"nofollow\" href=\"//www.worldcat.org/issn/0099-9660\">0099-9660</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=Pfizer+Introduces+New+Logo+Playing+Up+Role+in+Drug+Creation&amp;rft.date=2021-01-05&amp;rft.issn=0099-9660&amp;rft.aulast=Bruell&amp;rft.aufirst=Alexandra&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2Fpfizer-introduces-new-logo-playing-up-role-in-drug-creation-11609844400&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-122\"><span><b><a href=\"#cite_ref-122\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.businesswire.com/news/home/20210428005147/en/Pfizer-Acquires-Amplyx-Pharmaceuticals\">\"Pfizer Acquires Amplyx Pharmaceuticals\"</a> (Press release). Pfizer. April 28, 2021 – via <a href=\"/wiki/Business_Wire\" title=\"Business Wire\">Business Wire</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Acquires+Amplyx+Pharmaceuticals&amp;rft.pub=Pfizer&amp;rft.date=2021-04-28&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20210428005147%2Fen%2FPfizer-Acquires-Amplyx-Pharmaceuticals&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-123\"><span><b><a href=\"#cite_ref-123\">^</a></b></span> <span><cite id=\"CITEREFTaylor2021\">Taylor, Nick Paul (April 28, 2021). <a rel=\"nofollow\" href=\"https://www.fiercebiotech.com/biotech/pfizer-buys-amplyx-to-grow-infectious-disease-pipeline\">\"Pfizer buys Amplyx to grow infectious disease pipeline\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Pfizer+buys+Amplyx+to+grow+infectious+disease+pipeline&amp;rft.date=2021-04-28&amp;rft.aulast=Taylor&amp;rft.aufirst=Nick+Paul&amp;rft_id=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fpfizer-buys-amplyx-to-grow-infectious-disease-pipeline&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-124\"><span><b><a href=\"#cite_ref-124\">^</a></b></span> <span><cite id=\"CITEREFWosen2021\">Wosen, Jonathan (April 28, 2021). <a rel=\"nofollow\" href=\"https://www.sandiegouniontribune.com/business/biotech/story/2021-04-28/pfizer-acquires-fungus-fighting-san-diego-biotech-amplyx\">\"Pfizer acquires fungus-fighting San Diego biotech\"</a>. <i><a href=\"/wiki/The_San_Diego_Union-Tribune\" title=\"The San Diego Union-Tribune\">The San Diego Union-Tribune</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+San+Diego+Union-Tribune&amp;rft.atitle=Pfizer+acquires+fungus-fighting+San+Diego+biotech&amp;rft.date=2021-04-28&amp;rft.aulast=Wosen&amp;rft.aufirst=Jonathan&amp;rft_id=https%3A%2F%2Fwww.sandiegouniontribune.com%2Fbusiness%2Fbiotech%2Fstory%2F2021-04-28%2Fpfizer-acquires-fungus-fighting-san-diego-biotech-amplyx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-125\"><span><b><a href=\"#cite_ref-125\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.reuters.com/business/pfizer-buy-trillium-therapeutics-226-bln-deal-2021-08-23/\">\"Pfizer to buy cancer drug developer Trillium in $2.3 BLN deal\"</a>. <i>Reuters</i>. August 23, 2021.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+to+buy+cancer+drug+developer+Trillium+in+%242.3+BLN+deal&amp;rft.date=2021-08-23&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Fbusiness%2Fpfizer-buy-trillium-therapeutics-226-bln-deal-2021-08-23%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-126\"><span><b><a href=\"#cite_ref-126\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.biospace.com/article/releases/pfizer-to-acquire-trillium-therapeutics-inc-/?s=79\">\"Pfizer to Acquire Trillium Therapeutics Inc\"</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+to+Acquire+Trillium+Therapeutics+Inc&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Freleases%2Fpfizer-to-acquire-trillium-therapeutics-inc-%2F%3Fs%3D79&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-127\"><span><b><a href=\"#cite_ref-127\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.reuters.com/markets/deals/pfizer-acquire-arena-pharmaceuticals-67-bln-deal-2021-12-13\">\"Pfizer bets on Arena's promising bowel disease treatment in $6.7 bln deal\"</a>. <i><a href=\"/wiki/Reuters\" title=\"Reuters\">Reuters</a></i>. December 13, 2021<span>. Retrieved <span>December 13,</span> 2021</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+bets+on+Arena%27s+promising+bowel+disease+treatment+in+%246.7+bln+deal&amp;rft.date=2021-12-13&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Fmarkets%2Fdeals%2Fpfizer-acquire-arena-pharmaceuticals-67-bln-deal-2021-12-13&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-128\"><span><b><a href=\"#cite_ref-128\">^</a></b></span> <span><cite id=\"CITEREFWalker2021\">Walker, Joseph (December 13, 2021). <a rel=\"nofollow\" href=\"https://www.wsj.com/articles/pfizer-to-acquire-arena-pharmaceuticals-in-6-7-billion-deal-11639414813\">\"Pfizer to Acquire Arena Pharmaceuticals in $6.7 Billion Deal\"</a>. <i><a href=\"/wiki/Wall_Street_Journal\" title=\"Wall Street Journal\">Wall Street Journal</a></i><span>. Retrieved <span>December 13,</span> 2021</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Wall+Street+Journal&amp;rft.atitle=Pfizer+to+Acquire+Arena+Pharmaceuticals+in+%246.7+Billion+Deal&amp;rft.date=2021-12-13&amp;rft.aulast=Walker&amp;rft.aufirst=Joseph&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2Fpfizer-to-acquire-arena-pharmaceuticals-in-6-7-billion-deal-11639414813&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-129\"><span><b><a href=\"#cite_ref-129\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.pharmaceutical-technology.com/news/pfizer-arena-pharmaceuticals-acquisition/\">\"Pfizer concludes Arena Pharmaceuticals acquisition for $6.7bn\"</a>. <i>Pharmaceutical Technology</i>. March 14, 2022<span>. Retrieved <span>March 14,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Pharmaceutical+Technology&amp;rft.atitle=Pfizer+concludes+Arena+Pharmaceuticals+acquisition+for+%246.7bn&amp;rft.date=2022-03-14&amp;rft_id=https%3A%2F%2Fwww.pharmaceutical-technology.com%2Fnews%2Fpfizer-arena-pharmaceuticals-acquisition%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-130\"><span><b><a href=\"#cite_ref-130\">^</a></b></span> <span><cite id=\"CITEREFCzachor2020\">Czachor, Emily (November 9, 2020). <a rel=\"nofollow\" href=\"https://www.newsweek.com/pfizer-avoided-rd-funding-trumps-operation-warp-speed-because-bureaucracy-politics-1546110\">\"Pfizer Avoided R&amp;D Funding From Trump's Operation Warp Speed Because of Bureaucracy, Politics\"</a>. <i><a href=\"/wiki/Newsweek\" title=\"Newsweek\">Newsweek</a></i><span>. Retrieved <span>May 18,</span> 2021</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Newsweek&amp;rft.atitle=Pfizer+Avoided+R%26D+Funding+From+Trump%27s+Operation+Warp+Speed+Because+of+Bureaucracy%2C+Politics&amp;rft.date=2020-11-09&amp;rft.aulast=Czachor&amp;rft.aufirst=Emily&amp;rft_id=https%3A%2F%2Fwww.newsweek.com%2Fpfizer-avoided-rd-funding-trumps-operation-warp-speed-because-bureaucracy-politics-1546110&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-131\"><span><b><a href=\"#cite_ref-131\">^</a></b></span> <span><cite id=\"CITEREFMinkoff2020\">Minkoff, Yoel (May 13, 2020). <a rel=\"nofollow\" href=\"https://seekingalpha.com/news/3573714-pfizer-sees-expanded-coronavirus-vaccine-trials\">\"Pfizer sees expanded coronavirus vaccine trials\"</a>. <i>Seeking Alpha</i><span>. Retrieved <span>May 13,</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Seeking+Alpha&amp;rft.atitle=Pfizer+sees+expanded+coronavirus+vaccine+trials&amp;rft.date=2020-05-13&amp;rft.aulast=Minkoff&amp;rft.aufirst=Yoel&amp;rft_id=https%3A%2F%2Fseekingalpha.com%2Fnews%2F3573714-pfizer-sees-expanded-coronavirus-vaccine-trials&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-132\"><span><b><a href=\"#cite_ref-132\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"http://www.globenewswire.com/news-release/2020/07/13/2061084/0/en/Pfizer-and-BioNTech-Granted-FDA-Fast-Track-Designation-for-Two-Investigational-mRNA-based-Vaccine-Candidates-Against-SARS-CoV-2.html\">\"Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2\"</a> (Press release). BioNTech. July 13, 2020<span>. Retrieved <span>July 15,</span> 2020</span> – via GlobeNewswire.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+and+BioNTech+Granted+FDA+Fast+Track+Designation+for+Two+Investigational+mRNA-based+Vaccine+Candidates+Against+SARS-CoV-2&amp;rft.pub=BioNTech&amp;rft.date=2020-07-13&amp;rft_id=http%3A%2F%2Fwww.globenewswire.com%2Fnews-release%2F2020%2F07%2F13%2F2061084%2F0%2Fen%2FPfizer-and-BioNTech-Granted-FDA-Fast-Track-Designation-for-Two-Investigational-mRNA-based-Vaccine-Candidates-Against-SARS-CoV-2.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-133\"><span><b><a href=\"#cite_ref-133\">^</a></b></span> <span><cite id=\"CITEREFDeArment2020\">DeArment, Alaric (July 13, 2020). <a rel=\"nofollow\" href=\"https://medcitynews.com/2020/07/pfizer-biontech-get-fast-track-from-fda-for-covid-19-vaccines/\">\"Pfizer, BioNTech get fast-track from FDA for Covid-19 vaccines\"</a>. <i>MedCity News</i><span>. Retrieved <span>July 15,</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=MedCity+News&amp;rft.atitle=Pfizer%2C+BioNTech+get+fast-track+from+FDA+for+Covid-19+vaccines&amp;rft.date=2020-07-13&amp;rft.aulast=DeArment&amp;rft.aufirst=Alaric&amp;rft_id=https%3A%2F%2Fmedcitynews.com%2F2020%2F07%2Fpfizer-biontech-get-fast-track-from-fda-for-covid-19-vaccines%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-134\"><span><b><a href=\"#cite_ref-134\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.wsj.com/articles/pfizer-sales-fall-as-company-races-toward-covid-19-vaccine-11595936314\">\"Pfizer Beats Forecasts as Vaccine Trial Enters Final Stage\"</a>. <i>The Wall Street Journal</i>. July 29, 2020.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=Pfizer+Beats+Forecasts+as+Vaccine+Trial+Enters+Final+Stage&amp;rft.date=2020-07-29&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2Fpfizer-sales-fall-as-company-races-toward-covid-19-vaccine-11595936314&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-135\"><span><b><a href=\"#cite_ref-135\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://news.yahoo.com/pfizer-charge-39-per-coronavirus-065224983.html\">\"Pfizer To Charge $39 Per Coronavirus Vaccine Course To All Developed Countries For Similar Volume Commitments As US\"</a>. <i>Benzinga</i>. <a href=\"/wiki/Yahoo!\" title=\"Yahoo!\">Yahoo!</a>. July 29, 2020.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Benzinga&amp;rft.atitle=Pfizer+To+Charge+%2439+Per+Coronavirus+Vaccine+Course+To+All+Developed+Countries+For+Similar+Volume+Commitments+As+US&amp;rft.date=2020-07-29&amp;rft_id=https%3A%2F%2Fnews.yahoo.com%2Fpfizer-charge-39-per-coronavirus-065224983.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-136\"><span><b><a href=\"#cite_ref-136\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.barrons.com/articles/pfizer-ceo-says-companies-should-make-profit-on-covid-19-vaccines-51595968611\">\"Pfizer CEO Says Companies Should Make Profit On Covid-19 Vaccines\"</a>. Barron's.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+CEO+Says+Companies+Should+Make+Profit+On+Covid-19+Vaccines&amp;rft.pub=Barron%27s&amp;rft_id=https%3A%2F%2Fwww.barrons.com%2Farticles%2Fpfizer-ceo-says-companies-should-make-profit-on-covid-19-vaccines-51595968611&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-137\"><span><b><a href=\"#cite_ref-137\">^</a></b></span> <span><cite id=\"CITEREFKilgore\">Kilgore, Tomi. <a rel=\"nofollow\" href=\"https://www.marketwatch.com/story/pfizer-biontech-conclude-talks-over-supplying-eu-with-sars-cov-2-vaccine-candidate-2020-09-09\">\"Pfizer, BioNTech conclude talks over supplying EU with SARS-CoV-2 vaccine candidate\"</a>. <i>MarketWatch</i><span>. Retrieved <span>September 10,</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=MarketWatch&amp;rft.atitle=Pfizer%2C+BioNTech+conclude+talks+over+supplying+EU+with+SARS-CoV-2+vaccine+candidate&amp;rft.aulast=Kilgore&amp;rft.aufirst=Tomi&amp;rft_id=https%3A%2F%2Fwww.marketwatch.com%2Fstory%2Fpfizer-biontech-conclude-talks-over-supplying-eu-with-sars-cov-2-vaccine-candidate-2020-09-09&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-138\"><span><b><a href=\"#cite_ref-138\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-potentially-supply-eu-200-million-doses\">\"Pfizer and BioNTech to Potentially Supply the EU with 200 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2\"</a>. <i>Pfizer</i> (Press release)<span>. Retrieved <span>September 10,</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+and+BioNTech+to+Potentially+Supply+the+EU+with+200+Million+Doses+of+mRNA-based+Vaccine+Candidate+Against+SARS-CoV-2&amp;rft_id=https%3A%2F%2Fwww.pfizer.com%2Fnews%2Fpress-release%2Fpress-release-detail%2Fpfizer-and-biontech-potentially-supply-eu-200-million-doses&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-139\"><span><b><a href=\"#cite_ref-139\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.bbc.com/news/health-54873105\">\"Covid vaccine: First 'milestone' vaccine offers 90% protection\"</a>. <i><a href=\"/wiki/BBC_News\" title=\"BBC News\">BBC News</a></i>. November 9, 2020.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Covid+vaccine%3A+First+%27milestone%27+vaccine+offers+90%25+protection&amp;rft.date=2020-11-09&amp;rft_id=https%3A%2F%2Fwww.bbc.com%2Fnews%2Fhealth-54873105&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-:1-140\"><span>^ <a href=\"#cite_ref-:1_140-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:1_140-1\"><sup><i><b>b</b></i></sup></a></span> <span><cite id=\"CITEREFKounang2020\">Kounang, Nadia (November 9, 2020). <a rel=\"nofollow\" href=\"https://www.cnn.com/2020/11/18/health/pfizer-coronavirus-vaccine-safety/index.html\">\"Pfizer and BioNTech say final analysis shows coronavirus vaccine is 95% effective with no safety concerns\"</a>. <i>CNN</i><span>. Retrieved <span>November 9,</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=CNN&amp;rft.atitle=Pfizer+and+BioNTech+say+final+analysis+shows+coronavirus+vaccine+is+95%25+effective+with+no+safety+concerns&amp;rft.date=2020-11-09&amp;rft.aulast=Kounang&amp;rft.aufirst=Nadia&amp;rft_id=https%3A%2F%2Fwww.cnn.com%2F2020%2F11%2F18%2Fhealth%2Fpfizer-coronavirus-vaccine-safety%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-141\"><span><b><a href=\"#cite_ref-141\">^</a></b></span> <span><cite id=\"CITEREFThomasGellesZimmer2020\">Thomas, Katie; Gelles, David; Zimmer, Carl (November 9, 2020). <a rel=\"nofollow\" href=\"https://www.nytimes.com/2020/11/09/health/covid-vaccine-pfizer.html\">\"Pfizer's Early Data Shows Vaccine Is More Than 90% Effective\"</a>. <i>The New York Times</i>. <a href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a>&nbsp;<a rel=\"nofollow\" href=\"//www.worldcat.org/issn/0362-4331\">0362-4331</a><span>. Retrieved <span>May 18,</span> 2021</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer%27s+Early+Data+Shows+Vaccine+Is+More+Than+90%25+Effective&amp;rft.date=2020-11-09&amp;rft.issn=0362-4331&amp;rft.aulast=Thomas&amp;rft.aufirst=Katie&amp;rft.au=Gelles%2C+David&amp;rft.au=Zimmer%2C+Carl&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2020%2F11%2F09%2Fhealth%2Fcovid-vaccine-pfizer.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-142\"><span><b><a href=\"#cite_ref-142\">^</a></b></span> <span><cite id=\"CITEREFRoberts2020\">Roberts, Michelle (December 2, 2020). <a rel=\"nofollow\" href=\"https://www.bbc.com/news/health-55145696\">\"Covid-19: Pfizer/BioNTech vaccine judged safe for use in UK\"</a>. <i><a href=\"/wiki/BBC_News\" title=\"BBC News\">BBC News</a></i><span>. Retrieved <span>December 2,</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BBC+News&amp;rft.atitle=Covid-19%3A+Pfizer%2FBioNTech+vaccine+judged+safe+for+use+in+UK&amp;rft.date=2020-12-02&amp;rft.aulast=Roberts&amp;rft.aufirst=Michelle&amp;rft_id=https%3A%2F%2Fwww.bbc.com%2Fnews%2Fhealth-55145696&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-Bahrain_Approves_Covid-19_Vaccine_(Al_Jazeera)-143\"><span><b><a href=\"#cite_ref-Bahrain_Approves_Covid-19_Vaccine_(Al_Jazeera)_143-0\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.aljazeera.com/news/2020/12/4/bahrain-becomes-second-country-to-approve-pfizer-covid-19-vaccine\">\"Bahrain becomes second country to approve Pfizer COVID-19 vaccine\"</a>. <i>www.aljazeera.com</i>. Al Jazeera. December 4, 2020<span>. Retrieved <span>December 11,</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=www.aljazeera.com&amp;rft.atitle=Bahrain+becomes+second+country+to+approve+Pfizer+COVID-19+vaccine&amp;rft.date=2020-12-04&amp;rft_id=https%3A%2F%2Fwww.aljazeera.com%2Fnews%2F2020%2F12%2F4%2Fbahrain-becomes-second-country-to-approve-pfizer-covid-19-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-Canada_Approves_Covid-19_Vaccine_(NYT)-144\"><span><b><a href=\"#cite_ref-Canada_Approves_Covid-19_Vaccine_(NYT)_144-0\">^</a></b></span> <span><cite id=\"CITEREFAusten2020\">Austen, Ian (December 9, 2020). <a rel=\"nofollow\" href=\"https://www.nytimes.com/2020/12/09/world/americas/canada-vaccine-approve.html\">\"Canada Approves Vaccine and Could Start Shots Next Week\"</a>. <i>The New York Times</i><span>. Retrieved <span>December 11,</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Canada+Approves+Vaccine+and+Could+Start+Shots+Next+Week&amp;rft.date=2020-12-09&amp;rft.aulast=Austen&amp;rft.aufirst=Ian&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2020%2F12%2F09%2Fworld%2Famericas%2Fcanada-vaccine-approve.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-Saudi_Arabia_Approves_Covid-19_Vaccine,_Bahrain_To_Distribute_Free_to_Public_(KTLA)-145\"><span><b><a href=\"#cite_ref-Saudi_Arabia_Approves_Covid-19_Vaccine,_Bahrain_To_Distribute_Free_to_Public_(KTLA)_145-0\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://ktla.com/news/nationworld/saudi-arabia-approves-pfizer-covid-19-vaccine-as-bahrain-plans-to-give-the-public-free-shots/\">\"Saudi Arabia approves Pfizer COVID-19 vaccine as Bahrain plans to give the public free shots\"</a>. <i>KTLA</i>. December 11, 2020<span>. Retrieved <span>December 11,</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=KTLA&amp;rft.atitle=Saudi+Arabia+approves+Pfizer+COVID-19+vaccine+as+Bahrain+plans+to+give+the+public+free+shots&amp;rft.date=2020-12-11&amp;rft_id=https%3A%2F%2Fktla.com%2Fnews%2Fnationworld%2Fsaudi-arabia-approves-pfizer-covid-19-vaccine-as-bahrain-plans-to-give-the-public-free-shots%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-US_FDA_Advisory_Panel_Backs_Covid-19_Vaccine_Approval_(Reuters)-146\"><span>^ <a href=\"#cite_ref-US_FDA_Advisory_Panel_Backs_Covid-19_Vaccine_Approval_(Reuters)_146-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-US_FDA_Advisory_Panel_Backs_Covid-19_Vaccine_Approval_(Reuters)_146-1\"><sup><i><b>b</b></i></sup></a></span> <span><cite id=\"CITEREFSteenhuysen2020\">Steenhuysen, Manas Mishra, Julie (December 11, 2020). <a rel=\"nofollow\" href=\"https://www.reuters.com/article/health-coronavirus-pfizer-vaccine/us-fda-advisers-wrestle-with-ethical-issues-linked-to-authorizing-pfizers-covid-19-vaccine-idUSKBN28K1O5\">\"U.S. FDA advisers overwhelmingly back authorizing Pfizer–BioNTech COVID-19 vaccine\"</a>. <i>Reuters</i><span>. Retrieved <span>December 11,</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=U.S.+FDA+advisers+overwhelmingly+back+authorizing+Pfizer%E2%80%93BioNTech+COVID-19+vaccine&amp;rft.date=2020-12-11&amp;rft.aulast=Steenhuysen&amp;rft.aufirst=Manas+Mishra%2C+Julie&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fhealth-coronavirus-pfizer-vaccine%2Fus-fda-advisers-wrestle-with-ethical-issues-linked-to-authorizing-pfizers-covid-19-vaccine-idUSKBN28K1O5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-147\"><span><b><a href=\"#cite_ref-147\">^</a></b></span> <span><cite id=\"CITEREFThomasLaFraniereWeilandGoodnough2020\">Thomas, Katie; LaFraniere, Sharon; Weiland, Noah; Goodnough, Abby; Haberman, Maggie (December 12, 2020). <a rel=\"nofollow\" href=\"https://www.nytimes.com/2020/12/11/health/pfizer-vaccine-authorized.html\">\"F.D.A. Clears Pfizer Vaccine, and Millions of Doses Will Be Shipped Right Away\"</a>. <i>The New York Times</i>. <a href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a>&nbsp;<a rel=\"nofollow\" href=\"//www.worldcat.org/issn/0362-4331\">0362-4331</a><span>. Retrieved <span>December 12,</span> 2020</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=F.D.A.+Clears+Pfizer+Vaccine%2C+and+Millions+of+Doses+Will+Be+Shipped+Right+Away&amp;rft.date=2020-12-12&amp;rft.issn=0362-4331&amp;rft.aulast=Thomas&amp;rft.aufirst=Katie&amp;rft.au=LaFraniere%2C+Sharon&amp;rft.au=Weiland%2C+Noah&amp;rft.au=Goodnough%2C+Abby&amp;rft.au=Haberman%2C+Maggie&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2020%2F12%2F11%2Fhealth%2Fpfizer-vaccine-authorized.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-148\"><span><b><a href=\"#cite_ref-148\">^</a></b></span> <span><cite id=\"CITEREFAbdullah2020\">Abdullah, Zhaki (December 14, 2020). <a rel=\"nofollow\" href=\"https://www.channelnewsasia.com/news/singapore/singapore-approves-pfizer-biontech-covid-19-vaccine-phase-3-13769570\">\"Pfizer–BioNTech COVID-19 vaccine approved by Singapore, first shipment expected by end-December\"</a>. <i>CNA</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNA&amp;rft.atitle=Pfizer%E2%80%93BioNTech+COVID-19+vaccine+approved+by+Singapore%2C+first+shipment+expected+by+end-December&amp;rft.date=2020-12-14&amp;rft.aulast=Abdullah&amp;rft.aufirst=Zhaki&amp;rft_id=https%3A%2F%2Fwww.channelnewsasia.com%2Fnews%2Fsingapore%2Fsingapore-approves-pfizer-biontech-covid-19-vaccine-phase-3-13769570&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-149\"><span><b><a href=\"#cite_ref-149\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.ema.europa.eu/en/news/ema-recommends-first-covid-19-vaccine-authorisation-eu\">\"EMA recommends first COVID-19 vaccine for authorisation in the EU\"</a>. <i><a href=\"/wiki/Europa_(web_portal)\" title=\"Europa (web portal)\">Europa</a></i>. December 21, 2020.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Europa&amp;rft.atitle=EMA+recommends+first+COVID-19+vaccine+for+authorisation+in+the+EU&amp;rft.date=2020-12-21&amp;rft_id=https%3A%2F%2Fwww.ema.europa.eu%2Fen%2Fnews%2Fema-recommends-first-covid-19-vaccine-authorisation-eu&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-150\"><span><b><a href=\"#cite_ref-150\">^</a></b></span> <span><cite id=\"CITEREFHiggins-Dunn2021\">Higgins-Dunn, Noah (May 4, 2021). <a rel=\"nofollow\" href=\"https://www.fiercepharma.com/pharma/thanks-to-revved-up-manufacturing-biontech-ceo-estimates-3b-covid-vaccine-doses-2021\">\"BioNTech, with partner Pfizer, on track to make 3B COVID vaccine doses in 2021, CEO says\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i><span>. Retrieved <span>May 18,</span> 2021</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=BioNTech%2C+with+partner+Pfizer%2C+on+track+to+make+3B+COVID+vaccine+doses+in+2021%2C+CEO+says&amp;rft.date=2021-05-04&amp;rft.aulast=Higgins-Dunn&amp;rft.aufirst=Noah&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fthanks-to-revved-up-manufacturing-biontech-ceo-estimates-3b-covid-vaccine-doses-2021&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-bullied-151\"><span>^ <a href=\"#cite_ref-bullied_151-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-bullied_151-1\"><sup><i><b>b</b></i></sup></a></span> <span><cite><a rel=\"nofollow\" href=\"https://www.aljazeera.com/news/2021/3/11/investigation-pfizer-bullied-latin-american-nations\">\"Investigation: Drugmaker 'bullied' Latin American nations\"</a>. <i><a href=\"/wiki/Al_Jazeera_English\" title=\"Al Jazeera English\">Al Jazeera English</a></i>. March 11, 2021.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Al+Jazeera+English&amp;rft.atitle=Investigation%3A+Drugmaker+%27bullied%27+Latin+American+nations&amp;rft.date=2021-03-11&amp;rft_id=https%3A%2F%2Fwww.aljazeera.com%2Fnews%2F2021%2F3%2F11%2Finvestigation-pfizer-bullied-latin-american-nations&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-152\"><span><b><a href=\"#cite_ref-152\">^</a></b></span> <span><cite id=\"CITEREFThacker\">Thacker, Paul. <a rel=\"nofollow\" href=\"https://www.bmj.com/content/375/bmj.n2635?utm_term=hootsuite\">\"Covid-19: Researcher blows the whistle on data integrity issues in Pfizer's vaccine trial\"</a>. thebmj<span>. Retrieved <span>November 2,</span> 2021</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Covid-19%3A+Researcher+blows+the+whistle+on+data+integrity+issues+in+Pfizer%27s+vaccine+trial&amp;rft.aulast=Thacker&amp;rft.aufirst=Paul&amp;rft_id=https%3A%2F%2Fwww.bmj.com%2Fcontent%2F375%2Fbmj.n2635%3Futm_term%3Dhootsuite&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-153\"><span><b><a href=\"#cite_ref-153\">^</a></b></span> <span><cite id=\"CITEREFEuropean_Medicines_Agency2021\"><a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a> (December 3, 2021). <a rel=\"nofollow\" href=\"https://www.ema.europa.eu/en/documents/other/ema-reply-letter-members-european-parliament-ms-m-rivasi-mr-p-pedicini-ms-t-metz-concerning-covid-19_en.pdf\">\"Reply letter on the Integrity of clinical data, additional clinical trials and studies, pharmacovigilance and mRNA COVID-19 vaccine safety\"</a> <span>(PDF)</span><span>. Retrieved <span>February 2,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Reply+letter+on+the+Integrity+of+clinical+data%2C+additional+clinical+trials+and+studies%2C+pharmacovigilance+and+mRNA+COVID-19+vaccine+safety&amp;rft.date=2021-12-03&amp;rft.au=European+Medicines+Agency&amp;rft_id=https%3A%2F%2Fwww.ema.europa.eu%2Fen%2Fdocuments%2Fother%2Fema-reply-letter-members-european-parliament-ms-m-rivasi-mr-p-pedicini-ms-t-metz-concerning-covid-19_en.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-154\"><span><b><a href=\"#cite_ref-154\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate\">\"Pfizer's novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR Study\"</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer%27s+novel+COVID-19+Oral+Antiviral+Treatment+Candidate+Reduced+Risk+of+Hospitalization+or+Death+by+89%25+in+Interim+Analysis+of+Phase+2%2F3+EPIC-HR+Study&amp;rft_id=https%3A%2F%2Fwww.pfizer.com%2Fnews%2Fpress-release%2Fpress-release-detail%2Fpfizers-novel-covid-19-oral-antiviral-treatment-candidate&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span><span><code>{{<a href=\"/wiki/Template:Cite_web\" title=\"Template:Cite web\">cite web</a>}}</code>:  CS1 maint: url-status (<a href=\"/wiki/Category:CS1_maint:_url-status\" title=\"Category:CS1 maint: url-status\">link</a>)</span></span>\n</li>\n<li id=\"cite_note-155\"><span><b><a href=\"#cite_ref-155\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.israelnationalnews.com/news/320624\">\"Pfizer CEO: Current wave will be last with so many restrictions\"</a>. <i>Israel National News</i><span>. Retrieved <span>January 17,</span> 2021</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Israel+National+News&amp;rft.atitle=Pfizer+CEO%3A+Current+wave+will+be+last+with+so+many+restrictions&amp;rft_id=https%3A%2F%2Fwww.israelnationalnews.com%2Fnews%2F320624&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-156\"><span><b><a href=\"#cite_ref-156\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.livemint.com/companies/news/pfizer-ceo-shares-some-good-news-on-covid-but-cautions-virus-could-circulate-for-years-11642405004050.html\">\"Pfizer CEO shares some good news on covid but cautions virus could circulate for years\"</a>. <i>Mint</i><span>. Retrieved <span>January 17,</span> 2021</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Mint&amp;rft.atitle=Pfizer+CEO+shares+some+good+news+on+covid+but+cautions+virus+could+circulate+for+years&amp;rft_id=https%3A%2F%2Fwww.livemint.com%2Fcompanies%2Fnews%2Fpfizer-ceo-shares-some-good-news-on-covid-but-cautions-virus-could-circulate-for-years-11642405004050.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-157\"><span><b><a href=\"#cite_ref-157\">^</a></b></span> <span><cite id=\"CITEREFKirkpatrick2000\">Kirkpatrick, David D. (May 15, 2000). <a rel=\"nofollow\" href=\"https://nymag.com/nymetro/health/features/3122/\">\"Inside the Happiness Business\"</a>. <i><a href=\"/wiki/New_York_(magazine)\" title=\"New York (magazine)\">New York</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+York&amp;rft.atitle=Inside+the+Happiness+Business&amp;rft.date=2000-05-15&amp;rft.aulast=Kirkpatrick&amp;rft.aufirst=David+D.&amp;rft_id=https%3A%2F%2Fnymag.com%2Fnymetro%2Fhealth%2Ffeatures%2F3122%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-158\"><span><b><a href=\"#cite_ref-158\">^</a></b></span> <span><cite id=\"CITEREFOldani2002\">Oldani, Michael (2002). <a rel=\"nofollow\" href=\"https://digitalassets.lib.berkeley.edu/anthpubs/ucb/text/kas087-006.pdf\">\"Tales from the Script\"</a> <span>(PDF)</span>. <i>Kroeber Society Papers</i>. <b>87</b>: 147–176 – via University of California Berkeley.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Kroeber+Society+Papers&amp;rft.atitle=Tales+from+the+Script&amp;rft.volume=87&amp;rft.pages=147-176&amp;rft.date=2002&amp;rft.aulast=Oldani&amp;rft.aufirst=Michael&amp;rft_id=https%3A%2F%2Fdigitalassets.lib.berkeley.edu%2Fanthpubs%2Fucb%2Ftext%2Fkas087-006.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-159\"><span><b><a href=\"#cite_ref-159\">^</a></b></span> <span><cite id=\"CITEREFOldani2004\">Oldani, Michael J. (2004). \"Thick Prescriptions: Toward an Interpretation of Pharmaceutical Sales Practices\". <i>Medical Anthropology Quarterly</i>. <b>18</b> (3): 325–356. <a href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" href=\"https://doi.org/10.1525%2Fmaq.2004.18.3.325\">10.1525/maq.2004.18.3.325</a>. <a href=\"/wiki/ISSN_(identifier)\" title=\"ISSN (identifier)\">ISSN</a>&nbsp;<a rel=\"nofollow\" href=\"//www.worldcat.org/issn/1548-1387\">1548-1387</a>. <a href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a>&nbsp;<a rel=\"nofollow\" href=\"//pubmed.ncbi.nlm.nih.gov/15484967\">15484967</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Medical+Anthropology+Quarterly&amp;rft.atitle=Thick+Prescriptions%3A+Toward+an+Interpretation+of+Pharmaceutical+Sales+Practices&amp;rft.volume=18&amp;rft.issue=3&amp;rft.pages=325-356&amp;rft.date=2004&amp;rft.issn=1548-1387&amp;rft_id=info%3Apmid%2F15484967&amp;rft_id=info%3Adoi%2F10.1525%2Fmaq.2004.18.3.325&amp;rft.aulast=Oldani&amp;rft.aufirst=Michael+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-160\"><span><b><a href=\"#cite_ref-160\">^</a></b></span> <span><cite id=\"CITEREFSteinmanBeroChrenLandefeld2006\">Steinman MA, Bero LA, Chren MM, Landefeld CS (August 2006). <a rel=\"nofollow\" href=\"https://doi.org/10.7326%2F0003-4819-145-4-200608150-00008\">\"Narrative review: the promotion of gabapentin: an analysis of internal industry documents\"</a>. <i><a href=\"/wiki/Annals_of_Internal_Medicine\" title=\"Annals of Internal Medicine\">Annals of Internal Medicine</a></i>. <b>145</b> (4): 284–93. <a href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span title=\"Freely accessible\"><a rel=\"nofollow\" href=\"https://doi.org/10.7326%2F0003-4819-145-4-200608150-00008\">10.7326/0003-4819-145-4-200608150-00008</a></span>. <a href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a>&nbsp;<a rel=\"nofollow\" href=\"//pubmed.ncbi.nlm.nih.gov/16908919\">16908919</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Internal+Medicine&amp;rft.atitle=Narrative+review%3A+the+promotion+of+gabapentin%3A+an+analysis+of+internal+industry+documents&amp;rft.volume=145&amp;rft.issue=4&amp;rft.pages=284-93&amp;rft.date=2006-08&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-145-4-200608150-00008&amp;rft_id=info%3Apmid%2F16908919&amp;rft.aulast=Steinman&amp;rft.aufirst=MA&amp;rft.au=Bero%2C+LA&amp;rft.au=Chren%2C+MM&amp;rft.au=Landefeld%2C+CS&amp;rft_id=%2F%2Fdoi.org%2F10.7326%252F0003-4819-145-4-200608150-00008&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-161\"><span><b><a href=\"#cite_ref-161\">^</a></b></span> <span><cite id=\"CITEREFHenney_JE2006\">Henney JE (August 2006). \"Safeguarding patient welfare: who's in charge?\". <i><a href=\"/wiki/Annals_of_Internal_Medicine\" title=\"Annals of Internal Medicine\">Annals of Internal Medicine</a></i>. <b>145</b> (4): 305–7. <a href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" href=\"https://doi.org/10.7326%2F0003-4819-145-4-200608150-00013\">10.7326/0003-4819-145-4-200608150-00013</a>. <a href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a>&nbsp;<a rel=\"nofollow\" href=\"//pubmed.ncbi.nlm.nih.gov/16908923\">16908923</a>. <a href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a>&nbsp;<a rel=\"nofollow\" href=\"https://api.semanticscholar.org/CorpusID:39262014\">39262014</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Internal+Medicine&amp;rft.atitle=Safeguarding+patient+welfare%3A+who%27s+in+charge%3F&amp;rft.volume=145&amp;rft.issue=4&amp;rft.pages=305-7&amp;rft.date=2006-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A39262014%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F16908923&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-145-4-200608150-00013&amp;rft.au=Henney+JE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-162\"><span><b><a href=\"#cite_ref-162\">^</a></b></span> <span><cite id=\"CITEREFMullenersMcCroryLinde2014\">Mulleners WM, McCrory DC, Linde M (August 2014). \"Antiepileptics in migraine prophylaxis: An updated Cochrane review\". <i>Cephalalgia</i>. <b>35</b> (1): 51–62. <a href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" href=\"https://doi.org/10.1177%2F0333102414534325\">10.1177/0333102414534325</a>. <a href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a>&nbsp;<a rel=\"nofollow\" href=\"//pubmed.ncbi.nlm.nih.gov/25115844\">25115844</a>. <a href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a>&nbsp;<a rel=\"nofollow\" href=\"https://api.semanticscholar.org/CorpusID:43079346\">43079346</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cephalalgia&amp;rft.atitle=Antiepileptics+in+migraine+prophylaxis%3A+An+updated+Cochrane+review&amp;rft.volume=35&amp;rft.issue=1&amp;rft.pages=51-62&amp;rft.date=2014-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A43079346%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25115844&amp;rft_id=info%3Adoi%2F10.1177%2F0333102414534325&amp;rft.aulast=Mulleners&amp;rft.aufirst=WM&amp;rft.au=McCrory%2C+DC&amp;rft.au=Linde%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-163\"><span><b><a href=\"#cite_ref-163\">^</a></b></span> <span><cite id=\"CITEREFLoderBurchRizzoli2012\">Loder E, Burch R, Rizzoli P (June 2012). <a rel=\"nofollow\" href=\"https://doi.org/10.1111%2Fj.1526-4610.2012.02185.x\">\"The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines\"</a>. <i>Headache</i>. <b>52</b> (6): 930–45. <a href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<span title=\"Freely accessible\"><a rel=\"nofollow\" href=\"https://doi.org/10.1111%2Fj.1526-4610.2012.02185.x\">10.1111/j.1526-4610.2012.02185.x</a></span>. <a href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a>&nbsp;<a rel=\"nofollow\" href=\"//pubmed.ncbi.nlm.nih.gov/22671714\">22671714</a>. <a href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a>&nbsp;<a rel=\"nofollow\" href=\"https://api.semanticscholar.org/CorpusID:540800\">540800</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Headache&amp;rft.atitle=The+2012+AHS%2FAAN+guidelines+for+prevention+of+episodic+migraine%3A+a+summary+and+comparison+with+other+recent+clinical+practice+guidelines&amp;rft.volume=52&amp;rft.issue=6&amp;rft.pages=930-45&amp;rft.date=2012-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A540800%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F22671714&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1526-4610.2012.02185.x&amp;rft.aulast=Loder&amp;rft.aufirst=E&amp;rft.au=Burch%2C+R&amp;rft.au=Rizzoli%2C+P&amp;rft_id=%2F%2Fdoi.org%2F10.1111%252Fj.1526-4610.2012.02185.x&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-164\"><span><b><a href=\"#cite_ref-164\">^</a></b></span> <span><cite id=\"CITEREFHarris2009\">Harris, Gardiner (September 2, 2009). <span title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" href=\"https://www.nytimes.com/2009/09/03/business/03health.html\">\"Pfizer pays $2.3 billion to settle marketing case\"</a></span>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+pays+%242.3+billion+to+settle+marketing+case&amp;rft.date=2009-09-02&amp;rft.aulast=Harris&amp;rft.aufirst=Gardiner&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2009%2F09%2F03%2Fbusiness%2F03health.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-largestdoj-165\"><span>^ <a href=\"#cite_ref-largestdoj_165-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-largestdoj_165-1\"><sup><i><b>b</b></i></sup></a></span> <span><cite><a rel=\"nofollow\" href=\"https://www.justice.gov/opa/pr/justice-department-announces-largest-health-care-fraud-settlement-its-history\">\"Justice Department Announces Largest Health Care Fraud Settlement in Its History\"</a> (Press release). <a href=\"/wiki/United_States_Department_of_Justice\" title=\"United States Department of Justice\">United States Department of Justice</a>. September 2, 2009.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Justice+Department+Announces+Largest+Health+Care+Fraud+Settlement+in+Its+History&amp;rft.pub=United+States+Department+of+Justice&amp;rft.date=2009-09-02&amp;rft_id=https%3A%2F%2Fwww.justice.gov%2Fopa%2Fpr%2Fjustice-department-announces-largest-health-care-fraud-settlement-its-history&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-Settle-166\"><span>^ <a href=\"#cite_ref-Settle_166-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Settle_166-1\"><sup><i><b>b</b></i></sup></a></span> <span><cite id=\"CITEREFHarris2009\">Harris, Gardiner (September 3, 2009). <a rel=\"nofollow\" href=\"https://www.nytimes.com/2009/09/03/business/03health.html\">\"Pfizer Pays $2.3 billion to Settle Marketing Case\"</a>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+Pays+%242.3+billion+to+Settle+Marketing+Case&amp;rft.date=2009-09-03&amp;rft.aulast=Harris&amp;rft.aufirst=Gardiner&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2009%2F09%2F03%2Fbusiness%2F03health.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-Improper-167\"><span>^ <a href=\"#cite_ref-Improper_167-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Improper_167-1\"><sup><i><b>b</b></i></sup></a></span> <span><cite id=\"CITEREFJohnson2009\">Johnson, Carrie (September 3, 2009). <a rel=\"nofollow\" href=\"https://www.washingtonpost.com/wp-dyn/content/article/2009/09/02/AR2009090201449_pf.html\">\"In Settlement, A Warning To Drugmakers: Pfizer to Pay Record Penalty In Improper-Marketing Case\"</a>. <i><a href=\"/wiki/The_Washington_Post\" title=\"The Washington Post\">The Washington Post</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Washington+Post&amp;rft.atitle=In+Settlement%2C+A+Warning+To+Drugmakers%3A+Pfizer+to+Pay+Record+Penalty+In+Improper-Marketing+Case&amp;rft.date=2009-09-03&amp;rft.aulast=Johnson&amp;rft.aufirst=Carrie&amp;rft_id=https%3A%2F%2Fwww.washingtonpost.com%2Fwp-dyn%2Fcontent%2Farticle%2F2009%2F09%2F02%2FAR2009090201449_pf.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-fine-168\"><span>^ <a href=\"#cite_ref-fine_168-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-fine_168-1\"><sup><i><b>b</b></i></sup></a></span> <span><cite><a rel=\"nofollow\" href=\"http://news.bbc.co.uk/2/hi/business/8234533.stm\">\"Pfizer agrees record fraud fine\"</a>. <i><a href=\"/wiki/BBC_News\" title=\"BBC News\">BBC News</a></i>. September 2, 2009.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Pfizer+agrees+record+fraud+fine&amp;rft.date=2009-09-02&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F2%2Fhi%2Fbusiness%2F8234533.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-169\"><span><b><a href=\"#cite_ref-169\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://oig.hhs.gov/fraud/cia/agreements/pfizer_inc.pdf\">\"Corporate Integrity Agreement between the Office of the Inspector General of the Department of Health and Human Services and Pfizer Inc\"</a> <span>(PDF)</span>. <i><a href=\"/wiki/Office_of_Inspector_General_(United_States)\" title=\"Office of Inspector General (United States)\">Office of Inspector General</a></i>. August 31, 2009. <a rel=\"nofollow\" href=\"https://web.archive.org/web/20110715112330/http://oig.hhs.gov/fraud/cia/agreements/pfizer_inc.pdf\">Archived</a> <span>(PDF)</span> from the original on July 15, 2011.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Office+of+Inspector+General&amp;rft.atitle=Corporate+Integrity+Agreement+between+the+Office+of+the+Inspector+General+of+the+Department+of+Health+and+Human+Services+and+Pfizer+Inc.&amp;rft.date=2009-08-31&amp;rft_id=https%3A%2F%2Foig.hhs.gov%2Ffraud%2Fcia%2Fagreements%2Fpfizer_inc.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-170\"><span><b><a href=\"#cite_ref-170\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://casetext.com/case/rost-v-pfizer-2\">\"ROST v. PFIZER, INC\"</a>. Casetext.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=ROST+v.+PFIZER%2C+INC.&amp;rft.pub=Casetext&amp;rft_id=https%3A%2F%2Fcasetext.com%2Fcase%2Frost-v-pfizer-2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-171\"><span><b><a href=\"#cite_ref-171\">^</a></b></span> <span><cite id=\"CITEREFBerenson2005\"><a href=\"/wiki/Alex_Berenson\" title=\"Alex Berenson\">Berenson, Alex</a> (June 8, 2005). <span title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" href=\"https://www.nytimes.com/2005/06/08/business/at-pfizer-the-isolation-increases-for-a-whistleblower.html\">\"At Pfizer, the Isolation Increases for a Whistle-Blower\"</a></span>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=At+Pfizer%2C+the+Isolation+Increases+for+a+Whistle-Blower&amp;rft.date=2005-06-08&amp;rft.aulast=Berenson&amp;rft.aufirst=Alex&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2005%2F06%2F08%2Fbusiness%2Fat-pfizer-the-isolation-increases-for-a-whistleblower.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-172\"><span><b><a href=\"#cite_ref-172\">^</a></b></span> <span><cite id=\"CITEREFStaton2010\">Staton, Tracy (June 14, 2010). <a rel=\"nofollow\" href=\"https://www.fiercepharma.com/pharma/congress-joins-probe-into-wyeth-s-rapamune-marketing\">\"Congress joins probe into Wyeth's Rapamune marketing\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Congress+joins+probe+into+Wyeth%27s+Rapamune+marketing&amp;rft.date=2010-06-14&amp;rft.aulast=Staton&amp;rft.aufirst=Tracy&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fcongress-joins-probe-into-wyeth-s-rapamune-marketing&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-173\"><span><b><a href=\"#cite_ref-173\">^</a></b></span> <span><cite id=\"CITEREFPalmer2010\">Palmer, Eric (June 14, 2010). <a rel=\"nofollow\" href=\"https://www.fiercepharma.com/regulatory/pfizer-settles-more-off-label-marketing-cases-tied-to-rapamune\">\"Pfizer settles more off-label marketing cases tied to Rapamune\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Pfizer+settles+more+off-label+marketing+cases+tied+to+Rapamune&amp;rft.date=2010-06-14&amp;rft.aulast=Palmer&amp;rft.aufirst=Eric&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fregulatory%2Fpfizer-settles-more-off-label-marketing-cases-tied-to-rapamune&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-174\"><span><b><a href=\"#cite_ref-174\">^</a></b></span> <span><cite id=\"CITEREFEdwards2010\">Edwards, Jim (June 10, 2010). <a rel=\"nofollow\" href=\"https://www.cbsnews.com/news/blue-cross-names-and-shames-pfizer-execs-linked-to-massages-for-prescriptions-push/\">\"Blue Cross Names and Shames Pfizer Execs Linked to Massages-for-Prescriptions Push\"</a>. <i><a href=\"/wiki/CBS_News\" title=\"CBS News\">CBS News</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CBS+News&amp;rft.atitle=Blue+Cross+Names+and+Shames+Pfizer+Execs+Linked+to+Massages-for-Prescriptions+Push&amp;rft.date=2010-06-10&amp;rft.aulast=Edwards&amp;rft.aufirst=Jim&amp;rft_id=https%3A%2F%2Fwww.cbsnews.com%2Fnews%2Fblue-cross-names-and-shames-pfizer-execs-linked-to-massages-for-prescriptions-push%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-175\"><span><b><a href=\"#cite_ref-175\">^</a></b></span> <span><cite id=\"CITEREFBounds2010\">Bounds, Jeff (June 10, 2010). <a rel=\"nofollow\" href=\"https://www.bizjournals.com/austin/stories/2010/06/07/daily52.html\">\"Blue Cross Blue Shield of Texas sues Pfizer\"</a>. <i><a href=\"/wiki/American_City_Business_Journals\" title=\"American City Business Journals\">American City Business Journals</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+City+Business+Journals&amp;rft.atitle=Blue+Cross+Blue+Shield+of+Texas+sues+Pfizer&amp;rft.date=2010-06-10&amp;rft.aulast=Bounds&amp;rft.aufirst=Jeff&amp;rft_id=https%3A%2F%2Fwww.bizjournals.com%2Faustin%2Fstories%2F2010%2F06%2F07%2Fdaily52.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-176\"><span><b><a href=\"#cite_ref-176\">^</a></b></span> <span><cite id=\"CITEREFStaton2010\">Staton, Tracy (June 11, 2010). <a rel=\"nofollow\" href=\"https://www.fiercepharma.com/pharma/bcbs-names-pfizer-managers-kickback-suit\">\"BCBS names Pfizer managers in kickback suit\"</a>. <i><a href=\"/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1\" title=\"FiercePharma (page does not exist)\">FiercePharma</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=BCBS+names+Pfizer+managers+in+kickback+suit&amp;rft.date=2010-06-11&amp;rft.aulast=Staton&amp;rft.aufirst=Tracy&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fbcbs-names-pfizer-managers-kickback-suit&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-177\"><span><b><a href=\"#cite_ref-177\">^</a></b></span> <span><cite><span title=\"Paid subscription required\"><a rel=\"nofollow\" href=\"https://www.dallasnews.com/business/2010/06/11/blue-cross-blue-shield-of-texas-sues-pfizer-over-drug-marketing/\">\"Blue Cross Blue Shield of Texas sues Pfizer over drug marketing\"</a></span>. <i><a href=\"/wiki/The_Dallas_Morning_News\" title=\"The Dallas Morning News\">The Dallas Morning News</a></i>. June 11, 2010.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Dallas+Morning+News&amp;rft.atitle=Blue+Cross+Blue+Shield+of+Texas+sues+Pfizer+over+drug+marketing&amp;rft.date=2010-06-11&amp;rft_id=https%3A%2F%2Fwww.dallasnews.com%2Fbusiness%2F2010%2F06%2F11%2Fblue-cross-blue-shield-of-texas-sues-pfizer-over-drug-marketing%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-toobig-178\"><span>^ <a href=\"#cite_ref-toobig_178-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-toobig_178-1\"><sup><i><b>b</b></i></sup></a></span> <span><cite id=\"CITEREFGriffinSegal2010\">Griffin, Drew; Segal, Andy (April 2, 2010). <a rel=\"nofollow\" href=\"https://edition.cnn.com/2010/HEALTH/04/02/pfizer.bextra/index.html\">\"Feds found Pfizer too big to nail\"</a>. <i><a href=\"/wiki/CNN\" title=\"CNN\">CNN</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNN&amp;rft.atitle=Feds+found+Pfizer+too+big+to+nail&amp;rft.date=2010-04-02&amp;rft.aulast=Griffin&amp;rft.aufirst=Drew&amp;rft.au=Segal%2C+Andy&amp;rft_id=https%3A%2F%2Fedition.cnn.com%2F2010%2FHEALTH%2F04%2F02%2Fpfizer.bextra%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-179\"><span><b><a href=\"#cite_ref-179\">^</a></b></span> <span><cite id=\"CITEREFSmythe2014\">Smythe, Christie (June 2, 2014). <span title=\"Paid subscription required\"><a rel=\"nofollow\" href=\"https://www.bloomberg.com/news/2014-06-02/pfizer-agrees-to-325-million-settlment-over-neurontin.html\">\"Pfizer Agrees to $325 Million Neurontin Marketing Accord\"</a></span>. <i><a href=\"/wiki/Bloomberg_News\" title=\"Bloomberg News\">Bloomberg News</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+News&amp;rft.atitle=Pfizer+Agrees+to+%24325+Million+Neurontin+Marketing+Accord&amp;rft.date=2014-06-02&amp;rft.aulast=Smythe&amp;rft.aufirst=Christie&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2F2014-06-02%2Fpfizer-agrees-to-325-million-settlment-over-neurontin.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-180\"><span><b><a href=\"#cite_ref-180\">^</a></b></span> <span><cite id=\"CITEREFPetrovich2013\">Petrovich, Dushko (March 15, 2013). <a rel=\"nofollow\" href=\"https://www.bookforum.com/culture/-11264\">\"The Art of Making Magazines edited by Victor S. Navasky and Evan Cornog\"</a>. <i><a href=\"/wiki/Bookforum\" title=\"Bookforum\">Bookforum</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bookforum&amp;rft.atitle=The+Art+of+Making+Magazines+edited+by+Victor+S.+Navasky+and+Evan+Cornog&amp;rft.date=2013-03-15&amp;rft.aulast=Petrovich&amp;rft.aufirst=Dushko&amp;rft_id=https%3A%2F%2Fwww.bookforum.com%2Fculture%2F-11264&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-181\"><span><b><a href=\"#cite_ref-181\">^</a></b></span> <span><cite id=\"CITEREFKary2013\">Kary, Tiffany (June 27, 2013). <a rel=\"nofollow\" href=\"https://www.theday.com/article/20130627/BIZ03/306279581\">\"Pfizer to pay $958M to end asbestos litigation\"</a>. <a href=\"/wiki/Bloomberg_News\" title=\"Bloomberg News\">Bloomberg News</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pfizer+to+pay+%24958M+to+end+asbestos+litigation&amp;rft.date=2013-06-27&amp;rft.aulast=Kary&amp;rft.aufirst=Tiffany&amp;rft_id=https%3A%2F%2Fwww.theday.com%2Farticle%2F20130627%2FBIZ03%2F306279581&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-182\"><span><b><a href=\"#cite_ref-182\">^</a></b></span> <span><cite id=\"CITEREFMeier1994\"><a href=\"/wiki/Barry_Meier\" title=\"Barry Meier\">Meier, Barry</a> (July 2, 1994). <span title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" href=\"https://www.nytimes.com/1994/07/02/business/pfizer-unit-to-settle-charges-of-lying-about-heart-valve.html\">\"Pfizer Unit to Settle Charges Of Lying About Heart Valve\"</a></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pfizer+Unit+to+Settle+Charges+Of+Lying+About+Heart+Valve&amp;rft.date=1994-07-02&amp;rft.aulast=Meier&amp;rft.aufirst=Barry&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F1994%2F07%2F02%2Fbusiness%2Fpfizer-unit-to-settle-charges-of-lying-about-heart-valve.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-183\"><span><b><a href=\"#cite_ref-183\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.courant.com/news/connecticut/hc-xpm-2010-03-14-hc-pfizer-virus-lawsuit-0314-artmar14-story.html\">\"Ex-Pfizer Worker Cites Genetically Engineered Virus In Lawsuit Over Firing\"</a>. <i><a href=\"/wiki/Hartford_Courant\" title=\"Hartford Courant\">Hartford Courant</a></i>. March 14, 2010. <a rel=\"nofollow\" href=\"https://archive.today/20120728144301/http://www.courant.com/news/connecticut/hc-pfizer-virus-lawsuit-0314.artmar14,0,5614508,print.story\">Archived</a> from the original on July 28, 2012.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hartford+Courant&amp;rft.atitle=Ex-Pfizer+Worker+Cites+Genetically+Engineered+Virus+In+Lawsuit+Over+Firing&amp;rft.date=2010-03-14&amp;rft_id=https%3A%2F%2Fwww.courant.com%2Fnews%2Fconnecticut%2Fhc-xpm-2010-03-14-hc-pfizer-virus-lawsuit-0314-artmar14-story.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-184\"><span><b><a href=\"#cite_ref-184\">^</a></b></span> <span><cite id=\"CITEREFPollackWilson2010\">Pollack, Andrew; <a href=\"/wiki/Duff_Wilson\" title=\"Duff Wilson\">Wilson, Duff</a> (April 2, 2010). <span title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" href=\"https://www.nytimes.com/2010/04/03/business/03pfizer.html\">\"A Pfizer Whistle-Blower Is Awarded $1.4 Million\"</a></span>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=A+Pfizer+Whistle-Blower+Is+Awarded+%241.4+Million&amp;rft.date=2010-04-02&amp;rft.aulast=Pollack&amp;rft.aufirst=Andrew&amp;rft.au=Wilson%2C+Duff&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2010%2F04%2F03%2Fbusiness%2F03pfizer.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-185\"><span><b><a href=\"#cite_ref-185\">^</a></b></span> <span><cite><span title=\"Free access subject to limited trial, subscription normally required\"><a rel=\"nofollow\" href=\"https://www.nytimes.com/2012/05/02/health/pfizer-settles-byu-lawsuit-over-development-of-celebrex.html\">\"Pfizer Settles B.Y.U. Lawsuit Over Development of Celebrex\"</a></span>. <i><a href=\"/wiki/The_New_York_Times\" title=\"The New York Times\">The New York Times</a></i>. <a href=\"/wiki/Associated_Press\" title=\"Associated Press\">Associated Press</a>. May 1, 2012.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+Settles+B.Y.U.+Lawsuit+Over+Development+of+Celebrex&amp;rft.date=2012-05-01&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2012%2F05%2F02%2Fhealth%2Fpfizer-settles-byu-lawsuit-over-development-of-celebrex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-186\"><span><b><a href=\"#cite_ref-186\">^</a></b></span> <span><cite id=\"CITEREFOldani2016\">Oldani, Michael (2016), <a rel=\"nofollow\" href=\"http://sk.sagepub.com/reference/the-sage-encyclopedia-of-pharmacology-and-society/i11727.xml\">\"Trovafloxacin (Trovan) Controversy\"</a>, <i>The SAGE Encyclopedia of Pharmacology and Society</i>, SAGE Publications, Inc., pp.&nbsp;1444–1447, <a href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" href=\"https://doi.org/10.4135%2F9781483349985.n409\">10.4135/9781483349985.n409</a>, <a href=\"/wiki/ISBN_(identifier)\" title=\"ISBN (identifier)\">ISBN</a>&nbsp;<a href=\"/wiki/Special:BookSources/9781483350004\" title=\"Special:BookSources/9781483350004\"><bdi>9781483350004</bdi></a><span>, retrieved <span>January 21,</span> 2019</span></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Trovafloxacin+%28Trovan%29+Controversy&amp;rft.btitle=The+SAGE+Encyclopedia+of+Pharmacology+and+Society&amp;rft.pages=1444-1447&amp;rft.pub=SAGE+Publications%2C+Inc.&amp;rft.date=2016&amp;rft_id=info%3Adoi%2F10.4135%2F9781483349985.n409&amp;rft.isbn=9781483350004&amp;rft.aulast=Oldani&amp;rft.aufirst=Michael&amp;rft_id=http%3A%2F%2Fsk.sagepub.com%2Freference%2Fthe-sage-encyclopedia-of-pharmacology-and-society%2Fi11727.xml&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-187\"><span><b><a href=\"#cite_ref-187\">^</a></b></span> <span><cite id=\"CITEREFMurray2007\">Murray, Senan (June 20, 2007). <a rel=\"nofollow\" href=\"http://news.bbc.co.uk/2/hi/africa/6768799.stm\">\"Anger at deadly Nigerian drug trials\"</a>. <i><a href=\"/wiki/BBC_News\" title=\"BBC News\">BBC News</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Anger+at+deadly+Nigerian+drug+trials&amp;rft.date=2007-06-20&amp;rft.aulast=Murray&amp;rft.aufirst=Senan&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F2%2Fhi%2Fafrica%2F6768799.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-188\"><span><b><a href=\"#cite_ref-188\">^</a></b></span> <span><cite id=\"CITEREFRamakrishnanUllandSteinhardtMoïsi2009\">Ramakrishnan M, Ulland AJ, Steinhardt LC, Moïsi JC, Were F, Levine OS (2009). <a rel=\"nofollow\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2759956\">\"Sequelae due to bacterial meningitis among African children: a systematic literature review\"</a>. <i><a href=\"/wiki/BMC_Medicine\" title=\"BMC Medicine\">BMC Medicine</a></i>. <b>7</b>: 47. <a href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" href=\"https://doi.org/10.1186%2F1741-7015-7-47\">10.1186/1741-7015-7-47</a>. <a href=\"/wiki/PMC_(identifier)\" title=\"PMC (identifier)\">PMC</a>&nbsp;<span title=\"Freely accessible\"><a rel=\"nofollow\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2759956\">2759956</a></span>. <a href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a>&nbsp;<a rel=\"nofollow\" href=\"//pubmed.ncbi.nlm.nih.gov/19751516\">19751516</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMC+Medicine&amp;rft.atitle=Sequelae+due+to+bacterial+meningitis+among+African+children%3A+a+systematic+literature+review&amp;rft.volume=7&amp;rft.pages=47&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2759956%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19751516&amp;rft_id=info%3Adoi%2F10.1186%2F1741-7015-7-47&amp;rft.aulast=Ramakrishnan&amp;rft.aufirst=M&amp;rft.au=Ulland%2C+AJ&amp;rft.au=Steinhardt%2C+LC&amp;rft.au=Mo%C3%AFsi%2C+JC&amp;rft.au=Were%2C+F&amp;rft.au=Levine%2C+OS&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2759956&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-189\"><span><b><a href=\"#cite_ref-189\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"http://news.bbc.co.uk/2/hi/business/1517171.stm\">\"Nigerians sue Pfizer over test deaths\"</a>. <i><a href=\"/wiki/BBC_News\" title=\"BBC News\">BBC News</a></i>. August 30, 2001.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Nigerians+sue+Pfizer+over+test+deaths&amp;rft.date=2001-08-30&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F2%2Fhi%2Fbusiness%2F1517171.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-DN-190\"><span>^ <a href=\"#cite_ref-DN_190-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-DN_190-1\"><sup><i><b>b</b></i></sup></a></span> <span><cite><a rel=\"nofollow\" href=\"https://www.democracynow.org/2010/12/17/wikileaks_cables_pfizer_targeted_nigerian_attorney\">\"WikiLeaks Cables: Pfizer Targeted Nigerian Attorney General to Undermine Suit over Fatal Drug Tests\"</a>. <i><a href=\"/wiki/Democracy_Now!\" title=\"Democracy Now!\">Democracy Now!</a></i>. December 17, 2010.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Democracy+Now%21&amp;rft.atitle=WikiLeaks+Cables%3A+Pfizer+Targeted+Nigerian+Attorney+General+to+Undermine+Suit+over+Fatal+Drug+Tests&amp;rft.date=2010-12-17&amp;rft_id=https%3A%2F%2Fwww.democracynow.org%2F2010%2F12%2F17%2Fwikileaks_cables_pfizer_targeted_nigerian_attorney&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-191\"><span><b><a href=\"#cite_ref-191\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.washingtonpost.com/wp-dyn/content/article/2006/05/06/AR2006050601338.html\">\"Panel Faults Pfizer in '96 Clinical Trial In Nigeria\"</a>. <i><a href=\"/wiki/The_Washington_Post\" title=\"The Washington Post\">The Washington Post</a></i>. May 7, 2006.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Washington+Post&amp;rft.atitle=Panel+Faults+Pfizer+in+%2796+Clinical+Trial+In+Nigeria&amp;rft.date=2006-05-07&amp;rft_id=https%3A%2F%2Fwww.washingtonpost.com%2Fwp-dyn%2Fcontent%2Farticle%2F2006%2F05%2F06%2FAR2006050601338.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-192\"><span><b><a href=\"#cite_ref-192\">^</a></b></span> <span><cite id=\"CITEREFEdwards2011\">Edwards, Jim (February 10, 2011). <a rel=\"nofollow\" href=\"https://www.cbsnews.com/news/pfizer-bribed-nigerian-officials-in-fatal-drug-trial-ex-employee-claims/\">\"Pfizer Bribed Nigerian Officials in Fatal Drug Trial, Ex-Employee Claims\"</a>. <i><a href=\"/wiki/CBS_News\" title=\"CBS News\">CBS News</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CBS+News&amp;rft.atitle=Pfizer+Bribed+Nigerian+Officials+in+Fatal+Drug+Trial%2C+Ex-Employee+Claims&amp;rft.date=2011-02-10&amp;rft.aulast=Edwards&amp;rft.aufirst=Jim&amp;rft_id=https%3A%2F%2Fwww.cbsnews.com%2Fnews%2Fpfizer-bribed-nigerian-officials-in-fatal-drug-trial-ex-employee-claims%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-193\"><span><b><a href=\"#cite_ref-193\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://cdn.pfizer.com/pfizercom/news/trovan_statement_defense_summary.pdf\">\"Trovan, Kano State Civil Case – Statement Of Defense\"</a> <span>(PDF)</span>. Pfizer. July 2007.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Trovan%2C+Kano+State+Civil+Case+%E2%80%93+Statement+Of+Defense&amp;rft.pub=Pfizer&amp;rft.date=2007-07&amp;rft_id=https%3A%2F%2Fcdn.pfizer.com%2Fpfizercom%2Fnews%2Ftrovan_statement_defense_summary.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-194\"><span><b><a href=\"#cite_ref-194\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"http://news.bbc.co.uk/2/hi/world/us_and_canada/10454982.stm\">\"Pfizer-Nigeria appeal dismissed\"</a>. <i><a href=\"/wiki/BBC_News\" title=\"BBC News\">BBC News</a></i>. June 29, 2010.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Pfizer-Nigeria+appeal+dismissed&amp;rft.date=2010-06-29&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F2%2Fhi%2Fworld%2Fus_and_canada%2F10454982.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-195\"><span><b><a href=\"#cite_ref-195\">^</a></b></span> <span><cite id=\"CITEREFBoseley2010\">Boseley, Sarah (December 9, 2010). <a rel=\"nofollow\" href=\"https://www.theguardian.com/business/2010/dec/09/wikileaks-cables-pfizer-nigeria\">\"WikiLeaks cables: Pfizer 'used dirty tricks to avoid clinical trial payout'<span></span>\"</a>. <i>The Guardian</i>. London.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Guardian&amp;rft.atitle=WikiLeaks+cables%3A+Pfizer+%27used+dirty+tricks+to+avoid+clinical+trial+payout%27&amp;rft.date=2010-12-09&amp;rft.aulast=Boseley&amp;rft.aufirst=Sarah&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fbusiness%2F2010%2Fdec%2F09%2Fwikileaks-cables-pfizer-nigeria&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-196\"><span><b><a href=\"#cite_ref-196\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://cdn.pfizer.com/pfizercom/news/the_guardian_nigeria_120910.pdf\">\"Pfizer Statement Regarding Article In The Guardian\"</a> <span>(PDF)</span> (Press release). Pfizer. December 9, 2010.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Statement+Regarding+Article+In+The+Guardian&amp;rft.pub=Pfizer&amp;rft.date=2010-12-09&amp;rft_id=https%3A%2F%2Fcdn.pfizer.com%2Fpfizercom%2Fnews%2Fthe_guardian_nigeria_120910.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-197\"><span><b><a href=\"#cite_ref-197\">^</a></b></span> <span><cite id=\"CITEREFEdwards2011\">Edwards, Jim (January 4, 2011). <a rel=\"nofollow\" href=\"https://www.cbsnews.com/news/in-defense-of-blackmail-why-shouldnt-pfizer-dig-dirt-on-crooked-pols/\">\"In Defense of Blackmail: Why Shouldn't Pfizer Dig Dirt on Crooked Pols?\"</a>. <i><a href=\"/wiki/CBS_News\" title=\"CBS News\">CBS News</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CBS+News&amp;rft.atitle=In+Defense+of+Blackmail%3A+Why+Shouldn%27t+Pfizer+Dig+Dirt+on+Crooked+Pols%3F&amp;rft.date=2011-01-04&amp;rft.aulast=Edwards&amp;rft.aufirst=Jim&amp;rft_id=https%3A%2F%2Fwww.cbsnews.com%2Fnews%2Fin-defense-of-blackmail-why-shouldnt-pfizer-dig-dirt-on-crooked-pols%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-198\"><span><b><a href=\"#cite_ref-198\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"http://saharareporters.com/2010/07/19/michael-aondoakaa-%E2%80%9Cunfit%E2%80%9D-remain-san-says-cdhr-high-powered-petition\">\"Michael Aondoakaa \"Unfit\" To Remain SAN, Says CDHR In High-Powered Petition\"</a>. <i>Sahara Reporters</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Sahara+Reporters&amp;rft.atitle=Michael+Aondoakaa+%22Unfit%22+To+Remain+SAN%2C+Says+CDHR+In+High-Powered+Petition&amp;rft_id=http%3A%2F%2Fsaharareporters.com%2F2010%2F07%2F19%2Fmichael-aondoakaa-%25E2%2580%259Cunfit%25E2%2580%259D-remain-san-says-cdhr-high-powered-petition&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-199\"><span><b><a href=\"#cite_ref-199\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"http://usafricaonline.com/2010/12/12/wikileaks-on-nigerias-oil-corruption-nnpc-shell-us-ambassador-attorney-general-aondoakaa/\">\"Wikileaks on Nigeria's Corrupt Oil Sales at NNPC, Shell, US Ambassador\"</a>. December 12, 2010.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Wikileaks+on+Nigeria%27s+Corrupt+Oil+Sales+at+NNPC%2C+Shell%2C+US+Ambassador&amp;rft.date=2010-12-12&amp;rft_id=http%3A%2F%2Fusafricaonline.com%2F2010%2F12%2F12%2Fwikileaks-on-nigerias-oil-corruption-nnpc-shell-us-ambassador-attorney-general-aondoakaa%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-200\"><span><b><a href=\"#cite_ref-200\">^</a></b></span> <span><cite id=\"CITEREFLenzer2011\">Lenzer, J. (August 16, 2011). \"Pfizer settles with victims of Nigerian drug trial\". <i>BMJ</i>. <b>343</b> (aug16 3): d5268. <a href=\"/wiki/Doi_(identifier)\" title=\"Doi (identifier)\">doi</a>:<a rel=\"nofollow\" href=\"https://doi.org/10.1136%2Fbmj.d5268\">10.1136/bmj.d5268</a>. <a href=\"/wiki/PMID_(identifier)\" title=\"PMID (identifier)\">PMID</a>&nbsp;<a rel=\"nofollow\" href=\"//pubmed.ncbi.nlm.nih.gov/21846712\">21846712</a>. <a href=\"/wiki/S2CID_(identifier)\" title=\"S2CID (identifier)\">S2CID</a>&nbsp;<a rel=\"nofollow\" href=\"https://api.semanticscholar.org/CorpusID:8758603\">8758603</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMJ&amp;rft.atitle=Pfizer+settles+with+victims+of+Nigerian+drug+trial&amp;rft.volume=343&amp;rft.issue=aug16+3&amp;rft.pages=d5268&amp;rft.date=2011-08-16&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A8758603%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F21846712&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.d5268&amp;rft.aulast=Lenzer&amp;rft.aufirst=J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-201\"><span><b><a href=\"#cite_ref-201\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.uschamber.com/article/pfizer-implemented-more-4000-greenhouse-gas-reduction-projects-2000\">\"Pfizer Implemented More than 4,000 Greenhouse Gas Reduction Projects Since 2000\"</a>. <i><a href=\"/wiki/United_States_Chamber_of_Commerce\" title=\"United States Chamber of Commerce\">United States Chamber of Commerce</a></i>. November 15, 2019.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=United+States+Chamber+of+Commerce&amp;rft.atitle=Pfizer+Implemented+More+than+4%2C000+Greenhouse+Gas+Reduction+Projects+Since+2000&amp;rft.date=2019-11-15&amp;rft_id=https%3A%2F%2Fwww.uschamber.com%2Farticle%2Fpfizer-implemented-more-4000-greenhouse-gas-reduction-projects-2000&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-202\"><span><b><a href=\"#cite_ref-202\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.businesswire.com/news/home/20120913006098/en/Pfizer-Recognized-Carbon-Disclosure-Project-Carbon-Performance\">\"Pfizer Recognized by Carbon Disclosure Project for Carbon Performance\"</a> (Press release). Pfizer. September 13, 2012 – via <a href=\"/wiki/Business_Wire\" title=\"Business Wire\">Business Wire</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Recognized+by+Carbon+Disclosure+Project+for+Carbon+Performance&amp;rft.pub=Pfizer&amp;rft.date=2012-09-13&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20120913006098%2Fen%2FPfizer-Recognized-Carbon-Disclosure-Project-Carbon-Performance&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-203\"><span><b><a href=\"#cite_ref-203\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.nj.gov/dep/srp/community/sites/pi/american_cyanamid_fs.pdf\">\"American Cyanamid Superfund Site Fact Sheet\"</a> <span>(PDF)</span>. <i><a href=\"/wiki/New_Jersey\" title=\"New Jersey\">New Jersey</a></i>. December 2011.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=New+Jersey&amp;rft.atitle=American+Cyanamid+Superfund+Site+Fact+Sheet&amp;rft.date=2011-12&amp;rft_id=https%3A%2F%2Fwww.nj.gov%2Fdep%2Fsrp%2Fcommunity%2Fsites%2Fpi%2Famerican_cyanamid_fs.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-204\"><span><b><a href=\"#cite_ref-204\">^</a></b></span> <span><cite id=\"CITEREFPaik2012\">Paik, Eugene (March 9, 2012). <a rel=\"nofollow\" href=\"https://www.nj.com/news/2012/03/activisits_say_epa_fix_for_pol.html\">\"Activists say EPA $204M fix for polluted American Cyanamid property will not permanently resolve problem\"</a>. <i><a href=\"/wiki/NJ.com\" title=\"NJ.com\">NJ.com</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=NJ.com&amp;rft.atitle=Activists+say+EPA+%24204M+fix+for+polluted+American+Cyanamid+property+will+not+permanently+resolve+problem&amp;rft.date=2012-03-09&amp;rft.aulast=Paik&amp;rft.aufirst=Eugene&amp;rft_id=https%3A%2F%2Fwww.nj.com%2Fnews%2F2012%2F03%2Factivisits_say_epa_fix_for_pol.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-205\"><span><b><a href=\"#cite_ref-205\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.washingtonpost.com/wp-dyn/content/article/2006/05/23/AR2006052301305_pf.html\">\"The tempest\"</a>. <i><a href=\"/wiki/The_Washington_Post\" title=\"The Washington Post\">The Washington Post</a></i>. May 28, 2006.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Washington+Post&amp;rft.atitle=The+tempest&amp;rft.date=2006-05-28&amp;rft_id=https%3A%2F%2Fwww.washingtonpost.com%2Fwp-dyn%2Fcontent%2Farticle%2F2006%2F05%2F23%2FAR2006052301305_pf.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-206\"><span><b><a href=\"#cite_ref-206\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.usglc.org/about-us/coalition-members/\">\"U.S. Global Leadership Coalition, Global Trust members\"</a>. <a href=\"/wiki/U.S._Global_Leadership_Coalition\" title=\"U.S. Global Leadership Coalition\">U.S. Global Leadership Coalition</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=U.S.+Global+Leadership+Coalition%2C+Global+Trust+members&amp;rft.pub=U.S.+Global+Leadership+Coalition&amp;rft_id=https%3A%2F%2Fwww.usglc.org%2Fabout-us%2Fcoalition-members%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-207\"><span><b><a href=\"#cite_ref-207\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.phrma.org/about\">\"About\"</a>. <i>PhRMA</i>. <a rel=\"nofollow\" href=\"https://archive.ph/gaGKc\">Archived</a> from the original on April 6, 2022<span>. Retrieved <span>April 6,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=PhRMA&amp;rft.atitle=About&amp;rft_id=https%3A%2F%2Fwww.phrma.org%2Fabout&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-208\"><span><b><a href=\"#cite_ref-208\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://web.archive.org/web/20180926013616/https://www.phrma.org/about\">\"About\"</a>. <i>PhRMA</i>. Archived from the original on September 26, 2018<span>. Retrieved <span>April 6,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=PhRMA&amp;rft.atitle=About&amp;rft_id=https%3A%2F%2Fwww.phrma.org%2Fabout&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span><span><code>{{<a href=\"/wiki/Template:Cite_web\" title=\"Template:Cite web\">cite web</a>}}</code>:  CS1 maint: unfit URL (<a href=\"/wiki/Category:CS1_maint:_unfit_URL\" title=\"Category:CS1 maint: unfit URL\">link</a>)</span></span>\n</li>\n<li id=\"cite_note-209\"><span><b><a href=\"#cite_ref-209\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://nationalhealthcouncil.org/members/\">\"Our Members\"</a>. <i>National Health Council</i>. <a rel=\"nofollow\" href=\"https://web.archive.org/web/20220406081753/https://nationalhealthcouncil.org/members/?m_cat=74&amp;m_key=\">Archived</a> from the original on April 6, 2022<span>. Retrieved <span>April 6,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=National+Health+Council&amp;rft.atitle=Our+Members&amp;rft_id=https%3A%2F%2Fnationalhealthcouncil.org%2Fmembers%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-210\"><span><b><a href=\"#cite_ref-210\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.researchamerica.org/about-us/member-organizations\">\"Member Organizations\"</a>. <i>Research!America</i>. September 28, 2007. <a rel=\"nofollow\" href=\"https://archive.ph/CR4A7\">Archived</a> from the original on April 6, 2022<span>. Retrieved <span>April 6,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Research%21America&amp;rft.atitle=Member+Organizations&amp;rft.date=2007-09-28&amp;rft_id=https%3A%2F%2Fwww.researchamerica.org%2Fabout-us%2Fmember-organizations&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-211\"><span><b><a href=\"#cite_ref-211\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.weforum.org/organizations/pfizer/\">\"Pfizer\"</a>. <i>World Economic Forum</i>. <a rel=\"nofollow\" href=\"https://archive.ph/gpwLc\">Archived</a> from the original on March 14, 2022<span>. Retrieved <span>April 6,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Economic+Forum&amp;rft.atitle=Pfizer&amp;rft_id=https%3A%2F%2Fwww.weforum.org%2Forganizations%2Fpfizer%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-212\"><span><b><a href=\"#cite_ref-212\">^</a></b></span> <span><cite id=\"CITEREFBourla2018\">Bourla, Albert (January 19, 2018). <a rel=\"nofollow\" href=\"https://www.weforum.org/agenda/2018/01/this-is-what-the-future-of-healthcare-looks-like/\">\"5 key trends for the future of healthcare\"</a>. <i>World Economic Forum</i>. <a rel=\"nofollow\" href=\"https://archive.ph/n5PLQ\">Archived</a> from the original on March 14, 2022<span>. Retrieved <span>April 6,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Economic+Forum&amp;rft.atitle=5+key+trends+for+the+future+of+healthcare&amp;rft.date=2018-01-19&amp;rft.aulast=Bourla&amp;rft.aufirst=Albert&amp;rft_id=https%3A%2F%2Fwww.weforum.org%2Fagenda%2F2018%2F01%2Fthis-is-what-the-future-of-healthcare-looks-like%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-213\"><span><b><a href=\"#cite_ref-213\">^</a></b></span> <span><cite id=\"CITEREFMishra2019\">Mishra, Manas (July 2, 2019).  Kuber, Shailesh (ed.). <a rel=\"nofollow\" href=\"https://www.reuters.com/article/us-pfizer-board-scott-gottlieb/senator-warren-asks-former-fda-chief-gottlieb-to-resign-from-pfizer-board-idUSKCN1TX2IX\">\"Senator Warren asks former FDA chief Gottlieb to resign from Pfizer board\"</a>. <i><a href=\"/wiki/Reuters\" title=\"Reuters\">Reuters</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Senator+Warren+asks+former+FDA+chief+Gottlieb+to+resign+from+Pfizer+board&amp;rft.date=2019-07-02&amp;rft.aulast=Mishra&amp;rft.aufirst=Manas&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-pfizer-board-scott-gottlieb%2Fsenator-warren-asks-former-fda-chief-gottlieb-to-resign-from-pfizer-board-idUSKCN1TX2IX&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-214\"><span><b><a href=\"#cite_ref-214\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.personalizedmedicinecoalition.org/Members/Current_Members\">\"Current Members\"</a>. <i>Personalized Medicine Coalition</i>. <a rel=\"nofollow\" href=\"https://web.archive.org/web/20210815032705/https://personalizedmedicinecoalition.org/Members/Current_Members\">Archived</a> from the original on August 15, 2021<span>. Retrieved <span>April 6,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Personalized+Medicine+Coalition&amp;rft.atitle=Current+Members&amp;rft_id=https%3A%2F%2Fwww.personalizedmedicinecoalition.org%2FMembers%2FCurrent_Members&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-215\"><span><b><a href=\"#cite_ref-215\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"http://innovativemedicines.ca/about/member-companies/\">\"Member Companies\"</a>. <i>Innovative Medicines Canada</i>. <a rel=\"nofollow\" href=\"https://archive.ph/nA2q9\">Archived</a> from the original on November 3, 2021<span>. Retrieved <span>March 8,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Innovative+Medicines+Canada&amp;rft.atitle=Member+Companies&amp;rft_id=http%3A%2F%2Finnovativemedicines.ca%2Fabout%2Fmember-companies%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-216\"><span><b><a href=\"#cite_ref-216\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://lobbyist.oico.on.ca/Pages/Public/PublicSearch/\">\"Consultant Lobbyist Registration No. CL4899-20200917025456\"</a>. <i>Office of the Integrity Commissioner of Ontario</i>. September 22, 2021. <a rel=\"nofollow\" href=\"https://ia601407.us.archive.org/2/items/consultant_lobbyist_registration_no._CL4899-20200917025456/screencapture-lobbyist-oico-on-ca-Pages-Public-PublicSearch-ConsultantLobbyistPreview-aspx-2022-03-08-09_54_13.pdf\">Archived</a> <span>(PDF)</span> from the original on March 8, 2022<span>. Retrieved <span>March 8,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Office+of+the+Integrity+Commissioner+of+Ontario&amp;rft.atitle=Consultant+Lobbyist+Registration+No.+CL4899-20200917025456&amp;rft.date=2021-09-22&amp;rft_id=https%3A%2F%2Flobbyist.oico.on.ca%2FPages%2FPublic%2FPublicSearch%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-217\"><span><b><a href=\"#cite_ref-217\">^</a></b></span> <span><cite id=\"CITEREFMaher2019\">Maher, Stephen (January 29, 2019). <a rel=\"nofollow\" href=\"https://www.macleans.ca/politics/for-access-to-the-ford-government-two-names-matter-most/\">\"For access to the Ford government, two names matter most\"</a>. <i>MacLean's</i>. <a rel=\"nofollow\" href=\"https://archive.ph/LJWg5\">Archived</a> from the original on March 22, 2021<span>. Retrieved <span>March 8,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=MacLean%27s&amp;rft.atitle=For+access+to+the+Ford+government%2C+two+names+matter+most&amp;rft.date=2019-01-29&amp;rft.aulast=Maher&amp;rft.aufirst=Stephen&amp;rft_id=https%3A%2F%2Fwww.macleans.ca%2Fpolitics%2Ffor-access-to-the-ford-government-two-names-matter-most%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-218\"><span><b><a href=\"#cite_ref-218\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://2020-annual-report.fnih.org/donors/\">\"2020 Donors\"</a>. <i>FNIH 2020 Annual Report</i>. <a rel=\"nofollow\" href=\"https://web.archive.org/web/20220402180716/https://2020-annual-report.fnih.org/donors/\">Archived</a> from the original on April 2, 2022<span>. Retrieved <span>April 6,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=FNIH+2020+Annual+Report&amp;rft.atitle=2020+Donors&amp;rft_id=https%3A%2F%2F2020-annual-report.fnih.org%2Fdonors%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-219\"><span><b><a href=\"#cite_ref-219\">^</a></b></span> <span><cite id=\"CITEREFPfizer2021\">Pfizer (October 1, 2021). <a rel=\"nofollow\" href=\"https://www.cnbc.com/advertorial/2021/10/01/for-pfizer-a-covid-19-vaccine-may-just-be-the-beginning-for-the-potential-revolutionary-promise-of-mrna-technology.html\">\"For Pfizer, a COVID-19 vaccine may just be the beginning for the potential revolutionary promise of mRNA technology\"</a>. <i>CNBC</i>. <a rel=\"nofollow\" href=\"https://archive.ph/N7oE7\">Archived</a> from the original on October 19, 2021<span>. Retrieved <span>March 28,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=CNBC&amp;rft.atitle=For+Pfizer%2C+a+COVID-19+vaccine+may+just+be+the+beginning+for+the+potential+revolutionary+promise+of+mRNA+technology&amp;rft.date=2021-10-01&amp;rft.au=Pfizer&amp;rft_id=https%3A%2F%2Fwww.cnbc.com%2Fadvertorial%2F2021%2F10%2F01%2Ffor-pfizer-a-covid-19-vaccine-may-just-be-the-beginning-for-the-potential-revolutionary-promise-of-mrna-technology.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-220\"><span><b><a href=\"#cite_ref-220\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.cpha.ca/sites/default/files/uploads/about/reports/2018-annual-report-web-e.pdf\">\"2018 Annual Report\"</a> <span>(PDF)</span>. <i>Canadian Public Health Association</i>. <a rel=\"nofollow\" href=\"https://web.archive.org/web/20210608184141/https://www.cpha.ca/sites/default/files/uploads/about/reports/2018-annual-report-web-e.pdf\">Archived</a> <span>(PDF)</span> from the original on June 8, 2021<span>. Retrieved <span>March 18,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Canadian+Public+Health+Association&amp;rft.atitle=2018+Annual+Report&amp;rft_id=https%3A%2F%2Fwww.cpha.ca%2Fsites%2Fdefault%2Ffiles%2Fuploads%2Fabout%2Freports%2F2018-annual-report-web-e.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-:2-221\"><span>^ <a href=\"#cite_ref-:2_221-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:2_221-1\"><sup><i><b>b</b></i></sup></a></span> <span><cite id=\"CITEREFPublic_Health_Agency_of_Canada2022\">Public Health Agency of Canada (February 25, 2022). <a rel=\"nofollow\" href=\"https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html\">\"National Advisory Committee on Immunization (NACI): Membership and representation\"</a>. <i>Government of Canada</i>. <a rel=\"nofollow\" href=\"https://web.archive.org/web/20220323061520/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html#fn1-rf\">Archived</a> from the original on March 23, 2022<span>. Retrieved <span>March 29,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Government+of+Canada&amp;rft.atitle=National+Advisory+Committee+on+Immunization+%28NACI%29%3A+Membership+and+representation&amp;rft.date=2022-02-25&amp;rft.au=Public+Health+Agency+of+Canada&amp;rft_id=https%3A%2F%2Fwww.canada.ca%2Fen%2Fpublic-health%2Fservices%2Fimmunization%2Fnational-advisory-committee-on-immunization-naci%2Fnaci-membership-representation.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-222\"><span><b><a href=\"#cite_ref-222\">^</a></b></span> <span><cite id=\"CITEREFBettinger2020\">Bettinger, Julie (January 24, 2020). <a rel=\"nofollow\" href=\"https://mediasite.phsa.ca/Mediasite/Catalog/Mobile/FolderPresentation/22912938f963448cab10cf3719de3d5e21/22912938f963448cab10cf3719de3d5e21/b27eb1456cb14e06af5370550b1c5e431d/\">\"Vaccine Hesitancy: It doesn't matter if the vaccine works if nobody gets it\"</a>. <i>Provincial Health Sciences Authority</i>. <a rel=\"nofollow\" href=\"https://web.archive.org/web/20210118225408/https://mediasite.phsa.ca/Mediasite/Catalog/Mobile/FolderPresentation/22912938f963448cab10cf3719de3d5e21/22912938f963448cab10cf3719de3d5e21/b27eb1456cb14e06af5370550b1c5e431d/\">Archived</a> from the original on January 18, 2021<span>. Retrieved <span>March 29,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Provincial+Health+Sciences+Authority&amp;rft.atitle=Vaccine+Hesitancy%3A+It+doesn%27t+matter+if+the+vaccine+works+if+nobody+gets+it&amp;rft.date=2020-01-24&amp;rft.aulast=Bettinger&amp;rft.aufirst=Julie&amp;rft_id=https%3A%2F%2Fmediasite.phsa.ca%2FMediasite%2FCatalog%2FMobile%2FFolderPresentation%2F22912938f963448cab10cf3719de3d5e21%2F22912938f963448cab10cf3719de3d5e21%2Fb27eb1456cb14e06af5370550b1c5e431d%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-223\"><span><b><a href=\"#cite_ref-223\">^</a></b></span> <span><cite><a rel=\"nofollow\" href=\"https://www.cfn-nce.ca/get-involved/our-partners/industry-and-association-partners/\">\"Industry and Association Partners\"</a>. <i>Canadian Frailty Network</i>. <a rel=\"nofollow\" href=\"https://archive.ph/BkHql\">Archived</a> from the original on March 28, 2022<span>. Retrieved <span>March 28,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Canadian+Frailty+Network&amp;rft.atitle=Industry+and+Association+Partners&amp;rft_id=https%3A%2F%2Fwww.cfn-nce.ca%2Fget-involved%2Four-partners%2Findustry-and-association-partners%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n<li id=\"cite_note-224\"><span><b><a href=\"#cite_ref-224\">^</a></b></span> <span><cite id=\"CITEREFKim2020\">Kim, Perry (April 7, 2020). <a rel=\"nofollow\" href=\"https://www.cfn-nce.ca/wp-content/uploads/2020/04/RFP-Frailty-and-COVID-April-7.pdf\">\"Request for Proposals (RFP) Frailty and COVID-19\"</a> <span>(PDF)</span>. <i>Canadian Frailty Network</i>. <a rel=\"nofollow\" href=\"https://web.archive.org/web/20220302175728/https://www.cfn-nce.ca/wp-content/uploads/2020/04/RFP-Frailty-and-COVID-April-7.pdf\">Archived</a> <span>(PDF)</span> from the original on March 2, 2022<span>. Retrieved <span>March 27,</span> 2022</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Canadian+Frailty+Network&amp;rft.atitle=Request+for+Proposals+%28RFP%29+Frailty+and+COVID-19&amp;rft.date=2020-04-07&amp;rft.aulast=Kim&amp;rft.aufirst=Perry&amp;rft_id=https%3A%2F%2Fwww.cfn-nce.ca%2Fwp-content%2Fuploads%2F2020%2F04%2FRFP-Frailty-and-COVID-April-7.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer\"></span></span>\n</li>\n</ol></div>\n<h2><span id=\"External_links\">External links</span><span><span>[</span><a href=\"/w/index.php?title=Pfizer&amp;action=edit&amp;section=38\" title=\"Edit section: External links\">edit</a><span>]</span></span></h2>\n<table role=\"presentation\">\n<tbody><tr>\n<td><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-Commons-logo.svg.png\" decoding=\"async\" width=\"30\" height=\"40\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/45px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/59px-Commons-logo.svg.png 2x\" data-file-width=\"1024\" data-file-height=\"1376\"></td>\n<td>Wikimedia Commons has media related to <span><a href=\"https://commons.wikimedia.org/wiki/Category:Pfizer\" title=\"commons:Category:Pfizer\">Pfizer</a></span>.</td></tr>\n</tbody></table>\n<ul><li><span><span><a rel=\"nofollow\" href=\"https://www.pfizer.com/\">Official website</a></span></span> <a href=\"https://www.wikidata.org/wiki/Q206921#P856\" title=\"Edit this at Wikidata\"><img alt=\"Edit this at Wikidata\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png\" decoding=\"async\" width=\"10\" height=\"10\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x\" data-file-width=\"20\" data-file-height=\"20\"></a></li>\n<li>Business data for Pfizer Inc.: <div><ul><li><a rel=\"nofollow\" href=\"https://www.google.com/finance?q=PFE\">Google Finance</a></li><li><a rel=\"nofollow\" href=\"https://finance.yahoo.com/q?s=PFE\">Yahoo! Finance</a></li><li><a rel=\"nofollow\" href=\"https://www.bloomberg.com/quote/PFE:US\">Bloomberg</a></li><li><a rel=\"nofollow\" href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=PFE\">SEC filings</a></li></ul></div></li></ul>\n\n\n<!-- \nNewPP limit report\nParsed by mw1429\nCached time: 20220406185917\nCache expiry: 86400\nReduced expiry: true\nComplications: [vary‐revision‐sha1]\nCPU time usage: 2.343 seconds\nReal time usage: 2.569 seconds\nPreprocessor visited node count: 11582/1000000\nPost‐expand include size: 425654/2097152 bytes\nTemplate argument size: 5383/2097152 bytes\nHighest expansion depth: 16/100\nExpensive parser function count: 17/500\nUnstrip recursion depth: 1/20\nUnstrip post‐expand size: 667427/5000000 bytes\nLua time usage: 1.367/10.000 seconds\nLua memory usage: 16345398/52428800 bytes\nLua Profile:\n    Scribunto_LuaSandboxCallback::callParserFunction                 220 ms       15.7%\n    ?                                                                200 ms       14.3%\n    Scribunto_LuaSandboxCallback::gsub                               120 ms        8.6%\n    type                                                             100 ms        7.1%\n    recursiveClone <mwInit.lua:41>                                   100 ms        7.1%\n    <mw.lua:690>                                                      80 ms        5.7%\n    Scribunto_LuaSandboxCallback::getExpandedArgument                 80 ms        5.7%\n    dataWrapper <mw.lua:668>                                          60 ms        4.3%\n    Scribunto_LuaSandboxCallback::plain                               40 ms        2.9%\n    makeMessage <mw.message.lua:76>                                   40 ms        2.9%\n    [others]                                                         360 ms       25.7%\nNumber of Wikibase entities loaded: 1/400\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00% 2217.874      1 -total\n 58.59% 1299.434      1 Template:Reflist\n 24.94%  553.177    128 Template:Cite_news\n 14.27%  316.417     57 Template:Cite_web\n 11.71%  259.687      1 Template:Infobox_company\n 11.11%  246.478      1 Template:Infobox\n  4.27%   94.741      1 Template:Short_description\n  3.78%   83.798     22 Template:Cite_press_release\n  3.46%   76.811     13 Template:Cite_journal\n  3.37%   74.794      1 Template:Official_URL\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:62304-0!canonical and timestamp 20220406185914 and revision id 1081304371. Serialized with JSON.\n -->\n</div></div>","textContent":"\n\n\n\nCoordinates: 40°45′01″N 73°58′21″W﻿ / ﻿40.75028°N 73.97250°W\n\nPfizer Inc.Pfizer headquarters on 42nd Street in Midtown ManhattanTypePublicTraded asNYSE: PFES&P 100 componentS&P 500 componentRussell 1000 Index componentIndustryPharmaceuticalBiotechnologyFounded1849; 173 years ago in New York CityFoundersCharles PfizerCharles F. ErhartHeadquarters235 East 42nd Street, New York City, U.S.Area servedWorldwideKey peopleAlbert Bourla, CEOFrank A. D’Amelio, CFOScott Gottlieb, DirectorHelen Hobbs, DirectorSusan Hockfield, DirectorDan Littman, DirectorShantanu Narayen, DirectorSuzanne Nora Johnson, DirectorJames Quincey, DirectorJim Smith, DirectorProductsPharmaceuticalsvaccinesRevenue $41.908 billion (2020)Operating income $7.497 billion (2020)Net income $9.616 billion (2020)Total assets $154.229 billion (2020)Total equity $63.473 billion (2020)Number of employees78,500 (2020)Websitewww.pfizer.com Footnotes / references[1]\nThe headquarters of Pfizer In Tokyo, Japan\nPfizer Inc. ( FY-zər)[2] is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The company was established in 1849 in New York by two German immigrants, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).\nPfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company has several blockbuster drugs or products that each generate more than US$1 billion in annual revenues.[1] In 2020, 52% of the company's revenues came from the United States, 6% came from each of China and Japan, and 36% came from other countries.[1]\nPfizer was a component of the Dow Jones Industrial Average stock market index from 2004 to August 2020.[3][4][5][6] The company ranks 64th on the Fortune 500[7] and 49th on the Forbes Global 2000.[8]\n\n\n\nHistory[edit]\nCharles Pfizer (1824–1906)\n1849–1950: Early history[edit]\nPfizer was founded in 1849 by Charles Pfizer and Charles F. Erhart, two cousins who had immigrated to the United States from Ludwigsburg, Germany, the year before. The business produced chemical compounds, and was headquartered on Bartlett Street[9] in Williamsburgh, New York, where they produced an antiparasitic called santonin. This was an immediate success, although it was production of citric acid that led to Pfizer's growth in the 1880s. Pfizer continued to buy property in the area (by now the Williamsburg district of the city of Brooklyn, New York and, beginning in 1898, the City of Greater New York) to expand its lab and factory, retaining offices on Flushing Avenue until the 1960s; the Brooklyn plant ultimately closed in 2009.[10] Following the success of citric acid, Pfizer (at the now-demolished 295 Washington Avenue) and Erhart (at 280 Washington Avenue) established their main residences in the nearby Clinton Hill district, known for its concentration of Gilded Age wealth. Pfizer spent summers in similarly exclusive Newport, Rhode Island, where he died in 1906.\nIn 1881, Pfizer moved its administrative headquarters to 81 Maiden Lane in Manhattan, presaging the company's expansion to Chicago, Illinois a year later.[9][11] By 1906, sales exceeded $3 million.[12]\nWorld War I caused a shortage of calcium citrate, which Pfizer imported from Italy for the manufacture of citric acid, and the company began a search for an alternative supply. Pfizer chemists learned of a fungus that ferments sugar to citric acid, and they were able to commercialize production of citric acid from this source in 1919. The company developed expertise in fermentation technology as a result. These skills were applied to the mass production of penicillin, an antibiotic, during World War II in response to the need to treat injured Allied soldiers.[13]\nOn June 2, 1942, the company incorporated in Delaware.[1]\n\n1950–1980: Pivot to pharmaceutical research and global expansion[edit]\nDue to price declines for penicillin, Pfizer searched for new antibiotics with greater profit potential. Pfizer discovered oxytetracycline in 1950, and this changed the company from a manufacturer of fine chemicals to a research-based pharmaceutical company. Pfizer developed a drug discovery program focused on in vitro synthesis to augment its research in fermentation technology. In 1959, the company established an animal health division with a 700-acre (2.8 km2) farm and research facility in Terre Haute, Indiana.[13]\nBy the 1950s, Pfizer had established offices in Belgium, Brazil, Canada, Cuba, Mexico, Panama, Puerto Rico, and the United Kingdom. In 1960, the company moved its medical research laboratory operations out of New York City to a new facility in Groton, Connecticut. In 1980, Pfizer launched Feldene (piroxicam), a prescription anti-inflammatory medication that became Pfizer's first product to reach $1 billion in revenue.[12]\nIn 1965, John Powers, Jr. became chief executive officer of the company, succeeding John McKeen.[12]\nAs the area surrounding its Brooklyn plant fell into decline in the 1970s and 1980s, the company formed a public-private partnership with New York City that encompassed the construction of low- and middle-income housing, the refurbishment of apartment buildings for the homeless and the establishment of a charter school.[11]\nIn 1972, Edmund T. Pratt Jr. became chief executive officer of the company, succeeding John Powers, Jr.[12]\n\n1980–2000: Development of Viagra, Zoloft, and Lipitor[edit]\nIn 1981, the company received approval for Diflucan (fluconazole), the first oral treatment for severe fungal infections including candidiasis, blastomycosis, coccidiodomycosis, cryptococcosis, histoplasmosis, dermatophytosis, and pityriasis versicolor.[14]\nIn 1986, Pfizer acquired the worldwide rights to Zithromax (azithromycin), a macrolide antibiotic that is recommended by the Infectious Disease Society of America as a first line treatment for certain cases of community-acquired pneumonia, from Pliva.[15][16]\nIn 1989, Pfizer scientists Peter Dunn and Albert Wood created Viagra (sildenafil) for treating high blood pressure and angina, a chest pain associated with coronary artery disease. In 1991, it was patented in the United Kingdom as a heart medication. Early trials for the medication showed that it did not work for the treatment of heart disease, but volunteers in the clinical trials had increased erections several days after taking the drug. It was patented in the United States in 1996 and received approval by the Food and Drug Administration in March 1998. In December 1998, Pfizer hired Bob Dole as a spokesperson for the drug.[17] The patents for Viagra expired in 2020.[18]\nIn 1991, William C. Steere, Jr. became chief executive officer of the company, succeeding Edmund T. Pratt Jr.[19]\nIn 1991 Pfizer also began marketing Zoloft (sertraline), an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class developed nine years earlier by Pfizer chemists Kenneth Koe and Willard Welch. Sertraline is primarily prescribed for major depressive disorder in adult outpatients as well as obsessive-compulsive disorder, panic disorder, and social anxiety disorder in both adults and children. In 2005, the year before it became a generic drug, sales were over $3 billion and over 100 million people had been treated with the drug.[20] The patent for Zoloft expired in the summer of 2006.[21]\nIn 1996, Eisai, in partnership with Pfizer, received approval from the Food and Drug Administration for donepezil under the brand Aricept for treatment of Alzheimer's disease;[22] Pfizer also received approval for Norvasc (amlodipine), an antihypertensive drug of the dihydropyridine calcium channel blocker class.[23]\n\n\nIn 1997, the company entered into a co-marketing agreement with Warner–Lambert for Lipitor (atorvastatin), a statin for the treatment of hypercholesterolemia. Although atorvastatin was the fifth statin to be developed, clinical trials showed that atorvastatin caused a more dramatic reduction in low-density lipoprotein pattern C (LDL-C) than the other statin drugs. Upon its patent expiration in 2011, Lipitor was the best-selling drug ever, with approximately $125 billion in sales over 14.5 years.[24]\n\n2000–2010: Further expansion[edit]\nIn 2001, Henry McKinnell became chief executive officer of the company, replacing William C. Steere, Jr.[25]\nIn 2004, the company received approval for Lyrica (pregabalin), an anticonvulsant and anxiolytic medication used to treat epilepsy, neuropathic pain, fibromyalgia, restless leg syndrome, and generalized anxiety disorder.[26][27][28] The United States patent on Lyrica was challenged by generic manufacturers and was upheld in 2014, extending the expiration date to 2018.[29] In 2016, the drug had sales of $4.2 billion.[30]\nIn July 2006, Jeff Kindler was named chief executive officer of the company, replacing Henry McKinnell.[25][31]\nOn December 3, 2006, Pfizer ceased development of torcetrapib, a drug that increases production of HDL, or \"good cholesterol\", which reduces LDL thought to be correlated to heart disease. During a Phase III clinical trial involving 15,000 patients, more deaths than expected occurred in the group that took the medicine, and the mortality rate of patients taking the combination of torcetrapib and Lipitor (82 deaths during the study) was 60% higher than those taking Lipitor alone (52 deaths during the study). Lipitor alone was not implicated in the results, but Pfizer lost nearly $1 billion developing the failed drug and its stock price dropped 11% on the day of the announcement.[32][33][34][35]\nBetween 2007 and 2010, Pfizer spent $3.3 million on investigations and legal fees and recovered about $5.1 million, and had another $5 million of pending recoveries from civil lawsuits against makers of counterfeit prescription drugs. Pfizer has hired customs and narcotics experts worldwide to track down fakes and assemble evidence that can be used to pursue civil suits for trademark infringement.[36]\nIn July 2008, Pfizer announced 275 job cuts at its manufacturing facility in Kalamazoo, Michigan. Kalamazoo was previously the world headquarters of Upjohn Company, which had been acquired as part of Pharmacia.[37][38]\n\nAcquisitions and mergers[edit]\nIn June 2000, Pfizer acquired Warner-Lambert outright for $116 billion. To satisfy conditions imposed by antitrust regulators at the Federal Trade Commission, Pfizer sold off or transferred stakes in several minor products, including RID (a shampoo for treatment of head lice, sold to Bayer) and Warner-Lambert's antidepressant Celexa (which competes with Zoloft).[39] The acquisition created what was, at the time, the second-largest pharmaceutical company worldwide.[40]\nIn 2003, Pfizer merged with Pharmacia, and in the process acquired Searle and SUGEN. Searle had developed Flagyl (metronidazole), a nitroimidazole antibiotic medication used particularly for anaerobic bacteria and protozoa.[38][41] Searle also developed celecoxib (Celebrex) a COX-2 inhibitor and nonsteroidal anti-inflammatory drug (NSAID) used to treat the pain and inflammation in osteoarthritis, acute pain in adults, rheumatoid arthritis, ankylosing spondylitis, painful menstruation, and juvenile rheumatoid arthritis.[42] SUGEN, a company focused on protein kinase inhibitors, had pioneered the use of ATP-mimetic small molecules to block signal transduction. The SUGEN facility was shut down in 2003 by Pfizer, with the loss of more than 300 jobs, and several programs were transferred to Pfizer. These included sunitinib (Sutent), a cancer medication which was approved for human use by the FDA in January 2006.[43][44] A related compound, SU11654 (Toceranib), was also approved for cancer in dogs, and the ALK inhibitor Crizotinib also grew out of a SUGEN program.[45][46]\nIn October 2006, the company announced it would acquire PowerMed.[47]\nOn October 15, 2009, Pfizer acquired Wyeth for $68 billion in cash and stock, including the assumption of debt, making Pfizer the largest pharmaceutical company in the world.[48][49][50][51][52] The acquisition of Wyeth provided Pfizer with a pneumococcal conjugate vaccine, trademarked Prevnar 13; this is used for the prevention of invasive pneumococcal infections. The introduction of the original, 7-valent version of the vaccine, developed by Wyeth in February 2000, led to a 75% reduction in the incidence of invasive pneumococcal infections among children under age 5 in the United States. Pfizer introduced an improved version of the vaccine in 2010, for which it was granted a patent in India in 2017. Prevnar 13 provides coverage of 13 bacterial variants, expanding beyond the original 7-valent version.[52] By 2012, the rate of invasive infections among children under age 5 had been reduced by an additional 50%.[53][54]\n\n2010–2020: Further discoveries and acquisitions[edit]\nIn 2010, Ian Read was named chief executive officer of the company.[55]\nIn February 2011, Pfizer announced the closure of its UK research and development facility (formerly also a manufacturing plant) in Sandwich, Kent, which at the time employed 2,400 people.[56] In March 2011, Pfizer acquired King Pharmaceuticals for $3.6 billion in cash. King produced emergency injectables such as the EpiPen.[57]\nOn September 4, 2012, the FDA approved bosutinib (Bosulif) for chronic myelogenous leukemia (CML), a rare type of leukemia and a blood and bone marrow disease that affects primarily older adults.[58] In November 2012, Pfizer received approval from the Food and Drug Administration for Xeljanz, a tofacitinib, for rheumatoid arthritis and ulcerative colitis.[59] The drug had sales of $1.77 billion in 2018, and in January 2019, it was the top drug in the United States for direct-to-consumer advertising, passing adalimumab (Humira).[60]\nOn February 1, 2013, Zoetis, the Agriculture Division of Pfizer and later Pfizer Animal Health, became a public company via an initial public offering, raising $2.2 billion.[61][62][63][64] Later in 2013, Pfizer completed the corporate spin-off of its remaining stake in Zoetis.[65][66]\nIn September 2014, the company acquired Innopharma for $225 million, plus up to $135 million in milestone payments, in a deal that expanded Pfizer's range of generic and injectable drugs.[67][68]\nOn January 5, 2015, the company announced it would acquire a controlling interest in Redvax, expanding its vaccine portfolio targeting human cytomegalovirus.[69] In February 2015, the company received approval from the Food and Drug Administration for palbociclib (Ibrance) for treatment of certain types of breast cancer.[70][71] In March 2015, the company announced it would restart its collaboration with Eli Lilly and Company surrounding the Phase III trial of Tanezumab.[72] In May 2015, Pfizer and a Bar-Ilan University laboratory announced a partnership based on the development of medical DNA nanotechnology.[73] In June 2015, the company acquired Nimenrix and Mencevax, meningococcal vaccines, from GlaxoSmithKline for around $130 million.[74] In September 2015, Pfizer acquired Hospira for $17 billion, including the assumption of debt.[75][76][77][78][79][80] Hospira was the largest producer of generic injectable pharmaceuticals in the world.[81] On November 23, 2015, Pfizer and Allergan announced a planned $160 billion merger, in the largest pharmaceutical deal ever and the third largest corporate merger in history. The proposed transaction contemplated that the merged company maintain Allergan's Republic of Ireland domicile, resulting in the new company being subject to corporation tax at the relatively low rate of 12.5%.[82] The deal was to constitute a reverse merger, whereby Allergan acquired Pfizer, with the new company then changing its name to \"Pfizer, plc\".[83][84][85] On April 6, 2016, Pfizer and Allergan terminated the merger agreement after the Obama administration and the United States Department of the Treasury introduced new laws intended to limit corporate inversions (the extent to which companies could move their headquarters overseas in order to reduce the amount of taxes they pay).[86][87]\nIn June 2016, the company acquired Anacor Pharmaceuticals for $5.2 billion, expanding its portfolio in both inflammation and immunology drugs areas.[88][89] In August 2016, the company made a $40 million bid for the assets of BIND Therapeutics, which was in bankruptcy.[90] The same month, the company acquired Bamboo Therapeutics for $645 million, expanding its gene therapy offerings.[91] In September 2016, the company acquired cancer drug-maker Medivation for $14 billion.[92][93][94] In October 2016, the company licensed the anti-CTLA4 monoclonal antibody, ONC-392, from OncoImmune.[95][96] In December 2016, Pfizer acquired AstraZeneca's small-molecule antibiotics business for $1.575 billion.[97][98][99]\nIn January 2018, Pfizer announced that it would end its work on research into treatments for Alzheimer's disease and Parkinsonism (a symptom of Parkinson's disease and other conditions). The company said about 300 researchers would lose their jobs.[100] In July 2018, the Food and Drug Administration approved enzalutamide, developed by Pfizer and Astellas Pharma for patients with castration-resistant prostate cancer.[101] In August 2018, Pfizer signed an agreement with BioNTech to conduct joint research and development activities regarding mRNA-based influenza vaccines.[102] In October 2018, effective January 1, 2019, Albert Bourla was promoted to chief executive officer, succeeding Ian Read, his mentor.[103][104][105][106]\nIn July 2019, the company acquired Therachon for up to $810 million, expanding its rare disease portfolio through Therachon's recombinant human fibroblast growth factor receptor 3 compound, aimed at treating conditions such as achondroplasia.[107] Also in July, Pfizer acquired Array Biopharma for $10.6 billion, boosting its oncology pipeline.[108] In August 2019, Pfizer merged its consumer health business with that of GlaxoSmithKline, into a joint venture owned 68% by GlaxoSmithKline and 32% by Pfizer, with plans to make it a public company. The transaction built on a 2018 transaction where GlaxoSmithKline acquired Novartis' stake in the GSK-Novartis consumer healthcare joint business.[109][110][111][112] The transaction followed negotiations with other companies including Reckitt Benckiser,[113] Sanofi, Johnson & Johnson,[114] and Procter & Gamble.[115]\nIn September 2020, the company acquired a 9.9% stake in CStone Pharmaceuticals for $200 million (HK$1.55 billion), helping to commercialise its anti-PD-L1 monoclonal antibody, CS1001.[116] In October 2020, the company acquired Arixa Pharmaceuticals.[117] In November 2020, using a Reverse Morris Trust structure, Pfizer merged its off-patent branded and generic drug business, known as Upjohn, with Mylan to form Viatris, owned 57% by Pfizer shareholders.[118][119][120]\n\n2021–onwards: Corporate developments and acquisitions[edit]\nOn January 5, 2021, Pfizer introduced a new logo.[121] In April 2021, Pfizer acquired Amplyx Pharmaceuticals and its anti-fungal compound Fosmanogepix (APX001).[122][123][124] In August, the company announced it would acquire Trillium Therapeutics Inc and its immuno-oncology portfolio for $2.3 billion ($18.50 per share).[125][126] In December, Pfizer announced that it had agreed to acquire Arena Pharmaceuticals for $6.7 billion in cash.[127][128] In March 2022, it was announced the acquisition of Arena Pharmaceuticals had been concluded.[129]\n\nAcquisition history[edit]\nPfizer acquisitions\nPfizer (Founded 1849 as Charles Pfizer & Company)\nWarner–Lambert\nWilliam R. Warner (Founded 1856, merged 1955)\nLambert Pharmacal Company (Merged 1955)\nParke-Davis (Founded 1860, Acq 1976)\nWilkinson Sword (Acq 1993, divested 2003)\nAgouron (Acq 1999)\nPharmacia (Acq 2002)\nPharmacia & Upjohn (Merged 2000)\nPharmacia (Merged 1995)\nFarmitalia Carlo Erba\nKabi Pharmacia\nPharmacia Aktiebolaget\nThe Upjohn Company (Merged 1995)\nMonsanto (Merged 2000, divested 2002)\nSearle (Merged 2000)\nEsperion Therapeutics (Acq 2003, divested 2008)\nMeridica (Acq 2004)\nVicuron Pharmaceuticals (Acq 2005)\nIdun (Acq 2005)\nAngiosyn (Acq 2005)\nPowermed (Acq 2006)\nRinat (Acq 2006)\nColey Pharmaceutical Group (Acq 2007)\nCovX (Acq 2007)\nEncysive Pharmaceuticals Inc (Acq 2008)\nWyeth (Acq 2009)\nChef Boyardee (Acq 1946, divested 1996 with food div)\nS.M.A. Corporation\nAyerst Laboratories (Acq 1943)\nFort Dodge Serum Company (Acq 1945)\nBristol-Myers (Animal Health div)\nParke-Davis (Animal Health div)\nA.H. Robins\nSherwood Medical (Acq 1982)\nGenetics Institute, Inc. (Acq 1992)\nAmerican Cyanamid (Acq 1994)\nLederle Laboratories\nSolvay (Acq 1995, Animal Health div)\nKing Pharmaceuticals (Acq 2010)\nMonarch Pharmaceuticals, Inc.\nKing Pharmaceuticals Research and Development, Inc.\nMeridian Medical Technologies, Inc.\nParkedale Pharmaceuticals, Inc.\nKing Pharmaceuticals Canada Inc.\nMonarch Pharmaceuticals Ireland Limited\nSynbiotics Corporation (Acq 2011)\nIcagen (Acq 2011)\nFerrosan (Consumer Health div, Acq 2011)\nExcaliard Pharmaceuticals (Acq 2011)\nAlacer Corp (Acq 2012)\nNextWave Pharmaceuticals, Inc (Acq 2012)\nInnopharma (Acq 2014)\nRedvax GmbH (Acq 2014)\nHospira (Spun off from Abbott Laboratories 2004, Acq 2015) \nMayne Pharma Ltd (Acq 2007)\nPliva-Croatia\nOrchid Chemicals & Pharmaceuticals Ltd. (Generics & Injectables div, Acq 2009) \nJavelin Pharmaceuticals, Inc. (Acq 2010)\nTheraDoc (Acq 2010)\nArixa Pharmaceuticals (Acq 2020)\nAnacor Pharmaceuticals (Acq 2016)\nBamboo Therapeutics (Acq 2016)\nMedivation (Acq 2016)\nAstraZeneca (Small molecule antibiotic div, Acq 2016)\nArray BioPharma (Acq 2019)\nAmplyx Pharmaceuticals (Acq 2021)\nTrillium Therapeutics (Acq 2021)\nArena Pharmaceuticals (Acq TBA)\n\n\n\nCOVID-19 vaccine and other initiatives[edit]\nCOVID-19 pandemic and vaccine development[edit]\n\nInitial development and testing[edit]\nIn March 2020, as the scale of the COVID-19 pandemic became apparent, Pfizer partnered with BioNTech to study and develop COVID-19 mRNA vaccine candidates. Unlike many of its competitors, Pfizer took no initial research funds from the United States' Operation Warp Speed vaccine development program, instead choosing to invest roughly $2 billion of its own funds. Pfizer CEO Albert Bourla has said that he declined money from Operation Warp Speed to avoid government intervention, stating later that \"when you get money from someone that always comes with strings. They want to see how we are going to progress, what type of moves you are going to do. They want reports. And also, I wanted to keep Pfizer out of politics, by the way.\"[130]\nIn May 2020, Pfizer began testing four different COVID-19 vaccine variations. Vaccines were injected into the first human participants in the U.S. in early May.[131] In July 2020, Pfizer and BioNTech announced that two of the partners' four mRNA vaccine candidates had won fast track designation from the FDA.[132][133] The company began Phase II-III testing on 30,000 people in the last week of July 2020 and was slated to be paid $1.95 billion for 100 million doses of the vaccine by the US government.[134] The U.S. deal priced two doses at $39, and the company stated that it would not lower the rates for other countries until the outbreak is no longer a pandemic.[135] Pfizer's CEO stated the companies in the private sector producing a vaccine should make a profit.[136] In September 2020, Pfizer and BioNTech announced that they had completed talks with the European Commission to provide an initial 200 million vaccine doses to the EU, with the option to supply another 100 million doses at a later date.[137][138]\n\n[edit]\n\nOn November 9, 2020, Pfizer announced that BioNTech's COVID-19 vaccine, tested on 43,500 people, was found to be 90% effective at preventing symptomatic COVID-19.[139] The efficacy was updated to 95% a week later.[140] Akiko Iwasaki, an immunologist interviewed by the New York Times, described the efficacy figure as \"really a spectacular number.\"[141] The announcement made Pfizer and BioNTech the first companies to develop and test a working vaccine for COVID-19.[140]\nOver the following month and a half, regulators in various countries approved Pfizer's vaccine for emergency use. The United Kingdom approved the vaccine first, on December 2,[142] followed by Bahrain on December 4,[143] Canada on December 9,[144] and Saudi Arabia on December 10.[145] On December 10, 2020, the United States FDA held an advisory committee meeting to discuss authorization of the vaccine.[146] The next day, the US officially became the 5th country to approve use of Pfizer's vaccine under an Emergency Use Authorization (EUA), with an independent panel voting 17–4 in support of approval.[146][147] On December 14, Singapore became one of the first in Asia to approve the vaccine through the Health Sciences Authority.[148] On December 21, the European Medicines Agency (EMA) recommended granting a conditional marketing authorisation for the vaccine in the European Union, under the brand name \"Comirnaty.\"[149]\n\nManufacturing and distribution[edit]\n\nAs of early May 2021, Pfizer and BioNTech had manufactured at least 430 million vaccine doses, which have been distributed to 91 countries and territories. The companies have said they expect to manufacture nearly 3 billion total vaccine doses in 2021.[150]\n\nControversy[edit]\nIn February 2021, after a year long investigation relying on unnamed officials, Pfizer was accused by The Bureau of Investigative Journalism (TBIJ) of employing \"high-level bullying\" against at least two Latin American countries during negotiations to acquire COVID-19 vaccines, including requesting that the countries put sovereign assets as collateral for payments.[151] According to TBIJ, these negotiation tactics resulted in a months long delay in Pfizer reaching a vaccine agreement with one country and a complete failure to reach agreements with two other countries, including Argentina and Brazil.[151]\nOn 2 November 2021, The BMJ published an article after obtaining information from a whistleblower from the Ventavia Research Group. Ventavia was hired by Pfizer as a research subcontractor. The company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial. The regional director, Brook Jackson, emailed a complaint to the US Food and Drug Administration (FDA). Ventavia fired her later the same day.[152] The European Medicines Agency (EMA) stated in a response to the European Parliament, that \"the deficiencies identified do not jeopardize the quality and integrity of the data from the main Comirnaty trial and have no impact on the benefit-risk assessment or on the conclusions on the safety, effectiveness and quality of the vaccine”.[153]\n\nOther initiatives[edit]\nIn November 2021 Pfizer started a new COVID-19 oral antivirus treatment, known as Paxlovid, which according to a recent study reduces the risk of hospitalisation or death by 89%.[154] In January 2022, the Pfizer CEO Albert Bourla confirmed that the trial results of a fourth dose were pending until March 2022. He also said that the firm was setting up a collaboration to develop an anti-Covid pill treatment along with French company, Novasep. He also said the Covid vaccine was “safe and efficient” for children.[155] [156]\n\nLegal issues[edit]\nAggressive pharmaceutical marketing[edit]\n\nPfizer has been accused of aggressive pharmaceutical marketing.[157][158][159]\n\nIllegal marketing of gabapentin for off-label uses[edit]\nIn 1993, the Food and Drug Administration (FDA) approved gabapentin only for treatment of seizures. Warner–Lambert, which merged with Pfizer in 2000, used continuing medical education and medical research, sponsored articles about the drug for the medical literature, and alleged suppression of unfavorable study results, to promote gabapentin. Within five years, the drug was being widely used for off-label uses such as treatment of pain and psychiatric conditions. Warner–Lambert admitted to violating FDA regulations by promoting the drug for pain, psychiatric conditions, migraine, and other unapproved uses.[160] In 2004, the company paid $430 million in one of the largest settlements to resolve criminal and civil health care liability charges. It was the first off-label promotion case successfully brought under the False Claims Act.[161] A Cochrane review concluded that gabapentin is ineffective in migraine prophylaxis.[162] The American Academy of Neurology rates it as having unproven efficacy, while the Canadian Headache Society and the European Federation of Neurological Societies rate its use as being supported by moderate and low-quality evidence.[163]\n\n[edit]\nIn September 2009, Pfizer pleaded guilty to the illegal marketing of arthritis drug valdecoxib (Bextra) and agreed to a $2.3 billion settlement, the largest health care fraud settlement at that time. Pfizer promoted the sale of the drug for several uses and dosages that the Food and Drug Administration specifically declined to approve due to safety concerns. The drug was pulled from the market in 2005.[164][165] It was Pfizer's fourth such settlement in a decade.[166][167][168] The payment included $1.3 billion in criminal penalties for felony violations of the Federal Food, Drug, and Cosmetic Act, and $1.0 billion to settle allegations it had illegally promoted the drugs for uses that were not approved by the Food and Drug Administration (FDA) leading to violations under the False Claims Act as reimbursements were requested from Federal and State programs. The criminal fine was the largest ever assessed in the United States to date.[165][166][167][168] Pfizer entered a corporate integrity agreement with the Office of Inspector General that required it to make substantial structural reforms within the company, and publish to its website its post approval commitments and a searchable database of all payments to physicians made by the company.[169]\n\nTermination of Peter Rost[edit]\nPeter Rost was vice president in charge of the endocrinology division at Pharmacia before its acquisition by Pfizer. During that time he raised concerns internally about kickbacks and off-label marketing of Genotropin, Pharmacia's human growth hormone drug. Pfizer reported the Pharmacia marketing practices to the FDA and Department of Justice; Rost was unaware of this and filed an FCA lawsuit against Pfizer. Pfizer kept him employed, but isolated him until the FCA suit was unsealed in 2005. The Justice Department declined to intervene, and Pfizer fired him, and he filed a wrongful termination suit against Pfizer. Pfizer won a summary dismissal of the case, with the court ruling that the evidence showed Pfizer had decided to fire Rost prior to learning of his whistleblower activities.[170][171]\n\nIllegal marketing of Rapamune[edit]\nA \"whistleblower suit\" was filed in 2005 against Wyeth, which was acquired by Pfizer in 2009, alleging that the company illegally marketed sirolimus (Rapamune) for off-label uses, targeted specific doctors and medical facilities to increase sales of Rapamune, tried to get transplant patients to change from their transplant drugs to Rapamune, and specifically targeted African-Americans. According to the whistleblowers, Wyeth also provided doctors and hospitals that prescribed the drug with kickbacks such as grants, donations, and other money.[172] In 2013, the company pleaded guilty to criminal mis-branding violations under the Federal Food, Drug, and Cosmetic Act. By August 2014, it had paid $491 million in civil and criminal penalties related to Rapamune.[173]\n\nIllegal marketing[edit]\nIn June 2010, health insurance network Blue Cross Blue Shield (BCBS) filed a lawsuit against Pfizer for allegedly illegally marketing drugs Bextra, Geodon and Lyrica. BCBS alleged that Pfizer used kickbacks and wrongly persuaded doctors to prescribe the drugs.[174][175] According to the lawsuit, Pfizer handed out 'misleading' materials on off-label uses, sent over 5,000 doctors on trips to the Caribbean or around the United States, and paid them $2,000 honoraria in return for listening to lectures about Bextra.[176][177] Despite Pfizer's claims that \"the company's intent was pure\" in fostering a legal exchange of information among doctors, an internal marketing plan revealed that Pfizer intended to train physicians \"to serve as public relations spokespeople.\"[178] The case was settled in 2014 for $325 million.[179] Fearing that Pfizer is \"too big to fail\" and that prosecuting the company would result in disruptions to Medicare and Medicaid, federal prosecutors instead charged a subsidiary of a subsidiary of a subsidiary of Pfizer, which is \"nothing more than a shell company whose only function is to plead guilty.\"[178]\n\nRemoval of ads after unflattering article[edit]\nAccording to Harper's Magazine publisher John R. MacArthur, Pfizer withdrew \"between $400,000 and a million dollars\" worth of ads from Harper's Magazine following an unflattering article on depression medication.[180]\n\nQuigley Company asbestos[edit]\nThe Quigley Company, which sold asbestos-containing insulation products until the early 1970s, was acquired by Pfizer in 1968. In June 2013, asbestos victims and Pfizer negotiated a settlement that required Pfizer to pay a total of $964 million: $430 million to 80% of existing plaintiffs and place an additional $535 million into a settlement trust that will compensate future plaintiffs as well as the remaining 20% of plaintiffs with claims against Pfizer and Quigley. Of that $535 million, $405 million is in a 40-year note from Pfizer, while $100 million is from insurance policies.[181]\n\nShiley defective heart valves[edit]\nPfizer purchased Shiley in 1979, at the onset of its Convexo-Concave valve ordeal, involving the Bjork–Shiley valve. Approximately 500 people died when defective heart valves fractured and, in 1994, Pfizer agreed to pay $10.75 million to settle claims by the United States Department of Justice that the company lied to get approval for the valves.[182]\n\nFiring of employee that filed suit[edit]\nA federal lawsuit was filed by a scientist claiming she got an infection by a genetically modified lentivirus while working for Pfizer, resulting in intermittent paralysis.[183] A judge dismissed the case citing a lack of evidence that the illness was caused by the virus but the jury ruled that by firing the employee, Pfizer violated laws protecting freedom of speech and whistleblowers and awarded her $1.37 million.[184]\n\nCelebrex intellectual property[edit]\nBrigham Young University (BYU) said a professor of chemistry, Dr. Daniel L. Simmons, discovered an enzyme in the 1990s that led towards development of Celebrex. BYU was originally seeking a 15% royalty on sales, equating to $9.7 billion. A research agreement had been made between BYU and Monsanto, whose pharmaceutical business was later acquired by Pfizer, to develop a better aspirin. The enzyme Dr. Simmons claims to have discovered would induce pain and inflammation while causing gastrointestinal problems and Celebrex is used to reduce those issues. A six-year battle ensued because BYU claimed that Pfizer did not give Dr. Simmons credit or compensation, while Pfizer claimed that it had met all obligations regarding the Monsanto agreement. In May 2012, Pfizer settled the allegations, agreeing to pay $450 million.[185]\n\nNigeria Trovafloxacin lawsuit[edit]\n\nIn 1996, an outbreak of measles, cholera, and bacterial meningitis occurred in Nigeria. Pfizer representatives and personnel from a contract research organization (CRO) traveled to Kano to set up a clinical trial and administer an experimental antibiotic, trovafloxacin, to approximately 200 children.[186] Local Kano officials reported that more than fifty children died in the experiment, while many others developed mental and physical deformities.[187] The nature and frequency of both fatalities and other adverse outcomes were similar to those historically found among pediatric patients treated for meningitis in sub-Saharan Africa.[188] In 2001, families of the children, as well as the governments of Kano and Nigeria, filed lawsuits regarding the treatment.[189] According to Democracy Now!, \"[r]esearchers did not obtain signed consent forms, and medical personnel said Pfizer did not tell parents their children were getting the experimental drug.\"[190] The lawsuits also accused Pfizer of using the outbreak to perform unapproved human testing, as well as allegedly under-dosing a control group being treated with traditional antibiotics in order to skew the results of the trial in favor of Trovan. Nigerian medical personnel as well as at least one Pfizer physician said the trial was conducted without regulatory approval.[191][192]\nIn 2007, Pfizer published a Statement of Defense letter.[193] The letter stated that the drug's oral form was safer and easier to administer, that Trovan had been used safely in more than five thousand Americans prior to the Nigerian trial, that mortality in the patients treated by Pfizer was lower than that observed historically in African meningitis epidemics, and that no unusual side effects, unrelated to meningitis, were observed after four weeks.\nIn June 2010, the US Supreme Court rejected Pfizer's appeal against a ruling allowing lawsuits by the Nigerian families to proceed.[194]\nIn December 2010, a United States diplomatic cables leak was released by WikiLeaks indicating that Pfizer hired investigators to find evidence of corruption against Nigerian attorney general Aondoakaa to persuade him to drop legal action.[195] The Washington Post reporter Joe Stephens, who helped break the story in 2000, called these actions \"dangerously close to blackmail\".[190] In response, the company released a press statement describing the allegations as \"preposterous\" and saying that it acted in good faith.[196] Aondoakka, who had allegedly demanded bribes from Pfizer in return for a settlement of the case,[197] was declared unfit for office and had his U.S. visa revoked in association with corruption charges in 2010.[198][199]\nThe lawsuits were eventually settled out of court. Pfizer committed to paying US$35 million \"to compensate the families of children in the study\", another US$30 million to \"support healthcare initiatives in Kano\", and 10 million to cover legal costs. Payouts began in 2011.[200]\n\nEnvironmental record[edit]\nSince 2000, the company has implemented more than 4,000 greenhouse gas reduction projects.[201]\nIn 2012, the company was named to the Carbon Disclosure Project's Carbon Leadership Index in recognition of its efforts to reduce greenhouse gas emissions.[202]\nPfizer has inherited Wyeth's liabilities in the American Cyanamid site in Bridgewater Township, New Jersey, a highly toxic EPA Superfund site. Pfizer has since attempted to remediate this land in order to clean and develop it for future profits and potential public uses.[203] The Sierra Club and the Edison Wetlands Association have opposed the cleanup plan, arguing that the area is subject to flooding, which could cause pollutants to leach. The EPA considers the plan the most reasonable from considerations of safety and cost-effectiveness, arguing that an alternative plan involving trucking contaminated soil off site could expose cleanup workers. The EPA's position is backed by the environmental watchdog group CRISIS.[204]\nIn June 2002, a chemical explosion at the Groton plant injured 7 people and caused the evacuation of more than 100 homes in the surrounding area.[205]\n\nOutreach[edit]\nPolitical lobbying[edit]\nPfizer is a member of the U.S. Global Leadership Coalition, a Washington D.C.-based coalition of more than 400 major companies and NGOs that advocates for a larger International Affairs budget, which funds American diplomatic, humanitarian, and development efforts abroad.[206]\nPfizer is a member company of Pharmaceutical Research and Manufacturers of America (PhRMA), a trade association that lobbies the U.S. Government on behalf of the pharmaceutical industry.[207] PhRMA has offices in Washington, D.C., Japan and the United Arab Emirates.[208]\nPfizer is a member organization of the National Health Council, a non-profit organization that lobbies the U.S. Government on issues related to healthcare reform.[209]\nPfizer is a member organization of Research!America, a medical research advocacy group.[210]\nPfizer is a partner organization of the World Economic Forum,[211] through which CEO Albert Bourla wrote in 2018 about the need to explore the consequences of tech-based personalized health care through filters of society, economy and politics.[212]\nScott Gottlieb, who resigned as FDA commissioner in April 2019, joined the Pfizer board of directors three months later, in July 2019.[213]\nPfizer is a member of the Personalized Medicine Coalition, a lobbying group with ties to members of the United States Congress.[214]\nPfizer is a member company of Innovative Medicines Canada, an association of pharmaceutical companies doing business in Canada.[215] The group lobbies the Government of Ontario through Rubicon Strategy, a firm owned by Progressive Conservative Party of Ontario campaign manager Kory Teneycke.[216][217]\nPfizer has donated between $5,000,000 and $9,999,999 to the Foundation for the National Institutes of Health between 1997 and 2020.[218]\n\nMedia[edit]\nDuring the COVID-19 pandemic, Pfizer engaged many forms of media to promote their COVID-19 vaccine, including paid editorial content on CNBC and a commissioned National Geographic documentary.[219]\n\nPublic health[edit]\nPfizer is one of several pharmaceutical companies disclosed as supporters of the Canadian Public Health Association in their 2018 annual report.[220] \nPfizer has provided funding to the Canadian Paediatric Society, the organization that administers the Canadian Immunization Monitoring Program, Active (IMPACT) vaccine safety program.[221] \nPfizer sponsored a presentation in January 2020 delivered through the Provincial Health Services Authority titled \"Vaccine hesitancy: It doesn't matter if the vaccine works if nobody gets it.\"[221][222] \n\nMedical research[edit]\nPfizer is an Industry Partner of the Canadian Frailty Network,[223] which has provided research grants related to COVID-19.[224]\n\nSee also[edit]\n\nBiotech and pharmaceutical companies in the New York metropolitan area\nCompanies of the United States with untaxed profits\nFire in the Blood (2013 film)\nList of pharmaceutical companies\nReferences[edit]\n\n^ a b c d \"Pfizer Inc. 2020 Form 10-K Annual Report\" (PDF). Pfizer.\n\n^ Wells, John C. (2008), Longman Pronunciation Dictionary (3rd ed.), Longman, ISBN 9781405881180\n\n^ Bomey, Nathan (August 25, 2020). \"Exxon Mobil, Pfizer removed from Dow Jones Industrial Average; Salesforce, Honeywell added\". USA Today.\n\n^ Stevens, Pippa (August 24, 2020). \"Salesforce, Amgen and Honeywell added to Dow in major shake-up to the average\". CNBC.\n\n^ Ponczek, Sarah; Greifeld, Katherine (August 24, 2020). \"Exxon Booted from Dow Industrials in Major Embrace of Tech\". Bloomberg News.\n\n^ \nLevisohn, Ben (August 25, 2020). \"Exxon and Pfizer Just Got Booted From the Dow. Here's What's Replacing Them\". Barron's.\n\n^ \"Fortune 500: Pfizer\". Fortune.\n\n^ \"Forbes Global 2000: Pfizer\". Forbes.\n\n^ a b Kenneth T. Jackson. The Encyclopedia of New York City. The New York Historical Society; Yale University Press; September 1995. P. 895. ISBN 978-0-300-05536-8\n\n^ \"Pfizer's Birthplace, Soon Without Pfizer\". The New York Times. January 28, 2007.\n\n^ a b \"Guide to the Pfizer Inc. collection ARC.084\". Brooklyn Public Library.\n\n^ a b c d \"Our People – The Journey\". Pfizer.{{cite web}}:  CS1 maint: url-status (link)\n\n^ a b \"Penicillin Production through Deep-tank Fermentation – National Historic Chemical Landmark\". American Chemical Society.\n\n^ \"Fluconazole\". The American Society of Health-System Pharmacists. Archived from the original on December 20, 2016.\n\n^ \"Azithromycin: A world best-selling Antibiotic\". World Intellectual Property Organization.\n\n^ Mandell LA, Wunderink RG, Anzueto A,  et al. (March 2007). \"Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults\" (PDF). Clin. Infect. Dis. 44 Suppl 2: S27–72. doi:10.1086/511159. PMC 7107997. PMID 17278083.\n\n^ Wilson, Jacque (March 27, 2013). \"Viagra: The little blue pill that could\". CNN.\n\n^ Cox, David (June 9, 2019). \"The race to replace Viagra\". The Guardian.\n\n^ \"Pfizer Inc., New York, has elected its...\" Los Angeles Times. March 29, 1991.\n\n^ \"Kenneth Koe '45\". Reed Magazine. Reed College. December 2015. Retrieved May 18, 2021.{{cite web}}:  CS1 maint: url-status (link)\n\n^ Smith, Aaron (April 4, 2006). \"Who stands to gain when Zoloft goes generic?\". CNN Money. Retrieved May 18, 2021.\n\n^ \"Highlights of Prescribing Information\" (PDF). Food and Drug Administration.\n\n^ \"Drug Approval Package\". Food and Drug Administration.\n\n^ Mehta, Praful (November 29, 2011). \"Lipitor Patent Expiration - The End of an Era for Atorvastatin Sales\". IHS Markit. Retrieved May 18, 2021.\n\n^ a b Berenson, Alex (July 29, 2006). \"A Long Shot Becomes Pfizer's Latest Chief Executive\". The New York Times.\n\n^ \"Pregabalin\". American Society of Health-System Pharmacists.\n\n^ Frampton, James E. (September 2014). \"Pregabalin: A Review of its Use in Adults with Generalized Anxiety Disorder\". CNS Drugs. 28 (9): 835–854. doi:10.1007/s40263-014-0192-0. PMID 25149863. S2CID 5349255.\n\n^ Iftikhar, I. H.; Alghothani, L.; Trotti, L. M. (December 2017). \"Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis\". European Journal of Neurology. 24 (12): 1446–1456. doi:10.1111/ene.13449. PMID 28888061. S2CID 22262972.\n\n^ Decker, Susan (February 6, 2014). \"Pfizer Wins Ruling to Block Generic Lyrica Until 2018\". Bloomberg News.\n\n^ Speights, Keith (April 17, 2017). \"How Pfizer Inc. Makes Most of Its Money\". The Motley Fool.\n\n^ \"Pfizer names new CEO\". CNN. July 28, 2006.\n\n^ Berenson, Alex; Pollack, Andrew (December 5, 2006). \"Pfizer Shares Plummet on Loss of a Promising Heart Drug\". The New York Times.\n\n^ Berenson, Alex (December 3, 2006). \"Pfizer Ends Studies on Drug for Heart Disease\". The New York Times.\n\n^ Agovino, Theresa (December 3, 2006). \"Pfizer ends cholesterol drug development\". The Seattle Times. Associated Press.\n\n^ Tanne, Janice Hopkins (December 16, 2006). \"Pfizer stops clinical trials of heart drug\". BMJ. 333 (7581): 1237.2–1237. doi:10.1136/bmj.39059.438044.DB. PMC 1702474. PMID 17170401.\n\n^ Bennett, Simeon (July 8, 2010). \"Pfizer: Civil Suits for Drug Counterfeiters\". Bloomberg Businessweek.\n\n^ Jones, Al (July 15, 2008). \"Pfizer job cuts don't equal a reduction in work load, says company spokesman\". Booth Newspapers.\n\n^ a b \"It's official: Pfizer buys Pharmacia\". CNN. April 16, 2003.\n\n^ Hensley, Scott (June 20, 2000). \"Pfizer Completes Stormy Takeover Of Warner-Lambert for $116 Billion\". The Wall Street Journal.\n\n^ Campbell, Todd (May 15, 2017). \"Here are the 7 biggest mergers of all time\". Business Insider. The Motley Fool.\n\n^ \"Metronidazole Monograph for Professionals\". Drugs.com.\n\n^ \"Celecoxib Monograph for Professionals\". Drugs.com. American Society of Health-System Pharmacists. November 11, 2019.\n\n^ \"The Spirit Of A Startup Lives On\". Bloomberg Businessweek. November 21, 2005.\n\n^ \"Pfizer expects to shutter South City biotech outpost\". American City Business Journals. April 30, 2003.\n\n^ Rockoff, Jonathan D. (August 26, 2011). \"FDA Approves Pfizer Lung-Cancer Drug\". The Wall Street Journal.\n\n^ Mortlock, A.A.; Wilson, D.M.; Kettle, J.G.; Goldberg, F.W.; Foote, K.M. (2017). \"Selective Kinase Inhibitors in Cancer\". Comprehensive Medicinal Chemistry III. pp. 39–75. doi:10.1016/B978-0-12-409547-2.12391-1. ISBN 978-0-12-803201-5.\n\n^ Barriaux, Marianne (October 9, 2006). \"Pfizer buys vaccine developer PowderMed\". The Guardian.\n\n^ Sorkin, Andrew Ross; Wilson, Duff (January 25, 2009). \"Pfizer Agrees to Pay $68 Billion for Rival Drug Maker Wyeth\". The New York Times. ISSN 0362-4331.\n\n^ \"Pfizer completes $67 billion deal for rival Wyeth\". Reuters. October 15, 2009.\n\n^ Karnitschnig, Matthew; Rockoff, Jonathan D. (January 23, 2009). \"Pfizer in Talks to Buy Wyeth\". The Wall Street Journal.\n\n^ Edwards, Jim (January 23, 2009). \"The Pfizer–Wyeth Deal Worst-Case Scenario\". CBS News.\n\n^ a b \"PFIZER COMPLETES ACQUISITION OF WYETH\" (Press release). Pfizer. October 14, 2009.\n\n^ \"CDC – ABCs: Surveillance Reports main page – Active Bacterial Core surveillance\". April 5, 2019.\n\n^ Herper, Matthew (August 24, 2020). \"In the race for a Covid-19 vaccine, Pfizer turns to a scientist with a history of defying skeptics – and getting results\". Stat.\n\n^ \"Ian Read to Retire as Executive Chairman of Pfizer's Board of Directors; Chief Executive Officer Dr. Albert Bourla Named Chairman\" (Press release). Business Wire. September 27, 2019.\n\n^ \"Pfizer to close UK research site\". BBC News. February 1, 2011.\n\n^ Mckinney, Maureen (March 1, 2011). \"Pfizer closes King Pharmaceuticals acquisition\". Modern Healthcare.\n\n^ Yukhananov, Anna (September 4, 2012). \"FDA approves Pfizer leukemia drug\". Reuters.\n\n^ \"Drug Approval Package\". Food and Drug Administration.\n\n^ Sagonowsky, Eric (February 20, 2019). \"Pfizer switches RA patients to lower dose of fast-growing Xeljanz as safety issues arise in postmarketing study\". FiercePharma.\n\n^ \"Zoetis™ Files IPO Registration Statement\" (Press release). Business Wire. August 13, 2012.\n\n^ J. de la Merced, Michael (February 1, 2013). \"Shares of Zoetis Surge on Debut\". The New York Times.\n\n^ Dieterich, Chris (January 31, 2013). \"Zoetis Raises $2.2 Billion in IPO\". The Wall Street Journal.\n\n^ \"Shares of animal health company Zoetis soar in IPO\". CBS News. Associated Press. February 1, 2013.\n\n^ Loftus, Peter (May 22, 2013). \"Pfizer to Spin Off Remaining Zoetis Stake\". The Wall Street Journal.\n\n^ Humer, Caroline; Pierson, Ransdell (May 22, 2013). \"Pfizer to spin off Zoetis stake to shareholders\". Reuters.\n\n^ Wasserman, Emily (September 29, 2014). \"Pfizer Completes Acquisition Of InnoPharma\". FiercePharma.\n\n^ \"Pfizer to Acquire InnoPharma for Up to $360M\". genengnews.com. July 16, 2014.\n\n^ \"Pfizer Buys Redvax, Boosting Vaccine Portfolio\". genengnews.com. January 5, 2015.\n\n^ Beaver, Julia A.; Amiri-Kordestani, Laleh; Charlab, Rosane; Chen, Wei; Palmby, Todd; Tilley, Amy; Zirkelbach, Jeanne Fourie; Yu, Jingyu; Liu, Qi; Zhao, Liang; Crich, Joyce; Chen, Xiao Hong; Hughes, Minerva; Bloomquist, Erik; Tang, Shenghui; Sridhara, Rajeshwari; Kluetz, Paul G.; Kim, Geoffrey; Ibrahim, Amna; Pazdur, Richard; Cortazar, Patricia (November 1, 2015). \"FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor–Positive, HER2-Negative Metastatic Breast Cancer\". Clinical Cancer Research. 21 (21): 4760–4766. doi:10.1158/1078-0432.CCR-15-1185. PMID 26324739. S2CID 24762535.\n\n^ \"Palbociclib (IBRANCE)\". Food and Drug Administration. February 9, 2019.\n\n^ \"Pfizer, Lilly to Resume Phase III Tanezumab Clinical Program\". genengnews.com. March 23, 2015.\n\n^ Gali, Weinreb (May 14, 2015). \"Pfizer to collaborate on Bar-Ilan DNA robots\". Globes.\n\n^ \"Pfizer Buys Two GSK Meningitis Vaccines for $130M\". genengnews.com. June 22, 2015.\n\n^ \"Pfizer Completes Acquisition of Hospira\" (Press release). Pfizer. September 3, 2015 – via Business Wire.\n\n^ \"Pfizer completes $17-billion Hospira acquisition\". The Pharma Letter. September 4, 2015.\n\n^ Gelles, David; Thomas, Katie (February 5, 2015). \"Pfizer Bets $15 Billion on New Class of Generic Drugs\". The New York Times.\n\n^ \"8-K\". U.S. Securities and Exchange Commission. February 6, 2015.\n\n^ \"Pfizer to Acquire Hospira\". Pfizer (Press release).\n\n^ Neilan, Catherine (February 5, 2015). \"Pfizer, Hospira share prices to soar after $17bn deal announced\". City A.M.\n\n^ Bhalla, Mohit; Singh, Khomba (December 16, 2009). \"US-based Hospira to buy Orchid Chemicals' injectables biz for $400 mn\". The Economic Times.\n\n^ \"Pfizer seals $160bn Allergan deal to create drugs giant\". BBC News. November 23, 2015.\n\n^ Pierson, Ransdell; Berkrot, Bill (November 24, 2015). \"Pfizer to buy Allergan in $160 billion deal\". Reuters.\n\n^ \"Pfizer to Acquire Allergan for $160B\". genengnews.com. November 23, 2015.\n\n^ Koons, Cynthia (November 22, 2015). \"Pfizer and Allergan to Combine With Joint Value of $160 Billion\". Bloomberg News.\n\n^ Bray, Chad (April 6, 2016). \"Pfizer and Allergan Call Off Merger After Tax-Rule Changes\". The New York Times.\n\n^ Humer, Caroline; Banerjee, Ankur (April 6, 2016). \"Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change\". Reuters.\n\n^ \"Pfizer Completes Acquisition of Anacor\" (Press release). Pfizer. June 24, 2016 – via Business Wire.\n\n^ \"Pfizer to Acquire Anacor Pharmaceuticals for $5.2B\". genengnews.com. May 16, 2016.\n\n^ \"Pfizer Places High Bid of $40M for BIND Therapeutics\". genengnews.com. July 27, 2016.\n\n^ \"Pfizer Acquires Bamboo Therapeutics in a $645M Deal\". genengnews.com. August 1, 2016.\n\n^ \"Pfizer to Acquire Medivation for $14B\". genengnews.com. August 22, 2016.\n\n^ \"Pfizer to buy cancer drug firm Medivation for $14bn\". BBC News. August 22, 2016.\n\n^ \"Pfizer Completes Acquisition of Medivation\" (Press release). OncoImmune. September 28, 2016 – via Business Wire.\n\n^ \"OncoImmune Licenses ONC-392 to Pfizer for Up to $250M\". genengnews.com. October 15, 2016.\n\n^ \"OncoImmune Announces Option and License Agreement with Pfizer Inc\" (Press release). Pfizer. September 15, 2016 – via Business Wire.\n\n^ \"Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca\" (Press release). Pfizer. December 23, 2016 – via Business Wire.\n\n^ \"Pfizer Buys AstraZeneca Antibiotics for Up to $1.575B\". genengnews.com. August 24, 2016.\n\n^ Staton, Tracy (August 24, 2016). \"Pfizer grabs AZ antibiotics in $1.5B deal. Pre-split prep or just another sales-boosting buy?\". FiercePharma.\n\n^ Hiltzik, Michael (January 8, 2018). \"Pfizer, pocketing a big tax cut from Trump, will end investment in Alzheimer's and Parkinson's research\". Los Angeles Times.\n\n^ \"FDA approves enzalutamide for castration-resistant prostate cancer\" (Press release). Food and Drug Administration. July 13, 2018.\n\n^ \"BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza\" (Press release). BioNTech. August 16, 2018.\n\n^ Mathias, Tamara; Banerjee, Ankur (October 1, 2018). \"Pfizer to replace longtime CEO Read with veteran Bourla\". Reuters.\n\n^ Maidenberg, Micah (October 9, 2018). \"Pfizer Prepares for CEO Transition With Executive Suite Changes\". The Wall Street Journal.\n\n^ Ramsey, Lydia (October 1, 2018). \"Pfizer's CEO is stepping down after 8 years — meet the man who will be replacing him\". Business Insider.\n\n^ Jarvis, Lisa M. (October 3, 2018). \"Pfizer unveils CEO succession plan\". Chemical & Engineering News.\n\n^ Bakolia, Ravikash (July 1, 2019). \"Pfizer completes acquisition of Therachon to bolster rare disease drug portfolio\". S&P Global.\n\n^ \"Pfizer Completes Acquisition of Array Biopharma\" (Press release). Pfizer. July 30, 2019 – via Business Wire.\n\n^ \"GSK completes transaction with Pfizer to form new world-leading Consumer Healthcare Joint Venture\" (Press release). GlaxoSmithKline. August 1, 2019.\n\n^ \"GlaxoSmithKline plc and Pfizer Inc to form new world-leading Consumer Healthcare Joint Venture\" (Press release). GlaxoSmithKline. December 19, 2018.\n\n^ \"Pfizer and GlaxoSmithKline Announce Joint Venture to Create a Premier Global Consumer Healthcare Company\". Pfizer (Press release). December 18, 2018.\n\n^ \"GlaxoSmithKline and Pfizer merge healthcare arms\". BBC News. December 19, 2018.\n\n^ Helfand, Carly (October 16, 2017). \"Reckitt Benckiser's still keen on a Pfizer OTC buy. But can it afford one?\". FiercePharma.\n\n^ Helfand, Carly (October 26, 2017). \"Sanofi, J&J could join GlaxoSmithKline, Reckitt in $20B bidding war for Pfizer OTC: report\". FiercePharma.\n\n^ Helfand, Carly (October 25, 2017). \"GlaxoSmithKline eyes Pfizer's OTC unit. But will a buy imperil its dividend?\". FiercePharma.\n\n^ \"Pfizer to buy 9.9% of CStone for $200 million, eyes collaboration\". Reuters. September 29, 2020.\n\n^ Al Idrus, Amirah (October 22, 2020). \"Biotech Pfizer snaps up antibiotics maker Arixa and its oral Avycaz follow-up\". FiercePharma.\n\n^ \"Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan\" (Press release). Pfizer. November 16, 2020 – via Business Wire.\n\n^ \"Pfizer Completes Combination Of Upjohn And Mylan; Viatris To Begin Trading On Nov. 17\". Nasdaq. November 16, 2020.\n\n^ Sabatini, Patricia (November 16, 2020). \"Mylan completes merger with Upjohn to form Viatris\". Pittsburgh Post-Gazette.\n\n^ Bruell, Alexandra (January 5, 2021). \"Pfizer Introduces New Logo Playing Up Role in Drug Creation\". The Wall Street Journal. ISSN 0099-9660.\n\n^ \"Pfizer Acquires Amplyx Pharmaceuticals\" (Press release). Pfizer. April 28, 2021 – via Business Wire.\n\n^ Taylor, Nick Paul (April 28, 2021). \"Pfizer buys Amplyx to grow infectious disease pipeline\". FiercePharma.\n\n^ Wosen, Jonathan (April 28, 2021). \"Pfizer acquires fungus-fighting San Diego biotech\". The San Diego Union-Tribune.\n\n^ \"Pfizer to buy cancer drug developer Trillium in $2.3 BLN deal\". Reuters. August 23, 2021.\n\n^ \"Pfizer to Acquire Trillium Therapeutics Inc\".\n\n^ \"Pfizer bets on Arena's promising bowel disease treatment in $6.7 bln deal\". Reuters. December 13, 2021. Retrieved December 13, 2021.\n\n^ Walker, Joseph (December 13, 2021). \"Pfizer to Acquire Arena Pharmaceuticals in $6.7 Billion Deal\". Wall Street Journal. Retrieved December 13, 2021.\n\n^ \"Pfizer concludes Arena Pharmaceuticals acquisition for $6.7bn\". Pharmaceutical Technology. March 14, 2022. Retrieved March 14, 2022.\n\n^ Czachor, Emily (November 9, 2020). \"Pfizer Avoided R&D Funding From Trump's Operation Warp Speed Because of Bureaucracy, Politics\". Newsweek. Retrieved May 18, 2021.\n\n^ Minkoff, Yoel (May 13, 2020). \"Pfizer sees expanded coronavirus vaccine trials\". Seeking Alpha. Retrieved May 13, 2020.\n\n^ \"Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2\" (Press release). BioNTech. July 13, 2020. Retrieved July 15, 2020 – via GlobeNewswire.\n\n^ DeArment, Alaric (July 13, 2020). \"Pfizer, BioNTech get fast-track from FDA for Covid-19 vaccines\". MedCity News. Retrieved July 15, 2020.\n\n^ \"Pfizer Beats Forecasts as Vaccine Trial Enters Final Stage\". The Wall Street Journal. July 29, 2020.\n\n^ \"Pfizer To Charge $39 Per Coronavirus Vaccine Course To All Developed Countries For Similar Volume Commitments As US\". Benzinga. Yahoo!. July 29, 2020.\n\n^ \"Pfizer CEO Says Companies Should Make Profit On Covid-19 Vaccines\". Barron's.\n\n^ Kilgore, Tomi. \"Pfizer, BioNTech conclude talks over supplying EU with SARS-CoV-2 vaccine candidate\". MarketWatch. Retrieved September 10, 2020.\n\n^ \"Pfizer and BioNTech to Potentially Supply the EU with 200 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2\". Pfizer (Press release). Retrieved September 10, 2020.\n\n^ \"Covid vaccine: First 'milestone' vaccine offers 90% protection\". BBC News. November 9, 2020.\n\n^ a b Kounang, Nadia (November 9, 2020). \"Pfizer and BioNTech say final analysis shows coronavirus vaccine is 95% effective with no safety concerns\". CNN. Retrieved November 9, 2020.\n\n^ Thomas, Katie; Gelles, David; Zimmer, Carl (November 9, 2020). \"Pfizer's Early Data Shows Vaccine Is More Than 90% Effective\". The New York Times. ISSN 0362-4331. Retrieved May 18, 2021.\n\n^ Roberts, Michelle (December 2, 2020). \"Covid-19: Pfizer/BioNTech vaccine judged safe for use in UK\". BBC News. Retrieved December 2, 2020.\n\n^ \"Bahrain becomes second country to approve Pfizer COVID-19 vaccine\". www.aljazeera.com. Al Jazeera. December 4, 2020. Retrieved December 11, 2020.\n\n^ Austen, Ian (December 9, 2020). \"Canada Approves Vaccine and Could Start Shots Next Week\". The New York Times. Retrieved December 11, 2020.\n\n^ \"Saudi Arabia approves Pfizer COVID-19 vaccine as Bahrain plans to give the public free shots\". KTLA. December 11, 2020. Retrieved December 11, 2020.\n\n^ a b Steenhuysen, Manas Mishra, Julie (December 11, 2020). \"U.S. FDA advisers overwhelmingly back authorizing Pfizer–BioNTech COVID-19 vaccine\". Reuters. Retrieved December 11, 2020.\n\n^ Thomas, Katie; LaFraniere, Sharon; Weiland, Noah; Goodnough, Abby; Haberman, Maggie (December 12, 2020). \"F.D.A. Clears Pfizer Vaccine, and Millions of Doses Will Be Shipped Right Away\". The New York Times. ISSN 0362-4331. Retrieved December 12, 2020.\n\n^ Abdullah, Zhaki (December 14, 2020). \"Pfizer–BioNTech COVID-19 vaccine approved by Singapore, first shipment expected by end-December\". CNA.\n\n^ \"EMA recommends first COVID-19 vaccine for authorisation in the EU\". Europa. December 21, 2020.\n\n^ Higgins-Dunn, Noah (May 4, 2021). \"BioNTech, with partner Pfizer, on track to make 3B COVID vaccine doses in 2021, CEO says\". FiercePharma. Retrieved May 18, 2021.\n\n^ a b \"Investigation: Drugmaker 'bullied' Latin American nations\". Al Jazeera English. March 11, 2021.\n\n^ Thacker, Paul. \"Covid-19: Researcher blows the whistle on data integrity issues in Pfizer's vaccine trial\". thebmj. Retrieved November 2, 2021.\n\n^ European Medicines Agency (December 3, 2021). \"Reply letter on the Integrity of clinical data, additional clinical trials and studies, pharmacovigilance and mRNA COVID-19 vaccine safety\" (PDF). Retrieved February 2, 2022.\n\n^ \"Pfizer's novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR Study\".{{cite web}}:  CS1 maint: url-status (link)\n\n^ \"Pfizer CEO: Current wave will be last with so many restrictions\". Israel National News. Retrieved January 17, 2021.\n\n^ \"Pfizer CEO shares some good news on covid but cautions virus could circulate for years\". Mint. Retrieved January 17, 2021.\n\n^ Kirkpatrick, David D. (May 15, 2000). \"Inside the Happiness Business\". New York.\n\n^ Oldani, Michael (2002). \"Tales from the Script\" (PDF). Kroeber Society Papers. 87: 147–176 – via University of California Berkeley.\n\n^ Oldani, Michael J. (2004). \"Thick Prescriptions: Toward an Interpretation of Pharmaceutical Sales Practices\". Medical Anthropology Quarterly. 18 (3): 325–356. doi:10.1525/maq.2004.18.3.325. ISSN 1548-1387. PMID 15484967.\n\n^ Steinman MA, Bero LA, Chren MM, Landefeld CS (August 2006). \"Narrative review: the promotion of gabapentin: an analysis of internal industry documents\". Annals of Internal Medicine. 145 (4): 284–93. doi:10.7326/0003-4819-145-4-200608150-00008. PMID 16908919.\n\n^ Henney JE (August 2006). \"Safeguarding patient welfare: who's in charge?\". Annals of Internal Medicine. 145 (4): 305–7. doi:10.7326/0003-4819-145-4-200608150-00013. PMID 16908923. S2CID 39262014.\n\n^ Mulleners WM, McCrory DC, Linde M (August 2014). \"Antiepileptics in migraine prophylaxis: An updated Cochrane review\". Cephalalgia. 35 (1): 51–62. doi:10.1177/0333102414534325. PMID 25115844. S2CID 43079346.\n\n^ Loder E, Burch R, Rizzoli P (June 2012). \"The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines\". Headache. 52 (6): 930–45. doi:10.1111/j.1526-4610.2012.02185.x. PMID 22671714. S2CID 540800.\n\n^ Harris, Gardiner (September 2, 2009). \"Pfizer pays $2.3 billion to settle marketing case\". The New York Times.\n\n^ a b \"Justice Department Announces Largest Health Care Fraud Settlement in Its History\" (Press release). United States Department of Justice. September 2, 2009.\n\n^ a b Harris, Gardiner (September 3, 2009). \"Pfizer Pays $2.3 billion to Settle Marketing Case\". The New York Times.\n\n^ a b Johnson, Carrie (September 3, 2009). \"In Settlement, A Warning To Drugmakers: Pfizer to Pay Record Penalty In Improper-Marketing Case\". The Washington Post.\n\n^ a b \"Pfizer agrees record fraud fine\". BBC News. September 2, 2009.\n\n^ \"Corporate Integrity Agreement between the Office of the Inspector General of the Department of Health and Human Services and Pfizer Inc\" (PDF). Office of Inspector General. August 31, 2009. Archived (PDF) from the original on July 15, 2011.\n\n^ \"ROST v. PFIZER, INC\". Casetext.\n\n^ Berenson, Alex (June 8, 2005). \"At Pfizer, the Isolation Increases for a Whistle-Blower\". The New York Times.\n\n^ Staton, Tracy (June 14, 2010). \"Congress joins probe into Wyeth's Rapamune marketing\". FiercePharma.\n\n^ Palmer, Eric (June 14, 2010). \"Pfizer settles more off-label marketing cases tied to Rapamune\". FiercePharma.\n\n^ Edwards, Jim (June 10, 2010). \"Blue Cross Names and Shames Pfizer Execs Linked to Massages-for-Prescriptions Push\". CBS News.\n\n^ Bounds, Jeff (June 10, 2010). \"Blue Cross Blue Shield of Texas sues Pfizer\". American City Business Journals.\n\n^ Staton, Tracy (June 11, 2010). \"BCBS names Pfizer managers in kickback suit\". FiercePharma.\n\n^ \"Blue Cross Blue Shield of Texas sues Pfizer over drug marketing\". The Dallas Morning News. June 11, 2010.\n\n^ a b Griffin, Drew; Segal, Andy (April 2, 2010). \"Feds found Pfizer too big to nail\". CNN.\n\n^ Smythe, Christie (June 2, 2014). \"Pfizer Agrees to $325 Million Neurontin Marketing Accord\". Bloomberg News.\n\n^ Petrovich, Dushko (March 15, 2013). \"The Art of Making Magazines edited by Victor S. Navasky and Evan Cornog\". Bookforum.\n\n^ Kary, Tiffany (June 27, 2013). \"Pfizer to pay $958M to end asbestos litigation\". Bloomberg News.\n\n^ Meier, Barry (July 2, 1994). \"Pfizer Unit to Settle Charges Of Lying About Heart Valve\".\n\n^ \"Ex-Pfizer Worker Cites Genetically Engineered Virus In Lawsuit Over Firing\". Hartford Courant. March 14, 2010. Archived from the original on July 28, 2012.\n\n^ Pollack, Andrew; Wilson, Duff (April 2, 2010). \"A Pfizer Whistle-Blower Is Awarded $1.4 Million\". The New York Times.\n\n^ \"Pfizer Settles B.Y.U. Lawsuit Over Development of Celebrex\". The New York Times. Associated Press. May 1, 2012.\n\n^ Oldani, Michael (2016), \"Trovafloxacin (Trovan) Controversy\", The SAGE Encyclopedia of Pharmacology and Society, SAGE Publications, Inc., pp. 1444–1447, doi:10.4135/9781483349985.n409, ISBN 9781483350004, retrieved January 21, 2019\n\n^ Murray, Senan (June 20, 2007). \"Anger at deadly Nigerian drug trials\". BBC News.\n\n^ Ramakrishnan M, Ulland AJ, Steinhardt LC, Moïsi JC, Were F, Levine OS (2009). \"Sequelae due to bacterial meningitis among African children: a systematic literature review\". BMC Medicine. 7: 47. doi:10.1186/1741-7015-7-47. PMC 2759956. PMID 19751516.\n\n^ \"Nigerians sue Pfizer over test deaths\". BBC News. August 30, 2001.\n\n^ a b \"WikiLeaks Cables: Pfizer Targeted Nigerian Attorney General to Undermine Suit over Fatal Drug Tests\". Democracy Now!. December 17, 2010.\n\n^ \"Panel Faults Pfizer in '96 Clinical Trial In Nigeria\". The Washington Post. May 7, 2006.\n\n^ Edwards, Jim (February 10, 2011). \"Pfizer Bribed Nigerian Officials in Fatal Drug Trial, Ex-Employee Claims\". CBS News.\n\n^ \"Trovan, Kano State Civil Case – Statement Of Defense\" (PDF). Pfizer. July 2007.\n\n^ \"Pfizer-Nigeria appeal dismissed\". BBC News. June 29, 2010.\n\n^ Boseley, Sarah (December 9, 2010). \"WikiLeaks cables: Pfizer 'used dirty tricks to avoid clinical trial payout'\". The Guardian. London.\n\n^ \"Pfizer Statement Regarding Article In The Guardian\" (PDF) (Press release). Pfizer. December 9, 2010.\n\n^ Edwards, Jim (January 4, 2011). \"In Defense of Blackmail: Why Shouldn't Pfizer Dig Dirt on Crooked Pols?\". CBS News.\n\n^ \"Michael Aondoakaa \"Unfit\" To Remain SAN, Says CDHR In High-Powered Petition\". Sahara Reporters.\n\n^ \"Wikileaks on Nigeria's Corrupt Oil Sales at NNPC, Shell, US Ambassador\". December 12, 2010.\n\n^ Lenzer, J. (August 16, 2011). \"Pfizer settles with victims of Nigerian drug trial\". BMJ. 343 (aug16 3): d5268. doi:10.1136/bmj.d5268. PMID 21846712. S2CID 8758603.\n\n^ \"Pfizer Implemented More than 4,000 Greenhouse Gas Reduction Projects Since 2000\". United States Chamber of Commerce. November 15, 2019.\n\n^ \"Pfizer Recognized by Carbon Disclosure Project for Carbon Performance\" (Press release). Pfizer. September 13, 2012 – via Business Wire.\n\n^ \"American Cyanamid Superfund Site Fact Sheet\" (PDF). New Jersey. December 2011.\n\n^ Paik, Eugene (March 9, 2012). \"Activists say EPA $204M fix for polluted American Cyanamid property will not permanently resolve problem\". NJ.com.\n\n^ \"The tempest\". The Washington Post. May 28, 2006.\n\n^ \"U.S. Global Leadership Coalition, Global Trust members\". U.S. Global Leadership Coalition.\n\n^ \"About\". PhRMA. Archived from the original on April 6, 2022. Retrieved April 6, 2022.\n\n^ \"About\". PhRMA. Archived from the original on September 26, 2018. Retrieved April 6, 2022.{{cite web}}:  CS1 maint: unfit URL (link)\n\n^ \"Our Members\". National Health Council. Archived from the original on April 6, 2022. Retrieved April 6, 2022.\n\n^ \"Member Organizations\". Research!America. September 28, 2007. Archived from the original on April 6, 2022. Retrieved April 6, 2022.\n\n^ \"Pfizer\". World Economic Forum. Archived from the original on March 14, 2022. Retrieved April 6, 2022.\n\n^ Bourla, Albert (January 19, 2018). \"5 key trends for the future of healthcare\". World Economic Forum. Archived from the original on March 14, 2022. Retrieved April 6, 2022.\n\n^ Mishra, Manas (July 2, 2019).  Kuber, Shailesh (ed.). \"Senator Warren asks former FDA chief Gottlieb to resign from Pfizer board\". Reuters.\n\n^ \"Current Members\". Personalized Medicine Coalition. Archived from the original on August 15, 2021. Retrieved April 6, 2022.\n\n^ \"Member Companies\". Innovative Medicines Canada. Archived from the original on November 3, 2021. Retrieved March 8, 2022.\n\n^ \"Consultant Lobbyist Registration No. CL4899-20200917025456\". Office of the Integrity Commissioner of Ontario. September 22, 2021. Archived (PDF) from the original on March 8, 2022. Retrieved March 8, 2022.\n\n^ Maher, Stephen (January 29, 2019). \"For access to the Ford government, two names matter most\". MacLean's. Archived from the original on March 22, 2021. Retrieved March 8, 2022.\n\n^ \"2020 Donors\". FNIH 2020 Annual Report. Archived from the original on April 2, 2022. Retrieved April 6, 2022.\n\n^ Pfizer (October 1, 2021). \"For Pfizer, a COVID-19 vaccine may just be the beginning for the potential revolutionary promise of mRNA technology\". CNBC. Archived from the original on October 19, 2021. Retrieved March 28, 2022.\n\n^ \"2018 Annual Report\" (PDF). Canadian Public Health Association. Archived (PDF) from the original on June 8, 2021. Retrieved March 18, 2022.\n\n^ a b Public Health Agency of Canada (February 25, 2022). \"National Advisory Committee on Immunization (NACI): Membership and representation\". Government of Canada. Archived from the original on March 23, 2022. Retrieved March 29, 2022.\n\n^ Bettinger, Julie (January 24, 2020). \"Vaccine Hesitancy: It doesn't matter if the vaccine works if nobody gets it\". Provincial Health Sciences Authority. Archived from the original on January 18, 2021. Retrieved March 29, 2022.\n\n^ \"Industry and Association Partners\". Canadian Frailty Network. Archived from the original on March 28, 2022. Retrieved March 28, 2022.\n\n^ Kim, Perry (April 7, 2020). \"Request for Proposals (RFP) Frailty and COVID-19\" (PDF). Canadian Frailty Network. Archived (PDF) from the original on March 2, 2022. Retrieved March 27, 2022.\n\n\nExternal links[edit]\n\n\n\nWikimedia Commons has media related to Pfizer.\n\nOfficial website \nBusiness data for Pfizer Inc.: Google FinanceYahoo! FinanceBloombergSEC filings\n\n\n\n\n\n\n","length":71605,"excerpt":"Coordinates: 40°45′01″N 73°58′21″W﻿ / ﻿40.75028°N 73.97250°W","byline":"Contributors to Wikimedia projects","dir":"ltr","siteName":"Wikimedia Foundation, Inc.","lang":"en"},"finalizedMeta":{"title":"American multinational pharmaceutical corporation","description":"Coordinates: 40°45′01″N 73°58′21″W﻿ / ﻿40.75028°N 73.97250°W","author":"Contributors to Wikimedia projects","creator":"Contributors to Wikimedia projects","publisher":"Wikimedia Foundation, Inc.","date":"2022-04-06T16:37:59Z","image":"https://upload.wikimedia.org/wikipedia/commons/9/94/Pfizer_World_Headquarters_Entrance.jpg","topics":[]},"jsonLd":{"@type":"Article","headline":"American multinational pharmaceutical corporation","description":false,"image":"https://upload.wikimedia.org/wikipedia/commons/9/94/Pfizer_World_Headquarters_Entrance.jpg","mainEntityOfPage":{"@type":false,"@id":false},"datePublished":"2002-07-15T03:25:40Z","dateModified":"2022-04-06T16:37:59Z","isAccessibleForFree":false,"isPartOf":{"@type":[],"name":false,"productID":false},"discussionUrl":false,"license":false,"author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https://www.wikimedia.org/static/images/wmf-hor-googpub.png"}},"editor":{"@type":false,"name":false,"description":false,"sameAs":false,"image":{"@type":false,"url":false},"givenName":false,"familyName":false,"alternateName":false,"publishingPrinciples":false},"@context":"https://schema.org","name":"Pfizer","url":"https://en.wikipedia.org/wiki/Pfizer","sameAs":"http://www.wikidata.org/entity/Q206921","mainEntity":"http://www.wikidata.org/entity/Q206921"},"twitterObj":false,"status":200,"metadata":{"author":false,"title":"Pfizer - Wikipedia","description":false,"canonical":"https://en.wikipedia.org/wiki/Pfizer","keywords":[],"image":"//upload.wikimedia.org/wikipedia/commons/thumb/5/57/Pfizer_%282021%29.svg/220px-Pfizer_%282021%29.svg.png","firstParagraph":"\n\nCoordinates: .mw-parser-output .geo-default,.mw-parser-output .geo-dms,.mw-parser-output .geo-dec{display:inline}.mw-parser-output .geo-nondefault,.mw-parser-output .geo-multi-punct{display:none}.mw-parser-output .longitude,.mw-parser-output .latitude{white-space:nowrap}40°45′01″N 73°58′21″W﻿ / ﻿40.75028°N 73.97250°W﻿ / 40.75028; -73.97250\n"},"dublinCore":{},"opengraph":{"title":"Pfizer - Wikipedia","description":false,"url":false,"site_name":false,"locale":false,"type":"website","typeObject":{"published_time":false,"modified_time":false,"author":false,"publisher":false,"section":false,"tag":[]},"image":["https://upload.wikimedia.org/wikipedia/commons/thumb/9/94/Pfizer_World_Headquarters_Entrance.jpg/1200px-Pfizer_World_Headquarters_Entrance.jpg","https://upload.wikimedia.org/wikipedia/commons/thumb/9/94/Pfizer_World_Headquarters_Entrance.jpg/800px-Pfizer_World_Headquarters_Entrance.jpg","https://upload.wikimedia.org/wikipedia/commons/thumb/9/94/Pfizer_World_Headquarters_Entrance.jpg/640px-Pfizer_World_Headquarters_Entrance.jpg"],"image:width":["1200","800","640"],"image:height":["814","543","434"]},"twitter":{"site":false,"description":false,"card":false,"creator":false,"title":false,"image":false},"archivedData":{"link":false,"wayback":false}},"localImage":"/assets/images/contexter/httpsenwikipediaorgwikiPfizer//Users/zuckerscharffa/Dev/context-center/_contexterCache/images/httpsenwikipediaorgwikiPfizer/Pfizer_World_Headquarters_Entrance.jpg"}